https://www.pharmaradar360.com 2026-06-11T09:36:59.448Z hourly 1 https://www.pharmaradar360.com/news 2026-06-11T09:36:59.448Z hourly 0.95 https://www.pharmaradar360.com/regulators 2026-06-11T09:36:59.448Z daily 0.9 https://www.pharmaradar360.com/trials 2026-06-11T09:36:59.448Z daily 0.85 https://www.pharmaradar360.com/pipeline 2026-06-11T09:36:59.448Z daily 0.9 https://www.pharmaradar360.com/tools 2026-06-11T09:36:59.448Z weekly 0.7 https://www.pharmaradar360.com/about 2026-06-11T09:36:59.448Z monthly 0.5 https://www.pharmaradar360.com/article/company-sellas-life-sciences-df8a2c2b7cd408ac 2026-06-10T10:31:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-workshop-on-new-approach-methodologies-nams-held-following-iccr-20-4329d3d1643c3425 2026-06-10T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-on-patient-enrollment-in-phase-2-study-of-enzomenib-for-acute-leukemia-325c6873bf0725d8 2026-06-10T02:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-lilly-s-ebglyss-lebrikizumab-lbkz-for-one-maintenance-dose-every-ei-9d4fc7426a3911aa 2026-06-09T22:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-accepts-takeda-sbla-for-review-in-pediatric-uc-and-crohn-s-disease-4216f81039e6b730 2026-06-09T20:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/jean-francois-brochard-elu-president-du-leem-et-composition-du-nouveau-bureau-801859f77000f7d7 2026-06-09T16:22:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/acceso-pre-registro-asistencia-telematica-c80d4e46b0cbb943 2026-06-09T16:13:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovent-submits-nda-for-cldn18-2-adc-for-gastric-cancer-daa68cf3c1501774 2026-06-09T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nmpa-gives-conditional-nods-to-drugs-by-lupeng-vcare-staidson-c88f64ff9fcc09b5 2026-06-09T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-enters-agreement-to-acquire-nuvalent-inc-7d7b7e5faa37410f 2026-06-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-deals-highlight-biopharma-evolution-reports-lek-7d4cc6cdf93b3192 2026-06-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/promotional-material-national-ai-commission-ask-me-anything-bfe3aa0539014dd3 2026-06-09T11:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-ai-airlock-simulation-workshops-62f59d59ddb2fd1b 2026-06-09T10:41:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-ai-airlock-sandbox-phase-2-programme-report-e042e8b71b7377de 2026-06-09T10:37:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/31-6204144f8c50e3b7 2026-06-09T10:08:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/emrn-884157d5592502ed 2026-06-09T09:59:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-guidance-on-digital-and-decentralised-clinical-trials-dct-has-been-updated-cfc2b16fbc16b9d6 2026-06-09T07:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ra-committee-townhall-how-agentic-ai-is-redefining-regulatory-excellence-58e5f910a0ab273a 2026-06-09T07:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-multi-stakeholder-hearing-on-pandemic-prevention-preparedness-and-response-pp-cb41d961f6a7a91c 2026-06-09T06:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-to-fund-medicines-used-by-ambulance-providers-bfcb61eac3282003 2026-06-09T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-de1cd4223d7b4ba2 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-5b945f6bb3137cbb 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b91463-crore-consolidated-revenue-and-e2-82-b9517-9-crore-of-0e126fd9215b56ce 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-erdafitinib-tablets-generic-of-balversa-fr-d16d0abf0ae297ed 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-9f991bda34984727 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-962d9fa9d7dd472d 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-84563d1cd0ff04ab 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-c658c7671c8f0311 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-announces-launch-of-its-everolimus-tablets-1-mg-generic-of-zortress-abeb351f0da8bc51 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-bccec93bc17beb39 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intimation-under-regulation-30-of-sebi-listing-obligations-and-disclosure-requir-2bb4a43449cd2136 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/disclosure-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-re-63b6fd5d13523fab 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adcock-ingram-completes-delisting-from-jse-natco-pharma-acquires-35-75-stake-aba0d7dc2cadb4a2 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-page-097414eacd628388 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-sleep-is-important-for-brain-health-74cb2281ea89d3b9 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-canada-inc-et-l-alliance-pancanadienne-pharmaceutique-concluent-av-f2f7997dc3e086bf 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-canada-inc-and-the-pan-canadian-pharmaceutical-alliance-sign-lette-9e77384c46509b25 2026-06-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-and-merck-announce-positive-topline-results-from-two-phase-3-studies-eval-49971b9dd9fe51c3 2026-06-08T20:39:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-and-gilead-provide-update-on-phase-3-keynote-d46-evoke-03-study-2d8fc949202d0f77 2026-06-08T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-oral-glp-1-foundayo-orforglipron-delivered-superior-a1c-control-and-weig-8f0559512800821a 2026-06-08T18:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-s-response-to-the-ebola-bundibugyo-virus-disease-outbrea-e947f2438a0dac0b 2026-06-08T14:50:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/crise-au-moyen-orient-un-impact-sur-les-prix-de-production-des-medicaments-a59e9e084e383264 2026-06-08T14:42:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-court-of-appeals-for-the-federal-circuit-affirms-victory-for-cormedix-therap-d7ddbf65e48c850b 2026-06-08T14:41:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-alert-no-030-2026-alert-on-the-withdrawal-of-levamisole-containing-medici-0424acf12a52a25d 2026-06-08T14:21:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-alert-no-029-2026-recall-of-impala-brand-gel-nail-polish-products-by-braz-a28afeb5d5f02df1 2026-06-08T14:15:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-alert-no-028-2026-recall-of-children-s-ibuprofen-oral-suspension-in-the-u-d64e33c10720829b 2026-06-08T14:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corporate-report-advertising-investigations-may-2026-300c34f00549b3ce 2026-06-08T13:37:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/geef-uw-mening-over-een-genetisch-gewijzigd-geneesmiddel-tegen-retinoschisis-0e14ea604e0c43f1 2026-06-08T13:22:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-s-response-to-the-ebola-bundibugyo-virus-disease-outbrea-0f83a94241cc5663 2026-06-08T13:08:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-nmpa-clears-hansoh-s-hs-10541-for-clinic-b06cc76eb8a1d6fa 2026-06-08T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nafdac-joins-federal-ministry-of-health-social-welfare-national-food-safety-mana-75df1fe0b1af974a 2026-06-08T12:59:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/exozymes-inc-announces-pricing-of-public-offering-of-common-stock-and-warrants-720962b226af3acc 2026-06-08T12:59:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-for-medicines-modifying-a-clinical-trial-approval-f4b4b249cdaf52b8 2026-06-08T12:27:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-presents-new-data-across-its-blood-cancer-portfolio-at-eha-2026-11d15d3125b04d8b 2026-06-08T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incorporacion-al-mercosur-sobre-materiales-envases-y-equipamientos-celulosicos-d-bf055398feae6589 2026-06-08T11:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/incorporacion-de-la-actualizacion-mercosur-sobre-el-uso-de-almidones-en-quesos-d-2d04f6fac5fd7dea 2026-06-08T11:53:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/incorporacion-de-la-actualizacion-mercosur-sobre-limites-de-arsenico-en-arroz-y-2bfe0e12c668ad73 2026-06-08T11:46:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/training-on-the-use-of-the-new-version-of-the-estonian-medical-devices-and-appli-7ac93c655025c419 2026-06-08T11:34:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/field-safety-notices-1-5-june-2026-f8d63ed9a914ab9f 2026-06-08T11:26:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/mariska-hargitay-partners-with-bristol-myers-squibb-for-investigating-myeloma-aw-13df25ac7537613d 2026-06-08T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-riesgo-de-suspension-de-la-administracion-de-insulina-en-afe16e16a0a7f51e 2026-06-08T10:46:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/class-4-medicines-defect-notification-cadila-pharmaceuticals-limited-mirtazapine-0a3af39ee32fb8cf 2026-06-08T10:02:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/find-product-information-about-medicines-80d956a3ea88da5f 2026-06-08T09:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-medical-devices-given-exceptional-use-authorisations-0075ab19af93c24e 2026-06-08T08:33:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biopharma-deals-thrive-on-creativity-from-structure-through-to-execution-d86c8fdc2d0efd4e 2026-06-08T08:09:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-organiza-una-sesion-informativa-sobre-la-circular-01-2025-de-comercio-e-e718054627035bae 2026-06-08T06:00:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/sesion-informativa-sobre-la-circular-1-2025-de-comercio-exterior-de-medicamentos-8ffe5f67436607d0 2026-06-08T05:55:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-announces-global-collaboration-with-nurix-therapeutics-to-co-develop-and-c-3fefb31882f405e5 2026-06-08T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sonota-project-team-for-consideration-of-guiding-principles-for-ai-utilization-h-77dc18201a286aaf 2026-06-08T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-women-can-reduce-risk-for-alzheimer-s-disease-b654cb6bcf83121f 2026-06-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-foundayo-orforglipron-the-only-oral-glp-1-taken-without-food-or-water-re-ed53ab67f2a99e26 2026-06-07T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/728aaf1d8c7c0d7f 2026-06-07T10:29:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-triple-agonist-retatrutide-drove-substantial-improvements-in-weight-a1c-ba397cad0db23257 2026-06-06T18:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuevo-proyecto-para-la-opinion-publica-0b1becdba3f640df 2026-06-05T17:33:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-human-and-veterinary-medicines-register-of-licensed-manufacturing-sites-3367cb4d275a6780 2026-06-05T16:03:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-register-of-brokers-authorised-to-deal-in-human-medicines-4fb943efd9f400d6 2026-06-05T16:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-gets-earful-on-cnpv-pilot-992cf241e7e77bf3 2026-06-05T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-medicines-new-manufacturing-and-wholesale-dealer-licences-3bd8a3a97bc78c42 2026-06-05T15:58:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-medicines-terminated-and-cancelled-manufacturing-and-wholesale-dealer-lic-65f2a54fdaf751cc 2026-06-05T15:58:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-human-medicines-register-of-licensed-wholesale-distribution-sites-c05f39a0ce1f0df6 2026-06-05T15:57:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-fragen-an-unser-neues-boardmitglied-julian-bertschinger-head-emea-external-sci-231164f22575b0ca 2026-06-05T14:12:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/field-safety-notices-18-22-may-2026-e557cadd11720e09 2026-06-05T12:23:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-announces-full-study-population-interim-phase-4-elevate-pd-results-reinfo-a1a9ba4a902b29fb 2026-06-05T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-deja-sin-efecto-la-baja-de-habilitacion-de-la-drogueria-alto-valle-dbf0dfb8ab2bfb65 2026-06-05T11:57:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/light-digest-vanilla-c19de129ca17e45f 2026-06-05T11:43:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/manushield-cleaner-aa289843a0d73452 2026-06-05T10:34:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/163-b425c952d23be09e 2026-06-05T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nicilan-tab-40-10-mg-tab-0221701-dd1a263bf8e3bfbe 2026-06-05T08:35:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/amarin-green-house-2026-bbed255ccd2834e0 2026-06-05T07:10:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-establishes-heatstroke-countermeasure-industry-government-academia-consor-c67f18ccb692c21d 2026-06-05T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-environment-day-acting-where-it-matters-most-fc0df8bb3ee30ace 2026-06-05T06:20:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/oversubscribed-strategic-equity-fundraise-of-9-million-3b66e33089442c75 2026-06-05T06:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/anzen-revisions-of-precautions-donanemab-genetical-recombination-etc-posted-9405a16d057e9e73 2026-06-05T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-software-as-a-medical-device-samd-page-updated-8034e21d3354e011 2026-06-05T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-presents-positive-interim-phase-3-visionary-egfr-data-showing-voyxact-sib-dd6dacb705969455 2026-06-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heat-or-ice-which-is-better-for-treating-minor-injuries-bb7db203675c0796 2026-06-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-animal-health-reinforces-commitment-to-help-protect-u-s-livestock-from-new-3b9b9e884ea6d617 2026-06-04T23:16:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ceo-who-wants-to-make-tacrolimus-history-c8cab7ccc6968579 2026-06-04T22:38:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/abpi-comment-on-bgma-proposals-for-a-new-voluntary-scheme-820698e6066fc502 2026-06-04T18:49:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-review-of-vpag-concludes-without-agreement-c1d196b3537dd0c4 2026-06-04T18:44:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/time-to-emphasise-the-economics-in-health-economics-a4e183c0612cc1ad 2026-06-04T18:38:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-announces-the-upcoming-launch-of-flora-sync-lf5tm-f599de9d911c1593 2026-06-04T18:15:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovent-submits-nda-for-cldn18-2-adc-for-gastric-cancer-5bdb0986511ccc2f 2026-06-04T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-impulsa-una-sesion-informativa-sobre-recops-la-nueva-aplicacion-para-el-185dbce6f015922b 2026-06-04T13:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/sesion-informativa-sobre-recops-la-nueva-aplicacion-para-el-registro-de-comercia-e9d41dfa95c2ae88 2026-06-04T13:56:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-announces-u-s-fda-approval-of-romidepsin-injection-solution-4d4eedc5c814c6e2 2026-06-04T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-cancer-before-it-starts-in-lynch-syndrome-37dc74d9712b0dcd 2026-06-04T11:03:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/taking-control-inspiring-others-to-beat-rare-diseases-f73f0b609f6b3d44 2026-06-04T10:56:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/paul-van-geest-presents-erasmus-university-research-to-pope-leo-xiv-in-rome-ecc4d4618204356e 2026-06-04T10:54:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicine-levy-makes-the-uk-un-investable-say-pharma-leaders-fcd8ecf60054a397 2026-06-04T10:45:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/teviot-joins-pride-edinburgh-celebrations-6e1c6e168dd16e4f 2026-06-04T10:34:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/come-on-england-fans-urged-to-register-their-organ-donation-decision-during-the-08fbad1366deb8d4 2026-06-04T10:32:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-health-coffee-time-briefing-8a35d4e112d8bb5f 2026-06-04T10:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-429-57e56d16f5bf0f31 2026-06-04T10:19:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-wave-of-harm-reduction-specialists-graduate-as-life-saving-programme-expands-227fce387363a048 2026-06-04T10:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-trending-in-oncology-a-discussion-following-asco-2026-with-anne-marie-rob-703172fdb4940001 2026-06-04T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-the-ile-de-france-region-the-city-of-paris-and-lvmh-lay-th-58f0e186d4ab3e4a 2026-06-04T09:52:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/ema-and-ama-collaborate-on-ebola-trials-amid-public-health-emergency-2be104594c2f66c9 2026-06-04T09:51:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/software-documentation-audits-after-qmsr-greenlight-guru-b54fa34c5af76511 2026-06-04T09:47:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-continues-genetic-medicine-push-with-1-9bn-ascidian-partnership-b18931cfcc532fcf 2026-06-04T09:44:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/internationalisation-at-home-why-get-started-0fe31bf714e3d8f8 2026-06-04T09:43:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/massive-bio-and-optellum-partner-on-early-nsclc-detection-and-trials-62a8b14065a54d5a 2026-06-04T09:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellares-and-tscan-to-assess-automated-manufacturing-of-tsc-101-therapy-3e11cadaa665c564 2026-06-04T09:28:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiopatie-il-convegno-in-humanitas-63f1ccef4c60c5ec 2026-06-04T09:02:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirius-5-fab01b1e5057dfa6 2026-06-04T09:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengue-vaccine-shows-favourable-safety-profile-in-travellers-from-non-endemic-re-5980ff1cb8d2604f 2026-06-04T08:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesite-les-disparites-s-accentuent-entre-pays-developpes-et-en-developpement-cd020fc6eea968b6 2026-06-04T08:49:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-premature-births-due-to-the-heat-what-can-we-do-9ea21cb28e6ea8a1 2026-06-04T08:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ame-ame-group-mice-standards-day-2026-f16dc26327f136dd 2026-06-04T08:28:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-s-nipocalimab-meets-primary-endpoint-in-phase-ii-jasmine-study-b5f3da99ff8ceb35 2026-06-04T08:27:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-cardiologie-des-hus-rayonne-a-l-international-af510242741fcf1f 2026-06-04T08:24:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/regeneron-and-cytomx-extend-cancer-therapy-partnership-to-4bn-deal-a0c26a07d3f47279 2026-06-04T08:21:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/private-equity-firm-invests-in-radiology-services-provider-radx-inc-37cffcefd2433d89 2026-06-04T08:09:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/radnet-seeks-to-secure-200m-term-loan-to-fuel-expansion-25eb7532fb46984d 2026-06-04T08:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/private-equity-firm-acquires-heritage-imaging-7b8ef20995be99b4 2026-06-04T07:46:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-leem-devoile-son-plan-competences-biotech-2030-a-l-occasion-de-la-jnbb-2026-f5f5a0d988987c8a 2026-06-04T07:43:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-refuerza-el-control-del-mercado-de-productos-cosmeticos-con-cerca-de-2-a5d6522a529d437f 2026-06-04T07:30:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-if-that-could-be-me-13a8c340544bd476 2026-06-04T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teresa-macarulla-and-tian-tian-lead-the-new-idibaps-research-group-translational-f2ed0736aab25a8a 2026-06-04T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-to-join-interim-chancellor-davies-at-june-8-forum-592b4d89a1e4f65d 2026-06-04T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healing-arts-program-launches-first-staff-art-exhibition-ed2696c934991dd5 2026-06-04T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nicki-simmons-retires-from-cahp-after-30-years-bd554083d96a1e69 2026-06-04T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/box-verification-system-changing-at-6-p-m-today-d7b04de0e54cbf8a 2026-06-04T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oculotect-50-mg-ml-colirio-en-solucion-1-frasco-de-10-ml-nr-61982-cn-755215-a7e3441cfcfa14d3 2026-06-04T06:35:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/vgr-vaxlar-upp-i-almedalen-tre-publika-panelsamtal-ed344081aa5a4570 2026-06-04T06:33:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/events-in-june-484e18661669d40c 2026-06-04T06:31:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/john-browett-named-chair-of-nhs-online-hospital-trust-dea2964dd05f530d 2026-06-04T06:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/bispecific-and-multi-specific-antibody-development-journey-at-wuxi-biologics-c660bd4ae358f0b1 2026-06-04T06:24:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-mystere-des-poissons-devenus-aveugles-ee8946d67756410a 2026-06-04T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-s-favorite-escape-trick-may-actually-make-it-easier-to-kill-bbfa8b4f26c30c53 2026-06-04T05:30:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/federation-plus-fine-tuning-the-push-for-federated-learning-models-continues-69d3c0547ad07b09 2026-06-04T05:01:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwest-arkansas-pathology-associates-adopts-techcyte-fusion-ap-to-enable-remo-02942e36485a469b 2026-06-04T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fa94eb9a008da98b 2026-06-04T04:16:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-pens-2b-deal-with-inceptive-to-transform-sirna-design-with-ai-pioneer-f970841bb7f6b396 2026-06-04T04:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-6811cfe4e486ffc8 2026-06-04T03:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-report-on-the-pmda-atc-10th-anniversary-ceremony-has-been-posted-e4c14047ed2b745b 2026-06-04T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-doptelet-partial-change-approval-5fa195e70e962aa6 2026-06-04T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-language-early-considerations-considerations-for-the-general-toxi-eff3a58e129481fb 2026-06-04T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/premio-innovazione-digitale-in-sanita-2026-anche-il-policlinico-di-milano-tra-i-c92ae3558119cc6f 2026-06-04T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/h-200mg-2-9ca521d4d334e8eb 2026-06-04T01:57:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/6ceb532d6c57218a 2026-06-04T00:54:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/menu-petro-s-chili-chipstm-ac77ea04bcbd6ad2 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intrathecal-nivolumab-in-metastatic-solid-tumors-with-leptomeningeal-disease-dos-36e66203c0d2a791 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bacterial-engineering-for-cancer-therapy-534bb9b520c0a116 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aberrant-tau-accumulation-caused-by-mapt-mutations-induces-early-pathological-ch-a717be9aa7429e50 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aav-gene-therapy-for-homozygous-familial-hypercholesterolemia-a-phase-1-trial-ae48c340949a8299 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spinal-cord-stimulation-for-upper-limb-motor-function-in-people-with-chronic-pos-da4f7fa27ece4773 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-socially-assistive-robot-to-support-mental-wellbeing-in-lgbtq-young-people-at-b90b9ea2c7cd356b 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-microglial-transitions-at-the-a-tau-inflection-point-associate-with-diverg-8489ad36c945e820 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/marked-for-destruction-37f9e7c70e774b3b 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-mysterious-lung-disease-affects-millions-of-people-a-drug-tested-in-mice-sh-912837976820fabb 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-behind-china-s-historically-high-counts-of-corresponding-authors-1fdbc792758fb9fa 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cer-under-meddev-2-7-1-rev-4-and-eu-mdr-greenlight-guru-413458cfb2d7ace7 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drew-brees-collaborates-with-ars-pharmaceuticals-to-raise-awareness-about-living-2efe4287399a80ac 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-announces-publication-of-phase-2a-postpartum-depression-results-1de2f83cdf501d33 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/riskgransvarden-for-njursjukdom-bekraftas-genom-mer-exakta-matningar-3c926190f334b9a9 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/overvakning-av-hjartrytm-i-mobilen-kan-spara-vardresurser-090496c2262ea14d 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/filantropiskt-stod-av-familjen-saven-starker-forskning-om-kolorektalcancer-6ee97200092b2a29 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-pool-water-really-dry-out-skin-and-hair-7ded023d5d5ec0f2 2026-06-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ft839-a-multi-antigen-targeting-off-the-shelf-dual-car-t-cell-for-the-treatment-831e6395a4574996 2026-06-03T22:57:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-an-off-the-shelf-anti-cd19-car-t-cell-therapy-with-reduce-b2c51a7c191a231e 2026-06-03T22:55:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/snmmi-unveils-2026-image-of-the-year-556016a12c4bc8b5 2026-06-03T21:06:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-executive-daily-new-fda-draft-guidance-targets-gene-therapy-submi-c52fe069c74c309a 2026-06-03T20:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-hookworm-engineered-to-produce-secrete-anti-tetrodotoxin-antibody-into-pre-de0e7a866048034f 2026-06-03T19:42:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/moving-trials-forward-inside-the-merck-and-wcg-partnership-that-unblocks-bottlen-7a286b7bcf7cd849 2026-06-03T19:19:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-molecules-to-big-partnership-incyte-genesis-expand-ai-collaboration-to-1b-c10a72d4abd3660d 2026-06-03T19:07:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellares-and-tscan-agree-to-evaluate-automated-manufacturing-tsc-101-for-patient-00fae60a0b595d9e 2026-06-03T19:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-antibiotic-manikomycin-acts-on-novel-ribosomal-target-086e63dd1417a342 2026-06-03T18:54:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-triage-tool-slashes-breast-cancer-screening-workloads-by-77-df84f2a87bc6fa61 2026-06-03T18:47:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-nursing-hires-2422784bc7ebcc25 2026-06-03T18:30:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/nord-joins-coalition-of-48-patient-advocacy-organizations-expressing-concerns-ov-bc2cc2eed1cbc203 2026-06-03T18:09:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-end-to-end-approach-to-specialty-patient-services-0f43f51f45e01df8 2026-06-03T17:47:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/dermacyd-lanca-campanha-sobre-intimidade-e-relacoes-ccc9831befd6d890 2026-06-03T17:36:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/grupo-ems-anuncia-rebranding-apresenta-nova-arquitetura-de-marcas-e-se-posiciona-115c1c66cc7aa5d1 2026-06-03T17:30:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/focus-apps-are-failing-neurodivergent-minds-new-research-finds-2abc1edd69fcba11 2026-06-03T17:21:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/tar-heel-researchers-share-their-work-with-chancellor-on-the-coast-842eb68a03c4557b 2026-06-03T17:07:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-covid-19-tracker-93446856b3088314 2026-06-03T17:03:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-collaboration-in-the-pharmaceutical-cold-chain-how-csafe-connects-data-s-dfb046437b00af6f 2026-06-03T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/33-jornadas-de-jovenes-investigadores-en-brasil-augm-5dee9f487593548b 2026-06-03T16:59:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/intelligence-for-the-decisions-that-matter-most-5cc46fd39bdd3da6 2026-06-03T16:59:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-strengthens-industry-collaboration-to-improve-access-to-safe-medicines-dbb248c0eba57c00 2026-06-03T16:59:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/commonwealth-fund-21-of-adults-experienced-a-coverage-denial-in-the-past-year-d4612f921be7372a 2026-06-03T16:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-new-topics-added-in-latest-acr-appropriateness-criteria-update-a3b1817ef172d077 2026-06-03T16:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-value-a-biotech-e2598798579b7c6a 2026-06-03T16:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/framework-for-review-of-clinical-research-involving-ai-advancing-ethical-oversig-62ab48e8e82c55f7 2026-06-03T16:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-to-deny-340b-drug-pricing-due-to-claims-data-policy-report-b64b030390c11dff 2026-06-03T16:26:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-instala-gabinete-de-crise-para-atuacao-em-situacoes-de-violencia-urbana-3c0ef02b9be036c1 2026-06-03T16:07:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-fda-draft-guidance-targets-gene-therapy-submission-burden-by-allowing-use-of-771a20c121070ac9 2026-06-03T16:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioproduction-pivots-from-centralized-to-regional-support-d1fccbc31ee53b01 2026-06-03T16:00:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/gentler-cell-separation-methods-gain-momentum-8bacc24fcc3604e8 2026-06-03T16:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/web-app-helps-flag-antibodies-where-manufacturability-might-be-an-issue-d32fab7467d1c226 2026-06-03T16:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/niimbl-to-support-vector-production-and-ai-ready-training-projects-f87b1a3d8a7774eb 2026-06-03T16:00:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/rubio-reopening-door-with-gavi-21f5cbcf95a9b9d1 2026-06-03T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/visita-de-la-universidad-china-de-yanshan-para-fortalecer-la-cooperacion-interna-f02564f6604ae6b7 2026-06-03T15:50:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/tauber-recorrio-las-obras-del-edificio-anexo-de-derecho-0006887a926d1ffc 2026-06-03T15:49:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/tauber-la-universidad-tiene-que-estar-donde-mas-se-la-necesita-d265f45ed41d332d 2026-06-03T15:48:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/over-8-600-class-of-2026-members-will-attend-commencement-ceremonies-this-month-24b03665804f3dd9 2026-06-03T15:44:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-e953c0e5029c58d7 2026-06-03T15:41:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/issue-no-49-nonclinical-toxicology-studies-857193c1a5018856 2026-06-03T15:33:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-cell-phenotyping-cell-surface-architecture-informs-disease-biology-75f73b3f3f674645 2026-06-03T15:28:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/saif-khairat-to-serve-as-chief-ai-officer-e24be1e61b6dddd2 2026-06-03T15:21:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-response-activated-by-rna-splicing-opens-targeted-therapies-7abbccb9733b4638 2026-06-03T15:16:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/highlights-of-asco-2026-how-is-cancer-care-evolving-206a08278d7c5fce 2026-06-03T15:03:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-advances-integrated-dna-to-ind-programs-through-acceleration-de-risking-an-c12101ea3c1e351e 2026-06-03T15:02:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/alabama-man-defies-early-prognosis-following-life-threatening-accident-81b9b52084efdb29 2026-06-03T15:00:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/preventing-a-cancer-from-ever-developing-is-one-of-the-greatest-contributions-we-f84b5425ff26f3fe 2026-06-03T15:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-american-diabetes-association-s-statement-on-the-omb-s-financial-assistance-202b4391134adbc2 2026-06-03T14:58:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/statement-from-the-american-diabetes-association-on-the-cms-s-medicaid-work-requ-b8156b76ab742edc 2026-06-03T14:50:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/viral-safety-2-0-plant-ready-actions-for-ich-q5a-r2-compliance-69d340ba2a4d7ea3 2026-06-03T14:50:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-boehringer-to-slash-at-least-1b-each-from-planned-investments-in-germany-93f940e97a2bdc8d 2026-06-03T14:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-boehringer-to-slash-at-least-1b-each-from-planned-investments-in-germany-ce979ce185fe5be0 2026-06-03T14:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presbyterian-healthcare-services-to-discontinue-ma-plans-in-2027-cut-150-jobs-e2791e300c00141f 2026-06-03T14:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/popular-glp-1-weight-loss-drugs-linked-to-lower-risks-of-addiction-and-overdose-9ee997373415d1cf 2026-06-03T14:04:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-the-widespread-use-of-large-language-models-in-scientific-writing-undermine-5ee500d53c0fc0b1 2026-06-03T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanomedicine-italian-research-to-improve-the-treatment-of-brain-tumors-e4477c55d7822b9f 2026-06-03T13:55:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-insights-from-acrp-2026-can-sites-sponsors-and-cros-all-just-get-along-c6ef58ee7ddf80e9 2026-06-03T13:41:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-lawmakers-reveal-policy-to-curb-collaboration-with-chinese-biotech-73bab01765328dd9 2026-06-03T13:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ascidian-and-eli-lilly-enter-1-9-billion-global-research-collaboration-to-develo-00d7c5ebba2d2cda 2026-06-03T13:34:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-new-diabetes-pill-burns-fat-without-the-downsides-of-ozempic-db93f4dd69f0b3af 2026-06-03T13:27:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-type-of-inhibitor-could-help-tackle-resistance-against-last-resort-antibioti-b3e159da392aff61 2026-06-03T13:25:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/spcg-key-messages-21-may-2026-87871d2cbb27e38f 2026-06-03T13:20:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/0c95d483966124ba 2026-06-03T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-s-sys-6063-gains-chinese-trial-clearance-for-sle-b3588ed11a65db8a 2026-06-03T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moglicher-biomarker-fur-personalisierte-leukamie-therapie-identifiziert-7247b8df1efd13a8 2026-06-03T12:56:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-faculty-of-medicine-at-universite-paris-cite-is-launching-its-first-internat-cf0123ab3fd01e7e 2026-06-03T12:56:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/june-12-13-and-14-three-days-of-student-engagement-for-an-ecological-and-sociall-fbc224b2067796e5 2026-06-03T12:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-as-part-of-a-negotiation-process-390181e83d8bcbe9 2026-06-03T12:47:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/spo-ecznosci-lokalne-632e0257fc15b4c1 2026-06-03T12:43:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/atrakcyjnosc-delpharm-4713313f7b9aa29f 2026-06-03T12:43:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/zaangazowanie-pracownikow-db58335ceb486c88 2026-06-03T12:43:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/delpharm-academy-d38e9005a624f9a4 2026-06-03T12:43:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/rozwoj-pracownikow-fea894f4d72ce405 2026-06-03T12:43:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/zdrowie-i-bezpieczenstwo-576a940d9bf65063 2026-06-03T12:43:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/w-delpharm-pracownicy-stanowia-najwieksze-bogactwo-grupy-9b1b02fd2c5111db 2026-06-03T12:43:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/karta-etyczna-kodeks-postepowania-c81b7209a8e256d8 2026-06-03T12:43:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/etyka-uczciwosc-i-zapobieganie-korupcji-8a1afe2dc42d95dc 2026-06-03T12:43:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/priorytet-dla-partnerow-lokalnych-i-europejskich-7eb6a3bb73bae8c4 2026-06-03T12:43:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/polityka-odpowiedzialnych-zakupow-2cf3e91ee640e788 2026-06-03T12:43:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasze-zaangazowanie-na-rzecz-odpowiedzialnego-ancucha-dostaw-40919b8c714d107a 2026-06-03T12:43:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasza-polityka-jakosci-8602070d8d9a01c2 2026-06-03T12:43:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/akredytacje-i-certyfikaty-6253b3e5f405d25a 2026-06-03T12:43:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/zaangazowanie-w-jakosc-wpisane-w-nasze-dna-e8412da37cb7e751 2026-06-03T12:43:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/kultura-jakosci-ea11e1d7d3735117 2026-06-03T12:43:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasze-zaangazowanie-na-rzecz-przysz-osci-niskoemisyjnej-68230856bc2c7ceb 2026-06-03T12:43:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cele-srodowiskowe-34382d2cdbb4d97f 2026-06-03T12:43:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/wyniki-w-zakresie-ochrony-srodowiska-faa55c39c48970e2 2026-06-03T12:43:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/odpady-i-gospodarka-o-obiegu-zamknietym-f7fa31a67b4f7806 2026-06-03T12:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-scientists-behind-the-data-investing-in-europe-s-data-stewardship-workforce-7c25fc5901abb5d5 2026-06-03T12:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/haus-buhl-to-be-reopened-as-venue-for-events-and-conferences-6d5aed4a458642ee 2026-06-03T12:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/almost-33-000-bedfordshire-patients-had-data-stolen-in-cyber-attack-44cb54626009e03f 2026-06-03T12:30:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/information-about-the-criminal-offence-committed-by-a-former-employee-of-the-uni-17db4f171183c648 2026-06-03T12:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/climate-is-the-real-game-changer-45205a482afe9837 2026-06-03T12:23:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-pathways-by-region-a-comparative-table-70928575a99eb897 2026-06-03T12:23:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-reverse-anxiety-by-fixing-a-tiny-brain-circuit-743d03eb3987947d 2026-06-03T12:16:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-mastectomie-endoscopique-poursuit-son-essor-7c6afa04891947b5 2026-06-03T12:16:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-lege-f973ceb363631ba7 2026-06-03T12:03:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-publica-el-sexto-informe-de-seguimiento-del-linfoma-anaplasico-de-celul-94ab7ad7c85b7b4a 2026-06-03T11:56:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/compras-y-contrataciones-c438fa90b018061a 2026-06-03T11:55:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-empty-promises-string-theory-finds-new-uses-a0c5eef0e5dead4c 2026-06-03T11:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/greetings-from-bi-annual-cbru-seminar-c225458579433105 2026-06-03T11:44:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/aha-lays-out-blueprint-to-improve-affordability-care-access-and-quality-f0461ff50cc6aa6d 2026-06-03T11:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jornada-por-el-dia-mundial-del-ambiente-accion-por-el-clima-del-saber-al-hacer-fad94d0642a308ba 2026-06-03T11:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/orgullo-maria-delfina-sciutto-se-graduo-con-honores-en-derecho-y-fue-premiada-po-f8bb6e7b2b81f565 2026-06-03T11:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/augm-domus-en-el-latindex-y-se-consolida-como-revista-cientifica-de-referencia-r-981cdac628735f0b 2026-06-03T11:12:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/jornada-por-una-universidad-libre-de-humo-y-nicotina-58ab75718e0a7e7c 2026-06-03T11:11:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-tren-universitario-cumple-13-anos-de-servicio-un-motor-que-transformo-la-movi-caaec9d38cb6c633 2026-06-03T11:10:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-submits-510-k-filings-to-expand-hugotm-robotic-assisted-surgery-system-d09308d7df524923 2026-06-03T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/magdalena-held-will-defend-her-phd-thesis-69f89d626d847feb 2026-06-03T10:56:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-strategic-investments-to-support-future-expansion-of-cardiac-55cffcffda0b58f9 2026-06-03T10:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezolute-s-stock-up-on-interim-phase-iii-tumour-hi-data-178298151e75868c 2026-06-03T10:47:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-reports-fourth-quarter-and-full-year-fiscal-2026-results-delivers-high-7f92b11714342011 2026-06-03T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amid-miplyffa-launch-zevra-ceo-aims-to-foster-eu-style-niemann-pick-market-in-us-d314e3b8fe1b604b 2026-06-03T10:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-eyes-pbc-expansion-for-livdelzi-on-positive-one-year-data-a861a6ff5a33b815 2026-06-03T10:09:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-unstructured-data-with-ai-for-optimized-protocol-development-d0129876d6569fb3 2026-06-03T10:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contraline-secures-92-5m-to-push-male-contraceptive-into-late-stage-trials-98be2bb182334a0e 2026-06-03T10:04:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/modernizing-market-access-and-patient-support-services-q-a-with-cam-olig-5dd01edd5e5869b8 2026-06-03T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/with-cencora-pact-gilead-looks-to-grow-car-t-treatment-center-network-f1a38c07b0346cfa 2026-06-03T09:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inipharm-commences-dosing-in-ini-822-trial-for-mash-b5692606330c155d 2026-06-03T09:53:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-watchdog-overseeing-the-integrity-of-hhs-programs-63217180d92a31f1 2026-06-03T09:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-receives-ec-approval-for-aquipta-to-treat-migraine-42c9cab466df5b73 2026-06-03T09:36:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/regeneron-pays-37m-adds-2b-in-biobucks-to-expand-cytomx-pact-e558bfdea0653ca9 2026-06-03T09:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/coffee-racetracks-beaches-and-more-coffee-inside-the-asco-2026-exhibit-floor-6d822f08498ffdbb 2026-06-03T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contactpunt-afdeling-geneesmiddelen-voor-diergeneeskundig-gebruik-51547deb486afaa2 2026-06-03T09:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/bidil-the-story-of-the-black-pill-10bf3f279286b5e0 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-transplantation-in-two-highly-sensitized-candidates-after-car-t-cell-ther-1a9865dd190f91e5 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/all-oral-treatment-of-newly-diagnosed-acute-myeloid-leukemia-3d8f2f219a9b37ce 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/chyluria-from-a-lymphatic-urinary-fistula-dcb30a3460e14fb2 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-unusual-suspects-16f9973503012997 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-only-or-in-person-interviews-for-residency-applicants-91b4501c81e0b38f 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fasting-glucocorticoids-and-breast-cancer-aebceac0d5b267f0 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/chronic-myeloid-leukemia-in-low-and-middle-income-countries-57194b62659ca0ad 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/romiplostim-versus-placebo-for-chemotherapy-induced-thrombocytopenia-d227afaff6736e40 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/polymyalgia-rheumatica-e810a7abbf9c07f9 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/finerenone-in-type-1-diabetes-and-chronic-kidney-disease-c338bd303770acc8 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-of-wnt-catenin-pathway-in-recurrent-ameloblastoma-a861c78c6381aef8 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-transplantation-after-clearing-anti-hla-antibodies-with-cd19-car-t-cells-32ab33620c537085 2026-06-03T09:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/trust-s-urgent-and-emergency-care-services-maintain-outstanding-and-good-ratings-eaa39d9d986f4770 2026-06-03T08:55:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/moonlight-begins-surveyor-phase-i-trial-for-peanut-allergy-9a7f978e10db82ca 2026-06-03T08:48:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-giredestrant-secures-fda-priority-review-for-breast-cancer-bd449a35f9785843 2026-06-03T08:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/ticket-sale-for-eurekaweek-2026-has-started-b1acafdb42ee3478 2026-06-03T08:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/choosing-the-hardest-problems-why-ipsen-focuses-where-unmet-need-is-greatest-3ba425f9fe852f55 2026-06-03T08:19:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-joins-landmark-uk-france-alliance-in-health-research-aeb524555a497514 2026-06-03T08:16:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/hssh-may-newsletter-5-2026-c839330fdb4eadc4 2026-06-03T08:10:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-scientists-criminally-charged-for-bringing-monkeypox-virus-into-us-although-9f81f1d46464900c 2026-06-03T08:05:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/30ee6b23afc4be77 2026-06-03T08:04:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/surge-in-m-as-driven-by-patent-expirations-3d4f084669b88209 2026-06-03T08:03:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/bewegung-verandert-leben-vom-patienten-zum-spitzensportler-59a2a6536241bddc 2026-06-03T07:59:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/call-for-papers-governing-and-navigating-everyday-life-interdisciplinary-perspec-811377b98e94db02 2026-06-03T07:53:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-crisis-experts-warn-of-impending-global-shortage-of-radiology-professiona-d8241ebfbcc30f06 2026-06-03T07:29:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/samtalsgrupper-ska-skapa-trygghet-for-patienter-med-konsdysfori-2d90f2bef1cd5595 2026-06-03T07:27:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/doctoral-dissertation-urban-environmental-choices-shape-the-microbial-community-f5719e19de581729 2026-06-03T07:24:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-cap-bringt-internationale-life-sciences-ki-und-investment-entscheider-nach-b-b51fb3110f430aaf 2026-06-03T07:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-medical-graduates-represent-nearly-25-of-diagnostic-radiologists-i-f0639a617a7549e6 2026-06-03T07:20:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/32-7-24-3d627b255c578cd6 2026-06-03T07:19:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-are-embl-neeya-jacob-on-streamlining-operations-and-preserving-the-spark-of-h-e2943c2412e4e073 2026-06-03T07:18:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/lumexa-imaging-inks-new-joint-venture-with-hospital-for-special-surgery-f6430cb8fe6931b7 2026-06-03T07:06:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/people-in-rotterdam-haven-t-dropped-out-but-have-good-reasons-for-avoiding-the-n-a8886f313a2aa61d 2026-06-03T07:05:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/40-7-18-3a042834d5ce5776 2026-06-03T07:04:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/edge-in-action-highlights-district-s-innovation-taking-shape-10dd73c675191c1b 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiding-in-plain-sight-2b90831a7cf19d01 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neutralizing-antibodies-elicited-in-nonhuman-primates-by-an-enterovirus-d68-viru-e4f86ea19d7373d2 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiv-1-infection-converts-cd4-t-cells-to-hla-class-ii-restricted-cd8-t-cells-f688fbd43ee13dc8 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryptic-splicing-in-synaptic-and-membrane-excitability-genes-links-tdp-43-loss-t-6400ef72365293b8 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reprogrammed-apoptotic-platelets-drive-rapid-hemostasis-through-phosphatidylseri-3bad7914b5bdbd09 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toll-like-receptor-5-protects-against-murine-lung-fibrosis-through-reduced-dysbi-7fa58c7a2cdfdc7e 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/claudin-1-targeting-suppresses-tumor-growth-invasion-and-metastasis-in-patient-d-b6cc8b6d07fd6b22 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/donazioneorgani-elisabetta-e-francesco-una-lezione-sul-tempo-futuro-a532707cf4e4ff61 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-burn-centre-to-host-international-conference-as-national-profile-grows-2d28f242f90b3fcd 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-thirds-of-the-most-severe-patients-with-anti-nmdar-encephalitis-recover-751c26f61970a5c3 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stroke-in-young-adults-why-it-is-increasingly-affecting-those-under-55-ca285c3461abaa4f 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/air-pollution-may-be-harming-your-brain-s-encyclopedia-79e8c9b2742ec2e3 2026-06-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-davies-visiting-scottsbluff-for-priority-candidate-forums-9e03ee85ad4d0b33 2026-06-03T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-nebraska-foundation-90-years-of-impact-d7cd7dd5f7778003 2026-06-03T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-era-for-lab-workflows-at-the-med-center-3abcd10bf2bedea0 2026-06-03T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-su-finalists-in-running-for-sa-s-prestigious-science-oscars-3e0dc7605c9c9318 2026-06-03T06:53:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-patient-first-shift-in-disease-language-and-communication-a6a924080b8a6fc9 2026-06-03T06:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhs-ai-scribe-rollout-should-include-national-oversight-report-finds-fefd44ba929ffac3 2026-06-03T06:30:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discovered-something-surprising-about-french-fries-and-diabetes-0bc9dc2d4e927cd0 2026-06-03T06:14:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/miikka-laitinen-s-doctoral-defence-12-6-2026-783c6a89b77ca8fc 2026-06-03T05:34:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/trends-from-the-trenches-ai-ready-life-sciences-data-fa73942c340d5853 2026-06-03T05:01:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-logistics-finding-shipping-solutions-that-match-your-level-of-pre-24eccf2e91b416d4 2026-06-03T04:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-cold-chain-logistics-protecting-integrity-from-end-to-end-may-202-39c0568f73d978f2 2026-06-03T04:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-dashboard-why-certification-is-the-new-currency-in-pharma-logistics-60e6f8651a172806 2026-06-03T04:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brain-scans-reveal-two-distinct-types-of-autism-c91aec60c9da832b 2026-06-03T04:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-untitled-letter-after-finding-eye-catching-graphics-in-promotional-em-2592c1ceff24d6a0 2026-06-03T04:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/volontariato-22-06-cieli-azzurri-concerto-jazz-per-i-bambini-del-policlinico-di-4c80b6fb88c84b2d 2026-06-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imu-biosciences-nabs-53m-funding-round-to-decode-the-immune-system-76cfb621f275fc1d 2026-06-03T02:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-final-guidance-for-content-of-human-factors-information-in-medical-de-29a1d7bf86c08c41 2026-06-03T01:46:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurotech-launches-new-youtube-channel-to-spotlight-patients-stories-for-rare-ey-a2ddcd3bd4fd87d2 2026-06-03T01:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-3f368a3009cdccff 2026-06-03T01:30:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-aya-aya-7-12-7d7820249b5408b4 2026-06-03T01:14:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/facultades-de-campus-san-joaquin-dialogaron-sobre-el-plan-estrategico-uc-desde-l-721e81808d5e3bb7 2026-06-03T01:04:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-research-leader-recognised-as-outstanding-educator-cd05e4e21d8e8a50 2026-06-03T00:04:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/tumor-transcriptional-state-predicts-survival-in-immune-checkpoint-blockade-trea-1f53e61a1914c335 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-and-deep-learning-based-drug-drug-interactions-prediction-a-sys-6aa0d65844ed5de3 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-cell-multi-omic-atlas-and-morphogen-screening-informs-midbrain-and-hindbr-ad59d278c46399a1 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-representational-geometry-of-emotional-states-in-basolateral-amygdala-150171f9abcffe3e 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-brainstem-pathway-underlying-vagal-modulation-of-somatic-pain-and-affective-st-60ec8b3ee44b71ff 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/limited-evidence-of-ai-superiority-in-seasonal-influenza-vaccine-strain-selectio-ae93d79e441aec92 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-limited-evidence-of-ai-superiority-in-seasonal-influenza-vaccine-strain-d2cf35c6b5afec05 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reinventing-biotech-systems-for-patient-impact-6e3a87322fc40cd6 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-quality-of-childbirth-care-provided-by-skilled-health-personnel-in-exe-bafca617b10e641f 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmable-control-of-bacterial-operons-with-a-single-cas13-rna-effector-334d6ad3160fcf18 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-cell-spatial-pharmacobiology-identifies-conserved-stromal-barriers-to-the-2ad93690712cb3a4 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-expression-of-concern-functional-proteomic-identification-of-dna-repli-5dd1fc8dcb811845 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chiral-superfluorescence-from-perovskite-superlattices-at-room-temperature-5b98102c34123a27 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-type-resolved-genetic-variation-shapes-inflammatory-bowel-disease-risk-db829895089d9fa8 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/earth-s-east-west-albedo-symmetry-274de2ff6ab4092b 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acquired-genetic-and-cell-state-changes-in-idh-mutant-glioma-progression-d37f8266030edb7d 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plastoglobules-compartmentalize-nitrogen-assimilation-in-maize-a7d6a637cec960be 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-trade-offs-of-post-sorting-plastic-packaging-91ebffcab417b06e 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-induced-peptide-signalling-secures-pollen-resilience-and-crop-yield-ed57ad02c97969f9 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spermine-is-an-endogenous-iron-chelator-that-inhibits-ferroptosis-14ef8b65c17a2267 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commensal-derived-acetylcholine-enhances-mucosal-immune-education-d90a25b6897d4a90 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-natural-depsipeptide-antibiotic-binds-the-e-site-of-the-bacterial-ribosome-d4814ba85a9af1a1 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teosinte-alleles-enhance-nitrogen-assimilation-and-seed-protein-in-maize-09207b6dbeb3bff2 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-size-of-tropical-vegetation-gross-primary-production-989e31fb9ff69ef5 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-the-size-of-tropical-vegetation-gross-primary-production-433c1a3ed6d3256f 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanophore-cross-linking-enhances-ballistic-energy-dissipation-of-polymers-078b122232825faf 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mining-triggers-extensive-additional-deforestation-in-sub-saharan-africa-15da759bd5b75352 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relativistic-electron-acceleration-at-the-bow-shock-of-jupiter-and-beyond-1c603e1deca972fb 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/towards-mrna-therapeutics-2-0-d65f1b4aec9db7c6 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/your-phone-can-use-tiny-skin-colour-changes-to-measure-your-heart-rate-07ce3d7167fad4cb 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/informing-hiv-vaccine-design-c1fb175b0cc1489c 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhibiting-nipah-virus-93ec9750443a5e2f 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-ras-inhibitor-resistance-6bf1b1ff91c0c10f 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhibiting-lactate-transport-reduces-lung-fibrosis-e3428aaad155b94c 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stort-anslag-for-forskning-om-hur-viktpendling-paverkar-hjart-och-karlhalsan-52b9bd6e4c1ee0ac 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ki-motte-framtidens-studenter-och-nyfikna-besokare-pa-jarvaveckan-cbd7d332161d5ae1 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kartlaggning-av-hallbarhetsforskning-vid-ki-kth-och-stockholms-universitet-084f8122ac697250 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hon-soker-svar-hos-mordarna-fd6a8862228d4e02 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlf-s-stora-forskningsanslag-till-charlotte-thalin-for-inhalationsbehandling-av-047660985686811a 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anslag-till-ki-forskare-for-skraddarsydd-behandling-mot-aggstockscancer-af328c328f24f77c 2026-06-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-bispecific-antibody-and-ret-fusion-targeting-assets-garner-attention-in-n-568f9c2118674b18 2026-06-02T23:44:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/applying-ai-driven-biosimulation-to-drug-discovery-d1e521ee2526b7c0 2026-06-02T23:24:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-akeso-takes-center-stage-at-asco-china-biotech-industry-cements-its-coming-of-81e34e65d763ab14 2026-06-02T22:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-akeso-takes-center-stage-at-asco-china-biotech-industry-cements-its-coming-of-7f4b177567cc34ff 2026-06-02T22:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nord-ceo-statement-in-response-to-cms-rule-for-medicaid-community-engagement-req-750f3aab663d27be 2026-06-02T22:46:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-dr-borja-ibanez-director-cientifico-del-cnic-recibe-el-premio-rei-jaume-i-de-846fc56046a9303c 2026-06-02T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amid-ebola-hantavirus-outbreaks-democrats-decry-trump-s-health-cuts-03f10e864a41aab2 2026-06-02T21:05:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/rochester-city-council-approves-7-7-million-funding-request-for-university-of-mi-47856f359b5b7f46 2026-06-02T21:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/fort-snelling-joins-nationwide-trend-of-holding-mega-master-immigration-hearings-9870c0cb8dbe3187 2026-06-02T21:03:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/society-of-interventional-radiology-updates-guidelines-for-prostatic-artery-embo-265b395234caf6e8 2026-06-02T20:42:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-recebe-aval-da-anvisa-e-consolida-potencia-na-saude-com-ozivy-sua-caneta-azu-1f72fd65e4005c10 2026-06-02T20:36:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-intermountain-study-finds-ai-technology-is-a-game-changer-for-treatment-of-t-7704f638c23a3d91 2026-06-02T20:21:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-ways-to-take-health-and-safety-into-your-hands-this-summer-2d01adf2c7062b82 2026-06-02T20:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/breakthrough-drug-nearly-doubles-survival-with-advanced-pancreatic-cancer-an-onc-564d7ce954f5db3e 2026-06-02T20:15:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-management-executive-powers-innovation-in-year-round-campaign-to-tran-2e41efdcd311ec7d 2026-06-02T19:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-executive-daily-fda-sends-complete-response-letter-for-cingulate-384d0bb597638783 2026-06-02T18:51:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumter-palmetto-tennis-center-to-serve-as-a-hub-for-expanded-hands-only-cpr-educ-910050bd52eb2b2d 2026-06-02T18:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-zero-risk-rethinking-quality-management-in-outsourced-biopharmaceutical-m-78b02799f0a29f60 2026-06-02T18:49:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/vinculaciones-municipios-unlp-2026-dd5e9d2c260b9510 2026-06-02T18:44:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-a-unified-eclinical-platform-actually-2d9f304780b6556c 2026-06-02T18:42:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/climate-smart-housing-innovations-offer-new-hope-in-the-fight-against-malaria-20c1889212e68363 2026-06-02T18:29:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/puentes-uc-el-programa-que-conecta-la-academia-con-las-necesidades-reales-de-los-e784641584970fed 2026-06-02T18:20:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-all-of-us-data-is-changing-rare-disease-research-using-wearable-data-and-pop-7673ac27940679c5 2026-06-02T18:13:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/strong-independent-science-is-critical-to-advancing-public-health-and-saving-liv-82571a239fc76552 2026-06-02T18:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-indigenous-knowledge-natural-products-and-science-advancing-sustainabil-ecd40f3e9ae0aa7d 2026-06-02T18:09:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-research-and-innovation-week-highlights-kemri-s-excellence-in-health-res-7012d69a147eeec3 2026-06-02T18:07:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-strengthens-national-ebola-preparedness-strategic-response-capacity-c9c9990808672a77 2026-06-02T18:06:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-analytical-method-control-strategy-967eb5489e6fa7fe 2026-06-02T18:01:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/microsoft-mayo-clinic-plan-to-build-frontier-ai-model-for-healthcare-754d560d595d0b4d 2026-06-02T18:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/memoria-y-compromiso-a-11-anos-de-ni-una-menos-1a85635079d2791d 2026-06-02T17:50:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/model-informed-development-accelerates-transformative-treatment-for-sleeping-sic-f3a7a0e64c04b17e 2026-06-02T17:29:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-bags-33m-to-advance-ai-powered-imaging-workflow-solutions-1c9a40acf41ebbfa 2026-06-02T17:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-consejo-superior-definio-la-composicion-del-gabinete-de-gestion-2026-2030-08b688f9cb5c0e79 2026-06-02T17:09:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/incoming-ad-steve-newmark-looking-forward-to-the-future-9ef5e612a761a664 2026-06-02T17:04:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-reveals-winners-of-the-2026-apple-design-awards-501f972a031f459f 2026-06-02T17:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-steps-to-boost-patient-access-to-clinical-trials-in-the-uk-6380fca3a3c41b3b 2026-06-02T16:49:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-medicine-shortages-and-how-we-re-working-to-avoid-them-98b0f00cbb256d60 2026-06-02T16:44:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/equity-in-the-age-of-advanced-therapies-insights-from-haemophilia-7da544e65caaaa6f 2026-06-02T16:40:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/growth-and-skills-levy-a-catalyst-for-the-uk-pharmaceutical-industry-9d42e0806e04ac55 2026-06-02T16:37:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ranking-cwur-2026-la-unlp-se-consolida-como-la-segunda-universidad-de-argentina-1d9a3d56582f7b9a 2026-06-02T16:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sesiona-el-consejo-superior-para-designar-a-las-nuevas-autoridades-9446ac9ac083734f 2026-06-02T16:33:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/labor-induction-not-linked-to-higher-cesarean-rates-in-midwife-led-births-71c1b3fa07547df4 2026-06-02T16:27:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/oig-feds-may-have-overpaid-ma-plans-by-millions-due-to-unsupported-stroke-diagno-938cd30d39e215fe 2026-06-02T16:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abpi-refreshes-its-commitment-to-improve-public-involvement-in-research-2e19ec3b3bd53f19 2026-06-02T16:21:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-nda-for-giredestrant-in-er-positive-early-stage-breast-cancer-a199d477d9f30b4c 2026-06-02T16:19:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/setor-farmaceutico-esta-entre-os-principais-depositantes-de-patentes-no-brasil-s-ccb605e47bb11442 2026-06-02T16:19:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-together-we-are-all-determined-to-create-more-medicines-for-pregnant-wom-1b1193819c31653b 2026-06-02T16:19:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/abpi-statement-on-bgma-legal-action-over-voluntary-scheme-negotiation-representa-a0fc0ad5110af229 2026-06-02T16:15:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-sam-turning-a-type-1-diabetes-journey-into-a-mission-to-inspire-610aa238e6509d77 2026-06-02T16:12:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/department-of-labor-s-proposed-foreign-worker-wage-increases-are-more-tough-news-eabd424f8a0e8816 2026-06-02T16:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-miquel-lozano-new-president-of-the-world-apheresis-association-63e993588b697a5e 2026-06-02T16:02:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-hengrui-deal-strikes-panic-in-washington-82638378be61c046 2026-06-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-launches-long-awaited-drug-data-protection-rules-80e9f89818553695 2026-06-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longbio-to-raise-hk-1-4b-in-hong-kong-ipo-for-immunology-work-2321df2a7beb0435 2026-06-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhs-industry-partnerships-can-support-the-nhs-to-make-the-government-s-three-big-ce87182366906693 2026-06-02T15:54:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/her-majesty-the-queen-opens-st-george-s-hospital-intensive-care-balcony-as-brain-fdc1311a558e8b18 2026-06-02T15:52:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/sustainable-lift-off-fraunhofer-is-shaping-the-future-of-aerospace-e905a40b7b38f0e2 2026-06-02T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stay-chill-show-up-move-forward-nolan-s-journey-with-itp-6cf59cd8513f3855 2026-06-02T15:51:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-study-identifies-serious-infection-risks-linked-to-targeted-cancer-the-23e512da491c1175 2026-06-02T15:48:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/equitable-access-to-medicines-and-vaccines-essential-for-patient-safety-and-outc-f7f1f7360844be4c 2026-06-02T15:46:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovation-with-integrity-why-nhs-industry-partnerships-matter-and-how-conflicts-957c19b7c16940d6 2026-06-02T15:43:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-next-in-access-affordability-a-biopharma-perspective-d62e74ca288f6c06 2026-06-02T15:42:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-of-its-kind-coalition-sees-health-industry-professional-bodies-and-experts-4f560f7af73b7df0 2026-06-02T15:39:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-american-diabetes-association-s-innovation-fund-invests-in-updoc-to-accelera-77357e3d7bb02de3 2026-06-02T15:31:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-contraception-policy-sharply-reduces-patient-costs-in-b-c-especially-for-yo-4decc47b9b582dce 2026-06-02T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-montana-runner-is-on-the-road-again-after-receiving-life-saving-care-at-in-de224a89f5cb81bb 2026-06-02T15:23:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/becas-unlp-0a71b60d9358d7e9 2026-06-02T15:21:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-kelonia-presents-positive-in-vivo-car-t-data-in-multiple-myeloma-b3a62d320ef0a7ec 2026-06-02T15:17:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/advanced-fetal-surgery-and-coordinated-care-at-intermountain-health-gives-montan-041fa20ec0a4e3ac 2026-06-02T15:10:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-volunteer-gains-valuable-experience-supporting-patients-at-local-hospital-5966a6eb1c7c07e4 2026-06-02T15:09:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/latest-disclosure-uk-data-higher-r-d-spend-greater-transparency-and-more-partner-e564b3eb6b9d09ff 2026-06-02T15:04:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-regulators-use-ai-what-it-means-for-medtech-teams-fbc4cf3aca0b2cc2 2026-06-02T15:02:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/se-entregaron-los-legajos-reparados-de-estudiantes-de-la-carrera-de-psicologia-v-4d8f933250be032d 2026-06-02T14:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3j-a-11-anos-de-ni-una-menos-universidad-publica-democracia-y-compromiso-frente-b62a7c2582b587fc 2026-06-02T14:57:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-single-protein-may-be-holding-back-car-t-cancer-therapy-127b742c916bd94e 2026-06-02T14:54:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ascidian-lilly-ink-rna-exon-editing-pact-worth-up-to-1-9b-for-genetic-kidney-dis-31723b202d006361 2026-06-02T14:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-in-vivo-oncology-approaches-continue-to-show-promise-afb86bbb59c09c64 2026-06-02T14:47:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-in-vivo-oncology-approaches-continue-to-show-promise-cfe4b2f40835633e 2026-06-02T14:47:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-blood-cancer-readouts-take-centre-stage-ed3d0e78e19a8f30 2026-06-02T14:35:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/department-of-pharmacology-recent-publications-february-2026-may-2026-fdf4a307c8d69d9a 2026-06-02T14:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/deep-science-ventures-and-medicines-discovery-catapult-partner-to-accelerate-nex-88748e17d8c77a29 2026-06-02T14:21:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-gut-bacteria-that-may-help-protect-against-autism-and-adhd-55d114109b986840 2026-06-02T14:18:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/industry-groups-say-final-medicaid-work-requirements-rule-imposes-onerous-docume-9ca6d7aa78d77a53 2026-06-02T14:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-sends-crl-to-cingulate-for-ctx-1301-8710b56d688490d8 2026-06-02T14:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbot-medical-secures-the-first-healthcare-system-in-north-carolina-to-adopt-e1356ff48f3f65cf 2026-06-02T14:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/mir408-5p-and-mir408-3p-cooperatively-reduce-cadmium-uptake-and-accumulation-in-3a273566463d5996 2026-06-02T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spherix-data-reveals-explosive-demand-for-wegovy-pill-as-100b-weight-loss-race-i-00668248d96e2361 2026-06-02T13:52:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cientificos-de-la-unlp-desarman-el-mito-del-vapeo-seguro-5b7cfd9cad3f2af2 2026-06-02T13:37:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiology-practice-agrees-to-3m-settlement-in-class-action-lawsuit-over-cyberatt-0c8a8d8b8e525f49 2026-06-02T13:36:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-first-america-first-the-case-for-global-collaboration-a1b9c2dfb08faab9 2026-06-02T13:35:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-launches-myovista-insightstm-version-1-3-with-ai-ecg-algorithm-mar-c70a82f167924e9e 2026-06-02T13:32:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-to-spotlight-growing-hematology-portfolio-at-2026-european-hematology-asso-d570667073ef265a 2026-06-02T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ftc-clears-ascension-s-3-9b-amsurg-purchase-but-requires-some-asc-divestitures-8d45f79bad0ec426 2026-06-02T13:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-dental-student-makes-graduation-photos-free-of-charge-158fd7b517edc010 2026-06-02T13:13:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/c-suite-roundtable-shaping-south-africa-s-sustainable-future-through-collective-a2c10bec35294210 2026-06-02T13:00:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biggest-biotech-funding-rounds-in-may-2026-eaf5ce17ab459e17 2026-06-02T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-international-family-planning-reproductive-health-requirements-in-law-and-po-7f762e75f720abb2 2026-06-02T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-look-at-wearable-adoption-trends-and-who-s-using-smart-devices-rock-health-29c07b3ea361f5f4 2026-06-02T12:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/review-application-and-opportunities-for-machine-learning-and-artificial-intelli-e67db5dadcd9e170 2026-06-02T12:50:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/avajaisseminaarin-tallenne-saatavilla-27597b8737b3bef1 2026-06-02T12:42:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/hampshire-and-isle-of-wight-adopts-continuing-healthcare-platform-b14b5418b4cdb67a 2026-06-02T12:30:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-topic-is-evidently-striking-a-chord-7b3f9d0d78c314f7 2026-06-02T12:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-demonstration-of-long-distance-video-transmission-exceeding-30-km-usi-4308d3f6c311f670 2026-06-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-an-optimal-node-selection-and-communication-route-construction-al-a8a188709e081e9a 2026-06-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-development-of-common-firmware-supporting-international-wireless-comm-b72a3d7ae427be3e 2026-06-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-drug-development-clinical-trial-design-and-regulatory-considerations-10d06c6137910a16 2026-06-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-246b52a85c4281ec 2026-06-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/izalontamab-brengitecan-iza-bren-demonstrates-statistically-significant-and-clin-9b9b225d3f738aff 2026-06-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ending-hunger-in-africa-needs-africa-led-science-and-the-governance-to-match-cb3a3e35c9ec89ee 2026-06-02T11:44:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-s-ultimatum-to-hospitals-send-340b-claims-data-by-june-8-or-lose-disco-2e6d73178cd03dca 2026-06-02T11:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-s-ultimatum-to-hospitals-send-340b-claims-data-by-june-8-or-lose-disco-30d8669edcaea65e 2026-06-02T11:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-100-banknote-is-back-but-do-we-really-need-it-85a5c62874d7d84c 2026-06-02T11:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/reitoria-amplia-investimento-em-jovens-doutores-da-ufrj-e-eleva-para-50-o-numero-6854000328607e33 2026-06-02T11:17:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/10x10-12ply-2584be305d0c5f74 2026-06-02T11:17:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/marilyn-monroe-and-amy-schumer-profiled-in-endometriosis-awareness-push-b66602feaf7ceae2 2026-06-02T11:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/azorg-hospitals-cut-subtle-heart-attack-treatment-delays-by-several-hours-with-p-9db835c2cb94f006 2026-06-02T11:05:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/vgr-s-delar-fler-far-vard-i-tid-men-sjukhusens-ekonomi-under-fortsatt-press-2e87b0617ddd7416 2026-06-02T10:59:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-shrinks-headcount-by-88-in-new-jersey-as-3b-cost-cutting-scheme-advances-5421981ed1915e14 2026-06-02T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-presenta-los-principales-hitos-de-2025-en-su-memoria-de-actividades-ea136623f08d2718 2026-06-02T10:49:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conferen-8df7ad55f69dc4e8 2026-06-02T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-del-cese-de-comercializacion-y-retirada-del-mercado-del-disposi-6319a26ea2a5eb86 2026-06-02T10:38:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/joint-commission-launches-voluntary-ai-certification-program-for-healthcare-orga-77f54abb06b784c0 2026-06-02T10:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-health-coffee-time-briefing-f21aea479acb65a3 2026-06-02T10:30:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-s-livdelzi-scores-in-rare-liver-disease-trial-portending-use-in-broader-p-b61cba0d5ad40e2b 2026-06-02T10:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-medical-writing-demand-gap-is-becoming-a-drug-development-bottleneck-fa4752dae8ceaf25 2026-06-02T10:05:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-shows-teachers-keep-on-learning-c5b5c808dedc1d95 2026-06-02T10:03:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/roadblocks-and-hurdles-for-dtc-prescription-drug-ad-oversight-q-a-with-dan-troy-7a2c5a3fd8ff5c5a 2026-06-02T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharma-patent-cliff-explained-what-it-is-and-how-companies-navigate-it-f5d68fe18e243f3f 2026-06-02T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abivax-s-obefazimod-met-primary-endpoint-in-phase-iii-abtect-trial-193e9375a993be7a 2026-06-02T09:56:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/travere-scales-everest-with-1-1b-deal-for-btk-inhibitor-aimed-at-rare-kidney-dis-adef99d26f54987c 2026-06-02T09:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-taps-snowflake-for-ai-field-agent-help-816302417319627f 2026-06-02T09:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-weighs-use-of-covid-antiviral-lagevrio-as-ebola-outbreak-worsens-4968310dc3999335 2026-06-02T09:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adhd-drug-delivery-specialist-cingulate-hit-with-manufacturing-related-fda-rejec-0fb2da98115dae08 2026-06-02T09:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cre-wireguided-balloon-dilatation-catheter-cre-pro-cre-pro-gi-1792a56b7ff75d7e 2026-06-02T09:31:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-a-new-era-for-cancer-prevention-research-4b4b691d0caa2cd0 2026-06-02T09:30:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ficus-publikation-im-intensive-care-medicine-veroffentlicht-908d7a3c6de1b9de 2026-06-02T09:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/smooth-capsule-tablet-and-gummy-supplement-production-dca2977c2916c66e 2026-06-02T09:13:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcing-the-cambridge-protein-screening-facility-website-c9a0da086f6cbb2c 2026-06-02T09:08:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-secures-33-million-in-growth-capital-led-by-morgan-stanley-expans-faa2450851ade179 2026-06-02T09:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connecting-tissue-physical-changes-to-what-developing-cells-become-7f149789d2fb33c7 2026-06-02T09:05:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-intelligent-framework-for-rapid-media-customization-using-machine-learning-an-ff39a1c8a57c6329 2026-06-02T09:03:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/radical-proposal-would-block-solar-storms-with-orbital-airbag-80e8f1faed4dc2ec 2026-06-02T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/largest-study-of-knee-osteoarthritis-tissue-reveals-the-core-biological-pathways-9f1e4d50fd827c5a 2026-06-02T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-ai-better-for-patients-8ec2a1fd1c70f475 2026-06-02T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrasound-based-pacemaker-noninvasively-steadies-the-heart-f1de2f2d9fa47713 2026-06-02T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parasiten-als-urlaubsmitbringsel-3ed9bd4b4182b6e5 2026-06-02T08:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/eisenmangel-warum-eisen-fur-den-korper-so-wichtig-ist-4027cbd7c53943ae 2026-06-02T08:50:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-heights-for-newlimit-as-anti-aging-biotech-nabs-435m-to-rejuvenate-old-cells-0dc88a906612589e 2026-06-02T08:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-hospital-clinic-uses-ai-to-improve-diagnostic-imaging-03bb16007545255c 2026-06-02T08:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nafdac-launches-improved-med-safety-app-to-strengthen-reporting-of-substandard-a-14c872821cf15ddc 2026-06-02T08:25:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/fulcrum-scraps-scd-program-considers-options-after-fda-takes-hard-line-on-safety-53fa5d60cbda5005 2026-06-02T08:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-nsf-watchdog-unit-is-no-longer-investigating-research-misconduct-b92d9e05777c8b44 2026-06-02T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-announces-european-commission-approval-of-aquipta-atogepant-for-the-acute-71236effdcf9c013 2026-06-02T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-icu-to-giving-back-glasgow-patient-returns-to-the-ward-that-saved-his-life-99df4e12b5a7d588 2026-06-02T07:57:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-2-thermal-energy-storage-northern-entrance-at-kralingse-zoom-closed-for-fi-a5bf6f80ce1643f0 2026-06-02T07:27:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/knowledge-from-the-neighborhood-is-essential-to-the-city-af6d060033f55fec 2026-06-02T07:24:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundation-medicine-tallies-fda-nod-to-pair-its-blood-test-with-pfizer-s-prostat-f1ae7a38c3c6a502 2026-06-02T07:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-cancer-care-network-expands-rural-access-with-new-oncology-team-at-mars-56637efc58636cb1 2026-06-02T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hospital-in-the-home-iron-infusion-referrals-to-change-from-30-june-8ceb55435b6841e2 2026-06-02T06:36:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/birmingham-nhs-trust-to-digitise-over-235m-patient-records-c57682ba683db702 2026-06-02T06:30:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-on-recent-changes-to-our-pathology-system-4a85e52724a2f786 2026-06-02T06:18:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/72279ae90e13c70a 2026-06-02T06:09:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/prostate-cancer-education-day-full-day-session-for-gps-and-health-professionals-c04899dfb9c35a12 2026-06-02T06:05:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-fat-helped-pancreatic-cancer-grow-while-another-cut-disease-in-half-fe2ac0570883cd80 2026-06-02T05:55:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/eisai-whips-up-alzheimer-s-dietary-guidance-to-expand-nutrition-program-beyond-c-5eb25826a8c381f6 2026-06-02T05:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-medical-imaging-startup-subtle-medical-picks-up-33m-and-taps-new-ceo-a04c5de90d25b350 2026-06-02T05:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stavros-nicolaou-honoured-with-lifetime-leadership-award-e1942947ccb968ae 2026-06-02T05:32:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/praxis-pauses-one-of-its-seizure-programs-after-phase-2-fail-18c66aa590729fd1 2026-06-02T05:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-credit-score-like-risk-assessment-system-for-investigative-drugs-c4ab3db9f1a91611 2026-06-02T05:00:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/brain-mapping-effort-searches-for-roots-of-parkinson-s-and-other-diseases-6865dab99345c823 2026-06-02T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-new-drug-application-for-roche-s-giredestrant-in-er-positive-early-s-29e0285efa209b8b 2026-06-02T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abivax-stock-suffers-as-cancer-cases-overshadow-stellar-efficacy-in-ulcerative-c-da21ad16165f20a9 2026-06-02T04:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mathematicians-issue-warning-as-ai-rapidly-gains-ground-29bdcbddccdc5a72 2026-06-02T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-2-nhk-dc176b900d11c2ae 2026-06-02T04:23:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-cardiff-posts-updated-colorectal-cancer-data-ahead-of-pivotal-push-0acb861a7b7d7912 2026-06-02T03:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mindmaze-therapeutics-culls-program-ends-legacy-ops-from-relief-merger-to-cut-co-de737b9dc20674ed 2026-06-02T02:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/doubling-down-on-controversial-claims-microsoft-accelerates-quantum-computing-pl-a0606cfdcd423257 2026-06-02T02:15:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-named-to-cdp-supplier-engagement-assessment-a-list-for-the-second-d39d68bb014ca02a 2026-06-02T01:33:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-europe-hopes-to-lure-foreign-researchers-with-massive-new-grants-0d3a424bfa9071f7 2026-06-02T01:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stop-letting-trolls-keep-you-off-the-op-ed-page-f09f96f344145c09 2026-06-02T00:17:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-of-m-study-economic-growth-can-help-the-environment-45fd515b5fc79c9e 2026-06-02T00:17:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/objects-in-mirror-how-diet-culture-still-shapes-women-s-body-image-and-health-a1a767b478c4f514 2026-06-02T00:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-free-dna-methylation-biomarkers-for-the-early-detection-and-tumor-burden-mo-7c03440be59d44ff 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbial-reactivation-of-host-androgens-directs-enteric-neuronal-regulation-of-2c2e12473f1908b4 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmable-multiplexed-and-orthogonal-gene-control-in-bacteria-with-attenuated-293be2ad0c502724 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-utbildning-for-att-starka-arbetet-med-unga-med-angest-och-depression-9b2f5a455cadbdbd 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/missa-inte-arets-nicholsonforelasning-med-svetlana-mojsov-den-3-juni-e1daa87dc6e8ad16 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortify-ett-initiativ-for-att-starka-skyddet-av-innovationer-inom-europas-halsod-47d299e87d567142 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/andri-papakonstantinou-och-sean-rudd-nya-docenter-i-cancer-och-onkologi-405c0e6d7e968fd9 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jama-d22072523095b31d 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/audio-highlights-may-8-2026-81430aa37a94abcf 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-finds-no-link-between-acetaminophen-use-in-pregnancy-and-autism-663dcc88aafd8afa 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kratom-use-and-severe-health-outcomes-surge-in-the-us-a4f37d25a281c35b 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/syphilis-linked-to-higher-risk-of-some-cardiovascular-outcomes-e50b0740f2296571 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alternative-medicine-use-rises-among-us-children-1a3d6a78665997b6 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/excessive-daytime-napping-tied-to-mortality-in-older-adults-ab34420d877ebaa8 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-neurology-visits-comparable-with-in-person-for-initial-evaluations-3e0e0a0b5bdfca47 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-multicancer-detection-blood-tests-save-lives-0938a254064e7fc6 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intravenous-tenecteplase-prior-to-endovascular-treatment-for-ischemic-stroke-4d989079d7cd91f9 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intravenous-tenecteplase-prior-to-endovascular-treatment-for-ischemic-stroke-at-a372fde866aeab8b 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intra-arterial-alteplase-after-thrombectomy-for-acute-ischemic-stroke-8ae6af0f995209d9 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/current-comment-0f1f0f941d14dc03 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-year-mortality-among-opioid-overdose-survivors-dafc62b382003f45 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-at-the-policy-table-3cb840aecee14be0 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adjunctive-intra-arterial-alteplase-after-successful-thrombectomy-for-acute-isch-f4845018b855593f 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adjunctive-intra-arterial-alteplase-after-successful-thrombectomy-for-acute-isch-e0271908ece33c8e 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/promoting-clinical-expertise-in-the-age-of-ai-92d548aa75f2c403 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hepatitis-b-a-review-ca0bb21e02031821 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-of-anterior-cruciate-ligament-rupture-5e63f5ef4d33a4c6 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-7bd49f74f64a6e08 2026-06-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrff-drives-better-mental-health-at-home-for-older-australians-51665ba03e49d0dd 2026-06-01T23:56:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/progress-of-disclosure-matters-notice-regarding-completion-of-acquisition-of-bio-c3e86e9499cc6167 2026-06-01T23:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/model-acceptance-in-regulatory-submissions-practical-strategies-for-regulatory-s-a553a250565ecd5d 2026-06-01T23:36:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-students-win-nasa-blue-skies-award-253cf8d304517429 2026-06-01T22:42:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-1bf5477c0c67376f 2026-06-01T22:33:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-led-research-team-to-develop-evaluation-protocols-tools-for-city-chatb-e1504106a68d772a 2026-06-01T22:12:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/resultados-financieros-del-primer-semestre-de-2026-40df6d619efe51ab 2026-06-01T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-encuentro-safe-hearts-plan-young-scientists-engaging-with-europe-s-cardiovasc-8065d3c6ce97fa74 2026-06-01T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-celcuity-dares-to-dream-of-becoming-10b-company-after-breast-cancer-win-ove-07082cca1b0f3725 2026-06-01T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-on-glp-1-medications-may-be-less-likely-to-develop-breast-cancer-5544b90b4fa976b4 2026-06-01T21:38:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-practical-checklist-for-building-confidence-in-site-selection-cc00f38c6e950327 2026-06-01T21:13:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-heart-association-expands-nation-of-lifesavers-initiative-with-cpr-in-s-ed38e2284d56cc4b 2026-06-01T21:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commonly-prescribed-medication-for-sleep-problems-raises-alarm-bells-29499b308d09b149 2026-06-01T21:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/biopharma-partnerships-161e2db3b66137c0 2026-06-01T20:31:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/sponsor-s-guide-to-irb-approval-part-vi-after-irb-approval-compliance-multi-site-1c0c9c92847fa4cb 2026-06-01T20:22:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/su-s-tla-day-confronts-the-future-of-learning-and-teaching-in-the-age-of-ai-ef2448d241c0818d 2026-06-01T19:55:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/spect-agent-could-help-guide-lung-disease-treatments-new-data-suggest-a1cc2cf6f52db16c 2026-06-01T19:43:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwell-s-firearm-injury-risk-screener-now-widely-available-within-epic-48c94b2b7bc879fc 2026-06-01T19:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psi-cro-appoints-misoon-seo-to-lead-south-korea-operations-a2009b487e151e8e 2026-06-01T19:34:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-throughput-rt-qpcr-and-transcriptomics-powering-the-next-generation-of-drug-03080457998b43c2 2026-06-01T19:20:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/fueling-pharma-s-ai-revolution-with-the-right-content-governance-and-licensing-s-b214caef5db3c20a 2026-06-01T19:18:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/fueling-pharma-s-ai-revolution-with-the-right-content-governance-and-licensing-s-464f294ecbf8ca13 2026-06-01T19:18:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/hospital-follow-up-program-bridges-critical-care-gap-for-patients-in-crisis-14cf7ebf5c5b8b61 2026-06-01T19:12:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoparticle-drug-combo-treats-venous-malformations-7a24fe23a1c3be0d 2026-06-01T18:53:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/jackson-banking-executive-spearheads-local-women-s-heart-health-movement-38dc7e9e8eb65486 2026-06-01T18:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-shows-the-brain-uses-brief-slow-rhythms-to-organise-how-memories-are-f-acdf0666fa2328ea 2026-06-01T18:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiographer-arrested-for-possessing-creating-explicit-content-involving-childre-ce3974de7bbc8c4e 2026-06-01T18:32:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-executive-daily-fda-approves-xocova-303afff9aff04a3e 2026-06-01T18:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/lifesaving-hands-only-cpr-kiosk-finds-a-new-home-at-molloy-university-855a637b1e7eafd7 2026-06-01T18:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-ways-to-take-health-and-safety-into-your-hands-this-summer-452ca59c3139082d 2026-06-01T18:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aayas-joshi-26-films-scenes-of-resilience-e120b748ed45d6e6 2026-06-01T17:48:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/chancellor-s-enc-tour-kicks-off-at-fort-bragg-c09608df6a11347d 2026-06-01T17:21:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-phase-1-results-of-a-mica-b-targeted-car-t-cell-designed-to-overcome-e8f283e7115f7ab8 2026-06-01T16:38:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-matter-what-evidence-that-reflects-every-patient-13c2d09675559b16 2026-06-01T16:04:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-aka-politics-to-have-bigger-role-in-us-grants-2f783b2c0ae982a9 2026-06-01T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/athenahealth-rolls-out-over-80-new-expanded-ai-rcm-features-in-roadmap-on-athena-72bb542096b80d2a 2026-06-01T15:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovation-from-above-how-mesh-networks-help-control-drone-swarms-a1b5be6277d5a81f 2026-06-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-the-availability-of-mrna-based-drugs-2e956f6bad8b8acd 2026-06-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficiently-cooling-satellite-components-in-space-62b4e71cb8853335 2026-06-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-perspectives-on-the-transforming-diabetes-clinical-trial-landscape-6b4a656c0e5f3274 2026-06-01T15:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/contraline-and-its-male-birth-control-candidate-rally-92-5m-amid-push-into-massi-6766fe1218913f5f 2026-06-01T15:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mesutoclax-points-to-possible-shift-in-high-risk-mds-and-aml-4091780fb663b148 2026-06-01T15:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-2adb62a4cd52c744 2026-06-01T15:20:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-b2ba192c3388c738 2026-06-01T15:19:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-3b2c24f90bb0e459 2026-06-01T15:19:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/immatics-presents-clinical-activity-of-ima203cd8-prame-cell-therapy-in-hard-to-t-aeef73b690a63f85 2026-06-01T15:17:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-oss-earns-ecovadis-gold-e2827d51ac79712b 2026-06-01T15:14:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-class-of-2026-the-future-starts-here-86a437babcd59872 2026-06-01T15:13:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/edgewise-therapeutics-announces-sale-of-sevasemten-for-up-to-2-65-billion-streng-5f8a1060dbe221ec 2026-06-01T15:07:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-perspectives-for-permanent-positions-alongside-the-professorship-bff235212a512f2a 2026-06-01T15:01:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramorph-2-mg-ml-solucion-oral-1-frasco-de-100-ml-nr-62039-cn-821934-c7f6c63aabf6419a 2026-06-01T15:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/enzymes-that-assemble-into-droplets-can-speed-up-cellular-reactions-55afaa1c3658eb8a 2026-06-01T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/solucion-cardioplejica-varias-presentaciones-70641a65a9d5d5c9 2026-06-01T14:59:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/nouscom-receives-u-s-fda-fast-track-designation-for-nous-209-a-novel-immunothera-0e7362488455c9a9 2026-06-01T14:45:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-eurip-students-share-their-experience-as-part-of-the-circle-u-delegation-at-7eef9cd8f37a7b45 2026-06-01T14:40:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-university-of-freiburg-has-been-awarded-funding-for-the-innovative-transfer-3a0b5a71bd0a1f9c 2026-06-01T14:32:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-to-buy-three-vaccine-developers-for-nearly-4-billion-in-infectious-disease-13e7908d7cbc4a71 2026-06-01T14:31:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/pantracertm-portfolio-6bd114a6bec0fe79 2026-06-01T14:30:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-projects-funded-by-local-innovation-partnership-fund-e8fe11747b2b53fb 2026-06-01T14:28:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-del-cambio-en-la-denominacion-de-valium-solucion-inyectable-par-d5fe7bf0f81d286b 2026-06-01T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-xocova-as-first-oral-post-exposure-covid-19-prevention-therapy-17c1995801b2bb14 2026-06-01T14:14:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-her2-biology-is-shaping-next-generation-cancer-treatment-a1d32dcfa6bd68bd 2026-06-01T14:10:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/vienes-a-leer-en-el-verano-quedate-para-medirte-la-presion-arterial-en18-bibliot-cf9c91b1efe3b2ae 2026-06-01T14:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fans-can-learn-hands-only-cpr-at-fifa-fan-festivals-and-fan-zones-in-four-u-s-ho-f495ec42e5797d5e 2026-06-01T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/coming-for-summer-reading-stay-for-a-blood-pressure-check-at-18-central-valley-l-d29d212ad67a7f50 2026-06-01T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-leader-in-engagement-with-healthcare-stakeholders-ea289d36868ac4af 2026-06-01T13:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fadzai-sets-her-sights-on-a-global-career-7f92ce935d8edc36 2026-06-01T13:52:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-bristol-myers-800m-bispecific-adc-aces-china-breast-cancer-study-putting-tr-d71ee5e3151ecf4f 2026-06-01T13:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-common-amino-acid-helped-mice-survive-deadly-inflammation-f14766d79dadaa43 2026-06-01T13:44:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-kristin-baker-joins-unc-chapel-hill-board-of-trustees-ad4cde7995d8a042 2026-06-01T13:44:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-m-a-roundup-servier-acquiring-edgewise-therapeutics-muscular-dystrophy-bu-ab100eca5454a885 2026-06-01T13:42:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/lloyd-talks-purpose-resilience-and-finding-his-path-95a89adafbcf02fc 2026-06-01T13:31:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/exzellente-doktorandenausbildung-geht-in-die-zweite-runde-medizinische-fakultate-81726e9b84cc2137 2026-06-01T13:26:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-drug-delayed-rheumatoid-arthritis-for-years-after-treatment-ended-5fbaeac9dd27b5f0 2026-06-01T13:25:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-china-s-new-cgt-rules-mean-for-biotech-business-65109d9977dad88a 2026-06-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-77120ccfdb49fb19 2026-06-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-a4d84b9eb31b5be1 2026-06-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-nerve-pain-to-full-recovery-jason-s-cervicalstim-device-experience-1bb435376ed8af07 2026-06-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/actualizacion-de-aranceles-para-tramites-en-anmat-a3ac5495dd9ac05f 2026-06-01T12:56:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/nutrition-professor-fights-against-unhealthy-habits-3a8525278aed6d93 2026-06-01T12:47:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-patient-record-could-cut-20-000-a-e-visits-a-year-gov-claims-82d024d2acdf8867 2026-06-01T12:30:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/take-pride-in-learning-cpr-you-may-save-the-life-of-someone-you-love-a9420971964714e6 2026-06-01T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-c7ff20eb5f3f73de 2026-06-01T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zastuda-ta-alergiya-3d27038e3d32fb7a 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/problemi-bolyu-0b6522fe025837b1 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/nevrologiya-2ba6b3f806feccfe 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/kardiometabolichni-6318e7c3c92b1370 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/intimne-zdorovya-9d7fbed26eaeb3d0 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/gastroenterologiya-70c45b469bdf88a9 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/dermatologiya-a4a1e35e69706577 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotiki-a9d388648c79d781 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/alergiia-04d487a7da5ee372 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/usi-preparati-ea2e74a39cc49213 2026-06-01T12:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-archive-at-su-sheds-light-on-overlooked-liberation-history-c6cd4e26d9f666fc 2026-06-01T12:17:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-and-merck-present-5-year-data-for-intismeran-autogene-in-combination-wit-791ef689d61dae72 2026-06-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delegation-from-newcastle-university-visits-kyoto-university-8659e6a78193052c 2026-06-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-emerita-caroline-sy-hau-receives-fukuoka-prize-2026-academic-prize-88b973ddbeeda85c 2026-06-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-laboratories-to-present-at-william-blair-and-jefferies-conferences-c997d69c714256b3 2026-06-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-845a7837d40856bb 2026-06-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-training-group-in-the-field-of-immunology-continues-successful-work-b400a43213587998 2026-06-01T11:47:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/wolters-kluwer-health-survey-examines-ai-use-and-concerns-among-clinicians-patie-d0836d7cf3e87127 2026-06-01T11:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinician-s-lockdown-gaming-inspires-virtual-reality-dialysis-training-for-patie-742c3c429881ee5d 2026-06-01T11:01:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/barrhead-health-worker-praises-nhsggc-s-control-it-plus-programme-2230102eaced0104 2026-06-01T10:59:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-lecturers-take-centre-stage-at-tla-celebration-80e0cb18186a0511 2026-06-01T10:59:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-food-and-drug-administration-accepts-for-priority-review-bristol-myers-squib-b540e3eb7423cc98 2026-06-01T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-opdivo-nivolumab-in-combination-with-avd-receives-b6f8ae5c51db1363 2026-06-01T10:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fast-tracking-enrollment-in-personalized-immunotherapy-for-melanoma-87a88db4da807c78 2026-06-01T10:50:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/economist-identifies-pattern-in-eredivisie-predictable-champion-in-an-unpredicta-48e463bba0e8bd87 2026-06-01T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-health-at-heart-of-new-edinburgh-pop-up-festival-603051db6e55ecd2 2026-06-01T10:35:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-forgotten-organ-that-could-predict-how-long-you-live-c4f2261056742377 2026-06-01T10:17:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/guadalupe-sabio-wins-a-diario-medico-s-admirables-award-7fc3c8f208823742 2026-06-01T10:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-a-tumor-disrupts-an-illinois-woman-s-fertility-brain-surgery-helps-her-get-07bb565fb01b8e93 2026-06-01T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinic-barcelona-comprehensive-cancer-centre-participates-in-asco-2026-with-key-4b71c032a373b7a6 2026-06-01T09:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-s-special-message-of-thanks-for-volunteers-week-c3585728d05b10ac 2026-06-01T09:47:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxford-bundibugyo-ebolavirus-vaccine-candidate-receives-cepi-backing-34e61d44d38429de 2026-06-01T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/muevase-mas-para-tener-mejor-salud-no-solo-un-mejor-peso-8ac7e6503cde2330 2026-06-01T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/move-more-for-your-health-not-just-for-the-scale-2b44c6153103b58c 2026-06-01T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/f-rei-6-26-0d9ac9b7c6ca5d80 2026-06-01T08:58:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/day-of-clinical-research-2026-tag-der-klinischen-forschung-am-usz-3ed041f808a373f4 2026-06-01T08:48:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/journee-mondiale-sans-tabac-les-hus-engages-dans-le-soin-et-la-prevention-8bdf8c0b02b20ab8 2026-06-01T08:34:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-happens-when-a-child-never-sees-a-cow-993612dd8edb2fa8 2026-06-01T08:01:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-dialogue-explores-solar-radiation-modification-research-d27b269f98300132 2026-06-01T08:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-3-6-25-9e92d6f1b0bf6c71 2026-06-01T08:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/open-call-for-campus-clinic-innova-2026-cba4ceff3782cc70 2026-06-01T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rising-stars-wpp-s-meghan-o-hora-on-the-complex-puzzle-of-oncology-drug-marketin-c5183b0207d84bb8 2026-06-01T07:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/220-6-24-872692b11f051e76 2026-06-01T07:54:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-bakterien-zu-klimaneutralen-kunststoffen-und-kosmetika-a8915ad9e5b15ba3 2026-06-01T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/making-climate-neutral-plastics-and-cosmetics-using-bacteria-335b4ec1d00de8de 2026-06-01T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-culture-in-europe-invent-recognised-as-eu-horizon-success-story-a33d43210a10ffdb 2026-06-01T07:12:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-the-emergency-department-to-the-capitol-a-doctor-s-impact-beyond-the-bedsid-211f7143fd22f226 2026-06-01T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-shows-little-shift-in-americans-views-on-political-violence-9cbcbfed760c9692 2026-06-01T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/il-policlinico-di-milano-vanta-una-delle-biblioteche-ospedaliere-piu-importanti-e0fed4da4ed11405 2026-06-01T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhs-trusts-lack-support-to-manage-epma-safety-risks-hssib-says-9b4a23941f429f8d 2026-06-01T06:30:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiologists-anesthesiologists-and-em-docs-jointly-praise-no-surprises-act-chang-09ec1975a9632ceb 2026-06-01T06:12:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/society-of-interventional-radiology-announces-support-for-bill-that-would-cut-70-7d1d8838498987b2 2026-06-01T06:07:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-presents-updated-clinical-data-showing-encouraging-early-efficacy-signals-eeee342b7fc0c1b3 2026-06-01T06:05:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-diminuer-le-nombre-de-maladies-cardiovasculaires-d4b0d91039b9b8b6 2026-06-01T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/desperate-to-fight-ebola-outbreak-congo-weighs-using-longshot-vaccine-options-96864b1b2860e7d8 2026-06-01T05:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/court-blocks-nsf-s-transfer-of-climate-lab-s-supercomputing-facility-917ad666e2fd296d 2026-06-01T05:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-cincinnati-opens-new-research-facility-aimed-at-advancing-mri-inno-177a9f15afd7a9cb 2026-06-01T05:10:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-american-academy-of-physician-associates-officially-recognizes-apps-in-radio-4b5bfb325930538c 2026-06-01T05:04:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-to-present-new-data-advancing-its-obesity-portfolio-at-the-american-diabet-8b2a023920450683 2026-06-01T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/change-in-siegfried-s-management-team-00f8aefd84317bdf 2026-06-01T04:23:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclic-deformation-resets-a-rock-s-microstructural-clock-59af214242a54a30 2026-06-01T03:30:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-symposium-for-the-10-anniversary-of-the-pmda-hokuriku-branch-6dfb7bffdbbe86bf 2026-06-01T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-announces-organizational-change-change-in-the-responsibilities-o-6e0591c24ce6e1e8 2026-06-01T01:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flat-pack-packaging-now-uses-less-plastic-with-new-direct-printing-machine-19abc3fd2df5e618 2026-06-01T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-fb1e886627b91e31 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/s-p-global-sustainability-yearbook-member-2026-30a7a6f7b9bd314e 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/c8e3c3bc8d770480 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-5-5745af9ffa31d0a6 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-1-05740a8a29a6abb2 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3242a8e577228b41 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-84c25cad9a128d01 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/40-mg-ml-fe9f3228931ba455 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fuzuloparib-enhances-radiosensitivity-of-gain-of-function-mutant-p53-r273h-nsclc-56a0c8071cf589de 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-pain-biomarkers-cannot-replace-the-patient-experience-5febd2572356f41e 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/t-owards-a-holistic-understanding-of-pain-in-the-biomarker-age-e0ffe17f680d0bdb 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deep-brain-stimulation-induces-white-matter-remodeling-and-functional-changes-to-b0d3d89bb546f1c9 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decoding-the-origins-of-cellular-self-organization-for-engineered-biology-de6367fe2ef77029 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selection-of-human-hematopoietic-stem-cells-bearing-the-intended-functional-edit-ea8fdbf1baa835af 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aav8-mediated-mouse-human-proc-expression-rescues-thrombophilia-in-hereditary-pr-41ebaf2ee3fbbbe6 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficient-bridge-monitoring-d9c115b527e755ef 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-the-production-of-higher-performance-batteries-ff3294f2b2d47d5e 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/var-kunskap-om-hur-saker-hanger-ihop-driver-innovation-f241a45736213315 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skarpt-lag-minskade-inte-tvang-i-barnpsykiatrisk-heldygnsvard-46dfbd7ef2412dab 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/samverkan-larande-och-utveckling-under-curious-besok-vid-gph-951cbece53b947aa 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ratt-anvant-alkoholprov-kan-ge-vardefulla-insikter-vid-behandling-av-hogt-blodtr-9826a4324de7abc7 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mikroglia-kan-driva-aggressiv-hjarntumor-hos-barn-38f5b596f247b1ed 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ki-fortsatter-sin-strategiska-satsning-ny-rekrytering-av-21-bitradande-lektorer-7e08a0459357c9ac 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fran-italien-till-ki-studenten-paolo-vill-bidra-till-framtidens-cancerbehandling-a889da0b193e7af0 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-834b83922179c6fe 2026-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-found-the-hidden-switch-fueling-alzheimer-s-brain-inflammation-a6a805bcd0e238d0 2026-05-31T15:30:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-cancer-spreads-more-in-middle-age-than-in-old-age-e58b912ef1b47754 2026-05-31T15:25:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-safety-and-cytokine-profiling-with-addition-of-the-toll-like-receptor-t-3786e351423e530e 2026-05-31T14:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptive-phase-2-3-study-of-eik1001-a-tlr7-8-dual-agonist-in-combination-with-pe-c9fa16a70c0bc4c6 2026-05-31T14:09:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-2-3-study-of-eik1001-in-combination-with-pembrolizumab-and-chemotherapy-36a9888839684b39 2026-05-31T14:07:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-retevmo-selpercatinib-demonstrated-an-83-reduction-in-the-risk-of-diseas-bdc069d852308849 2026-05-31T12:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taking-cooking-together-to-the-next-level-an-inspiring-story-from-community-kids-0017d66c5e852621 2026-05-31T11:24:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermittent-fasting-triggers-surprising-changes-in-the-brain-35714db07b1d45d9 2026-05-31T09:01:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/omega-3-fish-oil-shows-promise-against-type-2-diabetes-d4387b0edce094a0 2026-05-31T05:15:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/costruire-relazioni-di-salute-e-serenita-le-cure-palliative-in-policlinico-di-mi-cdbbfe178ef8aed5 2026-05-31T03:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/31-05-giornata-mondiale-senza-tabacco-smettere-di-fumare-e-possibile-d44db24358ac7609 2026-05-31T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multicenter-multi-part-phase-1-2-study-of-eik1005-as-monotherapy-and-in-combin-894e12246b2b654b 2026-05-30T18:41:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/eik1003-a-parp1-selective-inhibitor-in-combination-with-paclitaxel-ptx-initial-c-e38732c652e1f0f5 2026-05-30T18:37:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/twin-cities-heart-walk-strives-to-make-every-household-cpr-ready-9420febdaca9d32a 2026-05-30T18:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eikon-therapeutics-presents-data-on-clinical-stage-programs-at-the-2026-annual-m-85d6e5717806293b 2026-05-30T18:32:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-data-for-biontech-and-bristol-myers-squibb-s-pd-l1xvegf-a-bispecific-pumi-1d31fa769a818054 2026-05-30T18:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-poster-presentation-a-multicenter-randomized-double-blind-phase-2-3-st-b067b4ebf4cef517 2026-05-30T12:01:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-poster-presentation-the-impact-of-depth-of-response-on-long-term-clini-d6df698a4beac182 2026-05-30T12:01:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-poster-presentation-sustained-depth-and-durability-of-response-with-tg-e9d2a4c8eb0171be 2026-05-30T12:01:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulating-corporate-control-in-the-u-s-health-care-system-a3d0a844164c6df9 2026-05-30T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dysphagia-lusoria-0540fa38df7be157 2026-05-30T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/repairing-dna-damage-scientists-discover-a-surprising-new-benefit-of-melatonin-5257bfe0f4b9a2bc 2026-05-30T09:11:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-tomato-soy-juice-reduced-inflammation-in-just-four-weeks-88f68e70be6c1791 2026-05-30T05:53:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-handcrafted-and-deep-learning-mri-signatures-an-interpretable-framew-cd79ca3abc2a14ed 2026-05-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinctive-features-of-the-tumor-and-immune-microenvironment-in-glioblastoma-6078c04149f9f11c 2026-05-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclin-e1-overexpression-identifies-a-therapeutically-relevant-poor-prognostic-p-5ad4244720bbd1d5 2026-05-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apatinib-enhances-anti-pd-1-efficacy-by-inhibiting-exo70-mediated-exosome-secret-306aa150243a994b 2026-05-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-uc-impulsa-un-aseguramiento-de-la-calidad-mas-articulado-y-transversal-016d782822180678 2026-05-29T21:21:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicaid-enrollment-and-unwinding-tracker-c7bb9a70954b5b49 2026-05-29T21:19:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/making-public-work-count-in-academia-c70d0b97037a0a33 2026-05-29T20:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-and-hantavirus-outbreaks-raise-questions-about-trump-s-health-agency-cuts-eebb9ac2c3ba91cd 2026-05-29T20:36:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-does-social-media-impact-youth-mental-health-and-what-can-parents-do-3c4b4ed95de687aa 2026-05-29T20:35:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-pancreatic-cancer-breakthrough-head-and-neck-cancer-jab-insomnia-and-c-71f6db6c944c059c 2026-05-29T19:46:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-claims-data-misses-finding-opportunity-at-the-point-of-care-f915f6e66e75d488 2026-05-29T19:12:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-claims-data-misses-finding-opportunity-at-the-point-of-care-755a8a00c5eee787 2026-05-29T19:12:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ecoa-supports-complex-obesity-clinical-trials-and-long-term-participant-enga-53d23fb2be6b810c 2026-05-29T19:09:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-technology-to-strengthen-emergency-response-in-chicago-dbbc4afadfaee6ee 2026-05-29T18:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/browns-denzel-ward-and-olympian-katie-moon-lead-cleveland-campaign-urging-reside-4ba2ad6cb14b3bc1 2026-05-29T18:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mannkind-announces-fda-approval-of-afrezza-the-first-and-only-inhaled-mealtime-i-155d604c09536d91 2026-05-29T18:31:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-dsmbs-need-ai-expertise-8f8cce9b7fd6aecd 2026-05-29T18:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kim-warner-builds-pathways-for-early-career-professionals-seeking-mission-driven-3a5899e66cc35dc0 2026-05-29T17:34:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-welcomes-45-scholars-in-first-wave-of-canada-impact-research-training-awards-9c2c790f8fcffbac 2026-05-29T17:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/grady-health-system-goes-live-with-sectra-amplifier-services-to-enable-smooth-im-224696952eb3dbc9 2026-05-29T17:23:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-grads-spring-2026-jamie-leone-bachelor-of-nursing-integrated-bni-f30ae727f5a4ac84 2026-05-29T16:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/longevite-en-sante-toulouse-trace-une-feuille-de-route-12095eb0c9b974e2 2026-05-29T16:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/climate-change-presents-new-challenges-regarding-water-regulation-for-plants-68d78f5c7698da10 2026-05-29T16:08:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidelines-on-the-use-of-generative-ai-in-teaching-and-studies-adopted-e87a830f319ea5c8 2026-05-29T16:03:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-launches-long-awaited-drug-data-protection-rules-cc29de71b10b811c 2026-05-29T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spring-convocation-2026-the-day-in-photos-19179ab77b7f2270 2026-05-29T15:59:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/detroit-s-rising-developers-are-supported-by-the-apple-developer-academy-17a52b8132adade7 2026-05-29T15:59:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/3eme-edition-de-la-journee-nationale-de-la-bioproduction-de-biomedicaments-le-le-680aae5b83881635 2026-05-29T15:33:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-internationalisation-strategy-2030-has-been-published-0e954e3a7f047856 2026-05-29T15:24:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/defi-solidaire-sylvain-furnon-fait-etape-a-toulouse-pour-sensibiliser-a-la-scler-b19e245c8a2ea0b1 2026-05-29T15:22:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/fonds-de-recherche-du-quebec-frq-support-for-fmhs-investigators-45647f170e8987a7 2026-05-29T15:10:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-r-d-ai-productivity-paradox-and-how-to-overcome-it-85705cfc3866b3e5 2026-05-29T14:35:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/79th-world-health-assembly-constituency-statement-on-the-follow-up-to-the-politi-79eda4d6e6c78745 2026-05-29T14:23:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-want-to-live-forever-lessons-learned-from-the-biology-of-aging-48213a2f00ec8720 2026-05-29T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/type-ii-trna-cleavage-by-slfn14-endoribonuclease-variants-linked-to-inherited-th-d0983af72f316ba7 2026-05-29T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flexible-goal-learning-involves-coordinated-population-activity-in-dca1-and-medi-0696e1f93243ef0c 2026-05-29T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/olfactory-bulb-cortex-oscillations-encode-perceived-odor-intensity-rather-than-c-af0606cd9db9fa5c 2026-05-29T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fmhs-events-and-calls-for-submission-c4bf561438f8a3a2 2026-05-29T13:54:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/fmhs-faculty-and-learners-shine-at-afmc-event-b656bbbb888cf1ca 2026-05-29T13:49:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/hidden-driving-danger-when-edible-cannabis-and-alcohol-mix-75aaf46af12c8ccf 2026-05-29T13:42:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-closer-look-at-north-carolina-s-implementation-of-the-2025-reconciliation-law-71f40c8ab926501a 2026-05-29T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooperation-with-harvard-cass-r-sunstein-visits-universitat-heidelberg-9d00b5e9bf39c8cb 2026-05-29T13:22:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-hengrui-deal-strikes-panic-in-washington-a841aead859a3856 2026-05-29T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-launches-food-prescription-program-with-gift-from-rbc-99757c2bf93da177 2026-05-29T12:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemistry-professor-awarded-up-to-2-million-over-5-years-1e05350fa5e179d4 2026-05-29T12:53:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-wee1-inhibitors-finally-make-replication-stress-druggable-33c2102f821051b1 2026-05-29T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/derbyshire-healthcare-to-roll-out-psyomics-mental-health-platform-f262e58bb35a9a7b 2026-05-29T12:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/overcoming-a-key-barrier-to-ips-cell-based-t-cell-immunotherapy-48a4330bed8bf0ea 2026-05-29T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lost-in-an-orange-blur-debafb5cc84d8d93 2026-05-29T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-announces-european-commission-authorization-of-expanded-label-for-venclyx-5c82f59a18d123bb 2026-05-29T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-celmod-mezigdomide-reduces-risk-of-disease-progre-8a75533e668f6813 2026-05-29T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/d9075b4e0a686c51 2026-05-29T11:43:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-biosciences-announces-update-on-anticipated-timing-of-closing-of-the-plan-c5f8cbf8c1d0b2ec 2026-05-29T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-our-people-nicolas-lachevre-it-ops-work-study-student-at-aspen-ndb-1111d2ae5846cc4f 2026-05-29T11:26:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-silent-kidney-crisis-is-spreading-far-faster-than-experts-expected-6cbd86c1ffb1c773 2026-05-29T11:10:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/90e5e5ab6a5f5792 2026-05-29T11:09:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/aacr-d3-the-global-one-stop-conference-for-drug-discovery-and-development-7b09c0ff32b2e20e 2026-05-29T11:03:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/fellowships-expand-research-horizons-cc972e23d1cd522c 2026-05-29T11:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/over-1-400-children-are-being-introduced-to-science-through-lessons-taught-by-pr-b056774d74a3c780 2026-05-29T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-supports-multi-institution-trial-to-expand-genetic-testing-in-colorectal-9c98c4857a292003 2026-05-29T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-estonian-medicinal-products-market-in-the-first-quarter-2026-05d20eaa16b88a67 2026-05-29T10:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-breakthrough-therapy-designation-for-calderasib-mk-1084-an-investigat-7f0ed94a1eac484b 2026-05-29T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cambridge-researchers-map-the-human-endocrine-system-cell-by-cell-9285903532f2a679 2026-05-29T10:42:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/eudamed-28-5-2026-544f0f87a97cf408 2026-05-29T10:31:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/reproductive-carrier-screening-portoflio-update-4ce5281cb7e6e4bd 2026-05-29T10:30:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-combiox-9a513b3db6023590 2026-05-29T10:19:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/annex-1-compliance-as-a-competitive-advantage-1526bc5e9a975a9a 2026-05-29T10:16:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-publica-su-codigo-de-conducta-164d59d176908fa8 2026-05-29T09:56:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-une-cartographie-inedite-des-tumeurs-pour-guider-le-choix-des-traiteme-0b14d9ed36240051 2026-05-29T09:16:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/al-policlinico-di-milano-approda-l-endomicroscopia-confocale-fra-i-primi-in-ital-fdc6c16745591c04 2026-05-29T09:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fci-supports-teaching-concept-for-the-chemistry-of-tomorrow-4c37919df763c16d 2026-05-29T09:02:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-and-france-launch-landmark-biomedical-and-ai-health-alliance-to-accelerate-re-feb599701bee0b6f 2026-05-29T08:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nominations-open-for-2026-principal-s-medals-e7b0a0bc0a09e3c1 2026-05-29T08:24:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2026-un-anticorps-conjugue-medicament-montre-des-signes-d-efficacite-encour-7c80465789582bfd 2026-05-29T08:11:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-ms-day-special-immunic-reveals-new-hope-for-progressive-ms-8f4b7d53a9c2ad83 2026-05-29T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anche-humanitas-alla-milano-health-week-2026-dal-4-al-6-giugno-in-piazza-gae-aul-6a467d4b7615ac21 2026-05-29T07:47:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/tva-vardcentraler-diplomerade-som-antibiotikasmarta-f2081f1069ef6af3 2026-05-29T07:46:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/zauberei-und-ganz-viel-gelachter-f6fd734361237b1b 2026-05-29T07:17:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-announces-successful-completion-of-aspen-apac-divestment-1f5f1fe8f0731c8c 2026-05-29T07:07:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/dieci-anni-di-urologia-in-humanitas-un-evento-scientifico-dedicato-33db5c9db0a1efc6 2026-05-29T07:01:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-the-resignation-of-an-outside-director-and-partial-withdrawal-o-5d8a15c654c8b662 2026-05-29T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/naloxone-use-during-cardiac-arrest-linked-to-improved-survival-fc633278df4844af 2026-05-29T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/participez-a-la-marche-du-mont-des-cats-le-07-juin-7ff197e2640dbaef 2026-05-29T06:25:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/posting-of-annual-report-and-notice-of-agm-d8979b10e7344b37 2026-05-29T06:08:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunai-astrazeneca-expand-partnership-rancho-biosciences-releases-multi-omics-d-b6a84abe1ec4fe19 2026-05-29T05:01:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/fm-dts-7-8-cd15192213b3936f 2026-05-29T05:00:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/newsletter-poliagora-le-tossi-sono-tutte-uguali-calcolosi-renale-cosa-sapere-tal-6af0198225f06614 2026-05-29T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-coseal-6e693dc891d7b57f 2026-05-29T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-view-on-iss-voting-recommendations-20abf89d80615dfd 2026-05-29T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-july-2026-rare-disorders-advisory-committee-meeting-016877b1f23d9ce2 2026-05-29T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/posted-notice-of-convocation-of-the-206th-annual-shareholders-meeting-4ce9ab7a2df1a143 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-presents-new-phase-3-post-hoc-analyses-of-centanafadine-highlighting-impr-510d58f2f73b8b93 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-correction-the-efficacy-of-chemotherapy-is-limited-by-intratumoral-senesc-a9aa71b4ffdb44e3 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multimodal-interpretable-deep-learning-radiomics-framework-for-predicting-lymp-6ae5ef5ecf1aff13 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optically-detected-and-radio-wave-controlled-spin-chemistry-in-flavoproteins-234ba316e4eb7ca3 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-and-developmental-factors-shape-anti-aav-immunity-in-pigs-fab70446b4f2f3ea 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/closing-the-paediatric-gap-in-cancer-drug-development-a-call-to-industry-367ab281438ef043 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/better-data-for-better-medicines-a-path-to-data-driven-medicines-regulation-0b68ac6e556ea07a 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-appoints-miguel-regueiro-m-d-executive-vice-president-and-enter-4c404e656f4f581f 2026-05-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jose-javier-fuster-recibe-el-premio-esci-2026-por-su-excelencia-en-investigacion-586475daacf542a5 2026-05-28T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jonatan-r-ruiz-quot-son-pequenos-cambios-sostenidos-los-que-pueden-generar-grand-7ee48950f23d37db 2026-05-28T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecografia-intestinale-al-policlinico-di-milano-il-ruolo-centrale-dell-ecografist-d980d75aec2dc2a4 2026-05-28T21:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-choose-the-right-llm-for-medical-writing-422fe3dbc366e49b 2026-05-28T21:24:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/spring-convocation-prizes-for-graduates-in-the-faculty-of-medicine-and-health-sc-c43aa0c73a3d2199 2026-05-28T21:12:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-protocol-amendments-reveal-about-trial-design-a88f147ded836b99 2026-05-28T21:04:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogene-therapeutics-announces-planned-ceo-succession-e28d0c1bf76d0501 2026-05-28T21:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/estudio-sobre-el-degu-entrega-nuevas-pistas-sobre-la-vision-binocular-d8105a88f801ffa8 2026-05-28T20:21:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-simon-to-receive-helena-modjeska-cultural-legacy-award-3fb939798907f4e3 2026-05-28T20:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/continuous-manufacturing-strategies-for-scalable-mab-production-3448a06944ef5588 2026-05-28T20:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/continuous-manufacturing-strategies-for-scalable-mab-production-a911ecccd8d81b0f 2026-05-28T20:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-receives-64-5-million-contract-modification-for-bat-botuli-cae5bc81b9054d9e 2026-05-28T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/certara-s-nlme-engine-setting-the-standard-for-run-speed-and-stability-5e96be8dee99571c 2026-05-28T19:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiopharmaceutical-imaging-in-pivotal-trials-aligning-sites-cros-and-sponsors-f-3c3c72ebd662a184 2026-05-28T19:44:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cdc-data-signal-potential-coverage-losses-as-policy-decisions-threaten-access-to-321b3d44f4ef24bb 2026-05-28T19:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiopharmaceutical-imaging-in-pivotal-trials-aligning-sites-cros-and-sponsors-f-02d0eba1a28cb1cc 2026-05-28T19:32:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/saanta-collective-s-gaaf-fuses-traditional-and-modern-somali-dance-storytelling-9a3c4d1baa6d0bfc 2026-05-28T19:08:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/greenlight-guru-ai-what-we-ve-built-and-where-we-re-headed-cf3a15a61db87ca4 2026-05-28T19:04:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/graduate-supervision-and-teaching-award-for-nancy-mayo-2f18866a13e8447d 2026-05-28T18:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-grads-spring-convocation-2026-nos-diplomees-et-diplomes-a-l-honneur-col-4abd07ebf0db289b 2026-05-28T18:53:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/osler-awards-for-outstanding-teaching-go-to-caroline-massicotte-and-tiina-podymo-58c433b2335d8504 2026-05-28T18:28:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-andrew-lewis-featured-in-pharma-fundamentals-utilizing-artificial-intelligenc-860e12c11a6639c1 2026-05-28T18:24:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-boosts-bfs-capacity-with-strategic-manufacturing-investment-438cbc3d704515af 2026-05-28T18:16:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-lowdown-on-high-blood-pressure-what-the-hispanic-community-needs-to-know-8b6982a0707722cc 2026-05-28T18:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-grads-spring-2026-zoe-edger-lacoursiere-phd-in-rehabilitation-sciences-e534c6ef9d6e9c18 2026-05-28T18:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-human-longevity-partner-for-longevity-foundation-model-30bef1fcd4d63661 2026-05-28T18:10:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-do-i-pheel-this-way-new-video-podcast-series-sheds-light-on-navigating-adole-815ed2e3981c2201 2026-05-28T18:08:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/todo-lo-que-hay-que-saber-sobre-la-presion-arterial-alta-lo-que-la-comunidad-his-916839272943b6ad 2026-05-28T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partners-in-care-foundation-honors-scripps-health-ceo-5086f905de4dc651 2026-05-28T17:48:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-iso-13485-s-production-controls-apply-to-samd-8d127a8aacd28309 2026-05-28T17:39:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-advantage-out-of-pocket-limits-variation-and-trends-791c563a2b6dbfe0 2026-05-28T17:17:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-to-present-new-data-on-foundayo-mounjaro-and-retatrutide-at-the-american-d-02363a54fed2d035 2026-05-28T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-names-new-vice-provost-for-graduate-education-and-dean-of-graduate-div-1e9134c831722340 2026-05-28T16:58:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-aav5-purification-development-with-high-throughput-screening-dcb47b61975f8ba6 2026-05-28T16:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lentiviral-vector-purification-for-in-vivo-applications-9c1d21846eb40eb9 2026-05-28T16:42:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-your-study-workflow-is-broken-and-it-s-not-your-team-68b68efb0813fc7e 2026-05-28T16:31:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/tales-of-identity-and-uprising-win-book-awards-dbb3799d4bf20e2a 2026-05-28T16:15:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/trop2-adcs-progress-into-first-line-for-lung-breast-cancers-90f10f5858c73401 2026-05-28T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longbio-to-raise-hk-1-4b-in-hong-kong-ipo-for-immunology-work-40240cecc22ce7b2 2026-05-28T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recap-nord-living-rare-living-stronger-in-colorado-4691760d030880ad 2026-05-28T15:44:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/multinational-firms-drive-growth-but-can-come-with-steep-environmental-costs-stu-b78d339fb8cb778e 2026-05-28T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxford-academic-neuro-oncology-pediatrics-braf-pub-growth-recovery-in-patients-w-7423514632a4c599 2026-05-28T15:14:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-school-senior-can-t-attend-graduation-ceremony-due-to-surgery-so-caregivers-8a81b6aa6775ba76 2026-05-28T15:04:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-governance-at-the-site-practical-frameworks-sites-need-now-bb5e191256cff6aa 2026-05-28T14:44:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-videos-help-ease-anxiety-about-visit-to-the-dentist-c208b2fa5884ad42 2026-05-28T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/les-aidants-en-entreprise-le-secteur-pharmaceutique-poursuit-son-engagement-aupr-c57962547a9c2e4b 2026-05-28T13:19:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fat-molecule-inside-cell-nucleus-shifts-with-cell-division-dd13efe72b2f1f16 2026-05-28T13:05:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cherokee-language-learners-bridge-generations-with-ipad-and-mac-20b20be4f6e126ea 2026-05-28T12:59:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-of-artists-unveil-creativity-a6509ec2c3cb2086 2026-05-28T12:53:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/gustave-roussy-au-congres-de-l-asco-2026-537da8e40fcaf73c 2026-05-28T12:40:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-ceo-adam-mendelsohn-to-present-at-the-jefferies-global-healthcare-f7fd7f0abd6a5c37 2026-05-28T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-del-cese-de-comercializacion-retirada-del-mercado-y-recuperacio-6082694fb7dd843a 2026-05-28T12:19:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-nsc-recommends-targeted-prostate-cancer-screening-294a41659065e606 2026-05-28T12:18:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrafast-microscopy-method-for-optical-processes-89f90a2bed4e811c 2026-05-28T12:16:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-use-your-cgm-to-make-nutrition-and-lifestyle-changes-db4ee8424bff165d 2026-05-28T12:00:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-700-million-year-history-of-our-blood-cells-3a728fb5152a9187 2026-05-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-durable-immunotherapy-with-stem-cell-derived-cd4-t-cells-931728f13892a3ce 2026-05-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/graduate-school-of-engineering-hosts-kyoto-university-acs-publications-joint-for-dc46ab2f413d57b7 2026-05-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hantavirus-outbreak-revives-covid-era-false-health-claims-the-monitor-2c9ccdd67b84797a 2026-05-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bepirovirsen-achieves-unprecedented-functional-cure-rates-with-potential-to-rede-d55bb7051bf519bf 2026-05-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-crime-does-not-rot-africa-day-lecture-calls-for-radical-slavery-reparations-d1bd8483678dc6b1 2026-05-28T11:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/nwo-grant-awarded-for-legal-compass-in-the-digital-research-landscape-4af7a1b63ff61815 2026-05-28T11:31:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-inicia-los-ipt-de-los-medicamentos-que-han-obtenido-una-opinion-positiv-27242f2409cfed48 2026-05-28T11:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/editors-picks-may-2026-insights-into-car-t-therapy-neuron-tumor-crosstalk-in-pan-4c71624dc6f6a329 2026-05-28T11:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-to-present-at-the-jefferies-global-healthcare-conference-i-a24c06731e8c8689 2026-05-28T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-ebecfa9a57278e86 2026-05-28T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-launches-expanded-dpyd-test-to-identify-cancer-patients-at-risk-for-seve-843d651aed4b5ce9 2026-05-28T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-to-participate-in-the-jefferies-global-healthcare-conference-d916f12746cb110c 2026-05-28T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundayo-and-zepbound-now-covered-for-millions-of-americans-582bd1ae4fcc111a 2026-05-28T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/service-agreements-tailored-to-your-production-c8536cfce5ed0d4e 2026-05-28T10:13:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspektivwechsel-sonderausstellung-horizontal-im-medizinhistorischen-museum-678a76b4430ae2b7 2026-05-28T10:07:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/lung-cancer-treatment-is-evolving-with-smarter-combination-therapies-a2e9cb8ddd61b9aa 2026-05-28T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pep-symposium-building-trust-in-partnerships-12fde4a706381152 2026-05-28T09:41:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-reports-fourth-quarter-and-full-year-2025-results-ec337d1e6382f637 2026-05-28T09:29:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-boosts-bfs-capacity-with-strategic-manufacturing-investment-f7110c2dacefa0a5 2026-05-28T09:21:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-event-helps-shape-future-of-parkinson-s-services-612e6fc8c784f5cc 2026-05-28T08:45:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/si-puo-parlare-di-dermatite-da-stress-7cf5d4e8a07150ee 2026-05-28T08:32:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-blumen-gegen-krebs-blumengeschafte-in-ganz-deutschland-sammeln-96-460-euro-f-1f841fe6f865b270 2026-05-28T08:18:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/partnership-between-heidelberg-and-harvard-implementation-of-initial-projects-be-48aed5945c72e652 2026-05-28T07:58:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/eudamed-precisions-concernant-les-obligations-a-partir-du-28-mai-2026-504c5b0d6322ea1b 2026-05-28T07:22:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-high-potent-adc-vial-filling-lines-for-customers-in-china-641c83ccfb6c9bef 2026-05-28T07:03:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-biopharmaceutical-leaders-meet-japanese-prime-minister-to-reinforce-actio-1d243930d436e477 2026-05-28T07:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/lab-thread-integrating-workflows-to-replace-fragmented-systems-7005c49b0e587663 2026-05-28T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-launches-first-long-term-u-s-study-led-by-nurses-on-humanoid-robots-in-6e4285a6bbeb7727 2026-05-28T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bienvenue-aux-nouveaux-professionnels-des-hopitaux-universitaires-de-strasbourg-d84e072cce7b7336 2026-05-28T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-post-approval-evidence-is-redefining-the-future-of-patient-care-ab5ab21e24c6832c 2026-05-28T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/des-challenges-infectieux-pour-reveler-la-dynamique-du-virus-respiratoire-syncyt-b731b2c55616e6db 2026-05-28T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bnct-6c9f9d25bc631f44 2026-05-28T05:15:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-uc-abre-sus-puertas-para-el-dia-del-patrimonio-404868ff40a71c1a 2026-05-28T02:25:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-stage-cmc-development-service-overview-6fe2d7bd73010e94 2026-05-28T02:19:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-30-bs-fresh-faces-851276f0f6cf6892 2026-05-28T01:14:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-national-academy-of-sciences-brings-professor-emerita-mizrahi-into-fold-c3bc4f3a807da6e3 2026-05-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-claudins-in-cancer-a1b1c34bb89d0307 2026-05-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-oxford-launches-new-public-awareness-campaign-for-neurodevelopment-08f3acaebe2ff841 2026-05-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/christopher-l-augostini-named-22nd-president-of-emory-university-emory-universit-89e4d8817808c4f0 2026-05-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-s-aesthetic-business-solta-medical-earns-prestigious-trademark-cer-cd6efa3fa9de5468 2026-05-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bienestar-estudiantil-e-infraestructura-los-ejes-de-la-gira-uc-por-universidades-5bb0c6191eadc8e4 2026-05-27T23:49:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-decnupaztm-pivekimab-sunirine-pvzy-for-treatment-of-adult-patie-821ea2b634ab496e 2026-05-27T22:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiovascular-research-un-estudio-revela-diferencias-entre-los-dos-ventriculos-2724fb6eac4fa417 2026-05-27T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beone-medicines-announces-phase-3-herizon-gea-data-published-in-nejm-and-present-318623ef5be7f187 2026-05-27T21:07:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-herizon-gea-01-results-published-in-the-new-england-journal-of-medicine-16637e370205f3b5 2026-05-27T21:07:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotient-sciences-advances-ai-designed-drug-product-into-clinical-development-a67fbb811ec14c5e 2026-05-27T20:23:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-unlp-sera-sede-de-una-maraton-de-programacion-de-mujeres-4e164aeb69391257 2026-05-27T20:01:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-is-changing-is-pharma-marketing-changing-with-it-01d3608b9b6a452a 2026-05-27T19:08:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-is-changing-is-pharma-marketing-changing-with-it-b9e566f14d0f4db8 2026-05-27T19:08:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/drew-altman-founding-president-and-ceo-of-kff-announces-retirement-plans-board-a-8e0ccebd6d08f00b 2026-05-27T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/70-years-of-healing-science-and-humanity-celebrated-at-fmhs-gala-c18683fed7b3005a 2026-05-27T18:37:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fireside-chat-accelerating-14c-human-adme-by-integrated-radiosynthesis-gmp-manuf-19c2dda273013f3d 2026-05-27T18:22:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/recordati-performance-share-plan-2023-2025-resolutions-regarding-the-acceleratio-be2ebc76bd52d5b7 2026-05-27T17:54:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/marianjoy-driver-rehabilitation-program-supports-drivers-on-the-autism-spectrum-9c85da7a5cd31490 2026-05-27T16:09:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-hengrui-deal-strikes-panic-in-washington-60403d75de9672fe 2026-05-27T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-reveals-blood-stem-cells-can-remember-inflammation-6297648b764af8dc 2026-05-27T15:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-727b6fd3f5115f29 2026-05-27T15:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viridian-awaiting-fda-decision-taps-wuxi-bio-in-eye-drug-supply-deal-e0a724373fab6f77 2026-05-27T15:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-lab-building-histology-capabilities-for-modern-clinical-trials-q-a-wi-cbf49e57975e7b7b 2026-05-27T14:42:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-questions-with-nurse-and-rare-patient-advocate-jill-pollander-f52f0d4747526e4c 2026-05-27T14:28:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-oxford-scientists-elected-fellows-of-the-royal-society-a495dfddeb645c59 2026-05-27T14:28:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/gelijkspel-workshop-during-student-wellbeing-week-c0b4f3d6a4b7245a 2026-05-27T14:05:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-facts-about-health-care-affordability-for-people-with-medicare-e66c7cc1f40227f0 2026-05-27T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-medical-frailty-exemption-from-medicaid-work-requirements-key-issues-to-watc-7eb2415879cdc0f3 2026-05-27T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-reproduction-the-ovary-as-a-systemic-regulator-of-female-health-and-aging-3769bc970d5814d3 2026-05-27T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/disease-experts-join-study-of-andes-hantavirus-6bdc18ff0ed576a4 2026-05-27T13:57:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-diabetes-association-scientific-sessions-2026-2671ff14e1708300 2026-05-27T13:49:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/annual-youth-day-lecture-confronts-the-widening-gap-between-degrees-and-jobs-9e96b3304aaa630c 2026-05-27T13:39:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-just-bought-renowned-regulator-peter-marks-a-pipeline-to-play-with-7bfc9745be0198ea 2026-05-27T13:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbc-ideas-film-highlights-urine-test-for-endometriosis-c07c38013d26d54e 2026-05-27T13:04:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/backbeat-timeline-update-reinforces-momentum-to-pivotal-trial-data-presentation-9b29287b1d58710f 2026-05-27T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-we-ready-for-the-next-wave-of-proximity-degraders-56a555a49e568629 2026-05-27T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chirurgie-robotique-une-premiere-francaise-dans-le-cancer-de-l-sophage-4fd4496fc15ab07e 2026-05-27T12:40:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/igr-4135-58800a0881bfeeaa 2026-05-27T12:30:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cset-4323-8654c54a14e61793 2026-05-27T12:28:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-to-present-at-the-jefferies-global-healthcare-conference-5a13928225538223 2026-05-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/award-for-heidelberg-evolutionary-geneticist-6066009f2dc33867 2026-05-27T11:20:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-pixels-to-patients-how-aacr-on-campus-is-transforming-cancer-research-in-co-3c3e0802d4d9a5f7 2026-05-27T11:03:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/body-by-apyx-takes-center-stage-at-miami-swim-week-showcasing-real-patient-trans-d508b0457a59297c 2026-05-27T11:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-reports-first-quarter-2026-financial-results-and-provides-corporate-up-64e527a32d278020 2026-05-27T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-to-participate-in-the-goldman-sachs-47th-annual-global-heal-b0c3d55a630908e8 2026-05-27T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arctic-food-chain-hit-as-tipping-point-passed-b09c713c6918536e 2026-05-27T10:41:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/puesta-en-marcha-de-recops-la-nueva-aplicacion-para-el-registro-de-comercializac-488b6c24d1983d4f 2026-05-27T10:21:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-receives-fda-clearance-for-subtlehdtm-pet-next-generation-ai-powe-350a4b7dae70b99e 2026-05-27T10:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-interferon-and-brain-development-new-clues-about-neurodevelopment-disor-0626d69d5d6dbc09 2026-05-27T10:08:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-manufacturer-cordenpharma-strikes-deal-for-peptide-cdmo-lining-up-new-prod-054ed5c9b55f2689 2026-05-27T10:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-the-whistle-with-brendan-hunt-and-rebecca-lowe-returns-130742743f419f50 2026-05-27T09:59:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/cset-4317-df0d284abbadae44 2026-05-27T09:42:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/cset-4316-003d09ceb01f1ea5 2026-05-27T09:38:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-future-ready-talent-how-we-hire-for-what-comes-next-8d496ab176a36a20 2026-05-27T09:22:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/john-mccafferty-the-antibody-pioneer-c2684382d8932e1d 2026-05-27T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lebensretter-auf-vier-radern-das-ecmobil-der-charite-b6474f603b272713 2026-05-27T08:16:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-achieves-gmp-release-of-18th-drug-product-facility-advancing-inte-c4c03d91444c4f78 2026-05-27T08:07:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-future-of-organ-transplants-xenotransplantation-3d-bioprinting-and-stem-cell-3102293b24cce75c 2026-05-27T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antimetaboliten-im-fokus-neue-emmy-noether-nachwuchsgruppe-erforscht-wirkmechani-2ff3279783b341d7 2026-05-27T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erasmus-university-reaches-the-highest-point-of-the-renovated-tinbergen-building-48bf6ad3492a08d2 2026-05-27T07:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/invanare-far-snabbare-hjalp-nar-1177-i-vastra-gotaland-vaxlar-upp-fe64b81de63ca5d4 2026-05-27T07:00:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-mind-institute-seeks-research-partners-in-the-community-6f79b98c966c2233 2026-05-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spine-surgery-with-custom-lumbar-implants-helps-woman-move-again-without-pain-31b27f72b755c570 2026-05-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-q-a-what-is-ebola-and-how-uc-davis-health-is-uniquely-prepared-to-evaluat-3d18cc1a41f509f9 2026-05-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-it-world-vip-conference-exploring-breadth-vs-depth-1b006246c4de30b3 2026-05-27T05:01:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-launches-the-liver-disease-panel-the-first-suite-of-certified-algorithms-t-27e58d6853dfe2b9 2026-05-27T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/5x1000-10-811-scelte-di-fiducia-per-il-policlinico-di-milano-grazie-a-chi-ha-sce-d1f4a78303030527 2026-05-27T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-university-joins-the-2050-alliance-f0f19db47be0aaa7 2026-05-27T03:28:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/yakkyokukata-schedule-of-jp19-i-publication-posted-ffde47ed0ce6d054 2026-05-27T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stigmar-xtra-d370fa2e7e7d7c12 2026-05-27T02:35:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/stigmar-xtra-ef576688907ea99a 2026-05-27T02:35:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-centro-que-transformo-el-desierto-de-atacama-en-un-laboratorio-natural-para-e-f73e693804ffd661 2026-05-27T00:22:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/scoring-gene-importance-by-interpreting-single-cell-foundation-models-d81a20b3e59c1f73 2026-05-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-analysis-finds-bempedoic-acid-reduces-risk-of-serious-blood-clo-2b67c1de7227dd6b 2026-05-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/angela-dash-to-join-emory-university-ombuds-office-emory-university-atlanta-ga-aa73dbea65d4f582 2026-05-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-to-present-at-the-jefferies-global-healthcare-co-ddb0cd4909378be8 2026-05-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-05e72784a6cf2903 2026-05-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-infectious-diseases-data-observatory-awarded-coretrustseal-certification-fb1503783f75a992 2026-05-26T23:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leon-xiv-y-la-inteligencia-artificial-una-enciclica-que-interpela-al-mundo-unive-87ef761bd76bb8df 2026-05-26T22:37:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/stress-before-conception-may-influence-offspring-growth-cu-anschutz-study-finds-582dfaa810d39869 2026-05-26T22:22:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-in-the-package-how-components-influence-yield-risk-e041263761ac1939 2026-05-26T20:25:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-to-participate-in-the-goldman-sachs-47th-annual-global-heal-2434723298394ad0 2026-05-26T20:14:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-modeling-advantage-how-forward-thinking-sponsors-are-moving-faster-de-riskin-0b511d7056c8a7ab 2026-05-26T19:57:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-receives-nih-funding-award-notice-to-advance-dare-01f5a5d3bbe8cf26 2026-05-26T18:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/driving-share-of-answer-through-optichannel-engagement-in-the-ai-era-9eb4178724c0f60d 2026-05-26T17:38:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-announces-third-quarter-2026-dividend-f94b001c2ae2fa9c 2026-05-26T17:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-key-mental-health-and-substance-use-policy-actions-under-the-trump-admi-231b6f790ef26a64 2026-05-26T17:26:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/labopat-diagnostics-goes-live-with-techcyte-fusion-expanding-access-to-digital-p-692129f233298856 2026-05-26T17:12:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-of-ketogenic-therapy-for-early-psychosis-funded-by-baszucki-group-7013391f2ffc162c 2026-05-26T16:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-announces-three-acquisitions-to-build-infectious-disease-portfolio-5f9bcfd6506b2ba4 2026-05-26T16:23:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/oct-uk-ireland-2026-ddd6de18398fe85c 2026-05-26T15:52:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/sweat-equity-a6b17a43f9a86732 2026-05-26T15:44:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/certainty-us-2026-recap-advancing-model-informed-drug-development-right-from-the-3205ff6067da2259 2026-05-26T15:26:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/premiere-exceptionnelle-en-france-un-quadruplet-de-dons-croises-renaux-realise-e-8d02a14d1ab72aed 2026-05-26T15:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/tennor-s-80m-hong-kong-ipo-to-fund-antibacterial-drug-pipeline-28f01e1b874d32db 2026-05-26T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-with-medpace-s-two-new-neurology-experts-68fe01e0a49a85b5 2026-05-26T14:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-somatosensory-input-drives-membrane-potential-dynamics-in-motor-corte-78b3da02bce3fbf9 2026-05-26T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-note-the-signal-sequence-coding-region-promotes-nuclear-export-of-mrna-2caf34afef1b0fed 2026-05-26T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-germline-immortality-to-somatic-rejuvenation-unlocking-the-ovarian-blueprin-0853db6f70c7964c 2026-05-26T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remembrance-of-things-past-towards-a-life-course-biology-of-aging-b94be046c36814a9 2026-05-26T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frank-ruschitzka-erhalt-auszeichnung-fur-sein-lebenswerk-0e25f66d1c43d2ac 2026-05-26T13:47:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/may-26-2026-3-30-pm-edt-td-cowen-7th-annual-oncology-innovation-summit-insights-e90599261e0a8410 2026-05-26T13:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/june-3-2026-8-10-am-edt-jefferies-global-healthcare-conference-new-york-308e1d00c5cd216c 2026-05-26T13:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/june-9-2026-h-c-wainwright-4th-annual-cell-therapy-virtual-conference-5e6e8acfe7929706 2026-05-26T13:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacovigilance-and-safety-reporting-requirements-for-clinical-trials-c4a39d134721f10f 2026-05-26T13:40:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ricerca-malattia-di-charcot-marie-tooth-di-tipo-2a-identificati-i-primi-biomarca-3f10575843450b42 2026-05-26T13:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapies-ciblees-et-anticorps-une-vague-d-innovations-sans-precedent-arrive-sur-59599ee03bf696af 2026-05-26T13:11:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-fragen-an-unser-neues-boardmitglied-jerome-garcin-general-manager-for-switzerl-8e36d2a77f965e39 2026-05-26T13:07:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotle-s-fcrn-inhibitor-btl-203-cleared-for-clinic-in-china-90dfe51c666da367 2026-05-26T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/london-hospital-teams-join-forces-to-save-4-year-old-girl-6de5e8fb9b45c3a7 2026-05-26T12:57:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-startup-delays-often-begin-with-electronic-data-capture-design-897642260eb03244 2026-05-26T12:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogene-therapeutics-announces-participation-in-upcoming-investor-conferences-b8ed581d86e86f28 2026-05-26T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-participation-in-upcoming-investor-conferences-9756a46c0965f625 2026-05-26T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-challenges-into-opportunities-5085684ea397f591 2026-05-26T12:04:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-empresas-mais-inovadoras-da-forbes-brasil-eb944642aeb6efb4 2026-05-26T12:02:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-to-showcase-long-term-outcomes-and-pipeline-expansion-with-latest-oncology-r-b5a72454ce6ba1a9 2026-05-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/journee-mondiale-de-la-recherche-une-maison-de-la-recherche-au-c-ur-de-l-activit-a7a4dc5ed6790ef5 2026-05-26T11:34:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-announces-positive-independent-blinded-biomechanical-gait-analyses-demon-f4f3e19d5fd6e122 2026-05-26T11:16:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniid-tapeworm-detection-de3dc753e32f4fb4 2026-05-26T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prestigious-award-for-heidelberg-pain-researcher-3646c759169fd74e 2026-05-26T10:47:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-announces-three-acquisitions-to-build-infectious-disease-portfolio-3797ce71334566b2 2026-05-26T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adcs-remain-in-dealmakers-sights-here-s-why-d1f8f460f81bf8ba 2026-05-26T10:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-team-paul-verdin-a53037962bd12701 2026-05-26T10:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/entwicklung-aus-heidelberg-revolutioniert-hepatitis-d-therapie-weltweit-us-arzne-8ecea66a273a747d 2026-05-26T10:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/join-us-online-european-commission-samira-study-workshop-on-updated-criteria-for-ad43c17254bb60ad 2026-05-26T09:53:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-bioscience-links-up-with-colombia-to-enable-local-production-of-varicella-vac-995b17cfa43adcc3 2026-05-26T09:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxford-researchers-develop-wearable-ultrasound-patch-for-continuous-pregnancy-mo-a9a43531ca6a2191 2026-05-26T09:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-photon-counting-ct-scanner-to-enhance-patient-care-and-unlock-cardio-respira-30139f6c6ea96a41 2026-05-26T09:06:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/jyseleca-104a3f598184366f 2026-05-26T09:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-comment-landmark-plans-to-accelerate-rare-disease-treatments-in-the-uk-ar-0be4850275760a36 2026-05-26T08:45:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/9da26e92c7f994ef 2026-05-26T08:39:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/children-s-health-and-development-are-linked-to-just-about-everything-fa2acdc282b931ff 2026-05-26T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/des-soignant-et-des-patients-des-hus-mobilises-pour-sensibiliser-au-don-d-organe-8744ffdab8a1d4ae 2026-05-26T08:21:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-at-scale-does-it-deliver-6f49ce0d9cf7f62e 2026-05-26T08:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pushing-the-prostate-cancer-treatment-frontier-radioligand-therapy-and-beyond-7bc3323bf096967f 2026-05-26T07:52:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/santexpo-2026-recompenses-et-presents-les-hus-ont-porte-leurs-ambitions-4e15ed0f8bb4887f 2026-05-26T07:42:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-do-you-deal-with-traffic-nuisance-ba4bd24694fb67ba 2026-05-26T07:32:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-really-witnessed-it-first-hand-how-personal-experience-shapes-loubna-ouriaghli-f017ad51af9c8821 2026-05-26T07:20:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-successfully-places-senior-bonds-of-chf-200-million-c80c89f055954a5e 2026-05-26T07:18:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-announces-five-year-corporate-strategic-plan-to-deliver-greater-value-f-ac47c4020dc97135 2026-05-26T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ci-avete-aiutato-a-essere-mamma-e-papa-quando-noi-non-osavamo-crederci-una-lette-6fc8a10e35c36461 2026-05-26T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pourra-t-on-hiberner-un-jour-355128553445a738 2026-05-26T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/follow-the-money-ai-drug-design-engine-treating-multiple-myeloma-quantum-healthc-b7747732415c3366 2026-05-26T05:01:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/autistic-australians-three-times-more-likely-to-be-homeless-3b980a1e3ad391e7 2026-05-26T03:18:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-elevidys-and-vyjuvek-gel-f79a456758e09e7e 2026-05-26T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxiatm-truesite-targeted-integration-cell-line-development-for-high-protein-exp-d77d08b980a318d4 2026-05-26T02:49:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-513fe6205c08e3cb 2026-05-26T02:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-receives-8220-the-imperial-invention-prize-8221-the-highest-honor-of-the-e66563907bdab4f8 2026-05-26T02:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-extending-consultation-period-on-the-proposed-changes-to-diabetes-medici-3d2e71bc8085a463 2026-05-26T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-august-2026-cancer-treatments-advisory-committee-ctac-meeting-da2550bb410e0d17 2026-05-26T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-june-2026-cancer-treatments-advisory-committee-ctac-meeting-b37d18c995f4b430 2026-05-26T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/old-drugs-new-tricks-fda-s-drug-repurposing-initiative-9fbbb44a7f818cfd 2026-05-26T01:06:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/added-value-of-ctdna-testing-with-primary-treatment-for-metastatic-prostate-canc-9da5511942c0535f 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/docter-a-genetically-encoded-switchable-protein-module-for-er-mediated-transcrip-a66a491e08a138a2 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/characterization-of-car-t-cell-factors-that-contribute-to-myeloid-cell-activatio-99ea21e1406af08f 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-to-manufacture-teikoku-seiyaku-s-rhmmp-7-drug-substance-5215a7519ec9ecfe 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-analysis-finds-geographical-differences-in-access-to-donor-lungs-transplants-89bceac15cda0694 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspira-women-s-health-and-cleveland-clinic-expand-strategic-collaboration-to-adv-7c0cfd0de3755dd8 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-golf-wins-second-consecutive-ncaa-division-iii-championship-emory-univer-c9f9f075e4600193 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-06-01-awards-professor-emerita-caroline-sy-hau-receives-f-a8f95a83a0c494fb 2026-05-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/niowave-kicks-off-construction-of-75m-radiopharmaceutical-isotope-plant-in-michi-d57e38d86a8865d6 2026-05-25T23:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mostra-prendersi-cura-uno-sguardo-poetico-sull-arte-dell-aiuto-fino-all-8-giugno-cea2dcebc3933175 2026-05-25T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pelvic-pain-awareness-month-q-a-with-dr-tania-di-renna-ac2c8168a7a10f8a 2026-05-25T17:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-device-development-lifecycle-key-stages-from-concept-to-commercializatio-37a63f5d364ecfef 2026-05-25T15:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/chronic-myelomonocytic-leukemia-a-new-genetic-map-to-reinterpret-the-disease-and-b1f41de49ae5f81b 2026-05-25T14:46:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-tool-launched-to-help-people-through-grief-f65e3622f9422767 2026-05-25T14:37:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/blockbuster-sales-lawsuits-and-approvals-is-there-a-recovery-in-sight-for-bayer-31c413b939ed9856 2026-05-25T13:15:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/plate-and-screw-hardware-removal-set-f46f3cb9a0ad669b 2026-05-25T12:55:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/estonian-state-agency-of-medicines-among-europe-s-best-314307b9f00ccef3 2026-05-25T12:12:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/greater-manchester-is-leading-fight-against-lung-cancer-as-national-screening-hi-24da2d20a1d2db39 2026-05-25T12:00:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-the-mechanisms-of-collective-cell-movement-82b5f72bdb22c8e8 2026-05-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ashbi-international-workshop-for-data-science-x-mathematical-modeling-c21f014ed7aa30e4 2026-05-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-how-model-informed-drug-development-is-becoming-evidence-276dfcd6f4b2fed2 2026-05-25T11:15:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ricerca-brawo-un-nuovo-studio-europeo-del-policlinico-di-milano-per-capire-come-6f01d044adef8bc9 2026-05-25T10:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/upcycling-method-offers-plastic-waste-solution-4c93f219660f214d 2026-05-25T10:09:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-556efa3f6b3ec266 2026-05-25T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-la-deteccion-de-un-defecto-de-calidad-en-el-medicamento-vete-9a4126dc188d044b 2026-05-25T09:08:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/nicilan-40-mg-10-mg-comprimidos-para-perros-y-gatos-no-1814-esp-f6823f60a2a287af 2026-05-25T09:06:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/706daf0cbab289b4 2026-05-25T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organizational-and-personnel-changes-5c378c3d8a9b0ae4 2026-05-25T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/okad-livskvalitet-med-hjalp-av-verklighetstrogna-proteser-efe1ec3d698296ad 2026-05-25T05:59:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoya-miyosmart-6-1-77561bd9ece96020 2026-05-25T05:51:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-research-6-ways-we-ve-turned-evidence-into-impact-1e36048f46cf895b 2026-05-25T05:00:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-vishnunath-5ab615c8835cb761 2026-05-25T04:24:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-jitendra-narayan-24200e38f702284f 2026-05-25T04:24:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/alzheimer-s-linked-protein-found-to-shape-long-term-memories-6d6aa595e4003e08 2026-05-25T03:09:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/kokusai-registration-for-the-asean-japan-medical-devices-regulatory-symposium-is-8a8d7235e3734f3a 2026-05-25T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-05-28-research-graduate-school-of-engineering-hosts-kyoto-ab0755a1c86f2260 2026-05-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/copper-depletion-boosts-cns-leukemia-therapy-by-inhibiting-nucleotide-synthesis-9efd44845464919a 2026-05-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gemcitabine-and-nab-paclitaxel-with-or-without-the-vdr-agonist-paricalcitol-for-cb1cc5611833b86d 2026-05-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-progress-and-development-strategies-of-antibody-oligonucleotide-conjuga-6063290e5f06a359 2026-05-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-analysis-of-encorafenib-in-untreated-braf-v600e-mutant-metast-29ac30b6e9ffc3c4 2026-05-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/access-gap-2026-polska-pozostaje-liderem-panstw-v4-w-dostepie-do-innowacyjnych-t-22e7acbb90135f54 2026-05-24T22:24:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-investigadora-annalaura-mastrangelo-recibe-el-premio-jovenes-investigadores-2-bd35ac5e8f3c894f 2026-05-24T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rovi-refuerza-su-compromiso-con-las-personas-que-viven-con-esquizofrenia-9560f979d8e99d4a 2026-05-24T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-the-u-s-stepping-up-in-the-fight-against-ebola-bbef47bced9e2909 2026-05-23T15:54:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-and-the-sapc-crack-down-on-unlawful-manufacturing-of-unregistered-glp-1-g-ff3331653070c3d7 2026-05-23T12:12:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/79th-world-health-assembly-wha79-draft-updated-global-action-plan-on-antimicrobi-cbdcff94a678cf57 2026-05-23T11:33:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/79th-session-of-the-world-health-assembly-wha79-harmonization-of-regulatory-appr-158162c6445016f9 2026-05-23T11:13:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/il-futuro-della-sanita-milanese-apre-le-porte-successo-per-l-open-day-del-nuovo-28e3921ecd07dc43 2026-05-23T10:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-makary-s-ouster-another-win-for-lilly-s-triple-g-and-more-d93d5c98fa773b35 2026-05-23T10:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-utilization-and-use-of-implantable-cardiac-monitors-in-syncope-of-unk-cf7fdc205fc3e80b 2026-05-23T02:26:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fachada-consejo-78a7ce12b5eb0cf6 2026-05-22T22:11:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/newsletter-dottoressav-la-favola-della-neomamma-sempre-radiosa-e-una-truffa-f97d042e6efb778b 2026-05-22T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-do-i-still-feel-different-after-the-covid-19-pandemic-bd6550d9c10ec029 2026-05-22T21:43:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-promove-encontro-internacional-sobre-crise-climatica-e-cenario-global-6fb81598bdfc5339 2026-05-22T21:18:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/formazione-05-06-malattia-celiaca-focus-femminile-d87251ef70662d5f 2026-05-22T21:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scripps-physician-explains-new-name-for-common-hormonal-condition-129833d1219dfc48 2026-05-22T20:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/argentina-fortalece-su-posicionamiento-en-investigacion-clinica-farmacologica-428894cc532480c8 2026-05-22T18:53:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ask-your-cro-to-use-pinnacle-21-enterprise-801861f9fcdc887a 2026-05-22T18:39:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-clears-gilead-s-hepatitis-d-drug-four-years-after-prior-rejection-9537d96be31c4ea9 2026-05-22T18:35:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/gop-lawmaker-asks-trump-administration-to-curb-china-biotech-deals-abd6311f3e1ed482 2026-05-22T17:50:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-american-diabetes-association-honors-senator-scott-wiener-with-a-lifetime-ac-9e66fde3834d3ba6 2026-05-22T17:39:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-american-diabetes-association-honors-senator-laura-richardson-with-a-rising-c7af059c7f9c7a09 2026-05-22T17:37:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/em-ano-de-35-anos-interfarma-consolida-protagonismo-e-resultados-que-moldam-a-ag-93b694251bdffba1 2026-05-22T17:32:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-wins-eu-backing-for-breast-cancer-drug-splitting-with-fda-panel-3031757e0cb68aab 2026-05-22T16:47:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-is-hard-43north-invests-1m-in-teams-built-for-it-3ae68a0e23cc6ad8 2026-05-22T16:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-utah-s-ai-prescribing-experiment-is-going-so-far-911a62a589f8cb1c 2026-05-22T16:25:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-workforce-instability-slows-scientific-progress-a3ddf3250c6f6cc9 2026-05-22T16:21:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-u-s-president-s-emergency-plan-for-aids-relief-pepfar-defb8c42501eaf3a 2026-05-22T16:00:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-international-meeting-at-cnio-explores-whether-diet-and-exercise-can-help-tre-cf26893c44db2c7d 2026-05-22T16:00:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-daiichi-sankyo-and-astrazeneca-s-datroway-a-key-breast-cancer-approva-b1adf4be0560cd15 2026-05-22T15:28:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-excuse-for-abuse-280cd8a8b16fc658 2026-05-22T15:22:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/tender-offer-for-recordati-sobi-s-gout-drug-passes-phase-3-test-756f9229ad01b408 2026-05-22T15:14:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-timely-precise-lab-data-drive-decisions-from-discovery-to-post-marketing-sur-1008f5c0ed6723ed 2026-05-22T15:09:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-timely-precise-lab-data-drive-decisions-from-discovery-to-post-marketing-sur-e1b6d101e4004cbf 2026-05-22T15:09:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/john-carroll-and-dr-zachary-roberts-discuss-interim-alpha3-findings-and-the-futu-584a8a7d87b72689 2026-05-22T15:05:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-therapy-boost-for-advanced-liver-disease-treatment-2f811d795dc65afc 2026-05-22T15:04:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/abpi-welcomes-rare-diseases-research-landscape-report-ab2fb861b0785114 2026-05-22T15:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-we-need-the-new-rare-therapies-launch-pad-a50f23c3651b2d11 2026-05-22T15:03:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/abpi-response-to-the-government-s-commitment-to-boost-research-by-improving-acce-1c367b292b85f67e 2026-05-22T15:02:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/entry-japan-with-clarity-execute-with-confidence-987ce8efa788f4a3 2026-05-22T14:49:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuevo-proyecto-para-la-opinion-publica-6ebc07bcfa322fd9 2026-05-22T14:12:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-health-assembly-wha79-fight-the-fakes-alliance-statement-on-substandard-an-3324434d07e846a9 2026-05-22T14:08:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-the-stem-cell-potential-in-the-human-hippocampus-to-limit-cognitive-a-f92680c5984f60c6 2026-05-22T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-news-how-are-fda-and-ema-expectations-for-pediatric-investigation-pla-954807452d18491b 2026-05-22T13:55:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/opioid-addiction-linked-to-increased-risk-of-dementia-ce6c687ace4a771e 2026-05-22T13:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hommage-a-ceux-qui-ont-fait-l-hopital-d-aujourd-hui-d9507a2288ecea43 2026-05-22T13:16:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-one-health-ai-unicorn-is-giving-away-its-service-for-free-526bf973fce5f50e 2026-05-22T13:06:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-says-avidity-s-science-could-apply-beyond-muscular-dystrophies-107c5138c6c81975 2026-05-22T13:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/valeria-maria-susanne-a6db1706d7af7fa7 2026-05-22T12:32:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/musa-a48aa3c63ba0d87b 2026-05-22T12:30:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/camilo-augustin-8768262e35f1b208 2026-05-22T12:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anika-19dc9061991b8872 2026-05-22T12:27:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/thashivka-ebe6a342f411dda1 2026-05-22T12:25:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/robin-klaas-8f7caac28a7f1d33 2026-05-22T12:23:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/magnetic-resonance-imaging-safety-in-patients-with-conditional-mixed-manufacture-789fd84ed2d7782e 2026-05-22T12:22:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/mattheo-dda5c3c698c9452f 2026-05-22T12:21:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/leon-4ac70b6cfec4e880 2026-05-22T12:19:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/nayla-61836a3975b0f794 2026-05-22T12:17:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/accrual-based-capital-gains-tax-the-best-route-for-box-3-reform-55f093261232f751 2026-05-22T12:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pacing-induced-cardiomyopathy-in-leadless-and-transvenous-pacemakers-a-meta-anal-c6df7137d75fbfae 2026-05-22T12:10:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/access-to-answers-bridging-the-gap-to-genetic-expertise-653ae2452fc7490f 2026-05-22T12:04:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/lsx-nordic-congress-2026-what-came-out-of-the-biotech-partnering-event-0f1ce7bb035621ab 2026-05-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-porous-gel-changes-appearance-by-sensing-target-molecules-through-coordinati-f1a2a32a41716b52 2026-05-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-announces-the-election-of-william-k-dan-daniel-as-independent-chair-0ff700129fa5fafa 2026-05-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-announces-positive-chmp-opinion-for-maviret-glecaprevir-pibrentasvir-for-befcf54fb7f4a06b 2026-05-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-receives-positive-eu-chmp-opinion-for-keytruda-pembrolizumab-plus-padcev-e-d664e52ac3db357b 2026-05-22T11:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ema-s-human-medicines-committee-recommends-wegovy-in-tablet-form-1fd61f2f70f2e59a 2026-05-22T11:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evelina-london-staff-honoured-at-royal-garden-party-4872013b6cbf2be2 2026-05-22T11:32:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-establece-una-nueva-sustancia-de-referencia-farmacopea-argentina-54da355fb61bbc5c 2026-05-22T11:25:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/biogen-denali-to-drop-drug-in-non-genetic-parkinson-s-after-mid-stage-study-flop-3ce3598d5e496ba7 2026-05-22T11:09:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibrance-heirs-gilead-s-tubulis-data-and-more-at-asco26-b0d0c26e35a4972e 2026-05-22T11:05:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-research-pharmacy-a-blog-by-dr-beatriz-duran-head-of-pharmacy-clinical-ee43fd571d15b440 2026-05-22T11:04:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-alabama-at-birmingham-bb3a7ddbf936b625 2026-05-22T11:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/chatham-county-public-health-department-e38bae6c4e9110d9 2026-05-22T11:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-cfo-to-follow-david-reese-into-retirement-josh-smiley-is-out-at-zai-lab-07260d60763fe719 2026-05-22T11:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-and-hemispherian-as-highlight-new-data-on-glix1-at-the-american-societ-8cd3d3556339c3be 2026-05-22T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/academy-of-medical-sciences-elects-five-oxford-researchers-as-new-fellows-8c727accc8f2851b 2026-05-22T09:59:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-pccp-requirements-for-ai-samd-greenlight-guru-9f542e3f6e682080 2026-05-22T09:49:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/79th-world-health-assembly-wha79-rare-diseases-a-global-health-priority-for-equi-d0103c984b78771a 2026-05-22T09:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/79th-world-health-assembly-wha79-reform-of-the-global-health-architecture-and-th-ff06ca6fddd5b2d1 2026-05-22T08:30:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-interpharma-lehnt-kvv-revision-ab-grosse-risiken-fur-die-patien-9ff87a5ffed6edb8 2026-05-22T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/titan-a-translational-research-project-for-new-therapies-against-liver-cancer-da003224d7103713 2026-05-22T08:18:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bipedalism-may-have-had-a-more-circuitous-evolutionary-route-than-previously-tho-30dea57e1e271491 2026-05-22T08:12:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/melanoma-skin-cancer-cases-hit-a-record-high-in-the-uk-78329e2cc4c45f9d 2026-05-22T08:04:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-problem-at-the-heart-of-drug-discovery-lexogen-ochre-bio-on-the-power-of-ai-569c8ddabd6fa4cb 2026-05-22T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maarten-kroeze-appointed-as-president-of-the-dutch-supreme-court-26b22b08cfc74423 2026-05-22T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wearable-gps-data-expands-understanding-of-schistosomiasis-transmission-b5f55f79f19688a2 2026-05-22T07:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-results-of-capital-increase-by-way-of-third-party-allotment-not-9baf00c309ad03b9 2026-05-22T07:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erasmus-university-rotterdam-in-top-3-most-attractive-employers-in-the-public-se-81b61f23e265db12 2026-05-22T07:33:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/nar-diagnosen-landar-patientforeningen-kliver-fram-8ad0610be7b58e86 2026-05-22T07:24:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-research-provides-important-insights-into-diabetic-ketoacidosis-95e0f244307cf837 2026-05-22T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-informiert-uber-den-gesundheitszustand-des-an-ebola-erkrankten-patienten-f4ce277126760eba 2026-05-22T06:58:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-issues-update-on-the-condition-of-ebola-patient-044b2e0d6818ead8 2026-05-22T06:58:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-expands-export-operations-with-new-pharmaceutical-supplies-to-the-united-a9cda65e751f4ccf 2026-05-22T06:15:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-behalf-of-respighi-bidco-s-p-a-voluntary-totalitarian-tender-offer-launched-b-8ef08368b2f4cb92 2026-05-22T06:14:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-on-behalf-of-cvc-capital-partners-ix-aggregator-sca-sicav-raif-sub-d4a5d337c8214c41 2026-05-22T06:07:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/at-bio-it-world-s-25th-anniversary-rare-disease-takes-center-stage-ecfa985b5f4ce3f1 2026-05-22T05:01:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-29-05-smettere-di-fumare-si-puo-consulenze-gratuite-al-centro-antifu-2f9263ac35b0219f 2026-05-22T04:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-announces-pricing-of-us-60-0-million-public-offering-of-securities-daee113d666bd169 2026-05-22T03:28:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-the-new-website-overview-of-orphan-drug-designation-launched-0676916dd23cb9b4 2026-05-22T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-the-new-website-designation-early-access-launched-add813344cad5304 2026-05-22T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tumor-irradiation-promotes-antigen-dressing-of-dendritic-cells-to-enhance-car-t-cc8ab892fc4091d3 2026-05-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-joe-to-george-rethinking-age-survival-and-quality-of-life-with-durable-lvad-95f032ccdbaf8134 2026-05-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-expands-partnership-with-second-harvest-through-2-5-million-com-86e5a31b853a2aeb 2026-05-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/students-discuss-work-across-disciplines-at-annual-undergraduate-student-researc-c606e3302aa48427 2026-05-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/padcevtm-enfortumab-vedotin-in-combination-with-keytruda-pembrolizumab-receives-676f22c9a35d3210 2026-05-21T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-announces-new-data-at-asco-2026-demonstrating-breadth-and-momentum-across-50ddaed0633ade68 2026-05-21T22:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dermatologische-eigenpraxis-der-kv-sachsen-in-ebersbach-neugersdorf-eroffnet-d57a43eaaaeea089 2026-05-21T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-immunology-las-mitocondrias-controlan-la-activacion-de-las-celulas-inmun-59811e0da4776ed9 2026-05-21T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-fgfr3-pathway-activation-in-patients-with-muscle-invasive-bladder-canc-079beeb6bc0f0843 2026-05-21T21:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-hla-genotyping-algorithm-shows-extremely-high-accuracy-and-concordance-bet-5ab11db3a66850e8 2026-05-21T21:30:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/retrospective-evaluation-of-an-ai-based-fusion-prioritization-agent-for-oncogeni-e65e9945a6b27cec 2026-05-21T21:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/provider-insights-and-utilization-of-psychiatric-pharmacogenomics-for-patients-w-cb1fc12eddb898a2 2026-05-21T21:30:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-classification-of-neuroendocrine-carcinoma-of-the-bladder-669c138ff61eb44c 2026-05-21T21:30:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr1-mutation-longitudinal-dynamics-in-rwd-cohort-of-hr-her2-metastatic-breast-c-ac76a8f2706482be 2026-05-21T21:30:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimodal-immune-profile-score-ips-signature-as-a-predictive-response-biomarker-a3d68b9481b803f5 2026-05-21T21:30:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-line-lenvatinib-versus-dabrafenib-plus-trametinib-d-t-in-braf-mutated-diff-7f7fc5fd01cd05fb 2026-05-21T21:30:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/concurrent-rna-and-dna-ngs-testing-for-the-detection-of-clinically-relevant-fusi-8f342a1c0885096a 2026-05-21T21:30:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/plasma-tmb-ptmb-and-circulating-tumor-fraction-ctf-dynamics-as-biomarkers-of-ben-f48547518f672b1d 2026-05-21T21:30:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-to-unveil-new-data-at-asco-2026-demonstrating-strength-and-94f7858a94ee4262 2026-05-21T21:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-merck-partner-kelun-outlines-phase-3-lung-cancer-success-in-china-study-03726ccb2f7f6ba0 2026-05-21T21:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-key-head-and-neck-cancer-readouts-from-j-j-corbus-summit-akeso-and-bicara-f41f8d1b018a725c 2026-05-21T21:00:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco26-new-data-released-for-vegf-bispecifics-from-biontech-bms-pfizer-3sbio-28e071bef58c2fd6 2026-05-21T21:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/eikon-therapeutics-announces-availability-of-six-abstracts-for-presentation-at-t-39077a624118cd06 2026-05-21T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-american-diabetes-association-debuts-the-2026-scientific-sessions-driving-th-f3d442e23500762b 2026-05-21T20:51:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/teen-attitudes-to-exercise-shape-fitness-years-later-b830a5f753900d4b 2026-05-21T20:30:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/girotm-growth-modulation-system-c3794bf204511adf 2026-05-21T20:14:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-receives-positive-chmp-opinion-for-boey-trenibotulinumtoxine-c8f8064d3ead9ee0 2026-05-21T20:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-announces-proposed-public-offering-of-securities-de7d29e999d7739e 2026-05-21T20:02:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/pesquisa-clinica-brasil-sobe-no-ranking-global-mas-tem-dificuldade-para-recrutar-3fd1fa059c4790e7 2026-05-21T20:00:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-affiliates-elected-to-national-academy-of-sciences-for-2026-32cbc052bb09e80c 2026-05-21T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inicio-02a7c3993886947e 2026-05-21T19:51:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-tides-manufacturing-for-late-stage-and-commercial-readiness-aacccd9d51c29272 2026-05-21T19:45:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-reforca-compromisso-social-ao-patrocinar-torneio-de-golfe-da-obra-do-berco-e-0d2c00b0d22a6c81 2026-05-21T19:29:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/mental-health-care-in-salt-lake-valley-gets-major-boost-with-opening-of-new-inte-db2abfe637b4b31a 2026-05-21T19:19:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/litigation-involving-reproductive-health-and-rights-in-the-federal-courts-13f83b1af659ef2c 2026-05-21T19:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-a-group-of-biotechs-ran-a-covert-campaign-to-push-out-the-fda-commissioner-9065b53ecac96f0b 2026-05-21T18:26:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/recap-nord-living-rare-living-stronger-in-arizona-40f4a92ef2e30587 2026-05-21T18:01:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/adoption-of-ai-for-early-drug-discovery-challenges-and-opportunities-for-cros-335daec283767e15 2026-05-21T17:58:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-y-la-facultad-de-farmacia-y-bioquimica-de-la-uba-llevaran-a-cabo-un-progra-57fd6bc6d188033a 2026-05-21T17:52:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-palos-hospital-expands-specialized-emergency-care-for-olde-3b3df75fb30fe557 2026-05-21T17:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/raising-the-standard-in-pediatric-migraine-clinical-trials-6d9b6bcc9a8c5154 2026-05-21T17:33:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/interfarma-na-imprensa-interfarma-destaca-papel-da-inovacao-no-enfrentamento-do-41f4d7de3b344743 2026-05-21T17:25:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/79th-world-health-assembly-wha79-follow-up-to-the-political-declaration-of-the-h-4bfd589d1c81a97d 2026-05-21T16:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/tennor-s-80m-hong-kong-ipo-to-fund-antibacterial-drug-pipeline-9d9362d36a921dc5 2026-05-21T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-drugmakers-to-take-the-stage-at-asco26-331f0bb1490c15f8 2026-05-21T15:39:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/driving-progress-in-rare-liver-disease-ipsen-at-easl-congress-2026-4f1778b197f5f51a 2026-05-21T15:37:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-fully-enrolls-its-phase-2-placebo-controlled-multiple-sclerosis-trial-db19fa53f8c02c0f 2026-05-21T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-pr-anne-charloux-elue-doyenne-de-la-faculte-de-medecine-de-strasbourg-f53e65c3c8e385b0 2026-05-21T14:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-mrc-discovery-research-to-a-one-minute-cancer-treatment-3298f5775df752b9 2026-05-21T14:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-to-seek-further-approval-of-voxzogo-in-form-of-short-stature-86d2837ba6ca52df 2026-05-21T14:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incyte-signs-ai-deals-with-genesis-molecular-ai-edison-scientific-3a764082ad72d8a4 2026-05-21T14:22:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/rencontre-chercheurs-associations-grand-public-a-lyon-le-pouvoir-cache-des-ultra-a6c4137c950b2025 2026-05-21T14:16:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-anti-neural-role-of-bmp-signaling-is-a-consequence-of-its-ancestral-function-70841c94b8264a14 2026-05-21T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-non-canonical-jak-stat-pathway-promotes-viral-replication-through-the-lipoprot-c3acc71e0965eeb1 2026-05-21T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incorporating-variation-in-death-times-improves-predictions-of-ectotherm-respons-ef0a4ea94b396c01 2026-05-21T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-tv-to-air-first-major-live-pro-sports-event-shot-on-iphone-17-pro-a40ac0a8ec20677f 2026-05-21T13:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyberangriff-auf-externen-dienstleister-betrifft-auch-daten-von-patienten-des-un-aaca5fe7006ba635 2026-05-21T13:09:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/come-funziona-la-terapia-con-i-radiofarmaci-ae6f0c5021122011 2026-05-21T13:07:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/wcg-successfully-completes-iso-9001-audit-reaffirming-enterprise-wide-commitment-4d23a92fc1d50260 2026-05-21T13:04:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-eyes-new-campus-in-texas-novartis-looks-to-evict-tenant-at-slovenian-campus-838210f7bbf08418 2026-05-21T13:02:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/indigenous-genomics-projects-to-support-community-led-research-and-technology-ad-82e6534c71dc2a61 2026-05-21T13:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-incorporo-al-ordenamiento-nacional-requisitos-minimos-para-inspecciones-de-345b900596e68633 2026-05-21T13:00:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/asn-announces-new-editor-in-chief-of-asn-kidney-news-b964a454b300232a 2026-05-21T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-inhibio-las-actividades-productivas-de-la-firma-pm-chemistry-s-r-l-6de1061d7a3511d6 2026-05-21T12:53:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/faculty-of-health-at-universite-paris-cite-formalizes-partnership-with-the-chine-e03f88b9e0412719 2026-05-21T12:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-incorpora-nuevas-modificaciones-al-listado-de-sustancias-en-cosmeticos-y-p-e37d4e088d226019 2026-05-21T12:44:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-highlights-from-digestive-disease-week-2026-925ea9c363a5ea00 2026-05-21T12:44:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-incorpora-nueva-normativa-mercosur-sobre-sustancias-en-cosmeticos-y-produc-95f6ed28522a214f 2026-05-21T12:39:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-abre-sus-puertas-a-personas-mayores-durante-la-semana-de-la-administrac-c038a0ffaafb0eeb 2026-05-21T12:24:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-disability-progression-remains-the-key-challenge-3d5780838571f29a 2026-05-21T12:23:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/frattura-dell-omero-prossimale-sintomi-e-cura-bb932dccda3b7211 2026-05-21T12:18:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-real-world-evidence-picture-for-hematologic-cancers-trinetx-at-ispor-89ebaf3234ff9326 2026-05-21T12:00:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/revealing-molecular-cooperation-308a0a872a357027 2026-05-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gaming-monkeys-curiosity-453457825d562d76 2026-05-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/galenusprijs-2025-innovatie-die-het-verschil-maakt-ab675ee0c5a53daf 2026-05-21T11:32:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-george-vassiliou-and-dr-jyoti-nangalia-elected-2026-fellows-of-the-aca-6060be9dbef70982 2026-05-21T11:23:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-06-06-una-partita-del-cuore-per-dare-respiro-alla-vita-d1eaaf96a1f81b14 2026-05-21T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-catalyst-for-a-consistent-innovation-policy-384b1b410b77dea1 2026-05-21T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-delivers-kidney-stone-care-for-urology-teams-with-the-elyratm-thulium-fiber-l-baf42de2637c12ee 2026-05-21T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bloodlines-series-car-t-cell-therapy-shows-promise-for-smoldering-myeloma-ac5864a397c65a79 2026-05-21T10:22:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-mourns-the-passing-of-dr-gerard-d-hurley-a52864aec90e40c3 2026-05-21T10:07:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-gerard-d-hurley-obituary-5f4981c898688850 2026-05-21T10:06:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/staying-safe-in-the-sun-preventing-skin-cancer-with-upf-clothing-5edf8d64fc5c0360 2026-05-21T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-work-with-a-medtech-cro-and-stay-in-control-greenlight-guru-6168455ff849b6be 2026-05-21T09:47:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-estro-joint-session-sees-packed-room-at-estro-2026-62bd106eb153b6e1 2026-05-21T09:44:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-panel-portfolio-centopediatric-now-available-eb8cfc6d86384b6e 2026-05-21T09:36:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/nifekalant-magnesium-cocktail-for-chemical-cardioversion-of-atrial-flutter-a-mul-882f76ee3031a808 2026-05-21T09:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/web-emission-polluants-chimiques-un-poison-quotidien-c3ccd74d72d44b48 2026-05-21T08:51:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/concours-ingenieurs-techniciens-et-administratifs-2026-69-postes-ouverts-a1acd42de1b03ff3 2026-05-21T08:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuove-nomine-per-policlinico-di-milano-universita-degli-studi-di-milano-protagon-b49d284c81b57940 2026-05-21T08:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-nouveau-robot-de-chirurgie-dedie-a-la-sante-de-la-femme-et-des-enfants-aux-hu-f16a96a8123e0424 2026-05-21T07:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reimagining-vaccine-development-with-ai-bbb638d39a82a779 2026-05-21T07:33:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/freddy-sertin-nomme-directeur-des-affaires-publiques-du-leem-au-sein-de-la-direc-d955c103e7bf6f45 2026-05-21T07:33:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/gembrook-oshclub-celebrates-success-with-vic-kids-eat-well-6807222cd19cb31c 2026-05-21T07:12:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/warum-schmerzen-bleiben-obwohl-verletzungen-langst-verheilt-sind-6e94c3faf7389ccc 2026-05-21T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-center-lung-experts-help-create-new-national-guidelines-for-safe-ct-lung-1b13f7b1f9e87d98 2026-05-21T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tar-del-av-omvarlden-med-hjalp-av-ai-och-smarta-glasogon-9d55b04d9a9019d0 2026-05-21T06:55:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/3d-technologie-verbessert-die-fruherkennung-von-hautkrebs-36a7b83b8ec83121 2026-05-21T06:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/debout-c-est-quoi-le-systeme-vestibulaire-e10b1551ade4c1ea 2026-05-21T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-are-young-people-s-sleep-and-mental-health-so-poor-researchers-point-to-vici-42c043db06bf64fb 2026-05-21T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-new-products-at-bio-it-world-from-bioteam-dantech-rancho-284e7f6de081322e 2026-05-21T05:00:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-fossil-hunter-joins-elite-group-of-scientists-5cb47dbf60cb7a6e 2026-05-21T03:54:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-day-gains-national-recognition-through-first-ever-proclamation-i-387d1b1ceef22e5f 2026-05-21T02:53:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-shows-significant-improvement-in-cellulite-and-skin-laxity-with-advanc-b890165a8349f91b 2026-05-21T02:05:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-new-zealanders-could-benefit-from-funded-vaccines-from-2027-ca78d5e4e7d1c088 2026-05-21T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-april-2026-nephrology-advisory-committee-meeting-f2c005ff3eb693b0 2026-05-21T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genotype-influences-antidepressant-discontinuation-in-a-pre-emptive-pharmacogene-5c0145b72f20f738 2026-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-population-specific-pharmacogenomic-variants-on-drug-dosing-in-icu-pat-67dc1c07a3efd936 2026-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/baroreflex-activation-therapy-in-heart-failure-the-barostim-enabled-neurohormona-7bb8d49b2286c3b6 2026-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/carnegie-mellon-university-and-cleveland-clinic-develop-ai-system-to-interpret-c-672e009f61b4c2ff 2026-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/staff-fest-2026-fills-the-quad-with-laughter-games-and-community-emory-universit-2f0aa7f479109a11 2026-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-links-common-acid-reflux-drugs-with-negative-gut-health-effects-513a8609f5a500ca 2026-05-20T23:09:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-colourings-and-preservatives-three-new-studies-point-to-links-between-food-1b017af60c6feb56 2026-05-20T23:05:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-does-acetaminophen-work-study-links-pain-relief-to-the-endocannabinoid-syste-6df502b2125ca9f9 2026-05-20T22:54:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/nurses-at-intermountain-health-st-vincent-regional-hospital-nationally-recognize-55fcc13ff46f1d5e 2026-05-20T22:18:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/em-brasilia-reitor-da-ufrj-apresenta-ao-mec-demandas-por-obras-moradia-estudanti-acfece846ddb0d72 2026-05-20T22:05:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct-ucc-patiententag-am-06-06-2026-151ff97e8ce6d46a 2026-05-20T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/entidades-do-setor-farmaceutico-apoiam-anvisa-e-pf-no-combate-a-medicamentos-irr-e3b69aa85b7dbe07 2026-05-20T21:30:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/monthly-fda-guidance-and-regulatory-news-review-april-2026-de8abf90a9ebe48f 2026-05-20T21:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-from-mit-named-2026-searle-scholars-05d1c12f7e4ece46 2026-05-20T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patentes-farmaceuticas-demoram-20-mais-que-a-media-geral-para-decisao-no-brasil-51b93086084f9f33 2026-05-20T19:44:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/revista-cientifica-anmat-ingresa-al-catalogo-2-0-de-latindex-a5444a7f5c12a9e6 2026-05-20T19:40:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/irt-uat-for-clinical-trials-faster-go-lives-through-smarter-validation-b6dfe5fc2193b0e1 2026-05-20T19:37:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/clocib-720sl-c9d4777ab7f2f42e 2026-05-20T19:33:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/clocib-720sl-748caf82587ddf51 2026-05-20T19:33:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/apos-comprar-medley-ems-aumenta-a-dose-para-chegar-a-24-bilhoes-de-comprimentos-eb7144395f51a12c 2026-05-20T18:59:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/indigenous-data-in-the-canadian-precision-health-initiative-d242d45d4f46744d 2026-05-20T17:15:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-roche-head-held-high-details-oral-serd-s-first-line-flop-in-breast-cancer-05bd72ca59506d81 2026-05-20T16:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-roche-head-held-high-details-oral-serd-s-first-line-flop-in-breast-cancer-460ae0ba2c1fc9fd 2026-05-20T16:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sec-settlements-to-take-on-a-new-look-going-forward-eed15832825c2684 2026-05-20T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-with-advarra-s-manager-of-ongoing-review-maryjo-carter-d000fed1c5aa8abf 2026-05-20T15:59:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-clinical-trials-day-the-people-behind-medical-progress-e84a28eeff789405 2026-05-20T15:59:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/remember-to-monitor-deadlines-in-ctis-during-the-summer-period-d1ce01fc5fb823af 2026-05-20T15:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accentism-for-profit-what-telus-is-getting-wrong-about-accents-ee5d877d3737dbbb 2026-05-20T15:42:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-precision-in-next-generation-miniaturized-medical-connectors-04ce60d2cc44b183 2026-05-20T15:27:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/enabling-in-vivo-lentiviral-therapies-for-clinical-and-commercial-success-4b1aeeb8ce177aca 2026-05-20T15:25:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/efpia-and-vaccines-europe-welcome-the-commission-s-global-health-resilience-init-2b8ffad285537837 2026-05-20T15:05:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-rises-when-execution-holds-e8669649f319ff0a 2026-05-20T14:54:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/desertif-actions-summit-an-international-experience-shared-by-luna-colovray-winn-349caac7b4a14f64 2026-05-20T14:39:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgische-patienten-blijven-in-de-europese-middenmoot-qua-toegang-tot-innovatie-e2010bbb13cae49c 2026-05-20T14:38:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/dermatite-da-contatto-allergica-o-irritativa-7c5680b420b22ec2 2026-05-20T14:06:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-surveillance-and-microbial-escape-in-the-aging-host-why-does-the-microbio-8aacd0dbcc6f0bd5 2026-05-20T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-redox-conditions-and-strain-variation-define-phenazine-mediated-an-5160369370fda9fb 2026-05-20T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/redundant-and-distinct-mechanisms-suppress-innate-immune-activation-during-sars-e9a5a1bfaf94d7a5 2026-05-20T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mannose-binding-lectin-2-secreted-by-hepatocellular-carcinoma-cells-recruits-and-c39b2a2e22fdbeac 2026-05-20T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pseudomonas-aeruginosa-ribonuclease-ribocin-cleaves-eukaryotic-ribosomes-at-3d18587e544aa99a 2026-05-20T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-alert-no-26-2026-who-alert-on-substandard-accupaque-iohexol-omnipaque-ioh-881c8093c1c0831a 2026-05-20T13:58:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/patientnamnden-nar-vardnadshavare-inte-blir-lyssnade-pa-i-varden-leder-det-till-26e7741beb1063ac 2026-05-20T13:57:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-hinkt-achterop-minder-dan-de-helft-van-de-nieuwe-geneesmiddelen-bereikt-d-ae3d15110eaf705d 2026-05-20T13:53:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/universitat-heidelberg-sustainability-strategy-adopted-57b37ddb65092694 2026-05-20T13:32:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-waar-biosimilars-thuiskomen-waarom-het-doemverhaal-over-biosimilars-in-be-0c797c9402a9ffa8 2026-05-20T13:21:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-development-innovation-the-evolving-development-of-protacs-869b2438754c7fa7 2026-05-20T13:17:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-intent-to-acquire-spr-therapeutics-inc-expanding-care-option-30f4d3146e5a8d4d 2026-05-20T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tumori-della-tiroide-che-cos-e-la-terapia-radiometabolica-dd451cf5f07df097 2026-05-20T13:07:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/medidata-celebrates-clinical-trials-day-2026-be3c8da784dd5978 2026-05-20T13:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-highlights-stereochemistry-advances-for-scalable-rna-manufacturing-at-ti-67fed5e9d18ae48d 2026-05-20T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-app-store-stopped-over-2-2-billion-in-fraudulent-transactions-in-2025-49ae31556c9e5e5d 2026-05-20T12:59:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-alert-no-025-2026-alert-on-the-recall-specific-batches-of-antacid-citro-s-e22b77675ee08ba2 2026-05-20T12:57:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-to-participate-in-upcoming-investor-conferences-6441efda96cf0349 2026-05-20T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-launches-mylabcorptm-a-new-ai-powered-mobile-app-designed-to-help-consum-273336053f563781 2026-05-20T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-to-report-first-quarter-2026-results-on-may-27-2026-b387c78e371bc8d4 2026-05-20T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-strategic-agreement-with-anthropic-to-position-cl-b11faa698f5d2807 2026-05-20T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-more-than-3-000-years-of-nhs-service-as-healthcare-workers-welcomed-97a4c0f2aaf93ccb 2026-05-20T09:50:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-ibd-treatment-considerations-gi-trial-design-and-the-impact-of-ai-fa0365dfdda42650 2026-05-20T09:34:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-inks-another-deal-with-korean-api-manufacturer-yuhan-this-time-worth-140m-e2450eeae0c1e851 2026-05-20T09:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/norfolk-and-north-suffolk-residents-can-sign-up-online-to-health-nutrition-and-f-c979296fc7237ec8 2026-05-20T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-8mg-04b253c8a9be6c5a 2026-05-20T08:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-philanthropy-is-helping-promising-cancer-treatments-reach-clinical-trials-so-4da257240d290930 2026-05-20T08:28:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-cookie-and-cracker-manufacturers-can-secure-long-term-line-performance-09ae9c65cc565908 2026-05-20T08:10:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/kimed-management-board-am-zmi-c1333ea8d02a08b5 2026-05-20T08:02:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/built-for-the-journey-the-value-of-active-uld-containers-in-pharma-air-freight-5676b4a7b081a4f4 2026-05-20T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/die-selbstheilungskraft-der-lunge-freisetzen-7e9210078e797d49 2026-05-20T07:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-tumor-dna-for-minimal-residual-disease-in-colon-cancer-ready-for-pri-c52dc0505af40fbd 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-money-cannot-buy-addressing-the-socioeconomic-status-ceiling-effect-for-bla-8e974d2194c0d2f5 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-quality-of-chemoradiotherapy-in-esophageal-adenocarcinoma-matters-44d70daac66824d4 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-immune-checkpoint-blockade-in-deficient-mismatch-repair-microsatellite-140866ab2d4e0e23 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-checkpoint-blockade-in-deficient-mismatch-repair-microsatellite-instabili-797664e74b837bed 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selpercatinib-and-the-crossover-conundrum-potential-impact-of-postprogression-th-18be9e20a57a0b4d 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/body-size-and-bladder-cancer-risk-a-pooled-analysis-of-prospective-studies-from-6ac8509a4e4f3bd9 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-it-time-to-move-beyond-graft-versus-host-disease-free-relapse-free-survival-a-e09712323c58c497 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-96cfda5271107a3c 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quality-of-chemoradiotherapy-in-esophageal-adenocarcinoma-matters-c76e2ae5f2b6f123 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/postoperative-hepatic-arterial-infusion-with-oxaliplatin-after-surgery-of-four-o-2b2258a068d25c96 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-phase-ii-iii-trial-comparing-hepatectomy-followed-by-mfolfox6-with-he-32b043bbb0d0333d 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diminishing-returns-among-black-patients-with-cancer-the-intersection-of-race-an-7746d317369b3b7d 2026-05-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/samen-sterker-de-sleutelrol-van-samenwerking-in-klinische-studies-f9b8459712af422a 2026-05-20T06:29:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/spriten-morkret-och-myllret-jakten-pa-sveriges-okanda-insekter-281c988976d555e7 2026-05-20T06:02:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-list-of-therapeutic-products-for-which-eligible-patients-can-be-identifie-abd710075be9c763 2026-05-20T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tjusto-el-centro-de-investigacion-que-promovera-un-transporte-mas-equitativo-e-i-85b34c1c8fca1d70 2026-05-20T01:31:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/prognostic-significance-of-large-language-model-extracted-clinical-features-at-a-fecaa752126c5a1c 2026-05-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bayesian-counterparts-to-the-frequentist-kaplan-meier-estimate-and-its-summary-m-b4f2d4e454d082b0 2026-05-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trouble-the-land-takes-audiences-on-a-multimedia-journey-through-civil-rights-hi-f0db4e3e4bd08c43 2026-05-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arc-projects-go-underground-for-answers-1ad31921e04cde8c 2026-05-19T23:21:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/bingo-spielen-und-unsere-patientinnen-und-patienten-unterstutzen-6a53e12519bb9934 2026-05-19T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/instituto-de-eticas-aplicadas-uc-ha-impactado-en-la-formacion-de-mas-de-5-500-es-0a2d343a89f4bd2a 2026-05-19T20:54:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/kids-take-the-wheel-in-custom-built-toy-cars-at-gobabygo-c46fbe2fbca37e24 2026-05-19T20:53:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-integrates-aira-matrix-ai-into-the-fusion-ap-digital-pathology-platform-b88009452d0532b8 2026-05-19T20:20:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/zelicapavir-reduces-symptom-duration-and-hospitalization-in-a-randomized-double-ef850cf9eb645d11 2026-05-19T18:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-embedded-engagement-improve-compliance-and-reduce-study-dropout-c07434fbcaf529e7 2026-05-19T18:26:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/nodthera-announces-late-breaking-oral-presentation-at-the-94th-eas-congress-a107a56071f1e03a 2026-05-19T17:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/eps-3903-is-a-potent-and-selective-oral-stat6-inhibitor-that-blocks-th2-inflamma-54c6bc1aa689586f 2026-05-19T17:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eps-3903-a-potent-oral-stat6-inhibitor-exhibits-preferential-lung-and-alveolar-m-4f4d060e1502774d 2026-05-19T17:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/win-the-pitch-showcase-highlights-innovative-startups-cb728247a15108f4 2026-05-19T16:33:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-should-sponsors-investigators-and-irbs-navigate-the-fda-s-updated-ind-safety-ad07c0afea6ae7ea 2026-05-19T16:15:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-sciences-sweet-opportunity-in-us-china-talks-84391fc5b43de72d 2026-05-19T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vincentage-s-oral-glp-1-meets-phase-iii-obesity-endpoints-73ef7e9b81f918e4 2026-05-19T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-sports-expands-to-more-than-90-new-countries-and-regions-e73098e4656cfbbd 2026-05-19T15:59:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/across-the-stage-thousands-of-journeys-converge-at-ubc-03342ea1f59c48ef 2026-05-19T15:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-consultant-reflects-on-role-of-aanhpi-heritage-in-her-profession-4b5662ad5e50bd1f 2026-05-19T15:45:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/good-science-requires-understanding-life-beyond-the-clinic-c72f2671d7314eab 2026-05-19T15:44:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-map-which-genes-are-active-in-a-developing-seed-to-build-hardier-crop-87b222d850ae630f 2026-05-19T15:09:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-expands-equity-derivatives-trading-team-f3634d0aaba577f0 2026-05-19T14:55:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/kids-who-take-risks-at-play-make-faster-smarter-decisions-in-traffic-b15171d3d1894d93 2026-05-19T14:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/empiric-and-trigger-guided-superior-vena-cava-isolation-in-af-ablation-systemati-2f80b1ac49ae6506 2026-05-19T14:51:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/scripps-chief-medical-officer-cited-as-a-top-patient-safety-expert-6f3ebe4babf6e861 2026-05-19T14:47:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/multi-million-pound-drive-to-revolutionise-healthcare-in-the-east-93a20b3af41efafa 2026-05-19T14:41:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-avanca-com-compra-da-medley-no-cade-9413b5e17ecf0c2e 2026-05-19T14:39:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/vermont-governor-signs-rare-disease-advisory-council-into-law-21d26c480762637e 2026-05-19T14:36:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/scripps-named-among-top-5-medium-sized-us-health-systems-bb0995d368dee7c5 2026-05-19T14:30:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-abre-vagas-de-estagio-em-quatro-estados-para-o-segundo-semestre-de-2026-7f168fae1e93f955 2026-05-19T14:29:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-rules-why-clinical-quality-needs-anomaly-detection-b64a92b0c0e3e8a1 2026-05-19T14:19:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/recherche-clinique-face-a-une-dynamique-mondiale-sous-tension-la-france-doit-tra-672d0ff2802863ac 2026-05-19T14:05:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-sciences-innovation-2026-498c3dfc7d8d7086 2026-05-19T13:56:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-signs-commercial-agreement-with-north-shore-health-the-first-hospi-0bf16cd4a13da0f0 2026-05-19T13:45:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/climate-universite-paris-cite-puts-two-assessments-in-place-to-prepare-for-the-f-24788e3487f71e93 2026-05-19T13:30:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/w-a-i-t-indicator-polska-awansuje-o-3-miejsca-i-po-raz-pierwszy-w-historii-jest-349ca39e69d09a97 2026-05-19T13:23:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pacjenci-w-europie-czekaja-d-uzej-na-nowe-leki-a-nierownosci-miedzy-panstwami-cz-f1e17e52849b58ac 2026-05-19T13:21:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-engages-cns-community-at-ascp-2026-8bc52fc51679de7e 2026-05-19T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-nmpa-clears-kat6-inhibitor-syh-2095-for-clinic-a70a055dc178f73f 2026-05-19T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccines-as-global-health-security-infrastructure-insights-from-a-descriptive-an-beea7cb85cbf6167 2026-05-19T12:58:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-and-tufts-csdd-publish-landmark-study-on-direct-to-patient-clinical-t-91eb902130410fdc 2026-05-19T12:49:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/pirbright-institute-scientist-recognised-for-outstanding-global-service-to-veter-0653ba5a241871d2 2026-05-19T12:46:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-dr-hanns-peter-knaebel-ubernimmt-vorstand-medizin-im-verbund-der-unive-7e534310d1eef481 2026-05-19T12:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-moment-worth-remembering-what-scale-tells-us-about-the-future-of-aesthetics-13fa685acf385e9b 2026-05-19T12:06:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/stellungnahme-der-universitatsmedizin-essen-zur-aktuellen-berichterstattung-rund-1e13f71770321bfb 2026-05-19T12:06:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-transforma-shopping-em-experimento-ao-vivo-para-provar-eficacia-de-lacday-lo-d0e060a51161650d 2026-05-19T12:06:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/visualizing-early-myelin-formation-using-a-nanofiber-based-platform-a-human-cell-8d9ac6f629662478 2026-05-19T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tell-me-senpai-what-s-next-after-graduation-connecting-international-students-at-68912eca9fc63fdf 2026-05-19T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-global-clinical-trial-performance-the-case-for-site-centric-design-and-23390b0e261587fa 2026-05-19T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-unveils-new-accessibility-features-and-updates-with-apple-intelligence-d08e5c5a9fa971f2 2026-05-19T11:59:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-the-bench-aacr-annual-meeting-2026-innovative-tools-uncover-new-insights-in-a8d00480a6060647 2026-05-19T11:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-announces-new-positive-clinical-data-for-intranasal-foralumab-in-non-act-9798213bc72872c1 2026-05-19T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-sdma-now-integrated-into-the-most-common-catalyst-chemistry-profiles-762b47f15a916507 2026-05-19T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-and-hemispherian-announce-new-glix1-data-demonstrating-potent-anti-tum-29461112c23a350b 2026-05-19T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-4219d62b2ab9335d 2026-05-19T10:31:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/fracture-ide-trial-of-the-boston-scientific-seismiqtm-4ce-coronary-intravascular-e7bf123b251b5ae2 2026-05-19T10:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lucelia-bf17550b54059c1f 2026-05-19T10:30:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/consultation-publique-sur-la-mise-a-jour-des-lignes-directrices-relatives-au-par-c0ffd4a85c4f8aea 2026-05-19T07:46:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/driven-by-patients-delivering-on-our-strategy-2025-integrated-annual-report-now-6793aff2cf5523b3 2026-05-19T07:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/zugang-zu-innovativen-medikamenten-die-schweiz-stagniert-weiterhin-hinter-deutsc-a70159aff4f2c327 2026-05-19T07:08:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-center-honors-strength-and-hope-on-national-cancer-survivors-day-june-4-9e5b086fa8885b87 2026-05-19T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unaudited-preliminary-results-for-the-year-ended-december-31-2025-f2a23ea12f29fea9 2026-05-19T06:07:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-biotronik-und-stiftung-deutsches-herzzentrum-kooperieren-f1471907ec1bb74b 2026-05-19T05:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-biotronik-and-german-heart-center-foundation-announce-partnership-to-adv-f74ffb6b7647e0a0 2026-05-19T05:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microchimerism-lifelong-biological-connections-impacting-everyone-37368433103a4e41 2026-05-19T05:01:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-to-present-new-data-at-asco-2026-reinforcing-giredestrant-s-potential-to-t-053be43f4967cf16 2026-05-19T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anzen-pmda-risk-communications-ferric-carboxymaltose-etc-posted-32584cbc6a2c185a 2026-05-19T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yakkyokukata-implementation-of-pdg-harmonized-texts-into-japanese-pharmacopoeia-9978dc2682d5b174 2026-05-19T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/utility-of-direct-fick-cardiac-output-in-patients-with-left-ventricular-assist-d-cb0a31a5f40c7c51 2026-05-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/camille-ruvo-honored-for-advancing-alzheimer-s-research-and-care-at-global-women-1976362e5d9d54c7 2026-05-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-2026-annual-meeting-of-shareholder-results-feafe866cc084858 2026-05-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-to-present-data-on-long-term-outcomes-and-clinical-use-of-its-portfolio-014e74a2713bc360 2026-05-18T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/colorado-stroke-survivor-s-recovery-underscores-importance-of-fast-action-aa42b28203852d83 2026-05-18T22:36:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-uc-irvine-3dfef7937725ce7a 2026-05-18T20:33:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-different-kind-of-classroom-744777e99179ab6f 2026-05-18T20:32:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-on-nafdac-findings-on-extended-shelf-life-of-bread-bon-9dc3a0f720a17945 2026-05-18T20:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/guest-blog-uniting-for-behcet-s-disease-awareness-on-may-20-a77e4d63d755c9ed 2026-05-18T19:49:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/some-early-herders-didn-t-quit-fishing-and-foraging-for-a-millennium-after-first-b5aa95453b219d05 2026-05-18T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sponsor-s-guide-to-irb-approval-part-v-how-to-speed-up-irb-approvals-0be816473a535e56 2026-05-18T18:55:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-safety-monitoring-boards-dsmbs-in-the-era-of-ai-and-adaptive-clinical-trial-c50415723d0ad06b 2026-05-18T17:57:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-initiates-phase-2-study-of-dare-hpv-a-novel-pharma-359319f942405470 2026-05-18T17:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-greatest-women-s-health-breakthroughs-of-2026-new-research-that-could-change-db49ccf05e09e3cf 2026-05-18T17:48:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/may-2026-science-day-video-recordings-57a7aa301d44e891 2026-05-18T17:34:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-straight-line-rethinking-how-we-forecast-clinical-trial-timelines-df42eab51b5df5cf 2026-05-18T17:30:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-kicks-off-worldwide-developers-conference-on-june-8-8533980864e1045b 2026-05-18T17:08:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-should-local-irbs-and-hrpps-collaborate-with-external-irbs-3f7e42ab52010ae7 2026-05-18T16:58:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-usc-receive-2-6-million-darpa-grant-for-ai-to-drive-math-breakthroughs-285e89611bfc8904 2026-05-18T16:51:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-s-third-cohort-of-lifted-graduates-to-receive-degrees-at-in-prison-cer-cd51cf4ebb0ab9ee 2026-05-18T16:29:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-lamenta-a-morte-de-noca-da-portela-doutor-honoris-causa-da-universidade-85459b9900765dd7 2026-05-18T16:15:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/jung-symposium-2026-neue-perspektiven-fur-ki-gestutzte-krebs-chirurgie-seltene-e-cfe95c4d1af98711 2026-05-18T16:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-terminates-plant-contract-with-chinese-cdmo-porton-threatens-64m-in-leg-59e407d6b04f9f05 2026-05-18T16:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sen-cassidy-s-primary-loss-increases-uncertainty-f948e9fdf2974917 2026-05-18T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/built-for-biotech-clinical-outsourcing-that-scales-with-innovation-77f98c35a4aebc6c 2026-05-18T15:54:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-riken-s-new-laboratory-heads-april-2026-403c3736bd89c3a9 2026-05-18T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-orforglipron-inside-a-cu-anschutz-clinical-trial-for-a-new-oral-glp-1-we-3bbe3b8f71fa90a7 2026-05-18T14:44:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/metagenomics-show-farming-method-not-a-major-driver-of-amr-in-uk-food-fe5a6d5f1ef50dfa 2026-05-18T14:00:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-with-new-medical-expert-dr-jack-bleesing-md-phd-af26373d49ea5873 2026-05-18T13:57:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-gatekeeper-and-the-invader-h-pylori-and-the-development-of-stomach-cancer-cfd6e9499c2f75e3 2026-05-18T13:54:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cell-keeps-the-score-memory-inflammation-and-bowel-cancer-f49ab5e68b9f671c 2026-05-18T13:21:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/whitehead-institute-remembers-brit-d-arbeloff-860cb8558610d2be 2026-05-18T13:19:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-presents-positive-preliminary-phase-1-bbt002-data-at-americ-9b07fee58b154943 2026-05-18T13:15:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/schwarzer-hautkrebs-moderne-therapien-geben-hoffnung-94153859da91b4df 2026-05-18T13:13:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/energy-efficient-pure-steam-with-syntegon-services-34982c3daf0a5f28 2026-05-18T13:05:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-receives-saudi-food-and-drug-authority-approval-for-acam20-87be27eabfd18645 2026-05-18T12:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/suburban-mother-of-two-diagnosed-with-metastatic-melanoma-urges-sun-protection-a-997548ed9c005478 2026-05-18T12:55:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-completes-transition-to-sap-s-4hana-marking-a-strategic-milestone-in-the-98e0fec112f861f9 2026-05-18T11:41:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-reports-first-quarter-2026-financial-results-and-provides-business-updat-295c92635fcf44c8 2026-05-18T11:17:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/raoul-klingner-is-the-new-director-of-fraunhofer-wki-in-braunschweig-47ca199787053b34 2026-05-18T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boston-scientific-enters-into-2-billion-accelerated-share-repurchase-agreement-5b73286356184a48 2026-05-18T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peter-menziuso-named-evp-and-president-bd-interventional-68bac8ef43d74cdc 2026-05-18T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-announces-trofuse-005-trial-evaluating-sacituzumab-tirumotecan-sac-tmt-met-d1ec90189a39d2cb 2026-05-18T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boston-scientific-announces-strategic-investment-in-mirus-llc-07db64a5de5c61c1 2026-05-18T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wanted-accommodation-for-international-visitors-3f2745e27c16a963 2026-05-18T10:26:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-looks-at-houston-for-potential-1b-manufacturing-plant-2fb47d788e3f8f01 2026-05-18T10:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inauguration-de-la-nouvelle-unite-de-sterilisation-et-des-nouvelles-salles-de-co-760c9da3010cdcb2 2026-05-18T09:39:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/economic-impact-report-examines-the-value-of-open-biodata-infrastructure-a36f97b26ddc5be5 2026-05-18T08:57:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-spin-outs-emerge-during-research-england-pilot-4c3897dbd851cb87 2026-05-18T08:00:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/donner-du-lait-un-geste-simple-pour-sauver-des-vies-1a5a467bbf74deb5 2026-05-18T07:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-rsv-vaccine-arexvy-receives-expanded-approval-in-japan-for-adults-aged-18-57146f9eff34ae94 2026-05-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/venez-echanger-sur-les-maladies-inflammatoires-chroniques-de-l-intestin-mici-a548b340b45671f4 2026-05-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-school-of-medicine-celebrates-its-largest-graduating-class-c3a733274249eede 2026-05-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-paralysis-to-cheer-practice-neurosurgeons-help-emily-be-a-kid-again-3c0edbe274268e2a 2026-05-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alk-98433ae0a92a28f0 2026-05-18T06:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/alecensa-receives-the-world-first-tumor-agnostic-approval-for-alk-fusion-gene-po-dcfccacdd67cfd36 2026-05-18T06:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundationone-cdx-alk-a36dc0e50782e0ee 2026-05-18T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-obtains-approval-for-foundationone-cdx-cancer-genomic-profile-as-a-compan-b0bdf13b1bceff21 2026-05-18T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inscience-la-programmation-du-festival-2026-6f461274f339cdfa 2026-05-18T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-ai-regulations-master-the-qara-skills-to-stay-ahead-1091824f96e99905 2026-05-18T04:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/garbage-collectors-of-the-brain-grind-to-a-halt-in-fatal-disease-0d6e00a6362a619c 2026-05-18T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-launches-new-program-faceduo-heat-illness-prevention-vr-enabling-early-aw-42c4140113706702 2026-05-18T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-concept-to-practice-advancing-regulatory-reliance-for-medical-devices-c1124339585df672 2026-05-18T03:44:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/mai-en-gris-journee-d-information-sur-les-tumeurs-cerebrales-e2d4e295991a6a9c 2026-05-18T01:48:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-teton-1-study-of-tyvaso-published-in-t-7183560a906f2fa7 2026-05-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-yukiko-mori-has-taken-up-her-post-in-the-center-for-digital-transformation-4fa0d529ad547a9b 2026-05-17T23:04:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-francesco-costa-el-uso-continuo-de-herramientas-como-chatgpt-provoca-un-efect-1a7bbf0c30d46ee2 2026-05-17T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharmaceutical-industry-and-the-impact-of-the-5-5-policy-48efec679790a33d 2026-05-17T16:55:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/prior-stroke-increases-residual-shunt-risk-after-combined-ablation-and-laao-a-de-e74b8b3b6ccc73eb 2026-05-17T13:19:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/infection-of-cardiac-implantable-electronic-devices-in-low-and-middle-income-cou-c78b99fc1975f345 2026-05-17T13:13:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-happens-when-ai-clashes-with-religious-belief-2cdca89515462968 2026-05-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-advance-outcomes-study-of-ralinepag-pr-b07829679464265d 2026-05-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-micra-transcatheter-pacing-system-curvature-and-capture-thre-c281e60cfbd2ff15 2026-05-16T15:15:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/remote-monitoring-of-implantable-loop-recorders-in-syncope-patients-management-o-710edeca96fc24dd 2026-05-16T15:14:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-a-novel-radiofrequency-wire-based-transseptal-puncture-sy-a4ae63cbcc53be0b 2026-05-16T15:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/insights-from-cell-and-gene-therapy-summit-at-chinabio-893011e40ae33823 2026-05-16T10:36:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-performance-of-invicta-df4-ventricular-defibrillation-lead-results-fr-8bae12d0ed7f49fc 2026-05-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-african-biomedicine-breaking-research-silos-through-translation-1d27f36ee8609bad 2026-05-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/raav8-encapsidated-hmr-001-z-enables-high-efficiency-hepatic-transduction-and-re-eab45960c9862402 2026-05-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impella-5-5-support-in-hf-cs-setting-the-stage-to-surpass-our-limitations-8fa9ef7b0dca837c 2026-05-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hybridization-lc-ms-ms-a-selective-solution-for-pmo-and-ppmo-bioanalysis-c88c7585e367fcab 2026-05-15T21:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/cu-anschutz-researchers-discover-new-clues-to-delaying-type-1-diabetes-9c759b79009e90ee 2026-05-15T21:41:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/closing-the-care-gap-63cceb6f2b8f7fb6 2026-05-15T18:24:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-nursing-meets-its-deepest-questions-d2bea7d690cb6470 2026-05-15T18:23:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-approach-to-dementia-care-c12b2086e09e6702 2026-05-15T18:22:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/diversity-in-dermatology-clinical-trials-a6fb309dd2af4e28 2026-05-15T17:44:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/designing-pivotal-adc-trials-that-actually-enroll-f521a1c0548f6f74 2026-05-15T17:36:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/off-the-shelf-anti-cd19-car-t-cell-therapy-with-reduced-or-no-conditioning-chemo-3afce944443b6324 2026-05-15T16:35:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/ft839-a-multi-antigen-targeting-off-the-shelf-dual-car-t-cell-for-the-treatment-3afcbc86398c91fb 2026-05-15T16:34:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-an-off-the-shelf-anti-cd19-car-t-cell-therapy-with-reduce-5efa8c757cd2266e 2026-05-15T16:31:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/ft819-drives-b-cell-compartment-remodeling-of-patients-with-systemic-lupus-eryth-b28da1a940589618 2026-05-15T16:30:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/car-t-cells-targeting-pan-tumor-antigens-mica-b-can-be-uniquely-combined-with-so-641973dd635b6fbf 2026-05-15T16:28:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipients-of-the-2026-ectrims-fellowships-announced-b2ecd135e8682533 2026-05-15T16:14:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-the-2026-world-cup-means-for-measles-risk-in-vancouver-ce644f9341c5cbd9 2026-05-15T15:14:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/trial-trends-table-talk-event-at-oct-east-coast-2026-59d37ea014692c59 2026-05-15T15:08:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/ben-goldsborough-mp-visits-to-learn-about-pioneering-vitamin-d-tomatoes-study-8940dcf6b93db5a8 2026-05-15T14:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-pharmteco-ceo-interviewed-at-dcat-week-2026-by-pharmaceutical-technology-1f310f8ec84fb019 2026-05-15T14:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/aaps-2026-pharmsci-360-7b45cc533984c457 2026-05-15T13:55:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-tariff-for-fees-has-come-into-effect-62386e35b79a7866 2026-05-15T13:43:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/rolling-stone-next-gen-cannabinoids-the-innovative-race-to-manufacture-compounds-7a4300d424c6692b 2026-05-15T13:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/warnstreik-am-19-mai-am-universitatsklinikum-heidelberg-akutversorgung-der-patie-bec2beb764236cc6 2026-05-15T13:18:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-labs-are-the-missing-link-in-patient-identification-9b9a28d4fef3868b 2026-05-15T13:08:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/previously-unrecognized-manuscript-from-the-bibliotheca-palatina-rediscovered-c47c820d3d412586 2026-05-15T13:02:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/lea-wh-fellowship-immersion-week-kicks-off-1a5b9e16452c0ae7 2026-05-15T12:22:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-researcher-leads-charge-to-transform-mental-healthcare-in-kenya-6ab525ddd00817cd 2026-05-15T12:22:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-3-24d07ed835c1cabf 2026-05-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/restructuring-hospitals-to-help-the-elderly-d5b1ea10032800f6 2026-05-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regenxbio-ii-rgx-121-f0bed87f2b27c7d0 2026-05-15T11:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supply-and-delivery-of-various-medical-equipment-tender-no-amref-15-05-2026-008-5b76afbbfc61995b 2026-05-15T11:53:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-athletics-club-shines-at-the-two-oceans-marathon-4c2b3ec72089c531 2026-05-15T11:47:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-conferred-with-a-charter-9fb3d53d36ae6e87 2026-05-15T11:04:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/inscrivez-vous-au-diplome-universitaire-sur-la-recherche-en-soins-645a788df5c6fee8 2026-05-15T10:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hi-tac-karina-yaniv-appointed-as-new-scientific-director-1da6721ccea0417b 2026-05-15T09:36:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/outstanding-nursing-and-midwifery-staff-celebrated-123a6a9ac07d10d3 2026-05-15T09:22:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/universitat-heidelberg-successful-with-application-for-collaborative-research-ce-e64a0c1b456aba2d 2026-05-15T08:41:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-biologics-dominate-biopharma-pipelines-manufacturing-hurdles-trip-up-new-laun-24a924c71d01fd8f 2026-05-15T08:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ancient-cyanobacteria-repurposed-plasmid-dna-perhaps-opening-the-door-to-multice-6b8499f41a027910 2026-05-15T08:17:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/heidelberger-sonderforschungsbereich-molekulare-schaltkreise-von-herzerkrankunge-9901772df474da6d 2026-05-15T08:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-wound-research-to-tackle-pain-and-cost-of-chronic-wounds-54fcb31cf3af8e5f 2026-05-15T08:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-jitendra-narayan-cc3900b201e24e09 2026-05-15T07:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/im-portrait-dr-christina-mertens-003aaa891001b496 2026-05-15T07:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/right-medicine-right-person-jacintha-sivarajah-on-science-with-purpose-516f0ec024d4f777 2026-05-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/attenzione-alle-telefonate-sospette-37ce8493b4383751 2026-05-15T06:49:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/guy-s-and-st-thomas-strengthens-partnership-with-london-south-bank-university-to-d22fac740d71a281 2026-05-15T06:48:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-day-at-a-time-fda-s-new-ai-informed-inspection-pilot-and-what-it-means-for-i-56cf48ddcc0b4115 2026-05-15T05:06:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-biomarkers-for-treatment-response-in-psoriatic-arthritis-a-focus-on-mu-61eed676600209d8 2026-05-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ars-pharmaceuticals-reports-first-quarter-2026-financial-results-and-corporate-u-1d75c70065f40187 2026-05-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/class-serves-up-a-taste-of-shakespeare-s-england-emory-university-atlanta-ga-41e1b937b366ac66 2026-05-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-fda-clearance-to-proceed-with-uheart-x-40dbf71bab7fbe23 2026-05-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-waiting-times-latest-updates-and-analysis-22c15b4e26ed00f9 2026-05-14T23:50:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/answers-are-in-our-dnatm-887acce9020da7d3 2026-05-14T21:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/sponsor-s-guide-to-irb-approval-part-iv-preparing-irb-documents-that-prevent-del-5c274fdfaa7af741 2026-05-14T20:40:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-to-present-at-stifel-conference-and-announces-2026-investor-d-2ba8d6d358781344 2026-05-14T20:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-with-advarra-s-associate-director-of-client-success-evan-sander-f019f1286b1fd341 2026-05-14T20:20:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-announces-share-repurchase-program-of-up-to-125-million-of-its-common-04baebe9cc278c87 2026-05-14T20:06:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-lusardi-tower-opens-to-patients-this-week-at-scripps-memorial-hospital-encin-d0117b02990af145 2026-05-14T19:48:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/diving-safety-this-summer-f6a4ca47a8cc641f 2026-05-14T18:21:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-is-no-longer-the-bottleneck-why-clinical-development-must-shift-from-innovati-bf7d86e0942815a7 2026-05-14T16:59:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/it-s-a-fact-sharing-clinical-trial-results-with-participants-builds-trust-50f1db08205612b7 2026-05-14T16:55:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-therapeutics-reports-first-quarter-2026-financial-results-and-provides-71a958f8225a1fb6 2026-05-14T16:02:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/uspto-doubles-down-on-inconsistencies-in-dual-ipr-court-action-32282ccb9f10489f 2026-05-14T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imp-release-and-supply-management-ensuring-compliance-from-manufacture-to-site-51fb1ad36b7de2c5 2026-05-14T15:54:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cd20-152f965481be2a1d 2026-05-14T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-reports-first-quarter-2026-financial-results-and-p-dd348cb5ad6f1b21 2026-05-14T15:19:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/w-m-keck-foundation-gives-1-2-million-to-uc-irvine-to-support-early-career-scien-d938d20ecf2042f6 2026-05-14T15:03:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-tissues-tune-immune-responses-to-match-the-threat-0be91df55cb9775c 2026-05-14T14:40:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/complications-of-temporary-transvenous-cardiac-pacing-by-access-site-a-systemati-392aa6275dfa3574 2026-05-14T14:34:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/recurrent-takotsubo-syndrome-after-pacemaker-implantation-20e20577a17d5f77 2026-05-14T14:32:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/welcome-to-the-inaugural-edition-of-the-beat-from-heartsciences-658fd508c2c6d93c 2026-05-14T13:55:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/recordati-publication-of-the-interim-report-as-at-31-03-2026-and-of-the-minutes-8c46b0c446956343 2026-05-14T13:44:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-s-aisight-dx-ims-platform-supports-the-aisight-consults-workflow-for-stre-97c4daaa407d041b 2026-05-14T13:34:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-launches-viz-pulmonary-suite-the-first-comprehensive-ai-powered-solution-74e5947a40879c7e 2026-05-14T13:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-announces-retrospective-clinical-publication-evaluating-85daac1165b1c481 2026-05-14T12:05:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-typhoon-intensity-using-ocean-surface-temperatures-c596707020e5f93f 2026-05-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-releases-third-quarter-2026-financial-results-and-provides-ope-703e1b8864fe6808 2026-05-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tied-up-in-the-lab-an-unexpected-catheter-knot-in-the-arterial-system-4e840a726b6843f6 2026-05-14T11:09:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-weight-adjusted-colchicine-to-prevent-post-cabg-arrhythmias-a-randomi-ad33bf0677e4fbf7 2026-05-14T11:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-reports-reduced-brain-inflammation-in-multiple-system-atrophy-patients-t-bd8941ecef5ab71c 2026-05-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canada-nabs-time-on-extremely-large-telescope-with-groundbreaking-instrument-inv-6fa75b549a23ca12 2026-05-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-one-releases-2026-catalyst-index-revealing-clinical-performance-as-dccf20beaf9ecd41 2026-05-14T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-s-largest-independent-gambling-harms-research-centre-launches-3a026fa9dd18b4ea 2026-05-14T09:00:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/developments-in-sepsis-antimicrobial-resistance-antifungals-and-immunotherapies-90ad1bd91237e8c1 2026-05-14T08:21:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/disruptions-may-occur-when-sending-e-mails-to-state-agency-of-medicines-contacts-fe31805b7d87a053 2026-05-14T08:06:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/sun-recalls-us-chemotherapy-batch-citing-glass-particle-contamination-concerns-028c10290a8f7f56 2026-05-14T08:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-new-trustees-join-board-of-quadram-institute-bioscience-e4813e2bc5cea7ae 2026-05-14T08:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/bora-snaps-up-macrogenics-manufacturing-cdmo-operations-for-up-to-127-5m-56186df5336892c2 2026-05-14T07:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nafdac-becomes-the-24th-member-of-the-international-council-for-harmonization-of-e8fa5f3061548bfc 2026-05-14T07:31:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-school-of-medicine-commencement-is-saturday-8fe50d940ea65e66 2026-05-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-patient-back-to-restoring-power-and-his-life-9ab6178bfd9c48a7 2026-05-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pdbe-sifts-for-protein-sequence-structure-mapping-4a5b6e358f77adcc 2026-05-14T06:57:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cd20-5284e730867fbce1 2026-05-14T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/filing-of-humanized-anti-cd20-monoclonal-antibody-gazyva-for-additional-indicati-5a938dd78fb47bdc 2026-05-14T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aesthetics-built-from-science-431759aef08e5986 2026-05-14T05:49:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/providing-a-cellular-all-clear-signal-to-resume-protein-synthesis-ccbfe204e1d04e51 2026-05-14T05:21:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-data-chaos-to-discovery-building-the-data-foundation-for-ai-ready-scientifi-ab2ca25dee0709a0 2026-05-14T05:01:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-clinical-trials-day-why-technology-helps-research-rise-1d9683b0d97e22d4 2026-05-14T03:34:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/wegovy-and-mounjaro-for-weight-loss-not-funded-f018438f713582bc 2026-05-14T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-inaugura-centro-de-livros-da-china-na-faculdade-de-letras-f282505dc65707ea 2026-05-14T01:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combin-30fa07b1e018c909 2026-05-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-reports-first-quarter-2026-financial-results-and-provides-business-u-f84ca61d613e6c34 2026-05-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-association-between-social-determinants-of-health-race-and-sex-on-risk-for-r-fc6f858ac4e7ccae 2026-05-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/class-of-2026-members-reflect-on-their-time-at-emory-emory-university-atlanta-ga-0d4639e47ec831d6 2026-05-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-reports-first-quarter-2026-financial-results-and-raises-ful-95128c0201becf26 2026-05-13T23:18:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/3c-therapeutics-and-variational-ai-launch-generative-ai-collaboration-to-design-6b284a1055fd4478 2026-05-13T22:36:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/smith-entertainment-group-and-intermountain-health-announce-groundbreaking-partn-506264ddc0fcfe6e 2026-05-13T22:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/challenging-negative-stereotypes-and-embracing-strengths-associated-with-aging-0523acfe7df18242 2026-05-13T21:52:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cytokine-driven-divergence-between-allogeneic-car-t-platforms-0d8664adf972f5ab 2026-05-13T21:19:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-reports-first-quarter-2026-results-ce7339b7dbd71c0c 2026-05-13T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/principales-logros-consejo-directivo-y-jvps-periodo-2024-2026-323365cd69861adb 2026-05-13T20:55:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-celebrates-nurses-week-2026-49ae1bbf9cc2208b 2026-05-13T20:30:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-first-quarter-2026-financial-results-and-provides-corporate-u-94d362aa299ae23d 2026-05-13T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-reports-first-quarter-2026-financial-results-and-provides-busines-7784751b02f266ce 2026-05-13T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogene-therapeutics-reports-first-quarter-2026-financial-results-and-business-b11d3d299fbec3c2 2026-05-13T20:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acesso-a-medicamentos-no-sus-exige-previsibilidade-escala-e-regulacao-eficiente-4d348af102c65085 2026-05-13T20:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/helmsley-charitable-trust-destina-20-millones-para-que-intermountain-health-expa-401e57050b49f4f8 2026-05-13T19:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/helmsley-charitable-trust-commits-20-million-to-intermountain-health-to-expand-p-86aa97dfc433ee28 2026-05-13T19:42:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/crossing-paths-how-the-national-mps-society-reaches-families-where-they-are-b67bce772e513971 2026-05-13T18:27:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-successful-viral-vector-production-processes-d133fa6d504a88ee 2026-05-13T16:32:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-elections-in-scotland-and-wales-a-turning-point-for-cancer-cc9eaef8c09515a0 2026-05-13T16:04:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-sciences-sweet-opportunity-in-us-china-talks-fa048afebf1be3cc 2026-05-13T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maintain-patient-trust-how-to-use-ai-in-lay-summary-development-3a47b61017920671 2026-05-13T14:58:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-want-to-help-patients-d4cea4995717851c 2026-05-13T14:22:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-researchers-invent-a-wearable-bioelectronic-sweat-sensor-for-long-term-73f7e93586d69714 2026-05-13T13:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/biventricular-repair-linked-to-better-outcomes-in-superior-inferior-ventricles-t-d08aceb03250818f 2026-05-13T13:55:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/norstellalinq-identify-obesity-treatment-opportunity-before-the-market-does-7880adffa4de6ae5 2026-05-13T13:38:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/sci-tif-community-gathers-for-4th-annual-networking-dinner-6a56721f2671ca5a 2026-05-13T13:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/dia-2026-e7a2d58ae39960c5 2026-05-13T13:18:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/diretores-e-decanos-debatem-protocolo-institucional-para-situacoes-de-violencia-44ffa98e6c300711 2026-05-13T12:59:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharma-days-2026-ef845f38b36f9b6b 2026-05-13T12:45:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-expands-us-early-phase-research-capabilities-eab3691dd6cddaf3 2026-05-13T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-laboratories-and-medipost-sign-non-exclusive-mou-to-advance-gmp-te-9e00b8ee1c3e2d47 2026-05-13T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jellinek-dialogues-power-conflicts-in-research-5db6def23c5c31a6 2026-05-13T11:56:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-reports-first-quarter-2026-results-and-provides-pipeline-upd-bdb669df1802d9f4 2026-05-13T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-fragen-an-prof-carolin-lerchenmuller-zur-frauen-herzsprechstunde-16bc52f00320aa49 2026-05-13T11:14:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/internationaler-tag-der-pflegenden-2026-am-ukhd-05fc4a69fddc98c7 2026-05-13T10:51:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/acne-in-estate-come-averne-cura-b3824692d5b1a202 2026-05-13T10:47:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/simultaneous-tricuspid-valve-replacement-and-left-bundle-branch-area-pacing-with-ea1fd28128e88b6c 2026-05-13T10:29:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cosa-sono-e-a-cosa-servono-le-paratiroidi-7e07a3ae743169e2 2026-05-13T10:21:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-atrial-appendage-thrombus-sludge-and-flow-velocity-in-patients-with-atrial-bcce517ba0243581 2026-05-13T10:20:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/zero-fluoroscopy-catheter-ablation-of-accessory-pathways-and-av-nodal-re-entry-t-af3f2b169a174550 2026-05-13T10:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-announces-participation-in-upcoming-investor-conferences-1b3628b5023e8bdc 2026-05-13T10:02:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuroepithelial-tumor-with-aav-integration-after-intracisternal-magna-vector-del-aafabd74af81aea0 2026-05-13T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-of-nightingales-honoured-with-unique-professional-award-07d3a53ab9a7dde2 2026-05-13T09:35:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ich-analysiere-leidenschaftlich-gerne-daten-794135d47a351a5e 2026-05-13T08:52:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-ai-for-more-efficient-clinical-trials-70ca39f48c384b7d 2026-05-13T08:40:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-tools-life-sciences-companies-bbc7155179299079 2026-05-13T08:12:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-society-for-nutrition-foundation-and-novo-nordisk-foundation-announce-2-4a7af8c29846d6f2 2026-05-13T07:54:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-emphysema-care-uc-davis-health-offers-innovative-lung-treatment-8571552498cbb224 2026-05-13T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-expands-early-phase-capabilities-ba6e103484947030 2026-05-13T06:32:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-opens-new-texas-clinical-research-unit-47646ae0160fd531 2026-05-13T06:28:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-opens-early-phase-research-unit-in-san-antonio-plus-satellite-clinics-to-gr-243b4b9d4824aee8 2026-05-13T06:25:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-nagoya-protocol-what-is-it-and-what-scientists-should-know-about-compliance-c10b1b23e88af6ff 2026-05-13T06:23:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-preliminary-results-and-investor-presentation-939329480d3c6ee5 2026-05-13T06:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/issue-of-equity-and-total-voting-rights-262427612cf95399 2026-05-13T06:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/36-new-products-at-bio-it-world-2026-f35487d1135aa21e 2026-05-13T05:01:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-announces-personnel-changes-52b448dbb122d2e3 2026-05-13T04:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-seven-english-translations-of-notifications-and-administrative-notices-re-f27bea3e1c10c7be 2026-05-13T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-hospitals-to-save-millions-on-drug-eluting-stents-c8453dcc90f226ce 2026-05-13T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/consultation-on-proposed-changes-to-diabetes-medicine-criteria-977102759ad37d8f 2026-05-13T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-june-2026-rheumatology-advisory-committee-meeting-b106242c61060257 2026-05-13T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glifoweed-platinum-416345da9a6d489f 2026-05-13T00:40:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-initial-insider-holdings-report-3ccc15bacc445ec8 2026-05-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ars-pharmaceuticals-strengthens-leadership-team-with-appointment-of-industry-vet-54e29bd5dc7d4dae 2026-05-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proton-pump-inhibitor-use-as-a-modifiable-etiological-factor-for-iron-deficiency-e3b67c0db8b5c5dd 2026-05-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-mentor-for-everyone-patty-brennan-honored-with-emory-college-s-cuttino-award-e-b612446103794c35 2026-05-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-to-participate-in-rbc-capital-markets-2026-global-healthcare-confe-51929ded1ac736a4 2026-05-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-stroke-symptoms-why-intermountain-health-experts-say-you-need-to-be-5d1b556fad2d49ca 2026-05-12T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-reports-first-quarter-2026-financial-results-and-provides-b-30805e21a8abe0e8 2026-05-12T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nord-statement-on-fda-leadership-change-65c19ed2e4d975dd 2026-05-12T19:52:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/patients-with-advanced-colorectal-cancer-have-new-offering-for-treatment-with-li-bb3ec52b92217a69 2026-05-12T19:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-participant-engagement-is-the-missing-link-in-clinical-trial-data-quality-c238853f314ccc41 2026-05-12T18:52:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/demanda-gigante-ems-fleury-e-anvisa-debatem-potencial-da-semaglutida-20a8d74cf38612c0 2026-05-12T17:57:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-faz-parceria-com-a-norte-americana-biotech-para-desenvolver-tratamentos-de-a-35db31cbf56c9acc 2026-05-12T17:46:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/qual-e-a-sua-verdade-dermacyd-propoe-olhar-para-a-intimidade-05d7a954ebc86be5 2026-05-12T17:42:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-compra-medley-da-sanofi-e-reforca-aposta-no-mercado-de-genericos-1a24cc2e7f994706 2026-05-12T17:38:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-st-james-hospital-in-butte-montana-earns-primary-stroke-cer-57c0c51d49b3667e 2026-05-12T17:36:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/lista-forbes-as-10-empresas-mais-inovadoras-do-brasil-1388f8eb39ae55a7 2026-05-12T17:29:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-promove-campanha-inovadora-para-anunciar-o-novo-lacday-long-action-bed9d506f727ee6f 2026-05-12T17:20:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/recordati-strong-momentum-of-the-group-continues-into-the-first-quarter-of-2026-45b0047e3cbc03fe 2026-05-12T16:15:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-med-tech-raises-star-sports-105m-ipo-cofoe-nabs-133m-bff97773f082ca6f 2026-05-12T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multiple-appearances-on-priority-watch-list-leading-to-action-8f2c4252981cba3d 2026-05-12T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/makary-out-at-the-fda-f9cc067e14e74d5e 2026-05-12T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metis-techbio-impact-tx-cleared-for-hong-kong-ipos-c4825b96be0529ba 2026-05-12T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryopak-engineering-insights-common-failure-points-in-cold-chain-packaging-and-w-879bbf02b3ead63e 2026-05-12T15:42:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fce-pharma-2026-solutions-for-latam-s-pharma-market-df80b4d5d94c9a39 2026-05-12T15:37:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-positive-interim-phase-3-results-highlight-potential-of-ovaprene-n-4632898dadab8b71 2026-05-12T15:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-team-identifies-where-renewable-hydrogen-delivers-the-greatest-social-927a5d155e7724f6 2026-05-12T15:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/official-statement-by-farmak-regarding-media-reports-about-the-possible-producti-2df4417218a5f0c2 2026-05-12T15:05:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-and-cms-device-access-programs-tempo-rapid-and-real-time-trials-greenlight-g-7e797cbb33cbf73d 2026-05-12T14:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-and-africa-cdc-advance-long-term-vaccine-supply-partnership-for-africa-611388032890ce33 2026-05-12T14:04:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/wackadoo-join-bluey-for-the-ultimate-playdate-on-apple-arcade-starting-may-21-6f5c2727ac99484a 2026-05-12T14:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/finding-genius-podcast-ai-enhanced-enzymes-the-future-of-sustainable-manufacturi-0647f31d72a14b92 2026-05-12T13:58:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/prelievi-ed-esami-a-domicilio-il-servizio-humanitashome-33d368f16ce30333 2026-05-12T12:48:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/samd-quality-ops-jira-and-github-in-your-qms-greenlight-guru-40fd9c8b1bc3fd87 2026-05-12T12:46:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/pirbright-expert-collaborates-with-punjab-agriculture-food-drug-authority-27ea83e5a28e5169 2026-05-12T12:41:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrp-fellow-highlights-ongoing-efforts-in-the-professionalization-of-clinical-re-3a95110493cc83fe 2026-05-12T12:18:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/reflections-on-klas-us-digital-pathology-report-what-it-means-to-be-a-long-term-c2719226c78f898d 2026-05-12T12:05:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-to-present-preclinical-data-of-new-next-generation-high-performing-ocula-940670cb98ed3ff2 2026-05-12T12:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/iec-62304-and-the-software-dhf-greenlight-guru-f4be799d4689afc4 2026-05-12T11:48:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/une-tombola-solidaire-organisee-par-le-chu-de-lille-1dcb714e9b7b1342 2026-05-12T11:27:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-war-to-recovery-how-global-collaboration-sustains-cancer-research-and-care-13befec2f3c725f2 2026-05-12T11:00:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-and-epic-expand-collaboration-to-advance-diagnostic-integration-across-h-4870b29e500e493e 2026-05-12T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blood-test-enables-earlier-detection-of-heart-and-kidney-disease-f1cc3644e6886fd8 2026-05-12T10:37:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/nurse-gives-kidney-to-stranger-on-same-day-husband-receives-kidney-transplant-to-aa63f5ed85c4ed54 2026-05-12T09:54:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-zero-fluoroscopy-frontier-current-tools-evidence-and-future-direc-ef57e64aad903135 2026-05-12T09:41:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-utilization-and-prognosis-of-cardiac-device-implantation-in-al-versus-c85350d749c09eb5 2026-05-12T09:37:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-advances-scheme-to-bolster-manufacturing-autonomy-avert-drug-shortages-30e5e1778eccfd57 2026-05-12T08:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-appoints-hunada-nouss-obe-as-non-executive-director-c3992795666722da 2026-05-12T08:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unsere-pflege-unsere-zukunft-pflegeperspektiven-am-ukhd-58b19e00a26c3ee8 2026-05-12T08:24:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/eucope-concerns-on-the-provisional-trilogue-agreement-of-eu-institutions-on-the-23e6b471b4bfc1d7 2026-05-12T08:17:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-starkt-pflegefachkrafte-mit-hochschulabschluss-d499ac507288cc62 2026-05-12T08:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-to-seek-out-microbial-triggers-of-me-cfs-c255f11f9f5d82ab 2026-05-12T08:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-uk-centre-to-fast-track-brain-inspired-computing-for-ai-6d2fdd7c7b0f5ac8 2026-05-12T08:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/psi-cro-establishes-mexico-office-to-strengthen-a-decade-of-proven-local-operati-3875111bcb540133 2026-05-12T07:55:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/faszinierend-was-ihre-niere-alles-kann-67290e5d6d381929 2026-05-12T07:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-launches-a-pill-for-everything-series-on-responsible-medication-use-054826f70c134f18 2026-05-12T07:07:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-roadmap-for-safer-explainable-protein-design-ai-7b960d79c479373e 2026-05-12T07:05:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/assistant-professor-alex-fauer-receives-uc-award-to-advance-cancer-care-for-olde-71be3c49885f5c9b 2026-05-12T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/financial-results-for-fiscal-year-2026-220a7940a9575dc3 2026-05-12T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/des-signaux-caches-dans-les-genes-3be969ffaa281a91 2026-05-12T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-receives-ce-mark-for-new-blood-test-to-detect-alzheimer-s-pathology-elecsy-181f15846c84014f 2026-05-12T05:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-framework-for-differentiating-neurodegenerative-diseases-25ab8d54d15c5a84 2026-05-12T05:01:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-and-hengrui-pharma-announce-strategic-agreements-to-advance-4c8e47af9419aec3 2026-05-12T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-pmda-atc-gmp-inspection-seminar-2026-applications-open-ea16981f511e5ced 2026-05-12T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-dose-escalation-and-safety-gene-therapy-study-in-a-model-of-cmt4c-neuropathy-ec1acf48d0fac6f2 2026-05-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-progression-and-prognosis-of-heart-stress-in-the-community-implicatio-96be5b75dda4ba44 2026-05-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-to-present-at-the-rbc-capital-markets-global-hea-0863fbe11690439d 2026-05-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-to-participate-in-barclays-30th-annual-leveraged-finance-conferenc-5135582693693dfa 2026-05-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-1536a63ba829dd38 2026-05-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eikon-therapeutics-reports-first-quarter-2026-financial-results-and-provides-cli-a44a0d9138278a9f 2026-05-11T23:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-exoz-investor-presentation-by-chris-marlett-f40224d22ad71217 2026-05-11T22:32:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-key-trends-and-insights-drug-developers-need-to-know-to-succeed-in-2026-f995ec13906b83b1 2026-05-11T21:02:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-microsampling-at-altasciences-by-jeff-plomley-deb23fef8ab0982e 2026-05-11T20:23:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-king-visits-guy-s-to-mark-300th-anniversary-03bd575bf3ec83f2 2026-05-11T19:56:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/cocktail-ddi-studies-myths-vs-facts-d08486fc958ef9cf 2026-05-11T18:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-fecha-primeiro-contrato-para-representar-medicamento-de-farmaceutica-interna-f980f69dc215f929 2026-05-11T18:40:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cap-002-program-update-a-letter-to-the-stxbp1-community-29a9aa72127429f6 2026-05-11T18:18:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/end-to-end-encrypted-rcs-messaging-begins-rolling-out-today-in-beta-db3aea513fbae3bb 2026-05-11T17:10:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-looks-for-better-ways-to-prevent-skin-cancer-in-the-people-most-at-ris-2747ca2af0a72ac5 2026-05-11T16:32:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/zonder-koerswijziging-geen-koppositie-belgie-op-een-kantelpunt-voor-innovatieve-aa1e7b7dfd969fb0 2026-05-11T15:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/visit-the-wch-archives-nursing-exhibit-1c981b30d29df3c7 2026-05-11T15:31:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-mother-s-day-montana-woman-is-grateful-for-life-saving-care-she-newborn-son-r-3104b37e225d4123 2026-05-11T15:10:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/mou-with-bipm-and-shimadzu-on-collaboration-toward-redefining-the-second-99446cd44123a22f 2026-05-11T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-advances-aisight-dx-with-the-v2-20-release-enhancing-viewer-usability-wor-17cfe361ba2759ad 2026-05-11T14:43:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/15809-2-8a29ed4c678f169b 2026-05-11T14:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-in-the-spotlight-for-the-75th-edition-of-the-lindau-nobel-3c2214a7401f8170 2026-05-11T13:42:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-reports-2026-first-quarter-financial-results-and-provides-0091c3e510406693 2026-05-11T12:30:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-activation-of-children-s-hospital-of-philadelphia-053cf1331cfb6118 2026-05-11T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinetx-wins-the-clinical-trial-innovation-award-and-what-it-means-for-the-futur-6fc373b60ce23ea8 2026-05-11T12:01:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-receives-expanded-fda-510-k-clearance-adding-power-lipo-7f7296cb6e49bbae 2026-05-11T12:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-joins-orphan-therapeutics-accelerator-s-clinical-development-netwo-fc04f72d7a576bbe 2026-05-11T12:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-enters-exclusive-collaboration-with-sbp-group-a-market-leader-in-hepatology-c791b3445d9ac552 2026-05-11T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-accelerates-digital-pathology-with-ai-powered-end-to-end-workflow-53ce90c7eed3d38e 2026-05-11T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flash-vig-news-paracetamol-bonnes-pratiques-d-utilisation-contre-la-douleur-et-l-11b21b165b005702 2026-05-11T11:56:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/cambridge-oncology-innovator-secures-500k-investment-to-improve-cancer-drug-deve-f6384f8da0052264 2026-05-11T11:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-bench-to-bedside-how-a-discovery-about-menin-led-to-new-treatments-for-acut-c24b68ede260be04 2026-05-11T10:55:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-talks-and-discussion-engineering-life-from-genomes-to-organs-d81625afd5eb3168 2026-05-11T10:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-leem-finalise-sa-nouvelle-gouvernance-avec-l-election-de-son-36eme-administra-62f7409b5605c5be 2026-05-11T09:58:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/space-mission-to-study-alien-worlds-passes-crucial-test-milestone-e3cacc085e2a0dd2 2026-05-11T09:35:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/museumsmeilemitte-mit-medizinhistorischem-museum-futurium-hamburger-bahnhof-und-cf103e764bf9ec13 2026-05-11T08:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/curarsi-con-l-intelligenza-artificiale-humanitas-al-festival-dell-economia-di-tr-5191ecbc8d19eecf 2026-05-11T08:39:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-supports-protecting-health-in-next-eu-long-term-budget-9d74c55b5e01b3f1 2026-05-11T07:55:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/chapelle-de-l-hotel-dieu-la-restauration-continue-avec-le-transept-nord-79a7dfe2835aaa05 2026-05-11T07:17:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/gratulation-an-prof-dr-med-roman-pfeifer-522ccfc06dc6cceb 2026-05-11T07:02:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/aging-with-hiv-what-the-next-major-challenge-is-for-drug-development-03dc84852366901e 2026-05-11T06:51:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/worldstar-global-packaging-awards-2026-worldstar-winner-2026-d88a8b30553b3461 2026-05-11T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-rsquo-s-pharmaceutical-packaging-leveraging-proprietary-technologies-wins-5877ecc3f3b404f7 2026-05-11T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-offers-insight-into-the-mysterious-roots-of-deep-earthquakes-d086ffe946678904 2026-05-11T01:38:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-guided-versus-natriuresis-diuresis-guided-decongestion-in-acute-heart-fai-18f14e3738413829 2026-05-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-low-serum-iron-and-transferrin-saturation-and-incident-heart-3749054eb123d5c2 2026-05-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-presents-new-data-from-teton-1-advance-outcomes-8dd8dfad2666696a 2026-05-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasa-engineer-receives-an-innovative-double-lung-transplant-at-northwestern-medi-971619071e0376ed 2026-05-10T05:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-gave-birth-kissed-my-baby-and-then-i-blacked-out-237918d6c1dffc71 2026-05-10T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-hard-tissue-catalyst-why-orthopedic-robotics-will-lead-the-autonomous-surgic-c86e39c6200b2e7e 2026-05-09T15:35:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/reitor-empossa-nova-direcao-da-faculdade-de-arquitetura-e-urbanismo-para-a-gesta-ab3c02b9ea7d952a 2026-05-09T00:24:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-divide-divergent-diagnostic-philosophies-and-practice-pathways-for-af4cd2c93a7d496c 2026-05-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/journal-of-clinical-oncology-ficerafusp-alfa-bca101-with-pembrolizumab-for-recur-05312d388cdba2ee 2026-05-08T21:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/element-biosciences-responds-to-10x-genomics-patent-infringement-complaint-a89030fe6111b7d9 2026-05-08T21:14:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/odyssey-therapeutics-announces-pricing-of-upsized-initial-public-offering-1e3b6ca675188bb7 2026-05-08T20:09:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/capping-coding-583beaa4fc9e9229 2026-05-08T18:52:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-st-mary-s-regional-hospital-sees-baby-boom-as-u-s-birthrate-44e654503a1b02ac 2026-05-08T18:30:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/aa4ccea105871c0c 2026-05-08T17:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cgt-manufacturing-scale-up-sk-pharmteco-featured-in-gen-894bf22f6777a475 2026-05-08T16:51:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategic-capital-supports-pivotal-stage-execution-fc3c00e4ede711f4 2026-05-08T15:08:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-secondary-packaging-s-potential-to-accelerate-smart-tech-adoption-and-fe02031f34d91891 2026-05-08T14:58:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/nota-oficial-9f1f13fc8d2fc846 2026-05-08T14:54:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/artiva-announces-positive-initial-clinical-data-with-allonk-across-multiple-auto-68cca9b871a0acfe 2026-05-08T14:50:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/artiva-biotherapeutics-announces-pricing-of-300-million-underwritten-offering-of-14472d87dbb4869d 2026-05-08T14:50:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-group-chief-operations-officer-highlights-aspen-s-role-at-the-world-bank-i-50a3596be3cd3129 2026-05-08T14:49:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-to-present-at-respiratory-innovation-summit-d9ec32b6e8654f2a 2026-05-08T13:23:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/africa-forward-a-call-for-health-sovereignty-and-people-centred-partnerships-5e47ff015989c7a6 2026-05-08T13:16:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/history-of-women-in-clinical-trials-a9591d8f1e624be7 2026-05-08T13:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrahigh-energy-cosmic-messengers-may-carry-ultraheavy-secrets-0cbf477b307620ef 2026-05-08T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biobase-and-techcyte-partner-to-advance-digital-pathology-and-unlock-the-full-po-b7a981ece068a83a 2026-05-08T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-off-a-simple-mechanism-as-the-key-to-new-insights-2d672faea7623ada 2026-05-08T09:53:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-1830780ebaff6633 2026-05-08T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-wins-at-the-davos-communications-awards-2026-in-switzerland-8a999302c2785601 2026-05-08T08:28:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/nevralgia-del-trigemino-ci-sono-rimedi-per-alleviare-il-dolore-cdde505445673a22 2026-05-08T08:24:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-launches-a-new-medicinal-product-for-the-management-of-anxiety-conditions-4ec9f6dd32227b54 2026-05-08T08:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/zhebrivsky-family-charitable-foundation-ranked-among-ukraine-s-top-100-largest-c-c5fe69e9da4bffb6 2026-05-08T08:10:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-provides-corporate-update-and-reports-first-quarter-2026-financial-res-036ec3e21cf16d55 2026-05-07T20:07:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-reports-first-quarter-2026-financial-results-46dff3e35186caf7 2026-05-07T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/purdue-cook-medical-build-upon-50-year-alliance-7ef71fa8ad1fccef 2026-05-07T20:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-reports-first-quarter-2026-financial-results-b82f1c0d93320182 2026-05-07T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genome-canada-strengthens-leadership-for-mission-driven-delivery-772659231583364b 2026-05-07T18:53:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-logistics-to-lifecycle-building-advanced-therapy-supply-chains-that-scale-30bad4281e3943e2 2026-05-07T18:02:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-enters-into-a-definitive-merger-agreement-to-acquire-pathai-to-transform-a-010bf4e68aea9290 2026-05-07T17:59:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-hidden-complexity-of-inhalation-drug-development-c71db1b65270cf61 2026-05-07T17:07:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-filmmakers-are-redefining-the-art-form-with-mami-select-filmed-on-iphone-5f93930732de34c6 2026-05-07T17:00:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-bottleneck-to-accelerator-how-strategic-dart-study-designs-can-speed-ind-ac-0512c454cc835088 2026-05-07T16:51:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-paper-to-practice-annex-1-has-reset-expectations-5723fabfa7f78ea5 2026-05-07T16:42:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-in-success-integrating-qbd-principles-in-biologics-formulation-developm-2f4b747ebbb11b98 2026-05-07T16:32:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fourteen-intermountain-health-hospitals-receive-leapfrog-a-grade-for-excellence-e31710cbb69d1e23 2026-05-07T15:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/curso-basico-para-regentes-de-laboratorio-clinico-070a20cb4fa9376f 2026-05-07T15:43:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-rising-a-commitment-to-advancing-human-life-8240bbf8f43a92f2 2026-05-07T15:27:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinetx-wins-clinical-trial-innovation-award-in-10th-annual-medtech-breakthrough-ea44c0516629f54b 2026-05-07T15:12:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapid-maternal-code-response-helps-doctors-save-mother-and-baby-at-northwestern-33f75c3a0de52208 2026-05-07T14:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-gains-with-big-meaning-loic-s-story-of-deep-brain-stimulation-for-pkan-car-0f13b47f3f62f9b5 2026-05-07T14:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hantavirus-cos-e-e-i-sintomi-a57c7cfcdc493ddd 2026-05-07T14:45:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-chain-logistics-enters-the-patient-centric-era-cfaeca62b4e9ed60 2026-05-07T14:42:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimizing-enrollment-in-an-asthma-clinical-trial-239320fedfed2b43 2026-05-07T14:05:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenya-elected-vice-president-of-ivi-global-council-as-biovax-joins-board-of-trus-75984395d0ea2b32 2026-05-07T14:01:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-meets-accessibility-in-this-year-s-swift-student-challenge-87baf9b28df3f559 2026-05-07T13:59:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/exozymes-announces-graduation-from-shell-gamechangertm-accelerator-powered-by-nl-18cc2c28428f5ed5 2026-05-07T13:01:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/structure-of-ancient-viral-protein-offers-new-therapeutic-possibilities-in-areas-f138c6c8ca445169 2026-05-07T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innocare-pharma-s-icp-b208-gains-ind-clearance-in-china-d655dd8ba918c175 2026-05-07T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ps-muthoni-inspect-a-site-for-the-construction-of-the-proposed-teaching-and-rese-04abbb340d208120 2026-05-07T12:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-investment-to-democratise-access-to-genomics-technology-152b3d417b94d281 2026-05-07T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/entrada-therapeutics-announces-positive-topline-results-from-cohort-1-of-partici-b69cb8ec2f5011e7 2026-05-07T12:38:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-the-future-kemri-s-benchmarking-visit-to-the-republic-of-korea-45f87b94d510c052 2026-05-07T12:35:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-publishes-2025-corporate-responsibility-report-highlighting-progress-in-e2ae2bed572d35c3 2026-05-07T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ruperto-carola-lecture-series-resistant-democracy-resilience-security-defense-eaf44a6cec5f4101 2026-05-07T12:13:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-3-cd91c6da9c111462 2026-05-07T11:09:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-reports-first-quarter-2026-financial-results-e992dd87fb7d8be2 2026-05-07T11:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-laboratories-announces-first-quarter-2026-results-badab5cf790c5c48 2026-05-07T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicina-nucleare-cosa-sono-i-radiofarmaci-023ce570cb84a974 2026-05-07T10:49:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-appoints-vitor-roque-chief-financial-officer-b2deb0fdae1b6d5d 2026-05-07T10:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-reports-second-quarter-fiscal-2026-financial-results-1e62b8a27517cd9b 2026-05-07T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/embl-corporate-partnership-programme-gets-new-member-66be0b7f71369d54 2026-05-07T10:07:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/bienvenue-aux-nouveaux-internes-et-docteurs-juniors-c11ac6d43534517e 2026-05-07T10:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/les-hus-accueillent-le-canceropole-est-comment-mieux-cibler-les-tumeurs-83aa1e8898b9d1c4 2026-05-07T09:59:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/operation-pangea-xviii-global-action-against-falsified-medicines-and-illicit-tra-080c22ea8c9f0b8d 2026-05-07T09:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-nouveau-protocole-pour-mettre-fin-aux-allergies-alimentaires-des-le-premier-a-7fd006c1d505587d 2026-05-07T09:10:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-pharmteco-collaborates-with-axle-informatics-and-the-national-institutes-of-h-5d4291c12afabd1c 2026-05-07T09:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nikotin-pravention-schulprojekt-uberzeugt-im-alltag-6a37168425097d5b 2026-05-07T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-vaccine-platform-shows-promise-against-pig-coronaviruses-d9af28da9fdfbecd 2026-05-07T08:04:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelika-wem-konnen-sie-helfen-wem-schaden-sie-stattdessen-fb97ad65898a3648 2026-05-07T06:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-substances-who-can-they-help-and-who-might-they-harm-941e84d242674072 2026-05-07T06:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trends-from-the-trenches-the-capability-jump-of-ai-and-its-impact-8791c1e7902f930d 2026-05-07T05:01:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-enters-into-a-definitive-merger-agreement-to-acquire-pathai-to-transform-a-382c1fda54d84a5a 2026-05-07T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/altasciences-and-certara-announce-strategic-partnership-to-accelerate-early-drug-d8133c6934acd80e 2026-05-07T04:41:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-included-in-dow-jones-best-in-class-europe-index-6a69894a0be8fb33 2026-05-07T04:20:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-top-fda-cdc-roles-filled-by-15-different-people-in-less-than-18-months-d16d8976a96de581 2026-05-07T04:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-capability-in-hot-clinical-event-debriefing-our-adelaide-training-exper-83d1ce6d5bd75ce0 2026-05-07T01:22:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-neel-33cb510d2493a313 2026-05-07T00:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-included-in-s-p-dow-jones-indicesa-global-esg-index-for-the-10th-consecut-fc52d2c6db4b440d 2026-05-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-flamma-group-receives-funding-from-regione-lombardia-in-2026-b593268b2acbcac5 2026-05-06T19:47:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-continuous-trials-could-mean-for-clinical-data-standards-and-oversight-56398c3e58113422 2026-05-06T18:51:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifarma-annual-summit-2026-define-roteiro-para-acelerar-o-acesso-a-inovacao-em-s-af103ac34523ae6f 2026-05-06T18:38:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-braintrust-supports-neighbors-living-with-brain-injuries-730adc659d49c8ee 2026-05-06T18:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediloc-femur-1f1c4a98c0889c67 2026-05-06T18:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/finding-a-way-forward-how-the-national-mps-society-s-pathways-program-supports-f-f7ad488e2dcb6398 2026-05-06T17:57:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-researchers-find-indigenous-lands-can-outperform-protected-areas-on-conserva-0da11b5cb78ce81b 2026-05-06T17:28:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/multiple-appearances-on-priority-watch-list-leading-to-action-0abd5e53f7850086 2026-05-06T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wtr-podcast-unlocking-hard-to-scale-molecules-with-ai-driven-cell-free-biomanufa-b8a675c41980190d 2026-05-06T14:49:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/bayer-to-acquire-perfuse-therapeutics-to-complement-ophthalmology-pipeline-1b48aac6d3cbfac3 2026-05-06T14:49:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-rolls-out-1-day-assessment-pilot-in-bid-to-refocus-inspection-resources-ae88168878b62412 2026-05-06T14:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nobelpreistrager-shimon-sakaguchi-spricht-beim-internationalen-symposium-frontie-bdac40a142202c2e 2026-05-06T14:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unforced-errors-flummox-hhs-radical-transparency-bid-again-336aed5dd3302fe2 2026-05-06T14:34:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-opens-new-air-medical-base-in-kingman-arizona-to-enhance-ac-599eaad6432a11d3 2026-05-06T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-glass-slide-to-molecular-proxy-the-pathology-ai-convergence-at-aacr-2026-ee9361abf5f59826 2026-05-06T12:56:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogene-therapeutics-to-report-first-quarter-financial-results-and-provide-busi-561a4ddf8e4e309e 2026-05-06T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-presents-latest-respiratory-research-to-advance-patient-care-at-ats-2026-a9ae56c261edff0e 2026-05-06T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-to-present-at-the-bank-of-america-securities-healthcare-conference-cfcb025e876cb770 2026-05-06T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthony-letai-md-phd-faacr-lays-out-nci-s-priorities-at-the-aacr-annual-meeting-2f5b244c517e39d8 2026-05-06T11:17:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-to-report-first-quarter-2026-financial-results-on-tuesday-m-642f464f4458d798 2026-05-06T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-named-among-ukraine-s-best-employers-2026-by-forbes-ukraine-46f1ca7ce6b2255b 2026-05-06T10:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-timing-is-right-for-psychedelics-manufacturer-optimi-health-s-ipo-41730bf4da6006dc 2026-05-06T09:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/von-aua-aha-bis-zahne-recyclen-das-charite-programm-zur-langen-nacht-der-wissens-dc69c85c0c0aee69 2026-05-06T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-to-invest-4-5b-more-into-massive-indiana-manufacturing-complex-0f91f9c1a1f9f492 2026-05-06T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/et-vous-avez-vous-deja-parle-don-d-organes-et-de-tissus-b046d439296bbeae 2026-05-06T07:29:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/articles-endovascular-treatment-for-medium-or-distal-vessel-occlusion-stroke-dis-fac20637330c093e 2026-05-06T06:55:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-presents-new-comparisons-of-pre-cision-payload-release-vs-approved-adcs-a-60a418171ab76943 2026-05-06T06:01:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/bacteria-unsung-players-in-the-tumor-microbiome-3ab63c80521d48cc 2026-05-06T05:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-rising-starts-with-people-4ad376d2b0cce5b0 2026-05-06T01:36:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/sounds-great-do-you-want-fda-approval-a-regulatory-analysis-of-psychedelics-767774bfc70c6a06 2026-05-06T01:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/1087-2-e0723cdfd19aaf01 2026-05-06T01:18:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/combined-enhanced-external-counterpulsation-and-hyperbaric-oxygen-therapy-in-isc-6066fa4af0ae920e 2026-05-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/congestion-obesity-and-survival-in-chronic-heart-failure-9618f445aa4984d4 2026-05-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-reports-first-quarter-2026-financial-results-a7661dd486fc2c01 2026-05-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-concede-titulo-de-doutor-honoris-causa-ao-cardiologista-portugues-fausto-pi-35de479cbe3817df 2026-05-05T23:46:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/sap-harmonisation-upgrade-programme-b889b5d38b36d0e6 2026-05-05T22:41:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/como-llegar-a-la-junta-d5fecfb31fc103d3 2026-05-05T22:08:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitudes-de-informacion-o-aclaracion-solicitadas-por-los-accionistas-2d799ad658bab939 2026-05-05T22:07:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitud-de-informacion-mediante-comunicacion-electronica-4382f798e5054aef 2026-05-05T22:06:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/delegacion-de-la-representacion-y-voto-mediante-comunicacion-electronica-9accb35989608f83 2026-05-05T22:06:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/acceso-asistencia-telematica-junta-general-ordinaria-de-accionistas-2026-c47345cdd4b9bafa 2026-05-05T22:05:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/foro-electronico-de-accionistas-ef6adc3241c3f5f3 2026-05-05T22:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/modelo-de-tarjeta-de-asistencia-delegacion-y-voto-a-distancia-482eff96a4f53104 2026-05-05T22:03:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/jennifer-davis-quot-debemos-tratar-la-ia-como-una-herramienta-para-generar-hipot-1c4a405ae4020591 2026-05-05T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diplomado-en-farmacologia-de-los-tratamientos-de-las-enfermedades-infecciosas-qu-34838094db964cbe 2026-05-05T21:43:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/construction-traffic-advisory-bay-college-intersection-bbbf5ce200316a5f 2026-05-05T20:50:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/interfarma-defende-proibicao-de-manipulacao-de-medicamentos-a-base-de-glp-1-8e5db748754f62a4 2026-05-05T19:31:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-ankle-based-nerve-stimulation-implant-for-bladder-control-now-offered-at-uab-c2d1caed1890daa6 2026-05-05T18:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-chapter-in-a-longstanding-partnership-scrs-supports-david-vulcano-s-transi-f67889780e31d0fd 2026-05-05T16:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-korea-2026-us-policy-risks-shift-to-execution-framework-8ae67aaaf9e8f17b 2026-05-05T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-looks-to-expand-mfn-pricing-for-530b-plus-in-savings-204b30d9e12a4bed 2026-05-05T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-informed-trial-design-how-granular-can-you-get-with-your-data-38d16e5ae6d37cd9 2026-05-05T15:34:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-success-with-the-ich-e6-r3-implementation-3c406a1e263c4f59 2026-05-05T15:29:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthofix-therapeutic-solutions-redefining-recovery-aa8fbbd7e7cb67dc 2026-05-05T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-signs-first-saas-revenues-agreement-following-full-launch-of-myovi-a3aeb9222015fd79 2026-05-05T13:52:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-7cd01ca22005d6e6 2026-05-05T13:47:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-differentiated-bispecific-antibodies-in-autoimmune-disease-e1284993a8b291ba 2026-05-05T13:35:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/designing-bispecifics-that-hold-up-in-the-real-world-ca714f9e1a72cacd 2026-05-05T13:27:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-and-a-c-camargo-cancer-center-announce-cooperation-to-expand-digital-path-e0562b93020792c4 2026-05-05T13:22:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoplasty-dr-w-cottone-bfb8e1ad2c4d3d20 2026-05-05T13:06:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/so-much-has-changed-advances-in-xlh-care-help-siblings-thrive-a32c5e58e38d362d 2026-05-05T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-manufacturing-academy-accelerates-ai-use-in-u-s-supply-chains-6c877c5b1b3a3ff6 2026-05-05T12:59:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoplasty-dr-sisto-26e4163247414f59 2026-05-05T12:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoplasty-dr-a-lonabaugh-3df82da97e4ac16a 2026-05-05T12:52:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-highlights-new-long-term-data-advancing-treatment-standards-in-inflammato-128dc3e842feebeb 2026-05-05T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/model-informed-drug-development-midd-a-data-driven-approach-to-end-to-end-drug-d-23053d4526cf75d5 2026-05-05T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-to-close-german-manufacturing-site-cutting-220-jobs-971ce6a83ba9e1d3 2026-05-05T11:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-to-present-ndv-01-abstracts-at-aua2026-13db037a7d2b68db 2026-05-05T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/technologies-for-identifying-deepfakes-cyberattacks-and-drone-threats-edb74f12b5c1389e 2026-05-05T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-and-wellstar-advance-patient-care-and-safety-with-medication-management-power-9a8dffb743e550f0 2026-05-05T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-to-slash-1-860-jobs-exit-sites-in-germany-and-singapore-in-major-manufa-aaafac922bb83fed 2026-05-05T10:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-announces-first-quarter-results-d650a7daceeef522 2026-05-05T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-reports-first-quarter-2026-financial-results-2d52a0d6fc0af255 2026-05-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-individual-consciousness-works-and-makes-us-unique-9ed6a204fd8a4a7d 2026-05-05T09:14:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-pharmteco-achieves-sbti-validation-for-2040-net-zero-science-based-targets-238bf44a0e1824b3 2026-05-05T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/universitatsspital-zurich-arbeitet-vergangenheit-auf-8e25d691a97fb08a 2026-05-05T08:55:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/travaux-d-amenagement-du-parking-p1-sur-le-site-hospitalier-de-purpan-82721781d996916f 2026-05-05T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/much-progress-needed-planning-research-to-consider-sex-as-a-biological-variable-7d673b9321df5454 2026-05-05T05:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-announces-changes-to-the-corporate-executive-committee-75315559001c4fc4 2026-05-05T04:57:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-achieves-iso-iec-42001-certification-setting-the-standard-for-agentic-ai-75ddabcee83f1f52 2026-05-05T04:00:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/biologist-joey-davis-explores-how-cells-build-complex-structures-372f6c53b4481f26 2026-05-05T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dog-training-choices-reflect-owners-ethical-views-on-animals-7f21a1cea849bd7e 2026-05-05T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alloy-therapeutics-and-institute-for-protein-innovation-announce-strategic-colla-8f73af194a75bb9d 2026-05-05T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fto-rs7195994-is-associated-with-tnf-inhibitor-response-in-lean-rheumatoid-arthr-045e32f1a83943a3 2026-05-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microaxial-flow-pumps-in-heart-failure-related-cardiogenic-shock-from-hemodynami-4a9d1f8fc3948521 2026-05-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthony-firulli-quot-mi-objetivo-es-pasar-el-mayor-numero-de-dias-posible-con-un-92acc600cd3c5c51 2026-05-04T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enabling-continuous-progression-to-first-in-human-through-coordinated-execution-b756803369d45b66 2026-05-04T21:07:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-is-ecoa-s-greatest-leap-forward-but-only-if-applied-where-it-matters-most-3163a4dee7dbb0c6 2026-05-04T19:59:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/arvinas-announces-fda-approval-of-veppanu-vepdegestrant-for-the-treatment-of-esr-6d0c1340a6ad636e 2026-05-04T18:05:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/rett-syndrome-study-highlights-potential-for-personalized-treatments-5e39a1de39a4b456 2026-05-04T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prolific-machines-sets-monoclonal-antibody-manufacturing-record-with-light-contr-f46e99a8cb2888c7 2026-05-04T16:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-korea-2026-us-policy-risks-shift-to-execution-framework-30c7aa16955a60a9 2026-05-04T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wireless-endoscope-transmits-data-via-light-e0e8d1ae55b07f88 2026-05-04T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmable-monomaterial-for-high-tech-athletic-shoes-9e9b4218af21db4c 2026-05-04T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-measurement-method-detects-field-emissions-of-nitrous-oxide-29619fe0660f444c 2026-05-04T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovative-numerical-simulation-methods-for-resilient-hydrogen-networks-7d52d09bcc1c6064 2026-05-04T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biodegradable-seed-coating-for-effective-seedling-protection-and-supply-9c43f91d74fe2c7b 2026-05-04T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acti-55f2e4afef35f2fe 2026-05-04T15:03:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/chamada-publica-para-livros-da-colecao-fazer-saude-no-sus-encerrada-d77cade110318fa7 2026-05-04T15:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/collaboration-with-cleveland-clinic-and-ibm-to-model-a-12-635-atom-protein-using-d796190dff3faf66 2026-05-04T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ucb-to-acquire-candid-therapeutics-building-upon-its-existing-immunology-pipelin-234e2159b474aef4 2026-05-04T14:57:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/noctrix-health-has-entered-into-an-agreement-to-be-acquired-by-resmed-for-approx-4908cc0465f68775 2026-05-04T14:57:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/whitehead-ai-fellow-na-sun-receives-a-national-institutes-of-health-director-s-e-d4155721118ec11f 2026-05-04T14:56:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/asn-kidney-week-transformative-nephrology-insights-318b5c952c90c94f 2026-05-04T14:46:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/raport-przyspieszenie-badan-klinicznych-to-257-mln-z-dla-gospodarki-i-nowoczesne-5d58c5d11e0383b8 2026-05-04T14:41:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-announces-a-parasitology-validation-study-at-the-association-of-public-15108e0293cace4f 2026-05-04T14:29:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ask-the-cmo-what-are-your-thoughts-on-imri-9f4d504ab8b63333 2026-05-04T14:05:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-introduces-a-new-pride-collection-a5321f9389b6edca 2026-05-04T12:59:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-post-dbl-data-trap-why-medical-writing-timelines-stall-at-the-finish-line-d4a227feff24ab74 2026-05-04T12:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-date-of-first-quarter-financial-results-4443872392d7980f 2026-05-04T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cdmo-samsung-biologics-estimates-102m-impact-stemming-from-ongoing-union-strike-9ffa2298e4cb0fc3 2026-05-04T10:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-to-participate-in-upcoming-investor-conferences-in-may-10ddc3526d52208a 2026-05-04T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-chromatin-movement-helps-control-gene-expression-d5963efc899e98e7 2026-05-04T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-channels-another-300m-into-us-outlay-bolstering-puerto-rico-biologics-expa-c093bb34242d5dfd 2026-05-04T07:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/complete-toolset-connected-intelligence-confident-decisions-a3358a4dc1912509 2026-05-04T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/demangeaisons-et-inflammation-de-la-peau-l-implication-etonnante-de-nos-neurones-eb9f2054b8a765d7 2026-05-04T07:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-farm-to-aggie-square-mobile-market-brings-produce-to-campus-9a7d262a7d2175d9 2026-05-04T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-stellt-kommunikation-neu-auf-45d2b2821a9ed530 2026-05-04T05:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-announces-new-real-time-clinical-trial-initiative-to-expedite-development-bu-71f8d8a6dd485953 2026-05-04T00:26:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-response-to-systemic-aav-gene-therapy-in-a-large-animal-model-of-late-s-dedc3636107385ec 2026-05-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atrial-fibrillation-and-heart-failure-with-preserved-ejection-fraction-one-step-a162faaa564bc7e7 2026-05-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate-799aca998095898a 2026-05-03T23:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-hospital-publico-infanta-leonor-se-incorpora-al-proyecto-internacional-react-baebae721d8d640c 2026-05-03T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-50-years-of-perc-553793527b1064d9 2026-05-01T19:41:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-presenta-nueva-evaluacion-de-las-necesidades-de-salud-comun-50d797fb788c788c 2026-05-01T18:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-an-ecrf-b0679f296a24cf9f 2026-05-01T18:35:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/edc-software-the-best-clinical-trial-software-for-cros-1986bd8c581c3309 2026-05-01T17:47:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-be72d3806f5a64b7 2026-05-01T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-empowers-patients-to-navigate-cancer-care-e03a33769f6fb2a7 2026-05-01T11:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/18-4f2a0b5440c9ab52 2026-05-01T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-amount-reporting-fda-publicly-identifies-over-7-700-noncompliant-companies-f45ecb1d05eef9fa 2026-05-01T09:58:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbsrc-reopens-applicant-led-funding-opportunities-500b5fbdbb348524 2026-05-01T09:41:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-eastern-europe-copper-age-societies-were-perhaps-the-first-to-adapt-to-floodi-ba27a96f6f09010e 2026-05-01T09:05:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/wfi-membrane-process-soon-a-global-standard-ae76f38b7f69645d 2026-05-01T07:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/mothers-without-specific-fatty-acid-in-the-blood-more-often-have-children-with-a-80bbf26d0cac3fcf 2026-05-01T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kokusai-pmda-atc-learning-videos-have-been-updated-48c0b8ebaa18b192 2026-05-01T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-manabu-hasegawa-has-taken-up-his-post-in-the-department-of-capacity-develop-0c8b1bc64180092c 2026-05-01T00:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-war-in-the-middle-east-collateral-damage-9418c4a970a5888f 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corrections-correction-to-lancet-oncol-2026-27-461-69-ae8ea2c6eed17e93 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-academic-clinical-cancer-trials-to-improve-patient-outcomes-752f0d9eb9c9e114 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correspondence-car-t-cell-therapy-at-first-relapse-in-myeloma-authors-reply-c0a613d457a1b373 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correspondence-car-t-cell-therapy-at-first-relapse-in-myeloma-f21fceaa0f5b8cc7 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corrections-correction-to-lancet-oncol-2026-27-e218-30-75eebafee9a09ba6 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correspondence-how-flaws-in-study-design-and-lead-time-bias-could-affect-the-int-8ae2c660bb70b55c 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correspondence-how-flaws-in-study-design-and-lead-time-bias-could-affect-the-int-90b47a5d3c934256 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-beyond-efficacy-cdk4-6-inhibitors-in-metastatic-breast-cancer-5aaa42168ecfc5dc 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-an-old-tool-for-new-strategies-in-advanced-prostate-cancer-436973114eec04bd 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-akt-targeted-triplet-therapy-in-advanced-breast-cancer-9234efcee420705d 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-ionising-radiation-and-cancer-a-un-review-of-the-recent-epidemiological-f02d90b2e3deae2a 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-refined-outcome-prediction-in-patients-with-extremity-soft-tissue-sarcom-a638504e8f50f853 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/20f-annual-report-of-the-financial-statments-as-of-december-31-2025-653f5b4256868e56 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-case-you-missed-it-tht-2026-2a34017fb8702012 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-perspectives-on-cardiac-gene-therapy-a-survey-of-knowledge-attitudes-and-cb981b619e81f6fa 2026-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-the-acn-supply-by-implementing-recovery-and-reuse-strategies-ab1329495f03ba41 2026-04-30T22:48:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/monica-mann-reflects-on-a-life-dedicated-to-healthcare-transformation-70c81412b747cae2 2026-04-30T21:07:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-announces-15-million-capital-raise-led-by-van-tuyl-companies-to-support-c1e0c934e9bd25d7 2026-04-30T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-reports-second-quarter-results-0ad35638ebfc3483 2026-04-30T20:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-reports-first-quarter-2026-financial-results-51de612c712a1b96 2026-04-30T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/happy-retirement-sal-8dd116d1432781b2 2026-04-30T20:18:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-protocol-complexity-keeps-increasing-and-how-to-fix-it-474f21e8dc10299a 2026-04-30T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/complexity-is-inevitable-design-is-essential-4f22a0d905db5f89 2026-04-30T18:56:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-gene-circuits-reshape-dna-folding-and-affect-how-genes-are-expressed-b5bfd95d6e627253 2026-04-30T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-unveils-new-nevada-community-health-needs-assessment-and-im-ff2597590f5ddbce 2026-04-30T17:18:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-launches-wise-women-in-shoulder-excellence-6caca8cc3621c476 2026-04-30T17:08:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/year-one-as-ceo-what-leadership-actually-feels-like-2b2acfc1004ab21a 2026-04-30T15:53:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/car-t-and-stem-cell-memory-t-cells-new-perspectives-against-blood-tumors-29d4a354c3f33118 2026-04-30T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-avim-therapy-s-regulatory-pathway-a-second-fda-breakthrough-device-4e7fd1a3d6f1dcfb 2026-04-30T14:56:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-prevention-must-be-at-the-center-of-the-lyme-disease-response-7f0f9376e4cf1660 2026-04-30T14:40:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/award-for-outstanding-studies-in-cancer-research-83fffb888713eb0f 2026-04-30T14:27:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-feeling-sick-may-be-important-for-surviving-infection-bd559b7cd6328c40 2026-04-30T14:12:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/craig-venter-genomics-pioneer-and-visionary-dies-7736c3553f1c5a45 2026-04-30T14:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-fillmore-community-hospital-breaks-ground-on-emergency-depa-13882fe12caee58d 2026-04-30T13:40:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortfuhrungslosung-fur-krankenhaus-salem-universitatsklinikum-heidelberg-sichert-639b6bab48b434e2 2026-04-30T13:31:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-protection-and-cross-border-transfers-ensuring-gdpr-compliance-in-multinati-3173b555bda0dd73 2026-04-30T13:16:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioreference-launches-bioreference-directtm-expanding-access-to-consumer-initiat-47d2bdeda79ea215 2026-04-30T12:37:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/media-recordati-summary-report-of-the-votes-ordinary-and-extraordinary-general-m-a5473bfe55edc115 2026-04-30T12:37:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-launches-rat-in-vitro-fertility-services-demonstrating-embryology-2555fd9038f6980f 2026-04-30T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-receives-approval-from-singapore-health-sciences-authority-be9785a6c3ef040e 2026-04-30T11:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-china-2026-5eb03c5a64bec7b9 2026-04-30T11:32:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-biosciences-announces-update-on-anticipated-timing-of-closing-of-the-plan-e09621dc108a8039 2026-04-30T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-announces-2026-first-quarter-results-raises-full-year-2026-guidance-b0218a0184060758 2026-04-30T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-achieves-excellence-in-employee-well-being-earning-top-industry-recognition-9a1d4812b8e4ff80 2026-04-30T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-psychiatric-admission-marks-the-beginning-of-a-long-term-illness-for-most-d2f0ba7f1aff5ebd 2026-04-30T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ms-spotlight-mogad-emerging-insights-and-evolving-challenges-bf939d23a16a310d 2026-04-30T10:41:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/dentrix-ascend-introduces-next-generation-clinical-workflow-built-with-aws-02378b4867f6f726 2026-04-30T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-opens-15-million-center-expanding-advanced-gastrointestina-32b0c1f39db317a7 2026-04-30T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intra-tumour-immunotherapy-mobilising-the-immune-system-against-cancer-while-avo-8b66993eac8bf951 2026-04-30T09:44:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-and-national-rural-health-association-launch-initiative-to-bring-ai-power-914405f80b4f5234 2026-04-30T09:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-west-genomic-hub-develops-test-that-can-improve-cancer-treatment-for-patie-7209eb7d0afb1162 2026-04-30T08:50:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/media-press-release-on-il-sole-24-ore-2025-final-payment-dividend-2aab7fb7ed9b4597 2026-04-30T08:42:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-completes-patient-enrollment-in-the-phase-1b-2a-trial-evalu-133689fc818f1e34 2026-04-30T08:00:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ein-abstrich-genugt-studie-ebnet-weg-fur-einfacheren-tuberkulose-nachweis-d624cc4c86eaf3c8 2026-04-30T07:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-accountability-in-strategic-health-purchasing-arrangements-for-pri-c95e38d0a48261c2 2026-04-30T05:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/follow-the-money-autoimmune-inflammatory-disease-therapies-antibody-drug-conjuga-bde6f026d4253a12 2026-04-30T05:01:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-to-present-extensive-data-showcasing-its-industry-leading-ophthalmology-po-6f64aa10fbae4a6c 2026-04-30T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approved-marijuana-products-and-those-subject-to-state-issued-licenses-resch-44571ee69a9e84a9 2026-04-30T04:05:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-launches-educational-materials-and-resources-by-otsuka-for-educators-to-s-4d61cea512104ec7 2026-04-30T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-05-07-admissions-gsges-releases-guidelines-for-summer-202-8f19332ca2479fa3 2026-04-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/faseeha-ayaz-quot-los-editores-estan-del-lado-de-los-investigadores-quot-a588406dd3039aac 2026-04-29T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-edge-smart-solutions-for-drug-development-a096e636d0de348a 2026-04-29T21:19:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-training-for-cpr-performed-on-athletes-with-disabilities-created-at-uab-abd526d0e97b026b 2026-04-29T20:53:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-next-for-id-v-clinical-development-trends-from-escmid-global-2026-c38cb51e7a4e7008 2026-04-29T20:08:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/tommaso-corio-discusses-his-journey-from-biomarin-internship-to-international-im-3a82204221e8ac92 2026-04-29T18:23:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-orthodontics-expands-myofunctional-portfolio-with-addition-of-frogg-adaac5da5403a256 2026-04-29T17:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-physician-performs-alabama-s-first-deceased-donor-bone-marrow-transplant-2037818573b54ab9 2026-04-29T17:08:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/breaking-new-ground-to-advance-science-with-the-potential-to-change-lives-beam-t-bdc3d8c015162bc1 2026-04-29T16:53:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/guaifenesina-oxomemazina-potassio-iodeto-sodio-benzoato-ee34ab49129afef1 2026-04-29T16:45:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-st-vincent-s-offers-low-dose-radiation-for-osteoarthritis-887063fdbd91fb57 2026-04-29T16:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-graft-migration-in-posterolateral-fusion-with-osteoballasttm-a47d184f45ff350b 2026-04-29T15:54:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/pet-cats-that-roam-outdoors-carry-similar-disease-risk-as-feral-cats-ubc-led-glo-2f91988e08ac8b52 2026-04-29T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paper-spotlight-cav3-1-is-a-neuronal-leucine-sensor-that-mediates-satiety-and-we-23f9a985fa761f79 2026-04-29T13:26:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-chair-of-universitat-heidelberg-s-academic-advisory-council-elected-b38f987982d842af 2026-04-29T13:23:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-grants-priority-review-to-beone-medicines-tevimbra-in-first-line-her2-ge-221b7ac047122b9f 2026-04-29T13:18:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-advances-ip-portfolio-with-new-u-s-utility-patent-applicat-7d42b66c47ca7e01 2026-04-29T13:07:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/crm-trial-connect-2026-9843342a28304ca2 2026-04-29T13:01:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-to-share-rna-manufacturing-advances-at-tides-usa-a08e8c2aee420fd2 2026-04-29T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formula-1-returns-to-the-u-s-this-weekend-streaming-live-on-apple-tv-caf4200c34bda2f8 2026-04-29T12:59:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-secures-long-term-strategic-manufacturing-contract-with-sa-50c193947f7e22ce 2026-04-29T11:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-it-world-honors-four-2026-innovative-practices-winning-projects-161427c4de87e6e6 2026-04-29T11:01:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/recordati-the-shareholders-meeting-approves-the-2025-financial-statements-and-th-f8e0df31f36a72ad 2026-04-29T10:54:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-partners-with-professional-baseball-player-davis-schneider-83c3a4333814dbf8 2026-04-29T10:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-reimagines-central-line-insertion-advancing-leadership-in-patient-safety-thro-9e8fc83edc070fcb 2026-04-29T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-research-and-innovation-challenge-to-improve-home-learning-environment-2fda3c1444662062 2026-04-29T09:14:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-international-convention-2026-7815be4047425cf8 2026-04-29T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/air-pollution-exposure-in-the-womb-linked-to-slower-development-eabdad72f8d09ed8 2026-04-29T08:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-dinamiqs-receives-swissmedic-license-for-viral-vector-manufacturing-b420b91935cc11c8 2026-04-29T04:20:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/across-the-codes-navigating-medtech-compliance-expectations-in-the-region-45bb611b8fa0992d 2026-04-29T03:47:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/crl-release-update-no-litigation-war-yet-but-new-citizen-petition-beats-the-drum-20bdd6cccd42d602 2026-04-29T02:31:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/cypri-a-clinical-decision-making-tool-to-select-psychiatric-patients-for-pharmac-4cd647ce6c6a3269 2026-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-delivers-strong-q1-performance-and-start-to-2026-71e03b0a0c896669 2026-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-announces-pricing-of-117-5-million-underwritten-offering-f1ea0ea596d228b5 2026-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-hospital-initiation-of-sglt2-inhibitors-in-patients-with-acute-heart-failure-0032f3f0ac5da382 2026-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-retirement-of-professor-raymond-dwek-c-56765e6acc772634 2026-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-first-quarter-2026-results-a4fe613b475fa968 2026-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/climate-policy-isn-t-partisan-research-suggests-more-on-the-right-support-it-tha-4c3270393bbd193f 2026-04-28T22:20:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-board-declares-dividend-90ad9dbb0a596a0c 2026-04-28T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arch-backed-paradigm-health-partners-with-fda-to-provide-technology-platform-for-bc490809a5e74d98 2026-04-28T20:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-academic-center-freeing-teams-from-maintenance-to-focus-on-research-623d1905ead9292d 2026-04-28T19:07:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-fact-checked-the-hype-behind-the-eledon-pharmaceuticals-type-1-diabetes-treat-4875a4b5bf7e7b09 2026-04-28T18:06:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-avanca-na-area-de-medicamentos-geneticos-e-firma-parceria-com-biotech-dos-eu-f11bf03fd75cdc21 2026-04-28T17:20:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-o-neal-cancer-center-is-expanding-its-acton-road-clinic-increasing-access-fo-ac2986e5cc949822 2026-04-28T16:29:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/yprime-introduces-ai-powered-ecoa-calculation-engine-8ff27ecc9f5729f4 2026-04-28T16:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-achieve-million-fold-leap-in-targeting-elusive-cancer-proteins-7a943ebf3e7e1b82 2026-04-28T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/camp4-therapeutics-preprints-pioneering-study-on-regulatory-rna-profiling-and-ge-7ef6f200b26996d2 2026-04-28T14:57:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-blood-pressure-reduction-to-cardiac-function-what-new-avim-therapy-data-sig-c6efa3cde128af63 2026-04-28T14:57:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/precede-biosciences-launches-precede-bio-insighttm-a-genome-wide-liquid-biopsy-f-aa4dfcf35a360f57 2026-04-28T14:57:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/quadram-institute-communications-team-shortlisted-for-two-top-awards-1dc5d5dce6b5616b 2026-04-28T14:41:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/dentrix-ascend-opens-its-mcp-layer-bringing-ai-agents-and-a-custom-build-platfor-9d81ee02855fbea2 2026-04-28T14:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scalable-catalytic-flow-chemistry-for-pharmaceutical-manufacturing-9d68fc2eb719cbe1 2026-04-28T13:46:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/yprime-ai-powered-ecoa-calculation-engine-d7c54148132fd65f 2026-04-28T13:08:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-friction-you-don-t-see-coming-in-clinical-development-4b33e3f7a2a5e201 2026-04-28T13:02:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-lege-825aa4a91e4481a4 2026-04-28T12:07:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-and-substipharm-biologics-announce-strategic-manufacturing-9dc9cb7085f37be6 2026-04-28T12:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bepirovirsen-accepted-for-priority-review-and-granted-breakthrough-therapy-desig-86b04b1d15809cac 2026-04-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-announces-oral-presentation-of-interim-phase-1b-2a-clinical-st-31c65661d7569975 2026-04-28T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-and-hemispherian-announce-first-patient-dosed-in-phase-1-2a-study-of-g-5490b81d3f4087ab 2026-04-28T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-study-by-cnio-discovers-a-mechanism-of-the-bile-ducts-that-could-help-personal-90a0095aa52b73a0 2026-04-28T10:43:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/brustkrebs-hirnmetastasen-immunzell-muster-konnten-therapie-entscheidungen-verbe-41b505acd59aae25 2026-04-28T10:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bladder-cancer-treatment-the-importance-of-accurate-diagnosis-and-staging-2588c05491dd99fd 2026-04-28T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partnership-for-education-of-health-professionals-pep-launches-new-phase-to-impr-b3873e695ddf0c75 2026-04-28T09:19:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-strengthens-route-to-market-for-novel-foods-with-expanded-pilot-scale-capabi-d7f57dc48bcb3119 2026-04-28T08:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-ce-mark-for-stealth-axistm-surgical-system-b04bf8ed33f54042 2026-04-28T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-oxipit-s-next-chapter-6ece885c58e082d2 2026-04-28T07:53:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-food-systems-for-a-world-under-pressure-80f0d935e7069139 2026-04-28T07:31:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cepheid-oxford-nanopore-expand-partnership-revvity-launches-new-platform-more-d092c63d35f7a342 2026-04-28T05:01:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-from-mit-awarded-2026-paul-and-daisy-soros-fellowships-for-new-americans-57bfdde73f3b4cf7 2026-04-28T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mapping-molecular-markers-of-physical-fitness-3ca2272d371c4718 2026-04-28T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/not-so-fast-when-rapid-isn-t-enough-b6e3778c5b9aeb43 2026-04-28T03:39:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-food-and-drug-administration-accepts-new-drug-application-for-zipalertinib-f-9012c0476fb7d655 2026-04-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiho-oncology-taiho-pharmaceutical-and-araris-biotech-ag-advance-adc-arc-02-int-fb06626cb5848656 2026-04-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shop-petro-s-chili-chipstm-f4534ddf982343f6 2026-04-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/petro-s-chili-chipstm-642dc01a7be358c1 2026-04-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/404-error-petro-s-chili-chipstm-4df9e50bf249cffc 2026-04-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cadence-trial-activin-type-ii-receptor-ligand-trapping-with-sotatercept-as-f-1ba2df933a736e0f 2026-04-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-to-present-at-bank-of-america-securities-health-care-conference-e523902816ca7968 2026-04-27T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-the-cut-4-organizations-take-on-site-training-reduction-301195f612f311fa 2026-04-27T20:13:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-st-vincent-regional-hospital-in-billings-montana-receives-n-1d0a5089b147d90b 2026-04-27T20:08:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/mab-based-immunosuppressant-supports-crucial-diabetes-cell-transplants-e9cc65bf1db4a7dc 2026-04-27T19:59:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-efficacy-of-fear-how-clinical-trials-gave-me-life-michelle-newby-0970c0c0ed63f132 2026-04-27T19:25:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-to-host-20th-commissions-for-charity-day-on-may-6-2026-clients-celebrities-120407d68e7fded0 2026-04-27T18:44:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-what-can-t-be-seen-how-ptsd-clinical-trials-prove-a-drug-works-d823df5080798217 2026-04-27T16:48:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-legislative-reforms-needed-to-make-biosimilars-competitive-cf2f9337322793fd 2026-04-27T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-wins-2026-fierce-outsourcing-award-for-leadership-in-regulatory-an-a76c055f42176a1f 2026-04-27T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/revealing-the-unusual-ability-of-a-protein-involved-in-lung-and-thyroid-cancer-ecd4ed4b1377ec34 2026-04-27T15:19:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-initiates-full-commercial-launch-of-the-insettm-i-135rfx-hu-ba73b154c670d2a6 2026-04-27T14:58:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-you-addicted-to-your-ai-chatbot-it-might-be-by-design-73da93a17199c413 2026-04-27T14:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-psychiatry-clinical-development-through-science-precision-and-human-ce-cdf3cbdbebcc921c 2026-04-27T14:31:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/pancreatic-cancer-an-antibody-proves-itself-in-an-early-clinical-trial-c06803b60d28cc95 2026-04-27T13:36:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-submits-application-to-fda-commissioner-s-national-priorit-5eb54e168c35bad1 2026-04-27T12:47:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/jazz-pharmaceuticals-announces-fda-acceptance-and-priority-review-of-supplementa-abc3282e65ac0345 2026-04-27T12:40:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-investigational-liver-therapy-efimosfermin-receives-us-fda-breakthrough-th-1328f12328d25d80 2026-04-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-therapeutics-announces-positive-topline-results-from-phase-iii-respect-14e82e4e2dc71444 2026-04-27T11:49:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-pharma-strengthens-leadership-team-with-appointment-of-keith-vendola-as-63942e363e7d3d45 2026-04-27T11:33:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/komentarz-z-okazji-swiatowego-dnia-w-asnosci-intelektualnej-prof-rafa-sikorski-u-068b74cebc797047 2026-04-27T09:35:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/self-organizing-pencil-beam-laser-could-help-scientists-design-brain-targeted-th-c3f70ff8cf6ffea6 2026-04-27T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/culturally-significant-private-collection-handed-over-to-nepali-government-5e607bacc33e2bd8 2026-04-27T08:47:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/attention-aux-confusions-entre-flacons-c27e20b58bbef60f 2026-04-27T07:46:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/tesaro-a-gsk-subsidiary-provides-update-on-anaptysbio-inc-litigation-813aae91d272993e 2026-04-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-confidence-through-cricket-tooradin-s-wellness-through-wickets-success-71ee10135b081c78 2026-04-27T06:39:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fimlab-expands-utilization-of-aiforia-s-clinical-ai-solutions-e3290f96a7a70280 2026-04-27T06:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-immune-system-and-the-sex-of-a-host-affect-virulence-652f741dbe33dd78 2026-04-27T03:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-withdrawal-of-shelf-registration-statement-for-issuance-of-new-da329d28cc7916ce 2026-04-27T02:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zentiva-appeals-eu-court-decision-on-urban-wastewater-directive-2b55bc94767c3c11 2026-04-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-san-diego-health-performs-first-west-coast-ai-robotic-spine-surgery-c8396da83614d1f3 2026-04-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abierta-la-1a-convocatoria-competitiva-para-infraestructuras-singulares-de-la-re-32a56dba40a90225 2026-04-26T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-at-heart-rhythm-2026-highlight-key-boston-scientific-therapies-beb7166503ff9b35 2026-04-26T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-a-step-towards-disease-modifying-therapy-for-multiple-system-atrophy-a0a128fe36521d53 2026-04-24T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/articles-safety-and-efficacy-of-the-anti-synuclein-monoclonal-antibody-amlenetug-77e30a8506146b38 2026-04-24T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/suspension-de-servicios-8da3013fbc220862 2026-04-24T20:21:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-psychedelic-setback-what-mdma-rejection-taught-drug-developers-2f1583a16906f6ce 2026-04-24T18:41:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/behind-the-budget-what-sites-really-need-to-know-today-3655a327bf552f29 2026-04-24T18:01:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-a-better-delivery-system-for-gene-editing-machines-by-re-engineering-th-3b47179e4dea58dc 2026-04-24T17:55:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-site-support-goes-unused-in-clinical-trials-1858133b71545cfb 2026-04-24T17:32:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/wch-presented-with-2026-excellence-in-inclusion-diversity-equity-accessibility-i-6eee23c94f346813 2026-04-24T17:28:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/mobility-in-clinical-trial-operations-with-the-sip-mobile-app-practical-gains-ne-f6854e926bdf73da 2026-04-24T17:27:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiometabolic-trials-are-exposing-a-flaw-in-the-clinical-research-model-retent-c83ceed34322ab63 2026-04-24T17:22:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-innovation-and-reality-why-human-support-is-essential-in-tech-enabled-c-8f4ca351670454d4 2026-04-24T17:20:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-volunteer-week-meet-aleksa-and-romina-9887af1738160bec 2026-04-24T16:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/achievements-in-family-medicine-dr-aisha-lofters-ddd533881459bd10 2026-04-24T15:16:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/8e580c6c2b578e3b 2026-04-24T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biospace-elevates-journalism-as-biopharma-evolves-in-the-trump-era-df05901b57a77dca 2026-04-24T13:16:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/rdd-usa-2026-92f4eaa5d313dd74 2026-04-24T12:13:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-bilanz-2025-deutliches-plus-bei-patient-innen-und-forschung-b951fe2673459694 2026-04-24T11:25:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/manchester-university-nhs-foundation-trust-ranked-most-digitally-mature-acute-tr-572d9f60498fa571 2026-04-24T11:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-major-international-clinical-trial-sheds-new-light-on-a-paediatric-brain-cance-37764f42892c8e1c 2026-04-24T10:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/universitat-heidelberg-to-open-new-learning-center-9e947cd9f90d0e1a 2026-04-24T10:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-inaugurates-building-k-in-bubendorf-strengthening-large-scale-production-a685c8f2595890c8 2026-04-24T04:54:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-obtains-antitrust-clearance-for-acquisition-of-three-drug-substances-s-a654a37b42728d9b 2026-04-24T04:37:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/results-may-vary-but-reporting-shouldn-t-fda-sends-a-not-so-gentle-reminder-on-c-03f8bc113e8e5ef0 2026-04-24T02:23:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-cytochrome-p450-polymorphisms-in-the-pharmacokinetics-of-oral-esketa-8c84208e24b068a1 2026-04-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mapping-neighborhoods-in-aggressive-childhood-brain-tumors-bf53cf34349b0a1d 2026-04-23T18:26:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/stay-humble-life-sciences-as-a-small-slice-of-an-increasingly-big-venture-pie-23dbf09910a492bb 2026-04-23T17:45:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/gene-therapy-for-hearing-loss-tag-teaming-from-the-lab-to-the-clinic-6d95d5682057e93e 2026-04-23T17:44:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/wcg-crc-support-identifies-700-participants-streamlines-edc-entry-0be1a6bd73aac018 2026-04-23T17:19:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/wcg-drives-identification-of-4k-participants-for-complex-cardiovascular-study-ec1cb1d069333971 2026-04-23T17:17:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-wulfstan-of-york-to-pete-hegseth-fake-bible-verses-have-often-been-politici-c6105257fc6899c2 2026-04-23T16:06:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-free-gene-therapy-regeneron-s-otarmeni-approved-for-hearing-loss-e6a3f18787b0b11e 2026-04-23T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cms-partner-to-deliver-rapidly-for-innovative-devices-084d259909a55cb8 2026-04-23T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-presidente-del-cssp-lic-daniel-quinteros-junto-con-equipo-tecnico-realiza-vis-66b43ea9ded26234 2026-04-23T15:21:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/powering-clinical-trial-innovation-how-trinetx-uses-databricks-to-accelerate-dru-ca825789abc7f9a8 2026-04-23T15:03:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-medical-earns-hirc-member-choice-award-for-supplier-transparency-427727d8a5b37caa 2026-04-23T14:38:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/semaine-europeenne-de-la-vaccination-27-avril-au-3-mai-2026-74182c4f5069a58b 2026-04-23T14:31:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2026-financial-1232539cbf462288 2026-04-23T13:49:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-to-report-first-quarter-2026-financial-results-on-may-7-165a8a67a8940dad 2026-04-23T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-announces-strategic-collaboration-to-expand-access-to-ai-powered-subdural-065dbfe397b906bb 2026-04-23T12:59:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/dierproeven-verminderen-verfijnen-vervangen-25122a5d2ad4a8de 2026-04-23T10:13:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-closes-a-deal-with-a-private-diagnostic-laboratory-in-italy-02888e904fb96026 2026-04-23T08:34:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-sees-huge-engagement-thanks-to-esor-special-focus-courses-on-tuberculosis-an-b71a76f89f765c54 2026-04-23T08:15:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/van-cijfers-naar-keuzes-hoe-houden-we-de-innovatiespiraal-draaiende-d2584eef9a4d12ca 2026-04-23T07:52:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/webinaires-eudamed-formation-aux-modules-acteurs-udi-dispositifs-et-organismes-n-1b4c0adc5efce5b3 2026-04-23T07:12:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/wereldvaccinatieweek-2026-ouderen-willen-zich-laten-vaccineren-maar-missen-een-d-08c955ebd047e9e9 2026-04-23T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/changes-to-pathology-results-from-sunday-3-may-9e1631e988a0af37 2026-04-23T06:48:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-funding-opportunities-pave-the-way-for-better-diagnostics-and-treatment-as-w-b5b1228ad8a1ecb9 2026-04-23T06:19:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ad-hoc-announcement-pursuant-to-art-53-lr-roche-reports-strong-sales-growth-of-6-a6d7fdb12a86a3e5 2026-04-23T05:12:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-may-2026-immunisation-advisory-committee-iac-meeting-8dec0c52b1fe5395 2026-04-23T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/csafe-advanced-parcel-data-sheet-268449918a370baa 2026-04-23T01:32:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/recor-medical-s-paradise-ultrasound-renal-denervation-system-honored-with-tag-aw-c084970771c3eab1 2026-04-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiovascular-prescriber-attitudes-to-pharmacogenomics-a-survey-by-the-esc-work-b4959c73cd9b76b4 2026-04-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/job-verdonschot-quot-el-siguiente-reto-es-integrar-la-genetica-en-los-programas-a5ddc7773084ef63 2026-04-22T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecopipam-significantly-reduces-risk-of-relapse-in-pediatric-overall-populations-165a802fca7776f3 2026-04-22T21:23:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-20-657b55f0f827bca4 2026-04-22T21:05:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/informacion-electronica-de-prescripcion-epi-acelerando-la-transformacion-digital-076c0cd6d99fda00 2026-04-22T20:39:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-reports-first-quarter-2026-results-57f71c2af5534da6 2026-04-22T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-affiliates-elected-to-the-american-academy-of-arts-and-sciences-for-2026-5539e67883714b43 2026-04-22T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/not-all-intravenous-irons-are-created-equal-considerations-for-rate-of-iron-rele-e75342cf5a9cc4b6 2026-04-22T19:53:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/mhc-class-ii-peptide-binding-prediction-challenges-alphafold-3-and-esm2-explaine-908062aa88925784 2026-04-22T18:49:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/actionable-alterations-and-ctdna-testing-may-refine-precision-strategies-in-brea-9ef8cf8445f80046 2026-04-22T18:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharmacist-s-role-in-evaluating-505-b-2-drugs-89e264e1e740f839 2026-04-22T17:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-linked-to-increased-risk-of-severe-infection-hospitalization-and-death-a-305c240b86b06a6e 2026-04-22T17:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-q-a-global-supply-chain-pressures-and-the-future-of-drug-availability-fd2986af7f8203b1 2026-04-22T17:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-certification-journey-why-credentialing-matters-562bdabf60a98d8a 2026-04-22T17:06:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-irt-in-clinical-trials-and-why-does-it-matter-36119fa8e84451b8 2026-04-22T16:47:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-nimble-trial-cemdisiran-proves-efficacy-treating-patients-with-generaliz-1279fecbfbc6975d 2026-04-22T16:39:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/damage-to-brain-s-white-matter-may-play-key-role-in-neurodegenerative-disease-an-f1d9a7e1d2eefaeb 2026-04-22T15:50:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-expands-its-mortgage-and-real-estate-franchise-6c61d2459b3270a6 2026-04-22T15:36:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-health-technology-assessment-moving-from-hype-to-resp-b8f93dcfaa25b691 2026-04-22T15:13:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-scientists-identify-bat-coronavirus-that-can-enter-human-cells-e90588b145802aff 2026-04-22T15:05:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-unlock-new-route-to-extreme-light-intensification-40797691082f7352 2026-04-22T15:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-tips-for-navigating-pharmacy-school-emails-569ad62209efeda1 2026-04-22T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapid-optimization-enabled-by-single-molecule-tracking-discovery-of-a-potent-ruv-13dbd7c99af400df 2026-04-22T14:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sppcp-2026-lorin-fisher-phd-examines-gabapentin-s-expanding-role-in-pain-care-8cf4a90e01962ce2 2026-04-22T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-lab-advancing-flow-cytometry-in-clinical-trials-q-a-with-andre-olsson-7074d806170f5cb0 2026-04-22T13:59:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/aan-2026-how-identifying-genetic-dees-within-existing-trial-data-could-expand-th-5425521acc44efc1 2026-04-22T13:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-expands-teplizumab-mzwv-approval-to-delay-stage-3-type-1-diabetes-in-childre-2bf0a4a8c91f1aa8 2026-04-22T13:39:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-successfully-completes-manufacturing-of-demonstration-batc-5e1d254961130747 2026-04-22T13:35:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/student-perspectives-on-well-being-in-pharmacy-education-815879b5c13c7527 2026-04-22T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aan-2026-what-is-pacap-and-why-does-it-matter-for-migraine-lundbeck-s-r-d-chief-f86a7f6dcae0e218 2026-04-22T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toronto-academic-hospitals-deepen-climate-leadership-in-second-annual-sustainabi-ac1e882ce99c1fe7 2026-04-22T13:14:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-new-way-coronaviruses-can-get-into-human-cells-fa8f8ffc462990f7 2026-04-22T13:01:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/nucleus-radiopharma-secures-50-million-financing-from-orbimed-to-expand-radiopha-dbf45d8c83a860f8 2026-04-22T12:42:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/tonic-le-magazine-des-hcl-decouvrez-le-n-205-1eb01f9caae5e770 2026-04-22T12:10:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-qtc-prolongation-with-cdk4-6-inhibitor-therapy-a-case-based-discussion-cd8ba2912dbccca7 2026-04-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/future-directions-for-cdk4-6-inhibitors-and-the-expanding-role-of-pharmacists-in-41f54878db2fde5e 2026-04-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decouvrez-le-magazine-tonic-205-612f4d166a1d0429 2026-04-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/water-energy-circularity-technologies-for-a-resilient-future-338a161945265544 2026-04-22T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-launches-fda-approved-companion-diagnostic-to-identify-patients-with-ova-0e3db441067392af 2026-04-22T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/feierliche-eroffnung-der-forschungszentren-si-m-und-becat-1161e31920c03346 2026-04-22T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-agrees-to-acquire-kashiv-biosciences-to-create-global-biosimilar-leader-r-27faad91f228325b 2026-04-22T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metagenomic-software-advance-boosts-research-into-microbial-diversity-8d45b6453c033a9d 2026-04-22T09:00:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-lege-8f3c67625d435b77 2026-04-22T07:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-fewer-cosmetics-quickly-reduce-exposure-to-certain-chemical-pollutants-and-5135ef44c98387cc 2026-04-22T07:00:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-chapter-for-children-with-plgg-eb2e3a0b7b356cca 2026-04-22T05:05:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-to-report-first-quarter-2026-financial-results-b-9b9f1b655dba912e 2026-04-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-mit-alumnae-named-2026-gates-cambridge-scholars-8bc3783067d5dacc 2026-04-21T22:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-presents-new-phase-1-data-for-zw191-a-folate-receptor-alpha-targeting-43d224474ac693de 2026-04-21T21:31:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-a-more-sustainable-cold-chain-through-intelligence-resilience-and-accou-0d8404cfb4e7e8d1 2026-04-21T20:47:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-department-of-defense-funding-advances-collaborative-research-between-uab-an-6e672c9d84a5c97a 2026-04-21T20:39:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/parkinson-s-disease-trial-readiness-diagnostic-f57f7a9078dfec97 2026-04-21T20:18:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/satralizumab-significantly-reduces-risk-of-attacks-in-relapsed-mogad-0ce68d4723d5ecb1 2026-04-21T19:57:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-gap-how-housing-status-and-race-shape-cancer-screening-disparities-2b6295b7f6ca0230 2026-04-21T19:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-once-daily-hiv-regimen-combining-doravirine-and-islatravir-402e37fba90dc336 2026-04-21T19:18:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoplasty-dr-lonabaugh-421ee8bc83419032 2026-04-21T19:15:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/beating-transplant-challenges-561f8f1515ce7cd7 2026-04-21T16:35:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-poll-shows-strong-region-wide-support-for-skytrain-extension-to-ubc-9e657631fd417cb1 2026-04-21T16:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cash-cows-scapegoats-and-now-global-talent-asian-international-students-want-to-da81cf8547013e8e 2026-04-21T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-enspryng-satralizumab-reduces-risk-of-relapses-by-68-demonstrating-poten-eee11c9a0be29289 2026-04-21T15:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canada-s-hardest-problems-demand-a-different-kind-of-science-here-s-how-we-work-be5318d169fcd169 2026-04-21T15:44:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/hub-prevention-cardiovasculaire-et-metabolique-et-si-vous-deveniez-acteur-de-vot-7bdf0065ece646f5 2026-04-21T15:42:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-participation-how-can-we-make-it-more-feasible-b6268973075353e1 2026-04-21T15:16:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/wcg-to-acquire-the-contract-network-extending-clinsphere-s-ai-driven-site-enable-4d039e70e85f83e0 2026-04-21T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/riken-invests-into-saimemory-corp-8b0ea0ba2a0fad47 2026-04-21T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gift-of-life-st-michael-s-hospital-hits-significant-milestone-with-50-living-kid-7c771fe1d6106bfb 2026-04-21T13:16:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-csr-vs-safety-narratives-in-clinical-research-0974bf37384fa3e8 2026-04-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-highlights-effectiveness-of-vcgs-in-toxicology-3654a4e9b556f37e 2026-04-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-do-forecasting-approaches-and-methodologies-change-through-the-product-lifec-3c5d711868c1bdf3 2026-04-21T10:52:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/groundbreaking-bowel-cancer-trial-follow-up-shows-zero-relapses-cae2edb8015be425 2026-04-21T07:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jake-birecki-makes-space-for-passion-purpose-and-play-40103e3aa187ed43 2026-04-21T06:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-cap-2026-wo-ki-auf-life-science-trifft-50f416c0d6fc2994 2026-04-21T06:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-data-at-aacr-2026-underline-favorable-profile-of-ava6103-and-advantages-o-0e2c0574e161c466 2026-04-21T06:02:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/tempo-420-sc-d7b38cfa80be5f79 2026-04-21T01:31:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/tempo-420-sc-c9acd1f44286fed9 2026-04-21T01:31:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-lactic-acid-bacterium-onricb0240-against-gingivitis-confirmed-a-coll-6daad4e605664174 2026-04-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/identifican-un-biomarcador-que-mejora-la-prediccion-del-riesgo-en-una-forma-grav-8023c35cdfbed295 2026-04-20T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/day-of-excellence-in-academics-2026-event-recap-7d9a2050cfeb4ae9 2026-04-20T21:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/tim-cook-to-become-apple-executive-chairman-john-ternus-to-become-apple-ceo-3ac4cfaac50b6234 2026-04-20T20:37:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/johny-srouji-named-apple-s-chief-hardware-officer-7f148a7f6b549b07 2026-04-20T20:31:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurologists-expand-global-health-program-to-bring-specialized-care-in-kenya-3dd0e6bd0197d2aa 2026-04-20T18:30:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-plating-platformtm-small-mini-357684fff4f54858 2026-04-20T18:11:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-study-simulation-fits-in-clinical-trials-936d28f80286e71d 2026-04-20T17:44:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/outsourcing-in-clinical-trials-oct-uk-ireland-2026-1cd6d22ab8404cd5 2026-04-20T16:53:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ergomed-clinical-research-named-finalist-in-fierce-outsourcing-awards-2026-for-c-4d1f45c486e95330 2026-04-20T16:39:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/gut-microbiome-changes-may-signal-parkinson-s-disease-risk-008eceb902bd0590 2026-04-20T15:10:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-genomics-clarifies-a-complex-campylobacter-picture-b15099ad5969634a 2026-04-20T15:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/geneesmiddelen-leveren-de-belgische-schatkist-geld-op-2dd26d3625b26d0b 2026-04-20T14:43:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/unity-health-toronto-strengthens-coordinated-care-for-patients-with-high-risk-pr-1bff7f69ca8ab7dc 2026-04-20T14:06:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/podcast-ceo-heltzen-executive-insights-for-life-sciences-innovators-a64c28f588244b52 2026-04-20T13:03:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-makes-real-world-evidence-credible-insights-from-academic-research-6028cb95ffb80079 2026-04-20T12:15:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/blenrep-belantamab-mafodotin-approved-in-china-for-treatment-of-2l-relapsed-refr-2cb3771be9720d43 2026-04-20T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-announces-additional-positive-interim-phase-4-elevate-pd-results-with-cre-175f8d3a7589f13e 2026-04-20T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skin-patch-helped-me-spot-lung-rejection-says-beneficiary-84e5256e6beb4e0d 2026-04-20T10:57:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-determination-of-issue-price-selling-price-and-other-matters-bec2fd01e5c09043 2026-04-20T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-iguide-goes-live-at-hospital-universitari-del-consorci-sanitari-de-terrassa-3f2bb1b16ba551ef 2026-04-20T08:15:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-position-at-suzuki-lab-center-for-cancer-immunotherapy-and-immunobiolog-50b74eb9368ea262 2026-04-20T06:02:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-may-2026-pharmacology-and-therapeutics-advisory-committee-ptac-meetin-ed0dee9ceb8d2c64 2026-04-20T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scleral-lens-time-xl-acquires-approval-in-china-new-option-for-patients-with-irr-8de956189b755751 2026-04-20T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-04-20-university-news-kyoto-university-releases-creating-243146afe3d2a299 2026-04-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/affirmation-of-a-shared-european-ambition-and-submission-of-a-report-to-the-fren-af69276d4f30556c 2026-04-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-welcomes-white-house-executive-order-to-accelerate-medical-treatment-e3e69902fef8812e 2026-04-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-presents-new-data-spanning-pulmonary-hypertensio-32713f0327898668 2026-04-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-national-volunteer-week-the-international-year-of-volunteers-772308c34a2e469f 2026-04-19T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-jitendra-narayan-a97eb6c6b7adfc20 2026-04-19T10:04:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-jitendra-narayan-162f9b1b107013ac 2026-04-19T00:25:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/zelicapavir-demonstrates-high-clinical-and-functional-barrier-against-antiviral-a075b48f50136515 2026-04-18T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zelicapavir-decreases-symptom-duration-hospitalization-and-viral-load-in-a-globa-292f40a55c3fcbda 2026-04-18T20:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potent-stat6-inhibitor-eps-3903-has-excellent-preclinical-pharmacokinetics-enabl-0294d9e731c9c3fd 2026-04-18T16:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-hopeful-sign-for-biotech-obesity-treatment-firm-kailera-raises-625-million-in-e6b126e68bc66b7e 2026-04-17T20:53:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/kailera-nets-625m-in-one-of-biotech-s-biggest-ever-ipos-eca3ec74a72c0f80 2026-04-17T20:51:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/discovery-and-characterization-of-a-potent-and-selective-oral-inhibitor-of-stat6-f6236872dba2a5af 2026-04-17T19:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-presents-new-preclinical-data-at-aacr-2026-highlighting-broad-antibody-95cad6bd54eb918c 2026-04-17T19:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-michael-laub-and-mit-alumni-named-2025-aaas-fellows-61c7b37be3a7c75f 2026-04-17T18:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-researchers-aim-to-deliver-earlier-warnings-on-the-toxic-drug-supply-0470c9bfe2587856 2026-04-17T17:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contextflow-collaborates-with-vuno-and-mesalvo-to-advance-cardiac-arrest-predict-c0351d9cdc64344b 2026-04-17T16:31:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/eps-3903-is-a-potent-and-selective-oral-stat6-inhibitor-that-blocks-th2-inflamma-65c209eca4ddc2d5 2026-04-17T16:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-successfully-refinances-term-loan-amends-asset-backed-loan-9f9a730f183dd574 2026-04-17T14:35:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-wins-gold-edison-awardtm-for-advancing-ai-driven-clinical-workflows-to-im-725a18c00ec759cc 2026-04-17T12:59:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/springwise-case-study-unpacking-how-exozymes-and-cayman-chemical-are-rethinking-3821fa9c4c9bc33b 2026-04-17T12:58:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacology-at-the-cambridge-festival-b6cbe03cb10412d8 2026-04-17T09:50:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-australia-participates-in-the-2026-app-conference-a19ff0bb7ec5a11c 2026-04-17T09:11:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-publication-describes-the-vesicular-disease-outbreaks-of-seneca-valley-virus-bde58466b2c90159 2026-04-17T08:49:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/grundlegend-neuer-therapieansatz-gegen-mukoviszidose-nanobody-repariert-zelldefe-19df308bb4844852 2026-04-17T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-fundamentally-new-therapeutic-approach-to-cystic-fibrosis-nanobody-repairs-cel-a186b0493579fc83 2026-04-17T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-information-leads-to-more-accurate-beliefs-except-in-echo-chambers-88617c4d0ba336ca 2026-04-17T07:52:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-2294f21f07d72e1c 2026-04-17T07:41:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-mr-for-every-radiologist-esr-steps-up-training-efforts-f8d21881d66905cb 2026-04-17T07:41:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/206551bd14516dc7 2026-04-17T07:28:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-china-signs-exclusive-distribution-and-promotion-agreement-for-five-marke-a575e8ea4849f5e4 2026-04-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/michael-reth-las-personas-con-dislexia-estan-especializadas-en-explorar-lo-desco-c560142ee93fe9fe 2026-04-16T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-successfully-refinances-term-loan-amends-asset-backed-loan-a2f1306db8293649 2026-04-16T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-biosolutions-to-report-first-quarter-2026-financial-results-on-april-30-cf5c0228090fc064 2026-04-16T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-safety-assessment-to-proof-of-concept-six-months-ahead-of-industry-22892198cc80e2d9 2026-04-16T19:08:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-of-a-prion-disease-drug-candidate-begins-enrolling-participants-72fd7b1d9da1b1f4 2026-04-16T18:35:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-must-have-to-meaningful-progress-creativity-innovation-day-a680d98ac8703f1a 2026-04-16T17:41:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-enters-definitive-agreement-to-acquire-ametris-7543c4a54bbc2746 2026-04-16T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ethics-review-and-localization-managing-multinational-approvals-effectively-63fc8c209dfa64eb 2026-04-16T16:44:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-stat6-inhibitor-eps-3903-demonstrates-good-preclinical-in-vivo-tolerability-d494831537d6d5ee 2026-04-16T16:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-cleavage-deprotection-and-tff-how-asahi-kasei-s-thesys-platform-is-r-ff4b7f94b43bd615 2026-04-16T15:32:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-research-incorporated-earns-first-of-its-kind-iso-certification-in-the-u-s-e71738f466ca3168 2026-04-16T15:08:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/verification-committee-report-regarding-a-media-report-on-riken-68bc1a0f96eea4f8 2026-04-16T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-glp-1-medications-increase-kidney-stone-risk-a-uab-urologist-offers-insight-fc551006ffbff514 2026-04-16T14:56:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/volunteers-provide-compassion-and-service-impacting-the-lives-of-those-who-give-1312a39fb34dc541 2026-04-16T13:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cnio-group-contributes-to-identifying-which-breast-lesions-will-progress-to-ca-7bc4f7c3dc68bf95 2026-04-16T13:13:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-presents-new-mechanistic-data-highlighting-differentiated-bi-dfbdf5a250f734d8 2026-04-16T12:15:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-accelerates-progress-with-highest-ever-recycled-material-in-its-products-fa0cae7acfb5e57f 2026-04-16T11:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-shareholders-approve-all-proposals-at-annual-general-meeting-2026-c9b4a56509c2ae93 2026-04-16T11:38:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-publication-of-positive-data-demonstrating-intra-450d8618e024178c 2026-04-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-earns-industry-top-honors-for-transparency-resiliency-and-partnership-64b0aec507028fe7 2026-04-16T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-has-been-selected-as-an-ai-partner-for-the-prostia-project-expands-to-fi-f441dca5b28b2ce9 2026-04-16T09:02:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/multifocal-liver-cancer-distinct-biological-origins-pave-the-way-to-precision-me-a714618adb93b062 2026-04-16T08:11:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/families-left-in-dark-on-upfs-risks-to-children-ukri-dialogue-6934c954982bcf40 2026-04-16T08:00:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/cepi-awards-seed-funding-to-analysis-zero-to-advance-real-time-rna-vaccine-quali-bde2f101b7832070 2026-04-16T08:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/flash-vig-news-vaccin-ixchiq-contre-le-chikungunya-rappel-des-recommandations-29d451c0bcb26f42 2026-04-16T07:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-study-reveals-a-new-role-for-cell-membranes-cbaea5b18af1cbbb 2026-04-16T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/educational-initiatives-for-the-next-generation-implementing-health-education-fo-503c871cc1064f1c 2026-04-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-of-launch-in-japan-of-ravicti-oral-liquid-1-1-g-ml-88c20c0964fa1de9 2026-04-15T20:48:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/youth-wellness-symposium-offers-parents-tools-to-support-children-s-mental-healt-d5c4f4fcc354ce1c 2026-04-15T18:18:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/massive-ancient-dna-study-reveals-natural-selection-has-accelerated-in-recent-hu-d627fe11a0c6a29c 2026-04-15T15:45:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/desi-completes-3d-map-of-the-universe-and-continues-exploring-abf63765e58080c7 2026-04-15T15:16:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-parliament-delegation-visits-wako-campus-e401e9f1f619f71b 2026-04-15T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-digital-protocol-what-it-is-why-it-s-the-future-of-clinical-trials-2078a629dc6fcc2c 2026-04-15T14:47:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidneyx-empower-prize-challenge-4439c6176dee4b2a 2026-04-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-completes-acquisition-of-35pharma-inc-8ad067bbd6ed0af5 2026-04-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-launches-home-groundtm-schizophrenia-community-a-new-online-resource-hub-fo-939026f5f828a35a 2026-04-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-launches-fda-cleared-fentanyl-test-delivering-results-in-10-minutes-580f95d18cdc66c7 2026-04-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alloy-therapeutics-announces-40m-series-e-to-scale-tech-enabled-biotech-infrastr-866302a4348f0ea0 2026-04-15T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-translational-cancer-research-58fc430b4d4a7e5f 2026-04-15T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-team-kelly-chamberlain-e453b2940699d41a 2026-04-15T09:21:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/bilaterale-iii-sichern-den-erfolgsweg-der-schweiz-dff0805852605fc4 2026-04-15T09:20:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-your-gp-details-up-to-date-for-clinical-handover-b9b696e1c981877a 2026-04-15T06:01:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/learn-about-our-paediatric-plastic-surgery-service-at-monash-health-34057a85d79da5e3 2026-04-15T05:49:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/neffy-epinephrine-nasal-spray-approved-in-canada-as-the-first-and-only-needle-fr-4c2d85a1f4a4616d 2026-04-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/las-mitocondrias-mantienen-a-las-celulas-inmunitarias-listas-para-responder-0160a22b05e71b27 2026-04-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/obsidian-will-go-public-via-merger-with-galera-and-raise-350m-793e2c44c3537599 2026-04-14T20:57:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-therapy-biotech-obsidian-leverages-galera-reverse-merger-to-go-public-cbc3526c3b05ddfe 2026-04-14T20:52:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-reminds-its-shareholders-to-submit-their-vote-at-the-upcoming-apri-f79530079d751da2 2026-04-14T20:18:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-dependency-map-consortium-launches-phase-3-to-accelerate-next-generation-63c7499c138130cf 2026-04-14T19:20:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/transplanting-islet-cells-with-piotr-witkowski-md-phd-f2dd91250352ddec 2026-04-14T17:53:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-vivo-s-2026-rising-leaders-265257b2c40e22cb 2026-04-14T17:52:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-medicine-expands-care-with-new-clinics-in-first-quarter-of-2026-1ff5dda08e47f861 2026-04-14T17:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sciences-clinical-biopharmaceutical-company-be836ce38eeb605d 2026-04-14T15:56:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-on-construction-of-new-plasma-derived-therapies-manufacturing-facility-in-febb72a16f92c72a 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/20-000-takeda-employees-voted-to-select-four-new-global-corporate-social-respons-49596db5be21d02f 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-announces-completion-of-acquisition-of-own-shares-takeda-pharmaceuticals-4c473af8e0fbba70 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/gammagard-liquid-erc-approved-for-primary-immunodeficiency-b3df3da3141e2541 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/filing-of-corporate-governance-report-to-the-tokyo-stock-exchange-takeda-pharmac-0822375a17c0bd15 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-announces-the-pricing-terms-of-the-previously-announced-cash-tender-offer-9d01a338763f48f6 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-announces-new-assignments-of-directors-93cdc620ada882fb 2026-04-14T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/statement-on-inadvertent-abstract-disclosure-for-oveporexton-tak-861-by-world-sl-fc204f1fc516c285 2026-04-14T13:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-reports-third-quarter-fy2025-results-takeda-pharmaceuticals-19683ea67614dfec 2026-04-14T13:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-phase-3-study-results-in-pediatric-ulcerative-colitis-be921822b3782fa3 2026-04-14T13:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/rusfertides-phase-3-trial-for-polycythemia-vera-at-asco-2025-bcdf75694a45a3b2 2026-04-14T13:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-presents-long-term-data-from-advance-cidp-3-trial-of-hyqvia-e4636f949c687c8b 2026-04-14T13:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-to-hold-third-quarter-fy2022-earnings-call-on-february-2-f48c3647ab28f713 2026-04-14T13:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-concerning-withdrawal-of-shelf-registration-statement-and-filing-of-new-s-f70640ce922ee02e 2026-04-14T13:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/adzynma-receives-european-commission-approval-as-first-recombinant-adamts13-ther-e6fc351dbf599bfb 2026-04-14T13:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-takeda-s-takhzyro-lanadelumab-flyo-to-prevent-hereditary-angioe-135d7003c473d4e8 2026-04-14T13:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-to-acquire-exclusive-worldwide-ex-china-license-of-hutchmed-s-fruquintini-7cdad0f9bfe50a36 2026-04-14T13:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-completes-acquisition-of-nimbus-therapeutics-tyk2-program-subsidiary-010103043cccafaa 2026-04-14T13:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-takeda-s-entyvio-bla-15ea49aded7a9dda 2026-04-14T13:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/base-editing-repairs-mutation-and-liver-function-in-mouse-model-of-zellweger-spe-8c58909436883ee5 2026-04-14T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-clinical-trial-operations-key-priorities-for-modern-development-690605c1292fe18a 2026-04-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/community-routes-access-to-mental-health-care-provides-continued-funding-for-men-45a66b8315871e3d 2026-04-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-launches-first-two-respiratory-metered-dose-inhalation-products-in-the-u-9ac778cddbd84a41 2026-04-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-late-breaking-poster-accepted-for-presentation-a-0e8229e036e90c55 2026-04-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-introduces-ai-powered-real-world-data-platform-with-aws-and-datavant-to-34760fdca1c179cc 2026-04-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-million-boost-for-mft-s-network-of-community-diagnostic-centres-which-have-del-076b9e8f098fc0eb 2026-04-14T09:24:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/pirbright-staff-support-heathland-restoration-at-bullswater-common-9469e474056d54ee 2026-04-14T07:42:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-concert-tour-for-the-science-year-medicine-of-the-future-5e386d97a258f868 2026-04-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-04-14-global-engagement-education-exchange-students-meet-0befafa79813a85c 2026-04-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/technology-transfer-and-high-tech-solutions-fraunhofer-at-hannover-messe-2026-1d4f68d254c922fb 2026-04-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-s-dermatology-business-ortho-dermatologics-announces-the-launch-of-853ebb17588ca640 2026-04-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-health-system-unites-emergency-departments-to-enhance-care-for-ventricular-a-b8ae0cb56fd58916 2026-04-13T18:40:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-improve-patient-engagement-in-clinical-trials-b6149fa247df1010 2026-04-13T18:09:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-bulls-breakthroughs-podcast-the-future-of-biomanufacturing-with-michael-150216043325e375 2026-04-13T17:47:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-international-convention-2026-c46e886c124f01c0 2026-04-13T15:22:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-on-the-riken-website-restoration-77e271d7176e08a8 2026-04-13T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/marking-the-2026-pharmacology-industry-engagement-day-5b14afdbd07d0d50 2026-04-13T14:22:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-fellows-to-tackle-how-food-environments-shape-microbial-adaptations-edfebf0d8f77ca49 2026-04-13T14:22:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/efpia-and-vaccines-europe-response-to-the-consultation-on-the-eu-global-health-r-6c9e9d9849a07c0b 2026-04-13T13:22:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-announces-kaitalitytm-a-first-in-class-digital-tool-for-improving-d-b664f807651cdfff 2026-04-13T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-medical-and-siemens-healthineers-debut-integrated-interventional-mri-suite-8a11cbb8d4e0eb3b 2026-04-13T11:56:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-pharma-to-participate-in-the-h-c-wainwright-hcw-home-series-and-the-2026-17606c0a5a9b4d51 2026-04-13T11:48:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/alejo-efeyan-awarded-a-cris-excellence-programme-to-unravel-why-dietary-restrict-86ce12392c4ec342 2026-04-13T11:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-eye-care-in-africa-introducing-atropine-1-eye-drop-from-fidson-s-avent-17509c409c8d3704 2026-04-13T08:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mg2-a-interpack-2026-con-le-opercolatrici-della-serie-e-80a2b0662d906a42 2026-04-13T07:55:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/mg2-at-interpack-2026-with-the-e-series-capsule-fillers-2da28cbccc1d1ba5 2026-04-13T07:34:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-launches-an-assay-kit-for-identifying-p-tau217-in-the-blood-a-biomarker-r-b88ffa2d02a08aab 2026-04-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-to-serve-as-special-sponsor-of-kobe-marathon-2026-a-supporting-the-event-82c82f3e675d6931 2026-04-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-girl-with-autism-finds-voice-thanks-to-therapy-dc4645fb19b9ee98 2026-04-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/many-americans-unaware-of-own-risk-for-heart-disease-survey-finds-3116c08f0bae7447 2026-04-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-symptoms-43-year-old-dad-shocked-by-colorectal-cancer-diagnosis-3a07e5577884bc78 2026-04-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-proyecto-liderado-por-david-sancho-que-impulsa-una-nueva-estrategia-contra-el-1419f41e2b62e798 2026-04-12T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-presents-positive-data-for-b7-h4-targeted-adc-in-gynaecological-cancers-d10b0fa4924d152f 2026-04-12T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-san-francisco-business-times-honors-arch-s-carol-suh-on-40-under-40-class-of-f7bb9ea4a22873c0 2026-04-11T17:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-briefs-vi-serie-2-5b90855103937e9a 2026-04-11T02:57:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-briefs-v-serie-2-88c4bfddfbe2bd21 2026-04-11T02:54:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-briefs-lv-serie-2-74c4d63459a7a483 2026-04-11T02:51:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-briefs-iii-serie-2-cac1371e04a44ff1 2026-04-11T02:48:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-briefs-ii-serie-2-3f94951f71b92d15 2026-04-11T02:44:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-briefs-l-serie-2-bdfb95b6d6d6d69a 2026-04-11T02:34:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/geliose-mobility-an-iit-delhi-incubated-startup-launches-hope-an-affordable-elec-19f59684ccd74cc6 2026-04-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-uk-mhra-nice-pathway-to-create-faster-regulatory-approval-d4f809a32ba48e7d 2026-04-10T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-t-cell-recognition-new-insights-from-large-scale-activation-data-98bd3f68fba7139f 2026-04-10T20:53:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/gap-nailtm-endo-exo-medullary-system-cd5efb6e2cb34c46 2026-04-10T20:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-now-utilizing-normothermic-machine-perfusion-providing-more-access-for-kidne-32cc9362ceba600a 2026-04-10T19:45:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/rna-5b715e12d81ebb52 2026-04-10T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-twins-what-they-are-their-impact-in-life-sciences-d9b6e6f4728831a0 2026-04-10T15:08:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-care-and-outcomes-for-hlh-patients-51de76d39553b9d0 2026-04-10T13:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exozymes-cco-damien-perriman-outlines-nctx-strategy-and-the-commercial-path-for-4d9ceb5c4c37ee01 2026-04-10T12:35:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-human-centred-design-to-engage-men-and-boys-in-ending-harmful-practices-am-f0d61b66548b5e62 2026-04-10T10:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/tislelizumab-combined-with-induction-chemotherapy-and-concurrent-chemoradiothera-3c0f8e692dacdbe3 2026-04-10T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amarin-2026-a6aa60bdd4629f4d 2026-04-10T09:23:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/alexion-data-at-2026-aan-annual-meeting-reflects-industry-leading-portfolio-and-9103b3a1cebe5467 2026-04-10T01:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-npc1-genotypes-findings-from-the-us-arimoclomol-expanded-access-prog-3dfd85876dbf074e 2026-04-10T01:15:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/shionogi-selected-as-a-dx-stock-2026-bc4fcba9d4b99077 2026-04-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/orion-publishes-interim-report-for-january-march-2026-and-holds-a-webcast-on-23-23aacc01a6fc6a7d 2026-04-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idorsia-issues-invitation-to-the-2026-annual-general-meeting-of-shareholders-40f7e2112f470eb9 2026-04-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viatris-announces-multiple-data-presentations-at-the-2026-american-society-of-ca-b13297fc24783793 2026-04-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-therapeutics-to-participate-at-upcoming-investor-conferences-fe73c55896b51a4b 2026-04-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-biosciences-to-announce-topline-results-from-phase-2-3-optimum-02-trial-i-43bf7ad07ba58d2f 2026-04-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cnic-celebra-un-encuentro-en-el-marco-del-programa-de-investigadores-visitantes-ece9315a4e95cd6a 2026-04-09T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-advances-cardiovascular-health-awareness-through-support-of-the-am-0ef10a540d9626dc 2026-04-09T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-college-of-london-hospitals-nhs-trust-uclh-5486fe20c3d68906 2026-04-09T18:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cambridge-university-hospitals-nhs-foundation-trust-9d41afe6edbeed52 2026-04-09T18:01:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/manchester-university-nhs-foundation-trust-4f30c0c42e06656e 2026-04-09T18:01:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/hopital-la-pitie-salpetriere-14fac09106a2bdec 2026-04-09T18:01:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-oklahoma-2367813701f1c55f 2026-04-09T18:01:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-nebraska-medical-center-fd3a8d745114c8b3 2026-04-09T18:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-minnesota-medical-school-59fa615992e55dea 2026-04-09T18:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-california-san-francisco-93bea680a38d09b9 2026-04-09T18:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/children-s-hospital-los-angeles-division-of-rheumatology-1dc34f6077220325 2026-04-09T18:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-california-irvine-42c769e00f4575e7 2026-04-09T18:00:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-university-of-texas-md-anderson-cancer-center-d36df08064bcd9cb 2026-04-09T18:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/sarah-cannon-research-institute-scri-oncology-partners-7764fef554a82976 2026-04-09T18:00:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/leukemia-cells-use-a-sugar-coated-protein-to-hide-from-the-immune-system-e942c30616f2b985 2026-04-09T18:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/slice-and-dice-773c1af9e1ccf259 2026-04-09T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/members-of-the-french-president-s-official-delegation-visit-wako-campus-7fe4da975b6ecbec 2026-04-09T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/call-for-applications-for-the-riken-ecl-program-for-fy-2026-877071e56be661f2 2026-04-09T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-this-unity-health-information-specialist-makes-knowledge-accessible-for-staf-ef28e97fdca37218 2026-04-09T13:46:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-earns-back-to-back-no-1-ranking-in-black-book-survey-of-ai-clinical-decis-0b5dbbd871b06c9a 2026-04-09T13:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cvim-and-tiba-biotech-join-forces-to-advance-rna-based-livestock-vaccines-f34868cf29f1d851 2026-04-09T12:22:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-launches-bimatoprost-ophthalmic-solution-0-01-cddd0e82ddba9096 2026-04-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-muscle-invasive-bladder-cancer-care-the-untapped-potential-of-peri-df19239161181587 2026-04-09T10:41:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-launches-ultimion-japan-s-first-domestically-produced-photon-counting-ct-42afac727f848e3d 2026-04-09T10:15:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-to-present-at-the-aacr-oncology-industry-partnering-event-7c31f3289b986473 2026-04-09T10:03:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeted-therapy-in-early-stage-classical-hodgkin-lymphoma-6d10f7d8570df6e0 2026-04-09T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/st-george-s-consultant-appointed-to-the-house-of-lords-2c1d503b267e30c5 2026-04-09T07:54:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-ranked-among-ukraine-s-top-10-employers-fc9650a85f0384bd 2026-04-09T07:24:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-combiox-e61695b68616c70c 2026-04-09T07:12:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-combiox-f06596aafe3175d5 2026-04-09T06:16:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-lege-36f8753e1676868a 2026-04-09T05:44:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-medical-announces-winner-of-its-2026-rising-star-award-4aaefd4ca7f89935 2026-04-09T04:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-to-fund-two-new-combination-treatments-and-widen-access-to-another-for-p-9a8cc9f87b8f7864 2026-04-09T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-ir-library-olympus-business-2c1db8b97354b400 2026-04-09T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sidewinder-therapeutics-announces-137-million-series-b-financing-to-advance-prec-f891ee72e2c55c24 2026-04-09T01:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gtcr-completes-acquisition-of-zentiva-1389c8cd5f13aace 2026-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-april-2026departmental-updatekazakhstan-becomes-first-country-in-central-asia-7be385973612f840 2026-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-should-i-get-lasik-age-eligibility-and-recovery-explained-8eef4f1fd11cab90 2026-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/orion-s-production-processes-in-turku-finland-to-become-carbon-free-with-new-ste-cd0c881f416c0fad 2026-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idorsia-welcomes-amer-joseph-as-new-chief-medical-officer-and-head-of-global-cli-f962f98b2e2e660d 2026-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunic-to-participate-in-scientific-and-medical-conferences-in-april-ab64493bb687833f 2026-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blaine-labs-inc-issues-voluntary-nationwide-recall-of-wound-care-gel-products-du-03ef8f9a85223c81 2026-04-08T22:14:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/investor-access-event-paris-france-194ed91c950cdccb 2026-04-08T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-suburban-pastor-returns-to-his-ministry-one-month-after-first-of-its-kind-54e6bf5b7b97d96a 2026-04-08T21:26:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-listening-session-summaries-9d1cf1d163d8a595 2026-04-08T21:18:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fueling-hope-in-charcot-marie-tooth-disease-through-transformative-clinical-tria-9e72e93ff4ab54e5 2026-04-08T20:54:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-safety-labeling-changes-for-opioid-pain-medicines-875a9550a96e7914 2026-04-08T20:09:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-warns-consumers-not-to-use-counterfeit-ozempic-semaglutide-found-in-u-s-drug-991e22be9f881505 2026-04-08T20:09:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-s-istand-pilot-program-accepts-submission-of-first-artificial-intelligence-b-bbb4a3a020ed9a96 2026-04-08T20:06:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-revises-letter-of-authorization-for-the-emergency-use-authorization-for-paxl-e7b337dbb00bb1d2 2026-04-08T20:05:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-guidance-regarding-drug-development-for-early-alzheimer-s-disease-b68d421386b21a7e 2026-04-08T19:45:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-announces-new-quality-oversight-webpage-cfd198095cb7760c 2026-04-08T19:45:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-establishes-cder-center-for-clinical-trial-innovation-c3ti-c25e09efbeb1ebd7 2026-04-08T19:43:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-agency-initiated-proposed-order-regarding-otc-monograph-drugs-contain-df9ea288dc0a278b 2026-04-08T19:41:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-guidance-on-interchangeability-083772a215c0308f 2026-04-08T19:40:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-s-istand-pilot-program-accepts-a-submission-of-first-organ-on-a-chip-technol-03e16993a733eb73 2026-04-08T19:39:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-clarifies-policies-for-compounders-as-national-glp-1-supply-begins-to-stabil-ef48c2f3a79c78cc 2026-04-08T19:38:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-rems-modification-advancing-new-drug-disposal-option-502649853e56f8ae 2026-04-08T19:37:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-acute-pain-uncertainty-principle-4c8bef01e6971c6b 2026-04-08T19:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryopak-engineering-insights-validating-cold-chain-packaging-54a9932d7aa32324 2026-04-08T18:03:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/nighttime-woes-how-spring-allergies-may-be-impacting-sleep-quality-56c28f844eef7944 2026-04-08T17:47:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-to-release-2026-first-quarter-financial-results-e919fbeeea0f5a8f 2026-04-08T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/media-recordati-appointment-of-the-board-of-statutory-auditors-publication-of-th-d28215948eebca9f 2026-04-08T15:33:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-taichung-veterans-general-hospital-is-advancing-real-world-evidence-research-8a9387bdb3426b22 2026-04-08T14:33:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-onko-talk-zu-hightech-medizin-bei-lungenkrebs-21350e48e512bdde 2026-04-08T13:29:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/ground-level-crossings-and-an-inclusive-public-space-planned-for-bessarabska-squ-bc12b8c683b5b368 2026-04-08T13:04:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/exdensur-depemokimab-approved-in-china-for-the-treatment-of-chronic-rhinosinusit-1e8b5d1ef6c358f2 2026-04-08T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shujie-yang-harnesses-sound-to-build-the-next-generation-of-microrobotic-medicin-42c4a359fb6c3c85 2026-04-08T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-biosciences-to-participate-in-the-25th-annual-needham-virtual-healthca-443bc79f436d33cf 2026-04-08T11:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-to-reduce-size-of-the-board-of-directors-following-2026-annual-meet-2231f6bd649eecd4 2026-04-08T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellforcure-launches-a-process-to-find-a-buyer-for-its-les-ulis-site-523fe13b774fd603 2026-04-08T10:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-about-the-phase-2a-study-of-baxdrostat-in-primary-aldosteronism-e8d99a21caad5bd0 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cd19-car-t-cell-therapy-for-autoimmune-hemolytic-anemia-reply-25c5f5103c04783a 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cd19-car-t-cell-therapy-for-autoimmune-hemolytic-anemia-9a924dc985bbce90 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-dose-influenza-vaccine-and-hospitalizations-in-older-adults-reply-e1033d8f2a7f0c38 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trends-in-youth-onset-type-2-diabetes-2013-2024-02f90858c538144b 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/altering-the-diet-to-rewire-cancer-6e9ed90ff59f2c8a 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-10-2026-a-70-year-old-woman-with-a-racing-heart-fatigue-and-dyspnea-3fb47d41d5cc7019 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/necrolytic-migratory-erythema-4ed0eb00ff39122d 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celiac-disease-0aac43ad6ba541d4 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-for-the-research-article-extracellular-vesicle-mediated-gene-editing-for-a203d5a94ae3a7fc 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-of-a-neutralizing-and-protective-pan-encephalitic-alphavirus-receptor-dec-a4cf68dcd823bafe 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-time-intraocular-pressure-monitoring-and-responsive-drug-release-in-preclin-a14e0ff41e92025f 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/keratin-16-inhibits-type-i-interferon-responses-in-differentiating-keratinocytes-e737d59de013a135 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-human-ipsc-model-of-tauopathies-engineered-for-4r-tau-isoform-expression-endog-f6900d52d51131a0 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-activation-of-wasp-potentiates-macrophage-phagocytosis-and-enhan-f2f55f2ee7cf2600 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corticosteroid-resistance-is-predetermined-by-early-immune-response-dynamics-at-10f4896d6405fb2d 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-1-1b-study-of-bcma-targeting-bispecific-t-cell-engager-pavurutamab-in-rela-b9c6849a72b6b96e 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tunneling-nanotube-mediated-filamin-a-transport-mechanosensitively-programs-oste-f4fdcc9c69746fda 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-tumor-suppressor-role-of-the-mir-15b-16-2-cluster-in-t-cell-acute-lymphoblasti-8b3e6fdda7970204 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ultimate-guide-to-new-usp-bioburden-standards-navigating-compliance-market-s-3c8fa9f878fb648c 2026-04-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-upgrade-to-histopathology-service-reduces-wait-time-for-cancer-diagnosis-0735d31535df2708 2026-04-08T09:37:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-epigenetic-changes-reveal-hidden-risk-in-myelodysplstic-syndromes-1cd730b98e037992 2026-04-08T09:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-reports-strong-2025-sustainability-performance-advancing-industry-lead-eecf4a246157133c 2026-04-08T08:00:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-issuance-of-new-shares-and-secondary-offering-of-shares-5d845a3a6343893c 2026-04-08T07:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-refinancing-of-existing-borrowings-through-a-bridge-loan-aec189315eaa11ec 2026-04-08T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-funds-medicine-to-reduce-complications-following-allogenic-haematopoieti-3a5608b3cf4ad8b3 2026-04-08T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-invites-feedback-before-possible-medicine-brand-changes-9d0367961f54bf35 2026-04-08T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/escmid-global-2026-shionogi-presents-new-real-world-data-highlighting-clinical-e-78bb0fe214831903 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sfda-and-saudi-innovation-club-sign-mou-to-advance-digital-transformation-and-in-da366d5b827cbf32 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-04-08-university-news-fy2026-graduate-school-entrance-cer-fd0d1cab6b34ea8e 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ispor-2026-plenaries-and-speakers-announced-6f6148bc4ab3c203 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/some-common-ibs-treatments-linked-to-higher-risk-of-deathapril08-2026-02-00-amam-2e9a38805f5ff0d8 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-receives-fda-regenerative-medicine-advanced-therapy-designat-0bf2fa05e52af155 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/urogen-launches-lg-utuc-luminaries-initiative-recognizing-excellence-and-leaders-2accff71dcba45e3 2026-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-at-websummit-vancouver-2026-63291ac8d41b81da 2026-04-07T23:32:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-one-thing-every-day-that-scares-you-b76b41d98bca2627 2026-04-07T20:54:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-new-for-biologics-3c3e82bc6cb61f4a 2026-04-07T20:11:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-to-report-first-quarter-2026-results-on-may-1-2026-3e8184c0c0b6e329 2026-04-07T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esubmitter-application-history-973ddaa7b599300f 2026-04-07T19:36:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-investigator-inspection-list-e-k-4ac6c7b37c044524 2026-04-07T18:19:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-investigator-status-biologics-e1734ae701dfbbb7 2026-04-07T17:48:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/crucial-data-solutions-expands-trialkit-ai-with-study-simulation-and-validation-73129ebb1da7a3b1 2026-04-07T16:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-reveals-two-factor-authentication-system-that-controls-microrna-destructio-db5da6143d37a449 2026-04-07T16:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transgene-to-participate-in-upcoming-investor-meetings-3d3d773b50e88351 2026-04-07T15:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-bacteria-suppress-immune-defenses-in-stubborn-wound-infections-41a5a0f4f5d50db6 2026-04-07T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remarks-by-fda-chief-scientist-denise-hinton-to-the-professional-services-counci-76d196d069f30145 2026-04-07T15:36:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-to-acquire-tubulis-adding-potentially-best-in-class-antibody-drug-conjuga-542c5acf27f72ae5 2026-04-07T15:08:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/welcoming-our-new-chief-executive-mat-shaw-deb240c1998d52b6 2026-04-07T14:37:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-to-particpate-in-needham-virtual-healthcare-conference-000331ef0cf3ed60 2026-04-07T14:31:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-releases-enki-4-major-update-to-foundation-model-for-small-molecu-aabba09b975bd23b 2026-04-07T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ergomed-group-announces-board-chair-transition-e5a97b6b5d7d71de 2026-04-07T13:15:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-and-medstar-health-announce-partnership-to-deploy-the-aisight-dx-digital-67f0d1e4e8207620 2026-04-07T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-dire-05a55de90c3dff35 2026-04-07T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-effective-long-term-follow-up-strategies-in-advanced-therapies-84acee1412c1a969 2026-04-07T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-announces-2-million-donation-to-support-patient-access-to-essential-medic-22c8686631dc1d90 2026-04-07T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natac-s-ceo-presents-sustainext-as-an-example-of-industrial-scale-up-at-the-cbe-db856c0240490cc2 2026-04-07T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-pharma-announces-successful-end-of-phase-2-meeting-and-fda-alignment-on-717478728f095a75 2026-04-07T11:34:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/yprime-expands-ecoa-platform-with-participant-hub-71f019d3242c0d56 2026-04-07T11:34:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinetx-enhances-its-ability-to-federate-genomics-data-across-its-global-network-58f27d3db1c79060 2026-04-07T11:30:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-technologies-for-sound-decision-making-in-medicine-f833cd846909637f 2026-04-07T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-identify-neural-fingerprint-of-psychedelic-drugs-in-the-brain-c03bb50de2420357 2026-04-07T09:50:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/good-luck-teamuclh-in-the-london-landmarks-half-marathon-ce5491e48febf09a 2026-04-07T09:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-spring-booster-available-for-eligible-groups-657f8095811d7e88 2026-04-07T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skye-bioscience-presenting-at-glp-1-based-therapeutics-summit-06a1c299ee5a17a2 2026-04-07T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alloy-therapeutics-enters-into-multi-target-collaboration-and-license-agreement-41d4f50f0b08af26 2026-04-07T04:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-stem-cell-descendants-preserve-flexibility-while-maintaining-distinct-identi-18d7d091c185ac41 2026-04-07T01:13:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/usp-revisions-what-they-mean-for-injectable-drug-quality-and-why-packaging-matte-f64678b8b4df4e06 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/read-the-press-release-a3d932d8145cb946 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tuhura-biosciences-inc-e5840ce00f2ffef9 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tuhura-biosciences-appoints-amanda-garofalo-mshs-as-senior-vice-president-of-cli-3c2291e9509c4c63 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharming-group-to-participate-in-april-investor-conferencesconference-attendance-eaa9007bf360d765 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-at-orion-the-many-paths-a-pharmacy-degree-can-open-up-in-the-pharmac-11c35d24d5834c31 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-04-07-university-news-fy2026-undergraduate-entrance-cerem-721156acfa6c6bc3 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ispor-publishes-recommendations-on-valuing-child-and-adolescent-health-for-econo-017bd5fd197d16e3 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-to-acquire-tubulis-adding-potentially-best-in-class-antibody-drug-conjuga-d5d1724a5634faa6 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-analytical-scientist-vibe-coding-comes-to-omics-aad7ffbb74c89147 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/member-press-releases-apr-07-2026variational-ai-releases-enki-4-major-update-to-a7698ed2de28913f 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spot-the-phish-in-less-than-five-minutes-db2fcbe9469635c7 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-gene-covers-the-challenges-with-implementing-annex-1-at-the-global-level-se-bab26f4bff950c9a 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvalent-announces-submission-of-new-drug-application-to-fda-for-neladalkib-in-t-5699bcb7e99adc87 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acadia-pharmaceuticals-announces-daybue-stix-trofinetide-is-now-broadly-availabl-d9cda0008ef93b04 2026-04-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cure-on-the-horizon-are-we-finally-close-to-ending-type-1-diabetes-3368b2c57293a6f6 2026-04-06T21:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/monthly-fda-guidance-and-regulatory-news-review-march-2026-4362487a77efb2a1 2026-04-06T21:15:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-oriented-management-declaration-1dafecdc90ed7924 2026-04-06T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reprotech-and-tmrw-life-sciences-enter-into-business-combination-to-create-the-m-42465f74bb62155a 2026-04-06T13:20:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-new-accelstim-advanced-features-same-proven-results-aa5c5509ae829300 2026-04-06T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-8cee2ba1ad57947b 2026-04-06T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-climate-change-fossil-fuels-and-war-a-call-for-action-564c7ed322f08afe 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sound-mind-sound-place-ibasho-and-post-disaster-mental-health-4bed563879d5c20c 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-ezekiel-emanuel-s-simple-rules-b7a8d02377c6ab94 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bp-lowering-drugs-reduced-major-cv-events-to-a-similar-extent-in-patients-with-o-3af245b16665603f 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multisite-external-validation-of-a-clinical-screening-tool-for-interpersonal-fir-a3b1fe98428ab3f6 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-minoca-stratified-treatment-guided-by-minoca-cause-vs-standard-care-improved-cf4fe2e6a9560697 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-sepsis-a-tailored-precision-immunotherapy-strategy-improved-organ-function-at-c5595cc40b16a48f 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-patients-with-painful-diabetic-neuropathy-pregabalin-does-not-differ-from-dul-e2ab711af628c11b 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-the-ed-the-wells-score-plus-age-adjusted-d-dimer-score-ruled-out-dvt-with-a-f-26626cf01c1701b3 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-patients-with-chronic-lung-disease-4-existing-pe-diagnostic-strategies-were-a-4687d3e3f86b08c7 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-adults-with-adhd-atomoxetine-methylphenidate-and-cbt-reduce-symptom-severity-576c66714a67478c 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/summary-for-patients-multisite-external-validation-of-a-clinical-screening-tool-5712dc01864c5652 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-ischemic-stroke-in-patients-receiving-aspirin-switching-to-another-antithr-bb84249b7858f5d9 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-study-of-il15-activated-cytokine-induced-killer-cells-after-allog-e42a54614eebea53 2026-04-06T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-appoints-christian-schade-as-senior-advisor-059ae0e22c89b279 2026-04-06T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ask-our-experts-monoclonal-antibodies-explained-cf0828014bcbe377 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/products-services-7040e2ff5487125b 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-04-06-aa-c-a1-4-a-q-aa-a-e-a-a-3-4a-a-79ee3901e2a4fee7 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/litigation-leaders-finnegan-s-jennifer-roscetti-on-the-advantages-of-being-fully-1f25a9ffebe9b709 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-announces-positive-topline-phase-3-results-for-subcutaneous-tepezza-in-adu-5433b8d829b55333 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-biosciences-announces-first-patient-in-for-phase-1-trial-of-ide574-a-pote-bde28323945e285f 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biogen-report-first-quarter-2026-financial-results-april-29-2026-1c206dd465b8928d 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-6-2026press-releaseagios-to-host-first-quarter-2026-financial-results-conferen-42b2575f78efa978 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transforming-high-quality-care-at-east-campus-medical-center-882699922fc9eb0b 2026-04-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canada-s-yukon-territory-publishes-first-nations-cancer-strategy-010defd4cc93b84a 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-breast-cancer-conference-2026-449ec2ece7eb55a8 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/senators-demand-explanation-for-us-preventive-services-task-force-halt-4c8248b2827a5b1d 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunogenicity-of-high-dose-recombinant-influenza-vaccine-versus-standard-dose-e-b1e70edeada6dd79 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concerns-regarding-study-of-spatial-emanators-for-malaria-control-cfa13d17d4c86552 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concerns-regarding-study-of-spatial-emanators-for-malaria-control-authors-reply-519de573ec819def 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/percutaneous-coronary-intervention-versus-coronary-artery-bypass-grafting-for-un-d8dee410a73bad09 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-burden-of-cancer-in-children-and-adolescents-aged-0-19-years-1990-2023-a-fbe0324b01c5eb31 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-immunotherapy-for-resectable-hepatocellular-carcinoma-authors-repl-b65873e0365b5403 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-immunotherapy-for-resectable-hepatocellular-carcinoma-5909b428cb348176 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-phenotyping-improves-choices-of-biologics-in-asthma-authors-reply-bf4731fb6d831f67 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-phenotyping-improves-choices-of-biologics-in-asthma-7af923edcf3b14e4 2026-04-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-past-cinnabar-use-left-a-mercury-signature-written-in-human-bone-d31be4f7ad2ba366 2026-04-05T01:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/washington-university-school-of-medicine-1e48be95bc87ef6d 2026-04-04T22:08:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/media-recordati-filing-of-a-sole-slate-for-the-renewal-of-the-bosa-extension-of-399e9975567ce5ed 2026-04-04T16:05:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-0e1e79ae8e0e3b6c 2026-04-03T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-democratization-of-care-scaling-the-artisan-surgeon-through-physical-ai-fee68fd31e54da4b 2026-04-03T18:36:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-on-fda-s-ongoing-evaluation-of-reports-of-suicidal-thoughts-or-actions-in-0f435b1fa5d01fe9 2026-04-03T16:40:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-adds-warning-about-rare-occurrence-of-serious-liver-injury-with-use-of-veoza-804ab4c4b8e5c4bc 2026-04-03T16:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-adds-boxed-warning-about-a-rare-but-serious-allergic-reaction-called-anaphyl-b61516ae705d3db3 2026-04-03T16:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-requires-warning-about-rare-but-severe-itching-after-stopping-long-term-use-a404d444d2011d8b 2026-04-03T16:37:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-adds-warning-about-serious-risk-of-heat-related-complications-with-antinause-728effda035abf2e 2026-04-03T16:34:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-is-requiring-opioid-pain-medicine-manufacturers-to-update-prescribing-inform-1fd9b354a64af8f6 2026-04-03T16:22:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-removes-risk-evaluation-and-mitigation-strategy-rems-program-for-the-antipsy-509da04ce09736d3 2026-04-03T16:21:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-to-recommend-additional-earlier-mri-monitoring-for-patients-with-alzheimer-s-0cb4a9273df8b292 2026-04-03T16:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-requests-removal-of-suicidal-behavior-and-ideation-warning-from-glucagon-lik-df707750700308f5 2026-04-03T16:19:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-is-requiring-warning-about-vitamin-b6-deficiency-and-associated-seizures-for-c52a0f1915d8ee77 2026-04-03T16:18:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-identifies-cases-of-serious-liver-injury-in-patients-taking-tavneos-avacopan-75ccb73b41c103f8 2026-04-03T16:17:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/generic-drug-user-fee-amendments-f089159bf084a00d 2026-04-03T16:14:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-they-grow-teaching-your-children-how-to-use-medicines-safely-526ea48a30db7604 2026-04-03T15:35:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-and-press-announcements-on-angiotensin-ii-receptor-blocker-arb-recal-8b52f918f614601a 2026-04-03T15:17:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/stop-learn-go-tips-for-talking-with-your-pharmacist-to-learn-how-to-use-medicine-b10fdd6b1624327b 2026-04-03T15:15:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-rare-disease-innovation-hub-665b9552c1f8a205 2026-04-03T15:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-draft-guidance-for-industry-on-the-design-and-evaluation-of-comparati-a1f855ee8b53ee47 2026-04-03T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lee-shapiro-on-data-driven-preventative-medicine-and-the-fight-against-sick-care-48425b19d6f284cd 2026-04-03T14:32:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/cinglan-30-mg-filmtabletten-012ae8a4ede7b4e6 2026-04-03T10:42:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/intravenous-immunoglobulin-treatment-for-long-covid-a-case-report-of-clinical-an-6a9fe6025b916bfb 2026-04-03T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-case-for-routine-patient-review-in-long-covid-research-e4b8b8274be981b6 2026-04-03T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-i-eb0b820b988694b8 2026-04-03T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-to-launch-pepticodetm-hp-9-the-first-european-biotech-hexapeptide-9-cdabbe15cef68042 2026-04-03T09:47:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-renames-its-sales-subsidiaries-in-malaysia-and-indonesia-promoting-brand-85c2da28dbcfb7d1 2026-04-03T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/join-icecure-at-asbrs-2026-cryoablation-for-breast-cancer-in-low-risk-patients-bd6c06dfe4321456 2026-04-02T23:49:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-canada-s-yukon-territory-publishes-first-nations-cancer-strategy-52acc1a97445fa6e 2026-04-02T22:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-european-breast-cancer-conference-2026-71b5d8a251f5d69a 2026-04-02T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-senators-demand-explanation-for-us-preventive-services-task-force-halt-5260994aa528aa06 2026-04-02T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-and-why-do-you-measure-a-year-in-the-life-a-practical-guide-to-defining-clin-8cb23c0badf96e95 2026-04-02T20:53:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/regeneron-collaborates-with-trinetx-to-access-de-identified-electronic-health-re-a3393a61098423d6 2026-04-02T20:25:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclarus-lab-data-ecosystem-delivering-complete-visibility-and-confidence-acros-f63dceab14b46e5b 2026-04-02T16:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmic-holdings-announces-changes-to-management-structure-910e89f0f39b39e2 2026-04-02T16:36:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-named-fill-finish-cdmo-of-the-year-and-best-in-class-for-cultural-0c25e0e8bb8e160e 2026-04-02T14:28:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-chief-warns-of-triple-trouble-as-doctors-strike-follows-easter-holiday-05faeef9b1d0d5d7 2026-04-02T13:56:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-data-to-compliance-key-elements-of-impd-and-cta-preparation-31266b2c88e5450b 2026-04-02T13:26:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-new-qualified-treatment-center-for-zevaskyn-in-new-567992195c17da7f 2026-04-02T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uclh-recruits-first-european-participant-to-advanced-phase-lung-cancer-trial-0c8b833a3b6e1b49 2026-04-02T11:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-appoints-dr-graham-c-ellis-as-clinical-vice-president-54db8c216f167cc5 2026-04-02T10:49:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-from-rowitch-and-collaborators-uncovers-vulnerable-brain-cells-prone-to-5cf9040746283910 2026-04-02T09:13:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-rudiger-zimmerer-ubernimmt-leitung-der-mkg-klinik-an-der-universitatsmedizi-b1b49450ee7d98ba 2026-04-02T08:44:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-tumor-microbiota-a-new-frontier-in-cancer-biology-a681fe0701d02e20 2026-04-02T08:24:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/resident-doctor-industrial-action-bff18de4ed9f5e96 2026-04-02T08:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-value-based-healthcare-vbhc-for-medtech-in-the-asia-pacific-region-5d2d4b62397d9eb0 2026-04-02T01:56:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyoto-university-and-jica-kansai-center-sign-japan-s-first-mous-for-jocv-science-5baca4ec21ea7130 2026-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/discover-icecure-breast-cryoablation-at-ecio-2026-join-us-at-the-european-confer-a3ea0ab2b1f59e3a 2026-04-01T21:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/module-level-sensor-system-detects-faults-in-large-photovoltaic-power-plants-ear-17312d4a1ac97cd2 2026-04-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/customized-fertilization-f834fae0297777b6 2026-04-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-the-unexpected-happens-cold-chain-disruption-case-study-active-vs-passive-p-3411406b5ee61c41 2026-04-01T15:49:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/baf9a1f94cf2ce5b 2026-04-01T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/behind-the-scenes-with-r-d-developing-osteocovetm-9f0cec11c24e2445 2026-04-01T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-presented-positive-results-from-the-phase-1-multiple-ascend-7a6fa6c72d2849bc 2026-04-01T13:10:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/renuvion-wins-2026-newbeauty-award-for-best-minimally-invasive-skin-tightner-1126ef2caa61ba67 2026-04-01T12:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medizin-der-zukunft-die-charite-im-wissenschaftsjahr-2026-15cbcf4c12e833ee 2026-04-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-announces-data-showing-nasal-anti-cd3-improves-cognition-associated-with-5e4f84ab1ef533fd 2026-04-01T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-study-design-decisions-with-real-world-data-e86c9e8a2c3e2953 2026-04-01T10:51:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/alloy-therapeutics-appoints-alexander-titus-ph-d-to-lead-new-vigilance-division-4f48776cea0caa27 2026-04-01T09:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunities-and-challenges-of-being-a-dual-listed-company-42cdade5f1e19f4d 2026-04-01T07:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-widens-access-to-two-melanoma-medicines-1d75eec40085a46f 2026-04-01T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-appoints-oxana-pastushenko-as-ceo-emea-4ba785dfafa56f73 2026-04-01T01:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-ichiro-tateya-has-taken-up-his-post-in-the-otolaryngology-head-and-neck-sur-4f2d032505f45336 2026-04-01T00:17:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-kazuto-yoshimi-has-taken-up-his-post-in-the-institute-of-laboratory-animals-b8201d2c96578138 2026-04-01T00:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/completion-of-the-acquisition-subsidiarization-of-jeola-s-clinical-chemistry-tes-addd838d90460a70 2026-04-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-to-launch-of-upneeq-mini-ophthalmic-solution-0-1-a-treatment-for-acquired-d91ca08622f3b6de 2026-04-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-04-01-industry-academia-government-collaboration-kyotou-k-c05d97c6e6f37ca7 2026-04-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-biosciences-announces-results-of-special-shareholders-meeting-announces-r-2b3dd329ef7ec392 2026-03-31T21:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-the-blocks-of-life-b9346ebcc0edba9a 2026-03-31T20:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridget-yates-on-the-power-of-purpose-cultivating-impact-through-scientific-disc-a4e3c66e406f87a2 2026-03-31T20:44:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/unity-health-toronto-s-march-honour-roll-37f96c16c0497e14 2026-03-31T20:31:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/diabetes-patients-cured-of-disease-with-groundbreaking-new-treatment-study-shows-aee07229af6300f8 2026-03-31T20:22:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/blackburn-facility-invests-in-mdi-can-wash-plant-685ffda119d7ae3e 2026-03-31T17:31:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-europe-spring-pharma-dealmaking-in-lisbon-24c9faafd1bc5e48 2026-03-31T16:21:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/scalable-cell-imaging-method-could-help-make-drug-safety-testing-faster-cheaper-8fe00eb8c781682f 2026-03-31T15:19:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-at-sbi-2026-symposium-discover-prosense-cryoablation-for-breast-tumors-b61e6e98f7cad2bd 2026-03-31T14:36:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/canada-s-environment-and-natural-resources-face-a-data-challenge-and-a-generatio-af8806f906b62f4e 2026-03-31T12:00:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-regulatory-trends-shaping-today-s-drug-development-a720e712d3e89373 2026-03-31T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-pharma-reports-full-year-2025-financial-results-and-provides-business-up-93254c6adab755a9 2026-03-31T11:59:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/newsletter-19-121a2afecdd5a235 2026-03-31T09:08:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-researcher-honoured-with-nordic-prize-for-uncovering-how-gene-activity-d-5abbbca72a44fced 2026-03-31T06:58:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/gender-dynamics-in-vaccine-acceptance-and-hesitancy-among-primary-caregivers-in-88375fd7ba102260 2026-03-31T06:41:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/disparities-and-barriers-to-life-course-vaccination-in-ethiopia-evidence-from-a-bb1937c0dbe11878 2026-03-31T06:37:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-ai-in-medtech-potential-for-china-policies-use-cases-and-future-outloo-59593517e43ae59e 2026-03-31T02:43:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-to-announce-first-quarter-2026-results-on-april-29-2026-935f9aab8c2b932c 2026-03-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eikon-therapeutics-announces-fourth-quarter-and-full-year-2025-financial-results-9d1f3d535f169392 2026-03-30T23:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cnic-participa-en-compass-un-proyecto-europeo-que-impulsa-la-deteccion-precoz-y-d4ffcd805e585af8 2026-03-30T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-lens-on-autism-s-sex-bias-1d99a0031bc27e85 2026-03-30T14:32:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-future-begins-here-with-three-new-lives-and-the-memory-of-two-daughters-held-c-2e5bd679454b875e 2026-03-30T14:19:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparing-canada-s-health-system-for-military-conflicts-e51808c381bbd0bb 2026-03-30T13:48:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-strategic-evolution-of-clinical-writing-moving-from-manual-drafting-to-high-bff8f3119aa02c09 2026-03-30T12:59:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/socra-2026-board-of-directors-election-a1143c1766bb7065 2026-03-30T12:31:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/exdensur-depemokimab-approved-in-china-for-the-treatment-of-severe-asthma-4f60aee0fa8f3604 2026-03-30T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-gains-biosimilar-momentum-with-u-s-fda-approval-of-ponlimsitm-denosumab-ade-6177a31e458e1712 2026-03-30T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ratings-raised-at-st-george-s-as-cqc-recognises-improvements-in-emergency-care-dbddb8df1041cf71 2026-03-30T10:23:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-the-role-of-the-health-bazaar-initiative-on-sexual-and-reproductive-h-11a00c77771348ca 2026-03-30T09:34:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/manchester-scientists-discover-one-of-the-most-common-genetic-causes-of-severe-e-df71b3dbd8641956 2026-03-30T09:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/highlights-of-the-orphan-drugs-report-by-its-creators-04d7683dfe4d9dde 2026-03-30T08:25:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-we-build-the-analysis-behind-our-orphan-drugs-report-7f429449787c152d 2026-03-30T08:20:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-puzzle-of-drug-resistance-27bf47a48b7d31c2 2026-03-30T07:35:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/bepirovirsen-accepted-for-regulatory-review-in-china-as-a-potential-first-in-cla-a728e79d95f2f856 2026-03-30T07:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-submits-partial-change-application-in-japan-to-add-pediatric-dos-c59225bd8dcd35c9 2026-03-30T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/die-innere-uhr-lasst-sich-an-einer-haarprobe-ablesen-851d9312ca99f81a 2026-03-30T05:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-body-s-internal-clock-can-be-determined-from-a-hair-sample-4ad826308b970970 2026-03-30T05:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-celebrates-its-75th-anniversary-enriches-the-content-of-the-special-webs-9658a1116ff075a4 2026-03-30T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-research-coordinator-level-3-programme-c8b744fc1e1adf97 2026-03-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newly-accredited-music-degree-opens-pathways-for-creative-artists-3f299f01629229a6 2026-03-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-teton-1-pivotal-study-of-tyvaso-meets-d5fe3b6aecf91199 2026-03-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/472-4b752bd5426a0867 2026-03-29T10:33:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/reprogrammed-astrocytes-clear-alzheimer-s-plaques-in-mice-e232e0035148af2e 2026-03-29T01:37:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-atrial-appendage-closure-or-anticoagulation-for-atrial-fibrillation-391245f5bab63a12 2026-03-28T02:31:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-atrial-appendage-closure-should-recommendations-be-expanded-b7cf950a2e6523d2 2026-03-28T02:31:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-us-cancer-vaccines-research-at-tipping-point-as-nci-backs-200-million-initi-6d0648e378a9f611 2026-03-27T23:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-us-oil-blockade-pushes-cuba-s-health-system-into-crisis-f8cedfea3f3283a0 2026-03-27T23:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/huntington-s-disease-and-the-triad-of-therapeutic-conviction-b9da5ccfa938f1a2 2026-03-27T21:55:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/monthly-fda-guidance-and-regulatory-news-review-february-2026-4df63a733b9ce619 2026-03-27T17:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-letter-to-the-pompe-and-fabry-communities-84954eb6529f9e3c 2026-03-27T16:05:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/bepirovirsen-accepted-for-review-by-the-european-medicines-agency-as-a-potential-ed227645f97a4d48 2026-03-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pigs-human-like-antibody-responses-to-flu-can-aid-advancement-of-novel-therapeut-0cdb7ae182ebc096 2026-03-27T11:20:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-carcinogenicity-of-tris-chloropropyl-phosphate-butyraldehyde-and-cumyl-hydr-ba6ef1a0a67b1eb5 2026-03-27T08:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/open-access-simulator-could-reduce-the-use-of-experimental-animals-in-teaching-bc13c6a3fb5d5c25 2026-03-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-april-2026-cancer-treatments-advisory-committee-ctac-meeting-a25641ae44de7ace 2026-03-27T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-03-27-global-engagement-9th-kyoto-university-mahidol-univ-00cc05de15c0bf10 2026-03-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-03-27-university-news-fy2025-degree-conferment-ceremony-h-d22ed446ff91642d 2026-03-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-03-27-university-news-fy2025-graduation-ceremony-held-698f957e3a20b7b6 2026-03-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ars-pharmaceuticals-receives-fda-approval-to-remove-age-requirement-from-neffy-1-62eea3a4469d24fe 2026-03-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-reports-full-year-2025-financial-results-and-provi-eabf8b4198d4ab98 2026-03-26T20:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-reports-fourth-quarter-and-full-year-2025-financial-results-and-p-2a8ef64c97f5d965 2026-03-26T20:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/malaria-transmitting-mosquitoes-in-south-america-are-evolving-to-evade-insectici-624b240b4d295815 2026-03-26T18:46:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/responsetm-4-5-5-0-f00df94326dd8a0e 2026-03-26T18:02:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-device-clinical-trials-key-considerations-for-sponsors-and-cros-4ee238e3cd39e241 2026-03-26T17:33:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/liquid-biopsy-entering-a-new-phase-in-cancer-diagnostics-c8f4a76c88ad7937 2026-03-26T15:54:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/ergomed-featured-by-microsoft-for-enterprise-data-transformation-174f259cb9222247 2026-03-26T15:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/riken-and-hamamatsu-photonics-sign-framework-agreement-on-collaboration-2c4e1866e47de2e1 2026-03-26T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/she-cheers-on-everyone-a-patient-s-journey-through-hip-fracture-rehabilitation-5d4638e8e6508e52 2026-03-26T14:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/ms-spotlight-a-look-at-the-global-application-of-the-2024-revisions-of-the-mcdon-938d1c9ed10ce135 2026-03-26T14:19:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-assessment-procedures-support-the-conduct-of-drug-trials-in-estonia-83cd2d1016d8eb7f 2026-03-26T14:04:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-jitendra-narayan-8eb8f331db9f0a04 2026-03-26T13:35:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-named-2025-infectious-disease-testing-solution-of-the-year-by-biotech-b-4af40f4cc3908151 2026-03-26T13:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-launches-viz-agent-studio-enabling-health-systems-to-build-and-scale-thei-c30d7ccba459304c 2026-03-26T13:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/berlin-ernennt-charite-und-bayer-zum-neuen-zukunftsort-a58167a509805eb6 2026-03-26T12:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-announces-initiation-of-phase-1-2a-study-of-glix1-for-the-treatment-of-2320f683967f5942 2026-03-26T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/london-hospital-cuts-nitrous-oxide-emissions-by-70-per-cent-with-new-gas-deliver-07299189698e9c3f 2026-03-26T09:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-adds-cellanome-cellcagetm-technology-for-enhanced-single-cell-insights-e11012e078a1ebb4 2026-03-26T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ir-58aad2100733e600 2026-03-26T04:53:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-ortho-dermatologics-2026-aspire-higher-scholarship-progr-d84e37984f8268c8 2026-03-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emily-lukacz-md-named-president-of-american-urogynecologic-society-df9d198ada88ff6b 2026-03-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimidocarbo-b12-2c1cee8b09175783 2026-03-25T19:06:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/5ce50f247c66a87f 2026-03-25T17:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-myovista-insightstm-receives-epic-toolbox-designation-for-ecg-mana-90a08b3da943f5a3 2026-03-25T15:52:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/sessoes-colaborativas-do-procc-abrem-o-ciclo-de-2026-com-debate-sobre-esporotric-4d578e38123c84ee 2026-03-25T14:49:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategic-clinical-leads-appointed-to-lead-on-population-health-and-integration-07be6bc43a515cd2 2026-03-25T14:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-discovery-on-brain-metastasis-reveals-how-tumors-hijack-immune-cells-to-use-557e0ab1088793b2 2026-03-25T12:52:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-two-abstracts-accepted-for-presentation-at-aki-crrt-2026-fa0e9f112a79542d 2026-03-25T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europa-traci-pozycje-w-globalnych-badaniach-nad-szczepionkami-be867723d4204030 2026-03-25T11:53:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-concerning-non-operating-income-recorded-in-the-company-s-non-consolidate-4c77a8b281b2fb0e 2026-03-25T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-proposal-to-procure-drug-eluting-stents-will-mean-savings-for-public-hos-62342a63122a87b1 2026-03-25T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-researcher-awarded-esteemed-iea-fellowship-1547e5514a3f5692 2026-03-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-announces-publication-of-phase-2b-results-for-mebufotenin-gh001-in-j-a613b348a47059c8 2026-03-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-milestone-for-breast-cancer-care-cryoablation-is-now-fda-cleared-for-low-r-cda52208fea6f42c 2026-03-24T23:44:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-heart-of-the-matter-biomarin-scientists-reflect-on-experiences-meeting-patie-340e558f915e0665 2026-03-24T21:14:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-releases-its-state-of-the-industry-report-33571f7d9b4521be 2026-03-24T20:13:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-to-report-first-quarter-2026-financial-results-on-april-22-0222652843ed3573 2026-03-24T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-a-st-michael-s-patient-and-his-caregiver-inspired-their-care-team-and-commun-3dec5ab240bb66f6 2026-03-24T17:53:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-clinical-vision-avim-therapy-for-hypertensive-heart-disease-53b7bbbf6cc829d0 2026-03-24T17:09:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/enamine-joins-variational-ai-in-agora-open-science-prmt6-discovery-effort-325551e899be6ef3 2026-03-24T15:57:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-to-present-at-investor-summit-group-virtual-conference-and-host-vi-97130c2ac54da8a5 2026-03-24T15:50:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-recalls-affected-batches-of-citro-soda-regular-following-safety-concerns-1f32b73217901dad 2026-03-24T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-early-decisions-shape-late-stage-risk-b43f49fe76e7af23 2026-03-24T15:12:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-successfully-transport-antimatter-in-a-truck-0ac40522acc05d8f 2026-03-24T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-everest-group-s-innovation-watch-8a07116478376c6e 2026-03-24T14:00:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/orphanpacific-obtains-marketing-approval-in-japan-for-joenja-leniolisib-for-the-aeb3dbd91a648aa5 2026-03-24T13:54:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/viz-ai-partners-with-alnylam-pharmaceuticals-to-advance-earlier-identification-a-82ebb998e09a4d60 2026-03-24T13:40:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-commends-congress-on-introduction-of-bipartisan-legislatio-36c717df21fc44fe 2026-03-24T13:07:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-endometriosis-research-the-importance-of-patient-centered-clinical-tri-9b5727f95a4c060e 2026-03-24T12:30:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-shift-toward-one-why-one-pivotal-study-demands-one-essential-tmf-b4e5fd7c3415de83 2026-03-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-40e1562f1f87abf7 2026-03-24T11:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-technology-does-not-speed-up-lung-cancer-diagnosis-9fef1a475a936759 2026-03-24T10:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-the-pharmaceutical-chain-invents-its-own-standards-for-its-invisible-links-929fbef155273752 2026-03-24T10:28:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/carriers-good-distribution-practices-for-medicines-cgdp-when-every-kilometer-mat-923b949988488fd5 2026-03-24T10:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-importance-of-cleaning-and-disinfection-procedures-in-controlling-contaminat-73c1aae3023f18b0 2026-03-24T10:27:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-next-generation-sequencing-ngs-on-quality-control-of-pharmaceutica-742c592a9255264a 2026-03-24T10:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-contamination-to-continuous-improvement-a-method-for-investigating-microbio-4d031f49b6d62be4 2026-03-24T10:25:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/economic-justification-for-automation-robotics-solutions-in-pharmaceutical-micro-c8415f4f34fdd977 2026-03-24T10:23:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-and-operation-of-a-microbiology-laboratory-the-collaborative-approach-of-929bfa4cfb47eeaf 2026-03-24T10:21:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/waste-mapping-fe0437d4c7e88286 2026-03-24T10:18:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-practices-for-using-a-class-ii-biological-safety-cabinet-in-a-microbiology-7a4e59633cdd336b 2026-03-24T10:17:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/oldest-ever-male-kidney-donor-at-a-manchester-hospital-saves-his-son-in-law-cc8bea0d73e7816a 2026-03-24T09:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-launches-5-million-next-generation-cancer-diagnostics-programme-to-accelerate-3cce85661dd5b446 2026-03-24T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/5389cfe6ef1a5889 2026-03-24T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immutrin-raises-65-million-87-million-series-a-to-develop-next-generation-antibo-644e503c07104420 2026-03-24T00:21:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-s-research-software-programme-innovation-strengthens-digital-research-infras-f20921a0f633b4f8 2026-03-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-on-national-viagra-day-women-finally-claim-their-turn-113b16d3766f1629 2026-03-23T20:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/open-by-design-how-trialkit-s-api-architecture-enables-custom-clinical-workflows-8ef1ea935a5beac1 2026-03-23T18:42:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-personalized-care-gave-a-patient-confidence-after-a-traumatic-brain-injury-50dad050ad0671e9 2026-03-23T18:29:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-vaccines-workshop-c715e40a232443a1 2026-03-23T15:41:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-new-studies-show-viz-ai-s-cardio-suite-speeds-detection-of-cardiac-disease-99feff8c17aadff6 2026-03-23T13:53:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-patient-recruited-to-phase-i-early-alzheimer-s-disease-study-6b12eb75b8d04fe2 2026-03-23T13:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-fourth-quarter-and-full-year-2025-financial-results-and-provi-f2638b65d1c8af85 2026-03-23T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-of-england-s-largest-nhs-trusts-is-scaling-ai-capabilities-across-its-workfo-77ab48719945d91f 2026-03-23T12:09:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/rewriting-the-playbook-for-als-drug-development-fc5899c51e1979b9 2026-03-23T12:01:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/insitro-and-bristol-myers-squibb-collaboration-expanded-with-nomination-of-new-t-661ec6d25285dcd4 2026-03-23T12:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-b7-h3-targeted-antibody-drug-conjugate-risvutatug-rezetecan-granted-orphan-504c6725c0529b50 2026-03-23T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-independent-proxy-advisory-firm-glass-lewis-endorses-aptose-plan-of-arra-236a33ab1bc058d8 2026-03-23T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/einstein-center-for-early-disease-interception-eroffnet-9f29089e1fc212db 2026-03-23T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/launch-of-the-einstein-center-for-early-disease-interception-ba3c20fe055fedc0 2026-03-23T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-reports-2025-financial-results-and-provides-corporate-update-f69d04610c5856f5 2026-03-23T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/closer-to-deciphering-tor-the-molecular-machinery-that-makes-humans-and-yeast-gr-31650c5ce7847d43 2026-03-23T09:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-information-about-pharmac-s-priority-lists-44c8a896c11e862a 2026-03-23T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoya-introduces-its-first-off-site-corporate-ppa-at-akishima-plant-80e3894a17cefa00 2026-03-23T01:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/ppa-a8776d1cab2a190c 2026-03-23T01:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-patient-safety-in-labor-and-delivery-with-point-of-care-ultrasound-74d9e2e3b6ce7cc3 2026-03-20T23:07:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-diagnostics-that-impact-lives-28053a2fbb6c3380 2026-03-20T20:28:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-data-solutions-d9b4f8fb7a747ef7 2026-03-20T20:04:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/solving-the-rare-disease-paradox-putting-patients-at-the-center-of-clinical-rese-59a53424f331c70b 2026-03-20T19:18:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-drug-discovery-startups-a-candid-talk-with-handol-kim-ceo-of-variational-ai-82584f254bb9a4d2 2026-03-20T18:21:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-medicine-city-of-oxford-announce-plans-for-freestanding-emergency-department-4ac1a3069ff6dd4c 2026-03-20T15:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-to-brief-media-on-the-recall-of-specified-batches-of-citro-soda-regular-a-59cd44cb54187870 2026-03-20T13:55:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/qualigen-diagnostics-announce-agreement-with-afaxys-gpo-to-expand-access-to-fast-4e0d2ff149049021 2026-03-20T13:43:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/flowing-toward-well-being-exploring-the-nexus-of-clean-water-access-and-sexual-r-deddc72a94bfbc93 2026-03-20T12:04:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-precision-medicine-needs-an-enterprise-digital-pathology-backbone-not-just-a-b7c633fd1f13bed1 2026-03-20T12:00:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cost-and-cost-drivers-of-delivering-covid-19-vaccines-in-low-and-middle-inco-5261dfe50d7c8a18 2026-03-20T11:54:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/abstracts-of-the-11th-tanzania-health-summit-e8d7f8982f59d90e 2026-03-20T11:49:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-find-the-right-therapist-for-you-cc292197c756af90 2026-03-20T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pirbright-ukhsa-and-glasgow-forge-partnership-to-strengthen-uk-epidemic-prepared-74822ca5c71e092f 2026-03-20T09:46:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-enzyme-released-during-exercise-protects-the-brain-from-aging-and-alzheimer-s-7f93615a44fb07a5 2026-03-20T08:09:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/herbicides-complete-guide-to-modern-weed-control-in-agriculture-2bf0fa1509120771 2026-03-20T05:55:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-unveils-upgraded-mobile-stroke-unit-delivering-life-saving-f2cc1a9346b5a36e 2026-03-19T21:20:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-releases-q1-2026-aide-memoire-c67d1f52bf574698 2026-03-19T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mft-chair-kathy-cowell-appointed-regional-chair-for-nhs-england-north-west-2a40a125cc8845e2 2026-03-19T20:18:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-reports-fourth-quarter-and-full-year-2025-results-and-provi-cf62e93d5b953053 2026-03-19T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cro-that-walks-in-with-a-platform-wins-the-room-5e3ea97b9c64d323 2026-03-19T18:01:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rare-injury-a-more-determined-player-adrian-s-knee-dislocation-a9bd4502298f6ea6 2026-03-19T14:46:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/laboratoires-pierre-fabre-confirms-the-strength-of-its-business-model-and-is-ste-28185321a8f0424b 2026-03-19T14:28:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-prize-for-excellence-awarded-to-clinical-researcher-for-distinguished-an-c0152863dcf4748d 2026-03-19T12:46:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-appoints-todd-james-chief-financial-officer-3fd6a812e8ce3eb1 2026-03-19T12:35:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-appoints-megan-osorio-as-chief-executive-officer-db01d04fe1a66279 2026-03-19T12:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/lynavoy-linerixibat-approved-by-the-us-fda-for-cholestatic-pruritus-in-patients-13dd231382558e74 2026-03-19T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-independent-proxy-advisory-firm-iss-recommends-aptose-biosciences-shareh-ae67cd9cfb61ba52 2026-03-19T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-robot-heart-op-patient-thanks-nhs-team-as-he-can-move-on-with-life-8e123a12c3b75c6f 2026-03-19T10:32:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/prac-assesses-that-naion-could-be-a-very-rare-side-effect-of-ozempic-rybelsus-an-b2507b9a6a29c100 2026-03-19T08:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-board-of-director-and-corporate-auditor-nominations-1b1a8f029aaca6fe 2026-03-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-to-host-virtual-investor-analyst-event-to-discuss-niyad-for-use-in-cont-fd6f8be2156cf4de 2026-03-18T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-lidera-movimento-de-conscientizacao-no-combate-ao-avanco-da-obesidade-no-bra-0a17acc8d2d94d8a 2026-03-18T19:47:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-high-quality-testing-portfolio-grounded-in-science-a-research-recap-07825254ec2022a3 2026-03-18T18:46:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/celltrion-healthcare-japan-and-cmic-group-enter-strategic-partnership-to-expand-ed193f49fe32d64b 2026-03-18T18:43:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-health-guidance-on-conservative-management-in-people-with-kidney-failure-650860bb7bc2a064 2026-03-18T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cnio-at-the-madrid-es-ciencia-fair-three-days-to-spread-the-passion-for-research-dd41578aaaec0d5a 2026-03-18T16:20:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-regulatory-systems-from-china-s-ind-to-europe-s-cta-b6bbf37eab989816 2026-03-18T16:07:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/canada-invests-in-genomics-r-d-to-accelerate-industry-growth-and-technology-adop-f629e6b7a35fd7b4 2026-03-18T16:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-healthtech-industrial-council-marks-first-year-accelerating-innovation-invest-61d4d36eaf206dd6 2026-03-18T13:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecr-2026-reinforces-its-role-as-a-leading-platform-for-interventional-radiology-f5fa52dd2da54de4 2026-03-18T13:17:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-st-michael-s-hospital-became-home-to-a-patient-96e1603f3d0cf290 2026-03-18T13:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eucope-reacts-to-the-vote-on-the-provisional-agreement-on-the-eu-general-pharmac-d7dbe48e8601e952 2026-03-18T11:15:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-teams-of-educators-receive-the-novo-nordisk-foundation-s-university-teachin-c40fc2b7836f4dc7 2026-03-18T11:14:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-teachers-and-educators-honoured-for-strengthening-children-s-and-young-peopl-190458a4bceec214 2026-03-18T11:03:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-over-a-new-leaf-supporting-more-sustainable-labs-at-pirbright-269f900b5b446006 2026-03-18T11:01:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/1mg-2-5mg-johnson-amp-johnson-ce6fe8e88206e970 2026-03-18T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/1000-g-e9bc8b69170f3ba0 2026-03-18T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-03-18-awards-18th-tachibana-award-ceremony-concludes-c67afdb1c7601914 2026-03-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-are-the-requirements-for-virtual-electronic-informed-consent-d8294f2774fcc0e8 2026-03-17T23:03:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/portal-instruments-signs-multi-million-dollar-development-agreement-to-advance-p-ce9f27114a26a051 2026-03-17T20:49:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/fellow-health-appoints-industry-executive-paul-kappelman-as-independent-chairman-4bb82d573fc0c5fe 2026-03-17T20:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/making-ai-work-where-it-matters-with-rob-dicicco-2edf2a54b3c4dcfa 2026-03-17T20:27:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-reveals-two-factor-authentication-system-that-controls-microrna-destructio-f970b00509f7db53 2026-03-17T19:17:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/transforming-clinical-research-with-ai-insights-from-next-new-york-2026-7e62e6cadd889761 2026-03-17T14:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/biopharma-s-growing-emphasis-on-highly-potent-drugs-drives-axplora-manufacturing-6529925155996cdf 2026-03-17T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardio-oncology-protecting-the-heart-during-cancer-care-00c37dfedd8d0b8c 2026-03-17T13:24:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-medical-launches-two-new-urology-products-1d3207fa969cc005 2026-03-17T13:24:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-history-month-clinical-regulatory-perspectives-in-women-s-health-b8bc2aa7aadbca63 2026-03-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-reports-full-year-2025-financial-results-and-corporate-updat-da02fc1260cfc907 2026-03-17T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-real-time-clinical-trial-visibility-matters-more-than-ever-fbdfc64ff8beede2 2026-03-17T11:09:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-and-medicines-discovery-catapult-launch-project-to-unlock-faster-lower-risk-b4ca504344c90585 2026-03-17T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-flow-or-standard-oxygen-in-acute-hypoxemic-respiratory-failure-4bfdc43a35b085ac 2026-03-17T08:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-high-flow-oxygen-in-acute-hypoxemic-respiratory-failure-2a711c5a2b0ea435 2026-03-17T08:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-launches-dedicated-pediatrics-department-to-expand-access-to-speciali-702116f7314a8458 2026-03-17T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-announces-the-next-generation-of-its-ce-ivd-marked-prostate-cancer-biops-a43ebd530f3cd8d3 2026-03-17T07:30:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/alloy-therapeutics-enters-into-agreement-to-advance-novel-antibody-discovery-pla-817355170e665282 2026-03-16T23:09:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-guide-to-medical-coding-in-clinical-trials-a291acf816161612 2026-03-16T21:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-receives-nih-funding-award-notice-to-advance-dare-d88faaea07033c6d 2026-03-16T20:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-radiation-oncology-what-it-takes-to-deploy-responsibly-e59e64417163afb4 2026-03-16T20:05:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartsciences-reports-fiscal-third-quarter-2026-financial-results-and-provides-b-17259edb2f30d59e 2026-03-16T15:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/przekszta-cenie-potencja-u-naukowego-ue-w-sukces-komercyjny-mog-oby-dodac-120-ml-89ecb410bb99105f 2026-03-16T15:36:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/keep-your-head-in-the-game-recognizing-concussions-in-basketball-b01c24640c1fcfba 2026-03-16T14:54:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/asn-seeks-nominations-for-the-annual-election-of-the-asn-council-f152e3fba627bbc9 2026-03-16T13:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-to-report-2025-annual-results-on-march-23-2026-53ca0c2f855ac818 2026-03-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-appoints-mansi-shinde-as-vice-president-of-company-creatio-5685f432483324dc 2026-03-16T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zentiva-publishes-2025-sustainability-report-reinforcing-commitment-to-people-pa-5ea21a874867684f 2026-03-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bird-flu-can-already-get-inside-human-cells-so-why-hasn-t-it-sparked-a-pandemic-c0b09cdf9509742e 2026-03-14T12:56:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-point-of-care-ultrasound-systems-clinical-use-case-b35401de8fcad59b 2026-03-13T21:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prioritize-colon-health-with-these-three-tips-6be494ddb15c415d 2026-03-13T20:00:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-fragmented-workflows-are-the-real-clinical-trial-enrollment-problem-fb6b9f711a570f78 2026-03-13T19:37:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/vanquish-2-phase-3-randomized-double-blind-placebo-controlled-trial-of-weekly-su-17ff95b3c4a3c78e 2026-03-13T17:35:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-subcutaneous-vk2735-a-gip-glp-1-receptor-dual-agonist-for-weight-manageme-427a8ca5b598fbd8 2026-03-13T17:32:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-vulnerability-identified-in-common-kidney-cancer-could-open-door-to-new-trea-1c8ba73a3db9e650 2026-03-13T11:38:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-rsv-vaccine-arexvy-approved-in-us-for-expanded-age-indication-in-adults-ag-ff08a514efb11ddb 2026-03-13T10:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/48d4dd8894e6534a 2026-03-13T09:45:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-pharma-announces-voluntary-delisting-from-tsx-venture-exchange-c8779cefb9d7d704 2026-03-12T20:18:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/facily-144sc-2e0b288114307286 2026-03-12T20:17:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/grunol-ebb6db1d95cbe3e5 2026-03-12T20:09:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cerio-75wg-5ae3f6988c09d1af 2026-03-12T20:08:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/api-integrations-in-clinical-trials-how-modern-platforms-enable-connected-clinic-5e1d361bc4f17166 2026-03-12T19:19:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cnio-research-links-fertility-with-immune-cells-in-the-brain-2899d8f52fa32409 2026-03-12T18:47:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-reports-strong-sales-growth-and-sustained-high-profitability-41e0a743d0d28716 2026-03-12T15:40:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-dr-dalia-rotstein-the-st-michael-s-neurologist-dedicated-to-improving-care-e9ac82e0f3dcd5d9 2026-03-12T13:35:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-proscia-s-top-klas-ratings-mean-for-life-sciences-companies-96b71a5e544b0828 2026-03-12T13:33:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/39c6b1a1407d5df1 2026-03-12T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-kidney-day-sockittokidneydisease-e38c612203c13d75 2026-03-12T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhs-staff-survey-2025-we-re-the-top-recommended-place-to-work-for-fourth-year-ru-36fb78ae6a2fc8e2 2026-03-12T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-to-report-fourth-quarter-2025-financial-results-on-thursday-abaa3e60066564d9 2026-03-12T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/los-angeles-mom-of-three-travels-to-chicago-for-lifesaving-liver-transplant-afte-67cfc04a9e646e65 2026-03-12T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/orphan-drugs-at-a-crossroads-bigger-numbers-tougher-calls-23fd27aa2bda9387 2026-03-12T10:49:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-new-way-of-measuring-activity-of-cell-editors-that-fuel-cancer-520387de49632671 2026-03-12T10:02:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/amarin-group-1-2569-24a99e174ba1d763 2026-03-12T09:27:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/sales-termination-of-high-speed-spectroscopic-ellipsometer-unecs-fc9fcf6983c01639 2026-03-12T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presentation-at-the-73rd-jsap-spring-meeting-2026-c4368d9f54b35ae9 2026-03-12T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-vision-to-value-a-blueprint-for-implementing-industry-consortia-innovations-37e6a668f37c0b1c 2026-03-11T20:37:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-to-participate-in-the-mars-impact-health-summit-381a57f1d522c340 2026-03-11T20:13:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-to-participate-in-the-bloom-burton-healthcare-investor-conference-bedca409cd2ba806 2026-03-11T20:06:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-reports-fourth-quarter-and-fiscal-year-2025-financial-results-ff5569864f3982b8 2026-03-11T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-c59817aede4cb268 2026-03-11T17:59:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmic-earns-sbt-certification-for-its-greenhouse-gas-reduction-targets-driving-fo-10b6d75599faeee9 2026-03-11T17:36:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/uclh-and-ucl-researchers-trial-proton-beam-therapy-in-bid-to-transform-treatment-0f7d4c3799ec3668 2026-03-11T17:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-ingredient-of-viagra-helps-treat-rare-genetic-disease-835a01f11467f795 2026-03-11T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/age-related-blood-cell-mutations-affect-heart-disease-risk-in-different-ways-stu-0127157b210896d3 2026-03-11T14:22:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/glenview-outpatient-center-celebrates-expanded-patient-services-a610710917b8a864 2026-03-11T13:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cap-1002-pdufa-date-8ce5c76a53eb6d30 2026-03-11T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-expands-aisight-dx-with-the-v2-19-release-enhancing-flexibility-collabora-459114768f312f9c 2026-03-11T11:29:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/vima-therapeutics-announces-first-dystonia-patient-dosed-in-phase-2-study-and-ex-9030770e06445b1f 2026-03-11T09:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-to-showcase-ai-innovations-at-nvidia-gtc-2026-3271221f41902938 2026-03-11T05:30:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-to-speak-at-all-in-talks-west-0f8b7ec3c75d6ce9 2026-03-10T23:46:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-to-present-at-pbss-event-on-ai-and-ml-in-drug-discovery-8133d0727de2f3c8 2026-03-10T23:18:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-year-end-q4-financial-results-and-update-190ab7c526523c48 2026-03-10T20:57:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-expands-fusion-partner-program-with-voicebrook-to-advance-voice-enabled-3457ff2544b453f5 2026-03-10T16:13:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-s-shift-to-one-pivotal-trial-what-it-means-for-modern-development-progra-af5253e745f784b1 2026-03-10T14:07:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-medical-selects-indiana-university-as-interventional-mri-center-of-excellen-f0e68517a3af47e1 2026-03-10T14:01:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmic-partners-with-bluenote-to-transform-clinical-development-operations-with-ag-076d9f635617efa1 2026-03-10T13:59:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-to-host-industry-forum-breakfast-event-at-the-2026-muscular-dy-69af8daa23bf32af 2026-03-10T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-chemistry-to-component-new-ncc-and-cpi-partnership-to-strengthen-uk-materia-87d91ce1036e16a0 2026-03-10T09:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-and-proscia-partner-to-accelerate-ai-driven-digital-pathology-47fff921aae94e36 2026-03-10T08:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-88a92158e09e8b44 2026-03-10T06:36:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-reports-fourth-quarter-and-full-year-2025-financial-res-6f29bf5d57be8376 2026-03-10T02:02:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-to-present-at-the-leerink-partners-global-healthcare-confer-7009e6d8f3d6e5a9 2026-03-09T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-at-bio-europe-2026-f1e6d58cf4a4965a 2026-03-09T18:20:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-500-6-c76d2e3d788730fc 2026-03-09T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-acusnare-polypectomy-snare-and-caesar-alligator-rat-tooth-grasping-forceps-ef19f78946a84345 2026-03-09T13:56:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-announces-oversubscribed-160-0-million-private-placement-fi-6d79ace6681961cb 2026-03-09T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-reports-12-month-phase-2-interim-data-for-ndv-01-in-non-mus-7a0bd7304cd700bf 2026-03-09T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-announces-positive-interim-phase-1b-2a-results-for-high-dose-b-e92c8e69d9ccdc51 2026-03-09T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-renames-its-sales-subsidiary-in-china-aiming-for-brand-value-enhancement-3539c6df47beed77 2026-03-09T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ars-pharmaceuticals-reports-fourth-quarter-and-full-year-2025-financial-results-820dc37bee8cb3a6 2026-03-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-cleveland-clinic-is-expanding-trauma-care-in-cleveland-fe279a3d511935df 2026-03-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remembering-anthony-j-leggett-1938-2026-a174ab65143442c2 2026-03-08T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/call-for-submissions-rachel-horne-prize-for-women-s-research-in-ms-2026-d0d575375243fbe0 2026-03-08T09:37:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/journey-to-better-health-driving-change-in-clinical-research-a650f46339f0ec25 2026-03-06T22:14:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-delnor-hospital-s-heart-failure-mobile-integrated-healthca-1bb41113898e87fd 2026-03-06T18:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-functional-antibodies-from-design-to-cell-binding-candidates-a95117e6dae73dde 2026-03-06T18:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-and-family-health-partnership-clinic-strengthen-lifeline-f-0f4e4faec10ce7b0 2026-03-06T17:36:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-reports-2025-fiscal-year-financial-results-and-provides-bu-b788a5caaa4756c2 2026-03-06T13:00:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-strands-of-rna-nearly-self-replicate-recreating-a-possible-step-in-the-daw-acfeed8240bbfc60 2026-03-06T10:31:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-has-a-unique-nuclear-metabolic-fingerprint-1b74e39e597b3dc5 2026-03-06T10:00:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/for-clinical-trials-with-atmp-guidance-to-the-content-of-the-investigator-s-broc-01c67d0cb255478e 2026-03-06T08:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-latest-issue-of-our-integrated-report-ulvac-value-report-2025-has-been-publi-ab1c87f9987831c2 2026-03-06T00:23:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-on-the-approval-for-manufacturing-and-marketing-authorization-of-th-7ff488ca2dac353d 2026-03-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/client-support-resources-49bf0a66699c1cae 2026-03-05T21:13:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/andre-matos-sousa-00f6fbd3a679a825 2026-03-05T18:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/prisma-medical-materias-cirurgicos-ltda-1b632826f1f67fe2 2026-03-05T18:20:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/dyne-therapeutics-a-biotechnology-company-developing-nucleic-acid-therapies-for-d9acef551e3ebadd 2026-03-05T18:08:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/handbook-de-farmacovigilancia-para-america-latina-4228329751ccab2f 2026-03-05T17:39:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-inc-reports-fourth-quarter-and-full-year-2025-financial-results-and-pro-22040588bd75eec5 2026-03-05T16:15:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/alzheimer-s-discovery-of-the-involvement-of-new-cells-in-the-onset-and-progressi-fb6ebd55fe22d645 2026-03-05T16:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-surgeons-achieve-comprehensive-spinal-fusion-with-facet-fixation-600d7b802bf95382 2026-03-05T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-reunion-of-the-heart-grace-and-amy-bond-through-hlhs-73b3eed8a91062f0 2026-03-05T13:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sale-of-our-limoges-botanical-actives-and-in-vitro-diagnostics-activities-to-sol-916f4deeba5d530b 2026-03-05T10:49:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/award-winning-author-joins-children-to-celebrate-world-book-day-b9266c2b1b9736d9 2026-03-05T10:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-hydrogen-technology-accelerator-drives-commercial-momentum-for-clean-tech-sta-73948eb8e8801639 2026-03-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-copenhagen-launches-major-knowledge-hub-for-women-in-menopause-8f5a0555e15555f1 2026-03-05T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jacopo-scrofani-178a99c415e8b412 2026-03-05T08:45:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxipit-enters-agreement-to-be-acquired-by-sectra-to-scale-autonomous-ai-in-radio-8da497fd826ffcc3 2026-03-05T07:36:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/mt-sinai-comprehensive-cancer-center-16288965aed9e4f4 2026-03-05T00:05:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-announces-new-group-mid-term-management-plan-a26cfd34d4922f94 2026-03-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ono-corporate-797e5c9e6ce287b1 2026-03-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-reports-full-year-2025-financial-results-and-provides-business-updat-438dfada352399b7 2026-03-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-device-trials-fall-behind-on-enrollment-a3e2daae28157705 2026-03-04T21:55:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthopediatrics-do-brasil-5f65da658f0d1879 2026-03-04T21:01:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/alcolea-group-discovery-on-tumour-development-could-help-catch-and-treat-cancer-064f59927b9d27a1 2026-03-04T19:19:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/uclh-accelerating-research-delivery-fb7fafe1440356e2 2026-03-04T15:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-signs-agreement-to-manufacture-50-g-sirna-using-its-eco-synthesis-manufa-3799a678e3d1639b 2026-03-04T15:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prepare-for-the-boards-brcu-registration-is-now-open-e1ef05ee56445bae 2026-03-04T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fitbonetm-trochanteric-lengthening-system-launches-commercially-in-the-u-s-expan-35b022a5fe6f03d7 2026-03-04T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-trains-mpumalanga-healthcare-workers-to-improve-medicine-and-vaccine-safe-c76f4d12e876b2fb 2026-03-04T13:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nervgen-pharma-appoints-shamim-ruff-as-chief-regulatory-affairs-officer-and-chri-f43f80cd70937987 2026-03-04T12:33:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/department-of-pharmacology-recent-publications-november-2025-january-2026-485fead97f0518fd 2026-03-04T11:53:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-opens-self-driving-labs-in-boston-bringing-ai-into-the-physical-world-of-368e19e6cd9750c8 2026-03-04T10:25:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/mastering-the-jungle-of-guidelines-with-ai-29c74ce9c7624e8b 2026-03-04T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/65th-sot-annual-meeting-and-toxexpo-518b19ff36ca6919 2026-03-04T00:17:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-receives-a-human-capital-management-excellence-2025-gold-awarda-for-outst-405b0b41ccf37517 2026-03-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-and-blackstone-life-sciences-announce-400-million-strategic-growth-capital-d0a6bb722bb3fef3 2026-03-03T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/computer-based-simulation-for-timely-and-cost-effective-design-and-optimization-5144004332d54787 2026-03-03T20:40:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-surgical-humanoids-from-trajectory-guide-to-therapeutic-executor-60570b3ebba7ae32 2026-03-03T18:45:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-seda-senior-director-research-strategy-and-innovation-12b37e44fa9c25f4 2026-03-03T16:34:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-signs-an-exclusive-ad04-collaboration-framework-with-molte-105c0c06e4a95782 2026-03-03T13:17:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-receives-u-s-fda-breakthrough-device-designation-for-pathassist-derm-an-a-d01f82bd60c26031 2026-03-03T12:44:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-the-tide-on-cardiovascular-diseases-cc04e05dac4952e2 2026-03-03T12:30:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrogel-based-airway-on-tube-to-advance-drug-development-for-lung-diseases-8fc18ab02462e31d 2026-03-03T11:03:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/crg-and-andorra-recerca-innovacio-launch-mountain-genomics-talent-programme-7fb0f1350ee23b2f 2026-03-03T09:49:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-advances-the-future-of-ai-powered-imaging-at-ecr-2026-1a7d03fb77273212 2026-03-03T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/german-medical-institute-selects-oxipit-ai-following-independent-700-case-clinic-08427e3d10865ae7 2026-03-03T04:13:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-announces-organizational-realignment-and-changes-in-executive-of-966867e438e72f56 2026-03-03T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shiga-university-of-medical-science-and-sysmex-identify-factors-associated-with-a310dc1d0cf7f50a 2026-03-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-antisense-architecture-with-transient-cyclic-oligonucleotides-for-nex-329d5e12bb7efa0c 2026-03-02T18:51:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-achieves-ce-marking-under-ivdr-for-fusion-ap-digital-pathology-platform-3085e63fa8ae69b7 2026-03-02T16:06:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-partnership-drives-progress-reflections-on-the-vivasure-journey-0e62b780182c6f64 2026-03-02T15:27:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/mg2-celebra-60-anni-di-innovazione-nelle-macchine-automatiche-per-la-farmaceutic-3322fe984ac55d47 2026-03-02T15:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/riken-r-ccs-collaborates-with-singapore-on-hybrid-quantum-classical-computing-bea86c48f776b624 2026-03-02T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-inc-to-report-fourth-quarter-and-full-year-2025-financial-results-and-p-0e5d3a539f5cb3c5 2026-03-02T14:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/mg2-celebrates-60-years-of-innovation-in-automatic-machines-for-the-pharmaceutic-a40c5435548c9f80 2026-03-02T14:00:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-50-enrollment-milestone-in-ongoing-nephro-crrt-registrational-f25ff2356714f7c3 2026-03-02T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-laboratories-to-present-at-td-cowen-and-barclays-conferences-11b3ec111451e110 2026-03-02T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-advanced-bio-to-deliver-series-of-seminar-to-u-s-fda-showcasing-novel-9b846316f2a7b871 2026-03-02T09:25:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/urgent-call-to-improve-survival-for-bile-duct-cancer-patients-0f2a4adb7bbe2000 2026-03-02T07:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-of-filing-of-shelf-registration-statement-for-issuance-of-new-share-48f92fbf81129ead 2026-03-02T06:30:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-announces-boost-2028-accelerating-strong-sumitomo-pharma-f52ef677bce560d7 2026-03-02T06:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-announces-revisions-to-its-financial-forecasts-57dcdb5330259f1a 2026-03-02T06:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/sharing-the-importance-of-screening-through-the-experience-of-a-colorectal-cance-381aceb9380fae7a 2026-03-02T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ono-corporate-84384fd9139c70a4 2026-03-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-k-current-report-19f97901d3ae7a90 2026-03-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-kidney-month-take-the-850challenge-07f170e2b490774c 2026-03-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/david-fajgenbaum-on-drug-repurposing-the-birth-of-every-cure-21e142dff6e2f320 2026-02-28T15:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/discovery-of-a-potent-and-selective-kit-inhibitor-for-the-treatment-of-mast-cell-d82aaf652f7ab1a9 2026-02-27T20:11:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-appoints-dr-christian-born-djurhuus-md-phd-as-chief-science-officer-eafbf9774c47de1c 2026-02-27T14:07:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrocytes-coordinate-fear-memories-alongside-neurons-91aeed96cc14abf2 2026-02-27T05:34:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-research-coordinator-level-2-programme-a706f8828443e321 2026-02-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-research-coordinator-level-1-programme-feedd4d9244b9049 2026-02-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-named-s-p-global-sustainability-yearbook-member-for-2026-118fc3ae6762fee9 2026-02-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-ranked-first-in-qs-sub-saharan-africa-rankings-c29527c45f8264e2 2026-02-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/empowering-patients-through-personalized-clinical-trial-searches-1ecac97bf4dcd941 2026-02-26T21:11:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivering-scalable-plain-language-summaries-for-global-transparency-e8de6da91f827247 2026-02-26T20:53:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-resurgence-of-antibody-drug-conjugates-how-adcs-are-taking-over-oncology-aga-3295d472c75244bc 2026-02-26T18:19:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/lunch-learn-powering-global-drug-development-unlocking-japan-apac-s-competitive-b6cba3287acd27ee 2026-02-26T17:38:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/11th-pulmonary-drug-delivery-workshop-86b7241f67b86ff6 2026-02-26T16:53:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/insitro-appoints-joe-hand-as-chief-people-officer-to-advance-talent-strategy-for-29f8b9856ca4a1b0 2026-02-26T13:59:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/mars-bleu-mois-de-sensibilisation-a-la-prevention-du-cancer-colorectal-0cc408cf7f03d198 2026-02-26T13:08:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/jumping-dna-parasites-linked-to-early-stages-of-tumour-formation-76105d331056a76b 2026-02-26T10:22:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/interim-analysis-cross-reactivity-of-phase-1-clinical-study-in-europe-on-novel-u-fdbe764a05464562 2026-02-26T06:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/termination-of-license-agreement-for-selective-orexin-2-receptor-agonist-dsp-018-462636cb03a45993 2026-02-26T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-and-omicinsight-partner-for-advanced-subcellular-imaging-and-data-analy-e1a70fff2e351ea0 2026-02-25T22:46:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/brandon-d-porter-esq-m-b-a-viking-therapeutics-ba084ea0767e1340 2026-02-25T21:20:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenneth-j-herman-viking-therapeutics-4c6d28f5d3f827f7 2026-02-25T21:19:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-sleep-apnea-causes-metabolic-jet-lag-3863407ae05411c7 2026-02-25T19:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/verteglidetm-fea6bf4bbd6c2e83 2026-02-25T16:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-enters-agreement-to-acquire-35pharma-inc-dc1006d1c2a34130 2026-02-25T15:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assistenza-tecnica-e-post-vendita-un-dialogo-costante-a-supporto-del-cliente-8b228bdac4400ce1 2026-02-25T14:30:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/technical-assistance-and-after-sales-support-a-continuous-dialogue-at-the-custom-fc4760d7bd0b8097 2026-02-25T14:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-d7f5c7fca30e540f 2026-02-25T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-to-release-fourth-quarter-of-fiscal-year-2025-financial-01549d31e7eb97a6 2026-02-25T12:31:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-new-biomarker-data-showing-nasal-foralumab-downr-06af022bfdf6f540 2026-02-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trouncing-career-regret-with-famed-vc-bill-gurley-a13d2d0b0112bf62 2026-02-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-laboratories-provides-update-on-planned-divestitures-fbbd42e07d98ceb2 2026-02-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-personalized-ovarian-cancer-treatment-0bc115b08736b190 2026-02-25T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/powering-excellence-sahpra-fuels-future-innovators-with-tech-boost-at-smu-awards-708117fcb252114f 2026-02-25T10:55:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/les-benevoles-de-la-ligue-contre-le-cancer-seront-presents-8a146771e8775778 2026-02-25T09:21:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-feel-like-i-got-a-second-chance-an-engineer-s-journey-with-bronchial-valves-a-7c02ab5e445ce29e 2026-02-25T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/they-gave-our-family-a-miracle-beloved-uncle-survives-heart-attack-thanks-to-exp-b4d8f4eb4dea8d70 2026-02-24T22:57:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-to-present-at-the-upcoming-investor-conferences-in-march-c48783dba4d6afda 2026-02-24T21:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-norstella-panel-the-engine-behind-smarter-access-decisions-365d4f26c3c02b9e 2026-02-24T18:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/varsetatug-masetecan-cx-2051-unlocking-epcam-as-a-cancer-target-via-a-masked-epc-69fa97d26ace878f 2026-02-24T15:08:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/35-000-dodatkowych-pacjentow-uzyska-dostep-do-badan-klinicznych-jesli-nowe-cele-074a5c4f1d14a353 2026-02-24T14:08:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-regains-full-compliance-with-nasdaq-listing-requirement-1da2d1a21fb0b49b 2026-02-24T14:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-biosciences-announces-amendment-to-arrangement-agreement-and-details-of-p-7212060c3fba5648 2026-02-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interventions-for-prostate-cancer-patients-on-active-surveillance-what-our-patie-d82ec349e44c2e4a 2026-02-24T11:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-yorgo-modis-leads-collaborative-project-on-morc2-related-disorder-852089349477aefa 2026-02-24T11:12:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-would-it-take-to-bring-ngs-to-the-point-of-need-7a63663f3bdcd962 2026-02-24T02:23:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/participation-in-the-sip-symposium-on-the-development-of-a-circular-economy-syst-ce50ce0078842ae5 2026-02-24T01:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-south-africa-s-carbon-tax-should-stay-2e28109ac51dab3a 2026-02-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-the-best-point-of-care-ultrasound-a-clinician-centered-framework-ee4fc9078f57d28c 2026-02-23T21:19:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-smarter-early-phase-oncology-programs-for-biotechs-e17484efe87bef20 2026-02-23T20:22:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-responds-to-carte-blanche-report-on-alleged-gmp-non-compliance-at-adcock-d8388d3d6837a41f 2026-02-23T14:33:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-york-times-letter-to-the-editor-ac684532d90d7ecb 2026-02-23T14:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-highlights-fda-policy-direction-that-may-reduce-pivotal-tr-72fe60f96acc35f2 2026-02-23T13:30:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/mast-platform-secures-additional-1-2-million-award-54dcea51f118af4b 2026-02-23T13:22:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-expands-collaboration-with-pathai-to-deploy-fda-cleared-digital-patholog-d7484889ce8e18a8 2026-02-23T12:13:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-announces-acceptance-of-late-breaking-abstract-for-the-bb-301-1bd3acdf7b4c8e36 2026-02-23T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-usa-successfully-passes-fda-inspection-f61c09a3c2836fc4 2026-02-23T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-interactive-review-listings-are-strengthening-cross-functional-clinical-data-a7bfceef0b5f072e 2026-02-23T06:45:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/meridian-bioscience-achieves-ivdr-certification-for-alethia-molecular-assay-port-ee6be09a9d331460 2026-02-23T02:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-s-aesthetics-business-solta-medical-announces-the-launch-of-clear-a8b6483f5255d6dd 2026-02-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-s-aesthetics-business-solta-medical-announces-the-launch-of-clear-dbba64fa5e013b5a 2026-02-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-food-and-drug-administration-fda-accepts-teva-s-new-drug-application-nda-for-3afe8b32621dc609 2026-02-20T19:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zonda-180-ec-26ff51e1c60ae50d 2026-02-20T18:12:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/zonda-180-ec-32e0a8d9bf9c6b8e 2026-02-20T18:10:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-clinical-trial-trends-from-scope-summit-2026-and-what-they-mean-for-your-opera-043a7d9b45534fa8 2026-02-20T15:28:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/luis-serrano-receives-catalonia-s-top-science-prize-3ea379820ddf4f67 2026-02-20T13:37:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/lanternflies-have-low-genetic-diversity-but-the-right-genes-to-take-over-cities-40c1cb3419d78d3b 2026-02-20T10:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-delivers-strong-profitability-and-continued-growth-c9e30a5137a8b1b5 2026-02-20T05:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/launch-of-joint-research-on-a-novel-multi-stage-malaria-vaccine-by-ehime-univers-c5d0deaed2779e6a 2026-02-20T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-awarded-the-medal-with-dark-blue-ribbon-certificate-of-commendation-of-j-b66fb9cdcdf7714a 2026-02-20T01:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-ranked-in-the-top-1-in-the-sustainability-yearbook-2026-by-s-p-global-fc4a940a95a3f84c 2026-02-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mhncs-2026-oral-presentation-ficerafusp-alfa-2000mg-q2w-and-pembrolizumab-in-hpv-885f5bda78f4a85f 2026-02-19T21:31:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-heart-valve-helps-83-year-old-hometown-woman-breathe-easier-and-creates-a-de-bf63b8971ca870f0 2026-02-19T19:35:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/element-biosciences-introduces-vitaritm-redefining-what-high-throughput-sequenci-ec9e0dca3b0f218a 2026-02-19T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arch-s-carol-suh-named-to-national-venture-capital-association-s-2026-list-of-ri-9e98781c16067b7f 2026-02-19T16:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/les-laboratoires-pierre-fabre-explorent-le-potentiel-de-l-intelligence-artificie-407580ab5fe1fc42 2026-02-19T14:58:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-leads-uk-biomanufacturing-and-pharma-sme-delegation-on-strategic-visit-to-in-d371e346c951c468 2026-02-19T13:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-kvv-revision-neueinschatzung-statt-umsetzung-mit-hochdruck-60947f3b560c6083 2026-02-19T11:48:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/mohn-research-center-for-neuroprotection-has-opened-6774d57de3467489 2026-02-19T10:04:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-strengthens-high-potency-capabilities-with-new-pilot-and-development-i-006718c4c1996fa3 2026-02-19T08:00:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/loyalty-details-petro-s-chili-chipstm-6117aa34393abe1f 2026-02-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cape-town-s-wildflowers-six-key-insights-from-a-new-checklist-8330dd43c53400e6 2026-02-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-s-orapharma-celebrates-25-years-of-arestin-minocycline-hcl-microsp-e799ae8c2b34da2f 2026-02-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediflextm-3a4259cd9e515a28 2026-02-18T19:29:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcelerate-highlights-digital-momentum-and-global-collaboration-in-2025-annua-385c7c0bf959eaa3 2026-02-18T18:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meridian-life-science-expands-ambient-stable-ngs-portfolio-with-the-launch-of-a-e59d0d474aaf697d 2026-02-18T10:09:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-announces-multi-million-euro-investment-to-expand-lyophilization-at-le-m-b26775beeeadd3d5 2026-02-18T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-k-current-report-0cfd2c53a36b31af 2026-02-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-fourth-quarter-and-full-year-2025-results-f80855629b210437 2026-02-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zimmer-biomet-launches-advancement-for-hindfoot-fusion-aa4e17552937b894 2026-02-17T18:09:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/ask-the-cmo-how-does-cook-differentiate-itself-c313eba03767023b 2026-02-17T17:25:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/search-test-menu-868198b0967519e7 2026-02-17T17:19:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/aleksander-kwiecinski-zosta-wybrany-na-stanowisko-przewodniczacego-rady-nadzorcz-939f7089e6088bac 2026-02-17T16:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-would-surgeons-using-percutaneous-techniques-choose-nanoplasty-dr-gonzalez-58d2492c15171b9c 2026-02-17T15:16:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/zwei-hochmoderne-magnet-resonanz-tomographen-fur-die-radiologie-8f5dc5c2beb0dd33 2026-02-17T15:13:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/riken-and-national-cancer-center-japan-revise-memorandum-of-understanding-to-acc-26a7fde5afcb4775 2026-02-17T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-estonian-medicinal-products-market-in-the-fourth-quarter-2025-89921aaad5ad8840 2026-02-17T14:49:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-two-screw-fixation-common-for-percutaneous-bunion-surgery-dr-kaplan-88d66804982c7994 2026-02-17T14:42:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-catherine-gratz-griffin-lake-forest-hospital-opens-two-new-c3612380a3113e41 2026-02-17T14:35:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-to-present-at-the-oppenheimer-36th-annual-healthcare-life-93cc49f572eb0dcc 2026-02-17T14:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-to-participate-in-td-cowen-46th-annual-health-care-conference-36525884221745a1 2026-02-17T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-to-present-preclinical-and-translational-data-on-novel-sik2-bfa02b7825757575 2026-02-17T13:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-announces-sale-of-yavne-israel-facility-and-strategic-commercial-colla-314293ebc05fcdac 2026-02-17T12:10:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-and-sanofi-s-duvakitug-phase-2b-maintenance-data-demonstrated-clinically-me-3a16ff15dd7752aa 2026-02-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paracetamol-challenge-a-reminder-of-the-risks-associated-with-overdosing-and-rul-86e429d33f7700f0 2026-02-17T10:36:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-surface-geometry-to-prevent-bacterial-infections-a-new-physical-strat-598db8d697575167 2026-02-17T09:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-expands-consumer-staples-research-coverage-with-the-addition-of-owen-bennet-8673567773ffc846 2026-02-17T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-receives-the-worldstar-2026-award-for-its-hiscla-line-washing-solution-co-1d8e85f4c0c2c814 2026-02-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-to-participate-in-the-j-p-morgan-global-leveraged-finance-conferen-3f3d72f4edd15d86 2026-02-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/echonous-unveils-major-kosmos-expansion-bringing-robust-ob-gyn-and-vascular-tool-60f59a1cc2e276f1 2026-02-16T23:48:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-ideas-to-care-new-arc-center-at-charite-accelerates-innovation-2596c7fc26186be2 2026-02-16T09:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-paris-trees-reduce-mortality-linked-to-heat-waves-71d3a3161f74e1c9 2026-02-16T08:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/yale-school-of-medicine-30490142ddaf4e9f 2026-02-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/robots-will-replace-surgeons-but-not-in-the-way-you-think-72dea746752b5ca9 2026-02-15T16:03:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/love-your-kidneys-e095bb587d23e561 2026-02-14T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tavette-neskorik-viking-therapeutics-d6a32e23495eec53 2026-02-13T21:15:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/karthik-srinivasan-ph-d-viking-therapeutics-8ec78dd884ac645c 2026-02-13T21:15:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/handheld-ultrasound-with-cw-doppler-a-new-era-for-tavi-follow-up-3b0eecdeda8d9f7d 2026-02-13T20:14:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-ai-close-the-diabetic-retinopathy-screening-gap-202f797588ce3fa4 2026-02-13T18:53:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-early-engagement-and-an-integrated-cdmo-cro-model-expedites-drug-development-fdd4b54aa1f20898 2026-02-13T16:19:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/uclh-clinician-scientist-wins-major-international-prize-for-pioneering-tumour-re-106da8dd45d525f6 2026-02-13T16:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-chu-de-lille-soutient-l-emergence-de-nouvelles-recherches-en-sante-5541c35fac1204c2 2026-02-13T13:28:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-after-cancer-treatment-managing-side-effects-54f7c8ca89efe7ef 2026-02-13T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uib-welcomes-first-charm-eu-master-s-students-to-campus-068e966b76912171 2026-02-13T10:57:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/special-guest-lecture-professor-bill-degrado-thursday-5-march-c21ce2e8ebfd250a 2026-02-13T09:30:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/regarding-the-scheduled-review-in-japan-of-the-allogeneic-ips-cell-derived-dopam-bd54ea69fb3ebd9e 2026-02-13T08:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-fast-tracks-access-to-critical-foot-and-mouth-disease-vaccines-to-protect-f4ae2108e60ccef8 2026-02-13T07:54:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/25-years-since-the-publication-of-the-human-genome-in-science-a-firsthand-perspe-b04f522ec567e5f1 2026-02-13T07:09:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/rising-ground-in-the-antarctic-lifts-melting-ice-sheets-limiting-sea-level-rise-b95df3935bc455c9 2026-02-13T06:49:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-sellas-life-sciences-51face877cadb1e3 2026-02-13T06:41:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-sellas-life-sciences-2f64da9adf832ae8 2026-02-13T06:38:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-to-present-at-two-institutional-investor-conferences-97b12733fd6f960b 2026-02-12T21:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-friction-meets-force-in-clinical-research-89a037a01fc85a83 2026-02-12T19:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dpi-china-2026-d9f947c3816bbeca 2026-02-12T14:26:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/spinal-muscular-atrophy-the-disease-begins-already-during-embryonic-development-4bc53c8f4cdfb336 2026-02-12T14:16:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-to-participate-in-upcoming-investor-conferences-0d794c5c31d090e6 2026-02-12T14:05:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-releases-second-quarter-2026-financial-results-and-provides-op-0692e81bd64ee2cd 2026-02-12T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apyx-medical-corporation-to-participate-in-the-citizens-life-sciences-conference-8a6638ebe30dd0ed 2026-02-12T13:16:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/uclh-lighthouse-highlighted-as-best-practice-in-the-independent-review-of-the-cr-8fa8171bf6206d4a 2026-02-12T11:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/testing-solutions-designed-for-oncologists-2daefcb327c147ea 2026-02-12T05:27:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivering-a-complete-gynecologic-cancer-solution-for-you-and-your-patients-1532d927b5965147 2026-02-12T00:43:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/europejskie-produkty-farmaceutyczne-kluczem-do-wzmocnienia-konkurencyjnosci-ue-a68cbdf397e731c7 2026-02-11T17:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/online-therapiehandbuch-zur-cidp-veroffentlicht-praxisnahe-orientierung-fur-diag-e4ca571203a6c0da 2026-02-11T15:28:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/happy-birthday-ucl-celebrating-200-years-of-london-s-oldest-university-ce90c15ff5b1f7d9 2026-02-11T10:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arnau-sebe-pedros-premi-ciutat-de-barcelona-2025-86678b422d305363 2026-02-11T07:42:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-2026-gastrointestinal-health-scholars-program-4e22a10ec67099f0 2026-02-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecg-market-keeps-evolving-thanks-to-ai-home-monitoring-and-epic-integration-8d17f1f51653e4f9 2026-02-10T21:10:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-genai-to-clinical-command-centers-understanding-the-3-generations-of-ai-in-661964c87444f67e 2026-02-10T15:06:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-achieves-iso-9001-2015-certification-7b0f291757fd996d 2026-02-10T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-expands-aisight-clinical-trials-platform-with-launch-of-aim-hitm-uc-and-i-88a02ac92d2b74fa 2026-02-10T13:59:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ice-on-greenland-is-acting-strangely-scientists-believe-they-finally-know-wh-f171964ae5e25a62 2026-02-10T12:06:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/albotherm-cpi-lead-2-million-collaborative-project-to-scale-low-emissions-greenh-2cbee4ba2fa21ea2 2026-02-10T10:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxipit-expands-radiology-ai-portfolio-beyond-cxr-with-ct-eyetm-and-msk-eyetm-20a4dd8d5504bfe7 2026-02-10T06:26:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/ars-pharmaceuticals-to-showcase-scientific-innovation-and-robust-clinical-data-o-75140a83b7d4a384 2026-02-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-reports-fourth-quarter-and-full-year-2025-results-1c1e6b6b8e72c999 2026-02-09T21:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-site-s-guide-to-managing-study-delays-holds-and-cancellations-52550530720fd91b 2026-02-09T17:42:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/uclh-clinician-awarded-medal-for-improving-prostate-cancer-care-7a5149760aa8961e 2026-02-09T14:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-functionalities-in-the-ctis-module-non-substantial-modification-c4f89f43c1e6709d 2026-02-09T13:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pregnancy-changes-women-s-responses-to-infants-93371928629d5a13 2026-02-09T13:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-in-concentriq-ap-smoother-review-and-enhanced-performance-01b9ffe079a16c3d 2026-02-09T13:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-celebrates-its-75th-anniversary-and-starts-the-winds-of-progress-project-452b5ad1c4711def 2026-02-09T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/president-gonokami-appointed-to-u-s-department-of-energy-panel-7c2704246353a6e0 2026-02-08T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tooth-structure-isn-t-always-a-good-indicator-of-diet-in-ancient-animals-87892a199e4061c2 2026-02-07T12:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/scrip-asks-what-does-2026-hold-for-biopharma-part-4-r-d-innovation-605abd241a7c9b67 2026-02-06T20:34:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/chembio-receives-1-8-million-carb-x-grant-to-develop-a-rapid-diagnostic-test-for-b7dc8461c2e7cd84 2026-02-06T13:47:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-die-generikadurchdringung-in-der-schweiz-schreitet-weiter-voran-39138af67bcb5ad2 2026-02-06T11:11:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/end-of-support-and-maintenance-to-vacuum-gauge-99a9407c988bbae7 2026-02-06T09:30:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fierce-healthcare-fundraising-tracker-26-novellia-picks-up-18m-lassie-nabs-35m-t-0ede0e5d749f5f7c 2026-02-06T08:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/linking-live-t-cell-function-with-spatial-biology-for-the-first-time-0a8ab287c3c4d4ec 2026-02-06T08:10:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-kenji-chamoto-has-taken-up-his-post-in-the-division-of-cancer-immune-regula-ecb2b8a5c17cd213 2026-02-06T04:40:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-trust-in-pharma-is-low-here-s-how-to-rebuild-it-24374b132c8cb8b0 2026-02-05T21:29:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/angitia-biopharmaceuticals-announces-130-million-series-d-financing-7477e76b8bde1f27 2026-02-05T19:29:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-biostar-8eb5fbd8e642a14f 2026-02-05T15:54:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/prix-gustave-roussy-pierre-fabre-partenaire-fondateur-du-prix-dedie-a-la-recherc-b43ae6000e8b1bfe 2026-02-05T15:12:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/webinario-reune-experiencias-da-fiocruz-em-formacao-de-integridade-e-etica-em-pe-898a9c213bc6f07b 2026-02-05T15:06:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/visit-by-u-s-department-of-energy-under-secretary-for-science-ace768199dbef040 2026-02-05T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-west-england-adopts-heartsciences-myovista-insightstm-platform-and-c8eb0c96d638365c 2026-02-05T14:59:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/parlamentarischer-staatssekretar-hauer-mdb-am-nct-west-1cab93e9597a488e 2026-02-05T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-advances-high-value-ophthalmic-manufacturing-in-malaysia-with-smart-fact-1862747c7e091535 2026-02-05T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/changes-to-siegfried-s-board-of-directors-c2cb296ed8436406 2026-02-05T05:15:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-and-fujirebio-begin-sales-collaboration-for-dementia-testing-59aa07230e65dc98 2026-02-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/media-report-related-to-riken-2a1afb6aff62a356 2026-02-04T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-the-orthofix-biologics-surgeon-advisory-board-2c56586bc124b122 2026-02-04T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-our-ceo-best-in-klas-and-why-it-matters-c2187e9d0c5ecedd 2026-02-04T12:20:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/facing-radiation-therapy-as-a-breast-cancer-doctor-and-survivor-aa13cdc9910caefd 2026-02-04T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electronic-dispatch-of-decision-letters-marks-its-fifth-anniversary-1acfff92179fd623 2026-02-04T10:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-the-occurrence-of-a-ransomware-incident-at-an-overseas-consolid-30838e78570aa0c0 2026-02-04T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-safety-and-effectiveness-arimoclomol-in-patients-with-npc-outcomes-fr-29ee2f9d5d132006 2026-02-04T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multi-year-subgroup-analyses-of-niemann-pick-disease-type-c-participantstreated-08121a21e963a690 2026-02-04T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-safety-and-effectiveness-of-arimoclomol-adult-and-pediatricniemann-pic-bafe6f743893a0bd 2026-02-04T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-arimoclomol-combined-with-miglustat-at-months-3-6-9-and-12-of-the-do-b16888b4073151c5 2026-02-04T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-organizational-restructuring-of-group-companies-9d006205ad3ce9f4 2026-02-03T20:45:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-lead-a-moonshot-collaboration-lessons-from-over-a-decade-of-competitors-w-533ae84c93060e51 2026-02-03T18:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenotypic-dna-encoded-library-screening-from-binding-to-function-in-small-molec-e4c07709983cc1c7 2026-02-03T18:28:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-seattle-site-now-certified-to-manufacture-biologics-for-largest-ph-7658c4ec77e16169 2026-02-03T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-revolutionising-medtech-symposium-australia-ce68a0ab90ed3355 2026-02-03T04:26:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/eagle-trial-shows-olympus-caddietm-ai-solution-aids-in-the-detection-of-high-ris-7da098d67d4c9490 2026-02-03T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mapping-the-genetics-of-brown-fat-ef2daa811e96ef4c 2026-02-02T22:39:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/insitro-completes-first-ai-enabled-human-genetics-study-of-brown-adipose-tissue-0eaf79f810412ac1 2026-02-02T21:29:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-registration-for-the-memorial-service-for-kazuo-nakamura-c0e144d3fa6c0bb4 2026-02-02T15:16:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-therapeutics-announces-share-repurchase-program-e31275a6de5f8dd7 2026-02-02T15:07:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-announces-fourth-quarter-and-full-year-2025-results-cc0b9b4d86386169 2026-02-02T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-releases-a-new-ce-ivd-marked-ai-solution-for-gastric-cancer-diagnostics-4b0043da3f4ca468 2026-02-02T08:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-nest-to-sky-three-falcons-take-important-step-toward-independence-80c90e61faa68a8d 2026-02-02T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-3-3-98a249786dfc8ccb 2026-02-02T01:03:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/eurneffy-1-mg-adrenaline-nasal-spray-recommended-for-approval-in-the-eu-for-emer-4b2b15cd66353e55 2026-02-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-toyofumi-yoshikawa-has-taken-up-his-post-in-the-thoracic-surgery-64ea3f94a44d6e03 2026-02-01T00:00:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-we-built-a-cro-partner-program-c018c1549d5f5b35 2026-01-31T03:55:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/pipeline-beam-therapeutics-4ec2c493fbd29a69 2026-01-31T02:13:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/underestimated-risks-in-bladder-cancer-drug-development-23eff8f1e41a9cba 2026-01-30T18:34:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/closing-the-loop-why-digital-therapeutics-are-the-future-of-clinical-evidence-7acb598da732af06 2026-01-30T16:42:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/senior-scientist-for-analytical-development-within-therapeutic-antibodies-aa97deaed766546e 2026-01-30T10:10:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasal-rna-flu-vaccines-build-mucosal-immunity-and-could-block-transmission-99f6a115b682ca02 2026-01-30T09:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/app-supported-help-for-people-with-dementia-and-family-caregivers-6738dfcfa521b3fa 2026-01-30T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-assisted-lvef-vs-cardiac-mri-2025-validation-study-in-italy-c44e753a98c3453a 2026-01-30T00:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-research-can-nephrologists-accurately-assess-heart-function-using-ai-f547b1b5d986d367 2026-01-29T23:02:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-differentiates-the-wires-and-screws-in-the-percuplastytm-system-dr-gonzalez-8f88954b5552576f 2026-01-29T15:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-are-the-benefits-of-the-percuplastytmguide-and-targeter-dr-gonzalez-e8bc3706d3bd7afc 2026-01-29T15:47:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-are-the-benefits-of-the-percuplastytmguide-and-targeter-dr-johnson-677457b08da97799 2026-01-29T15:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-therapeutics-to-host-in-person-and-virtual-analyst-day-in-new-york-on-f-4302cc5b1d3330fb 2026-01-29T14:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/emmanuelle-hocquard-de-kerleau-est-nommee-directrice-de-l-impact-et-de-la-reputa-30f2ee1d443adfff 2026-01-29T13:19:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/maximizing-your-epic-investment-why-deep-epic-beaker-integration-matters-for-dig-3353a8d5e6784be9 2026-01-29T13:00:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/spice-up-your-kitchen-with-a-game-changing-cooking-tool-f745caa73b74e5f2 2026-01-29T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-subsidiary-cortigent-presents-promising-6-year-early-feasibility-study-re-013d7388e27a6466 2026-01-29T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-research-in-mice-sheds-light-on-how-the-brain-understands-what-is-important-4dcfa9de031f9285 2026-01-29T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimacimab-enhances-incretin-therapies-in-dio-mouse-model-e6690e65bc2b26d8 2026-01-29T02:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parabilis-medicines-announces-oversubscribed-305-million-financing-to-support-on-c65be37dd058000d 2026-01-28T19:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blood-proteins-can-reveal-early-signs-of-heart-problems-5ab47403874c3922 2026-01-28T14:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-does-the-nanoplasty-instrumentation-streamline-surgeries-and-improve-efficie-9fb33df54128c5c4 2026-01-28T14:15:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/neo-solvents-5-criteria-for-a-more-sustainable-chemistry-e34b795c128f8fc8 2026-01-28T13:55:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-sports-betting-overthrow-iran-c131f0bfb0465d93 2026-01-28T12:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-innovative-portfolio-and-consistent-execution-of-pivot-to-growth-strategy-d-512975925111d253 2026-01-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/45d21f13d1f505e5 2026-01-28T11:09:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulating-differently-biobased-diols-the-key-to-ecofriendly-effective-cosmetic-9ce09aa9be35f574 2026-01-28T10:05:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-discovery-of-renal-and-inflammatory-markers-predictive-of-disease-sever-65a5077f9e51626a 2026-01-28T08:30:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/scri-nuhs-crc-lunch-workshop-2026-0f9c7b5e7cbb75cb 2026-01-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-inc-announces-closing-of-common-stock-offering-6faacd619b233b82 2026-01-27T21:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gba-innovationsausschuss-fordert-transsektorales-sepsis-projekt-optisep-mit-7-5-4b445d97225114d2 2026-01-27T14:22:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-welcomes-clay-alspach-as-new-executive-director-d327211958e93b48 2026-01-27T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-biomarker-analysis-in-concentriq-85d5ae8a6037d526 2026-01-27T13:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-appoints-kelly-johnston-mckee-as-vp-of-strategy-transformation-4771b7f761479d0d 2026-01-27T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/whistleblowing-scheme-of-the-danish-medicines-agency-from-1-january-2025-to-31-d-28b9c0740ce959f8 2026-01-27T07:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulvac-korea-pyeongtaek-factory-achieves-green-rating-in-third-party-audit-based-e14461add9093211 2026-01-27T07:01:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-to-acquire-high-quality-small-molecules-drug-substance-capacity-in-the-80fc956cecc74027 2026-01-27T05:07:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/fundraising-petro-s-chili-chipstm-ec09ffde96c159ac 2026-01-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mirum-pharmaceuticals-completes-acquisition-of-bluejay-therapeutics-expanding-gl-b476410190d77fa8 2026-01-26T23:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-research-ai-assisted-ultrasound-in-military-trauma-settings-c78c733de29facff 2026-01-26T19:23:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-of-its-kind-pressurization-test-could-improve-ross-procedure-outcomes-b0a05a48093cc69f 2026-01-26T18:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/riken-argonne-national-laboratory-fujitsu-and-nvidia-collaborate-to-advance-ai-a-cc16d69bdf791d83 2026-01-26T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-of-the-memorial-service-for-kazuo-nakamura-cfd9b8158fca48a2 2026-01-26T14:27:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-clinical-trial-complexity-with-modular-ai-agents-d0bea516b9f73ef4 2026-01-26T11:41:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-expands-manufacturing-to-meet-demanding-fda-requirements-3f20a4994ca4c52e 2026-01-26T08:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/modernising-fsc-cfg-practices-for-efficient-market-access-62c214b57594e387 2026-01-26T05:39:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-inc-announces-pricing-of-common-stock-offering-c790ac703195d5a4 2026-01-26T04:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-protocols-are-at-an-inflection-point-a-conversation-with-novartis-and-tr-b9abc6e48a6334ab 2026-01-23T20:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-candid-conversation-with-david-kelleher-ceo-4g-clinical-dfd127b6e726b1d3 2026-01-23T17:31:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/fierce-healthcare-layoff-tracker-centra-restructure-hits-90-workers-optum-cuts-5-7ad6614c51c8f6f4 2026-01-23T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supply-with-care-crafting-strategies-for-clinical-trial-excellence-in-apac-15ab9ec1756d9704 2026-01-23T16:13:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-collaboration-success-advancing-hpv-detection-in-nigeria-1cf97f5a01ebef12 2026-01-23T13:45:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/rar-ensemble-2026-9fd85ecb7e3fd149 2026-01-23T13:35:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/expedited-assessment-of-clinical-trials-in-the-eu-fast-eu-pilot-project-begins-o-54a4d17c0d58b59f 2026-01-23T11:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/specialized-cells-in-the-retina-stop-daylight-from-disrupting-the-circadian-cloc-40401847a6adc4b7 2026-01-23T10:42:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/developing-world-leading-research-on-proton-therapy-for-cancer-0ea75dde0b9c8d5a 2026-01-23T08:26:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-gmdp-inspection-focus-for-2026-0d1eb874e2ebd776 2026-01-23T08:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ole-f-norheim-honored-by-gates-foundation-1b74b83b17c4acbd 2026-01-23T08:05:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/discovering-clinical-research-at-republic-polytechnic-s-jumpstart-career-fair-f885cdfa914e29df 2026-01-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-provides-update-on-red-c-phase-3-clinical-trials-468b1a584d1811a1 2026-01-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/michael-morneau-viking-therapeutics-bda1970948add0c2 2026-01-22T19:16:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/chembio-announces-dual-fda-submission-of-dpp-syphilis-tnt-assay-following-breakt-1715b98d631e1cc7 2026-01-22T17:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/japanese-safety-pharmacology-society-17th-annual-meeting-8af36c0b5066bf0d 2026-01-22T16:30:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-carles-researcher-40f409c9399c0855 2026-01-22T15:47:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/hodson-group-develops-liquid-biopsy-test-to-predict-treatment-response-in-patien-b5c3d362d2700e75 2026-01-22T15:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-subsidiary-cortigent-to-present-orion-system-s-advanced-brain-implant-tec-0ff3d0ab86133149 2026-01-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-best-medical-school-in-germany-top-30-worldwide-6ad6b54defdc71b5 2026-01-22T11:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/coronavirus-disease-2019-44dcea9c9c62a34d 2026-01-22T11:18:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/learning-from-the-global-south-how-do-people-cope-with-heat-9003b877fb5255ac 2026-01-22T09:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-of-the-7th-kyoto-university-lifescience-showcase-san-diego-2026-d33ce8a26c4f6204 2026-01-22T04:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/launch-of-a-cna-9000-automated-hemostasis-solutiona-for-large-scale-laboratories-fdd696decafd3820 2026-01-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/site-visits-will-give-emory-undergraduate-students-direct-access-to-atlanta-empl-bae4d30d1022dc98 2026-01-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-risks-no-one-talks-about-b39cbefd3369226b 2026-01-21T17:06:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-abstract-on-bbt002-accepted-for-oral-presentation-at-ats-20-49508f5489cc08a6 2026-01-21T14:09:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-women-should-know-about-gynecologic-cancers-dba217a2e5882a59 2026-01-21T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-forward-key-takeaways-from-2025-and-priorities-for-2026-a638f4c439dbd0b0 2026-01-21T09:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/student-inspired-textbook-lending-program-marks-10-years-of-opening-the-doors-to-17cf28536b249bbc 2026-01-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-to-announce-fourth-quarter-and-full-year-2025-results-on-february-6c2e6da055773d91 2026-01-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zimmer-biomet-launches-new-foot-and-ankle-fixation-system-to-address-complex-sma-399073c62e0d5688 2026-01-20T19:12:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-the-peer-reviewed-publication-of-clinical-study-eae4e5007eba3575 2026-01-20T16:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-new-honorary-doctorates-at-uib-faba57cf2e59e464 2026-01-20T14:07:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/worldwide-clinical-trials-enters-definitive-agreement-to-acquire-catalyst-clinic-0d9721887217e488 2026-01-20T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mg2-a-pharmapack-europe-2026-fd242ee593f27baa 2026-01-20T12:35:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/mg2-at-pharmapack-europe-2026-9d795bbb8135e6cb 2026-01-20T11:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-parliament-adopts-the-critical-medicines-act-eucope-warns-against-unint-8d5e87c6befd1b06 2026-01-20T11:22:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-new-antiwear-additive-roscan-6253nv-is-registered-on-the-lusc-list-bc27da3442710bc4 2026-01-20T10:34:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-lorenza-r-d-team-manager-69b9475895a4528e 2026-01-20T09:39:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-lemelinda-senior-researcher-7fa381fe2e2f780f 2026-01-20T09:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-david-senior-scientist-3dcb41dd6b271292 2026-01-20T09:36:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-sponsor-and-cro-symbiosis-effect-how-cohesion-carried-us-through-a-high-pres-82a917d39a82f82d 2026-01-19T22:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-chapter-in-als-drug-development-how-smarter-trials-and-precision-medicine-77c46d4a7bd1150e 2026-01-19T17:17:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/scrip-asks-what-does-2026-hold-for-biopharma-part-2-competitive-dynamics-a-lands-25403b17d9ac1c0f 2026-01-19T15:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/by-splitting-pain-into-its-component-parts-researchers-provide-pain-relief-in-mi-09c9bf95eddde71c 2026-01-19T06:17:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-highlights-contribution-of-98-billion-by-the-small-to-mid-sized-biopha-cc20ed8a54cdabed 2026-01-19T05:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-announces-remaining-china-rights-to-gpc3-armored-car-t-therapy-to-be-ac-285a89948e098b9b 2026-01-19T00:30:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-closing-of-oversubscribed-8-8-million-registered-f711f63f7caeee54 2026-01-16T19:47:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-celebrates-u-s-and-eu-approval-of-fondazione-telethon-s-waskyratm-478e3b86f42bb8ca 2026-01-16T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcelerate-ceo-janice-chang-wants-trials-to-become-part-of-routine-care-49dcb59ab31239de 2026-01-16T16:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jennifer-goldsack-on-incentivizing-digital-innovation-ed2e93b1fb77a508 2026-01-16T15:31:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clearer-view-from-jpm-2026-day-four-0c5201d264afc40d 2026-01-16T15:12:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/ask-the-cmo-how-do-you-choose-the-best-device-for-your-patient-3f98cb26a039eaa4 2026-01-16T14:24:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/sf-healthcare-week-insitro-ceo-daphne-koller-on-how-ai-is-hitting-escape-velocit-6264ec36b359f712 2026-01-16T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clearer-view-from-jpm-2026-day-three-0cac0aa599099435 2026-01-15T15:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertragsverlangerung-fur-andrea-schmidt-rumposch-4e5eb2bed4d0cc58 2026-01-15T14:21:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-in-concentriq-ls-strengthening-review-integrity-and-speed-3c0c0c6dae272122 2026-01-15T13:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/immerse-yourself-in-a-new-level-of-gaming-experience-the-best-sound-quality-gami-c98a5e7100ffe27b 2026-01-15T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/lowest-dose-radiography-meets-next-level-imaging-idexx-launches-imagevue-dr50-pl-d503b421a190d4c3 2026-01-15T12:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-advances-the-future-of-veterinary-cancer-care-with-comprehensive-mast-cell-62832007f596cd4e 2026-01-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/15-16-january-2026-usjcmsp-boot-camp-in-2026-afa0bdb7ba9ca2bc 2026-01-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-are-the-origins-of-efficiency-ea523f8145acdeb0 2026-01-14T14:41:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clearer-view-from-jpm-2026-day-two-972d9cf609d47bc5 2026-01-14T13:56:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-fragen-an-die-neue-vize-vorsitzende-des-standortkomitees-bairbre-hickie-genera-3d7006313284e1d2 2026-01-14T09:45:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-common-diabetes-drug-may-slow-the-progression-of-atrial-fibrillation-61928692edf3fdf2 2026-01-14T08:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/select-2026-biophilic-living-66e1ae0cbe678044 2026-01-14T02:04:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-98320ffefd2d34c5 2026-01-13T21:26:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/perfusion-bioprocessing-and-pat-decisions-that-matter-70c624b6f8f7f3cc 2026-01-13T20:56:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clearer-view-from-jpm-2026-day-one-889b7902cda8d049 2026-01-13T17:52:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/investments-plan-2026-3f111a3f9b1cfb45 2026-01-13T15:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-announces-ceo-succession-f3490f10074dace9 2026-01-13T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-and-lifeward-announce-strategic-transaction-2b626b969bded24a 2026-01-13T12:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/csci-s-teichmann-lab-and-gsk-announce-new-partnership-to-advance-our-understandi-12adddfa851f40c1 2026-01-13T12:19:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/presentation-at-the-ieee-hybrid-bonding-symposium-hbs-2026-88e9757313122408 2026-01-13T07:57:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/royal-jazz-for-the-chaipattana-foundation-1566cae71c348fba 2026-01-13T02:16:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/sysmex-selected-for-cdp-2025-a-climate-changea-a-list-974cb07dca7a2b52 2026-01-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cater-with-petro-s-petro-s-chili-chipstm-1142f5ce7ee090fe 2026-01-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emavusertib-in-combination-with-folfox-pd-1-inhibitor-trastuzumab-as-first-line-f8d509442a2ac21e 2026-01-12T18:52:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-insitro-s-thermltm-rapidly-engineering-the-right-therapeutic-for-the-c6a303fb2cc9ba85 2026-01-12T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insitro-to-acquire-combinableai-to-complete-its-full-stack-modality-agnostic-ai-5f0a71f0dfa41e7f 2026-01-12T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-announces-spurtm-adherence-solution-for-cardiometabolic-disease-man-dd0e738348ccadee 2026-01-12T13:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-fa-community-b055ec56622de38e 2026-01-12T13:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/asimov-and-agc-biologics-team-up-to-provide-a-cost-effective-simplified-and-secu-7681996b11c46b4d 2026-01-12T12:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-therapeutics-provides-regulatory-update-confirming-fda-alignment-on-regi-6cf9ba2aa26410fa 2026-01-12T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-announces-doug-peddicord-retirement-after-24-years-6447b1f5864e7c67 2026-01-12T10:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-provides-positive-long-term-clinical-study-results-for-bb-301-818bcf1605cffbfc 2026-01-11T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nils-u-olsson-ph-d-viking-therapeutics-1ab2e7ee79d9f748 2026-01-10T01:34:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/neil-aubuchon-viking-therapeutics-9aa986007bd03946 2026-01-10T01:33:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/karen-modesto-md-viking-therapeutics-976a3c1f47f4a8d9 2026-01-10T00:33:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/karen-c-chung-pharmd-ms-viking-therapeutics-7f2184afe7562a80 2026-01-10T00:33:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/tailored-approach-supports-bladder-cancer-breakthrough-dbb93ce1fcc45d71 2026-01-09T18:22:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/marianne-mancini-viking-therapeutics-ee0109870501dd0b 2026-01-09T16:28:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/greg-zante-viking-therapeutics-df958056a438b543 2026-01-09T16:27:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/drought-decree-impacts-and-opportunities-for-the-pharmaceutical-industry-d9e7e5d1e2235876 2026-01-09T11:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pollen-records-suggest-that-early-humans-thrived-in-relatively-open-landscapes-c92af35d7dec6039 2026-01-09T09:16:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/biology-may-influence-who-benefits-from-ect-treatment-f57f171f1c2e0bcd 2026-01-09T08:44:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/pierre-fabre-laboratories-and-iktos-announce-an-integrated-ai-driven-drug-discov-a8f54190e26b3fa3 2026-01-09T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/01-09-2026-press-release-ir-news-launch-of-aflibercept-kit-for-ivt-inj-40-mg-ml-b36506f5b329a5dd 2026-01-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-bio-32a44936acfa70dc 2026-01-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-activism-to-advocacy-building-empathetic-technology-in-clinical-trials-back-a122ac89762b6160 2026-01-08T20:22:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/light-horse-therapeutics-selected-by-biospace-as-one-of-the-hottest-new-life-sci-29aedbfe688e0af9 2026-01-08T20:07:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nvidia-releases-new-physical-ai-models-as-global-partner-lem-surgical-unveils-ne-52d5f4e211136bc9 2026-01-08T19:44:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-important-update-regarding-our-cap-002-program-a-letter-to-the-stxbp1-communi-3e437eb0d69dcba6 2026-01-08T16:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-biotechs-can-win-capital-in-2026-highlights-from-evaluate-s-financing-forum-ae36c71ac0456e16 2026-01-08T14:24:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/transforming-cancer-treatment-with-the-power-of-the-immune-system-49e33ef79677209f 2026-01-08T13:19:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/researchers-have-created-the-first-map-of-lipid-transport-in-cells-148c4b9530c50d13 2026-01-08T09:33:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/warning-selenium-and-zinc-picolinate-containing-products-for-children-85b80a1ce7bac3ee 2026-01-08T08:35:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-schweizer-pharmastandort-am-scheideweg-neue-geopolitische-reali-efbd65941bd73093 2026-01-08T08:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-and-university-hospital-zurich-announce-collaboration-to-deploy-aisight-d-d78a31b3fb9d91b0 2026-01-08T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/whooping-cough-vaccination-during-pregnancy-strengthens-the-immune-system-in-new-9ca16e6a91760cba 2026-01-08T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-announces-strategic-hire-for-tmt-investment-banking-d472505fe24eecb4 2026-01-07T19:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lydia-s-story-b4e05703f71cf86a 2026-01-07T19:09:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-long-game-of-american-reindustrialization-1f830f5bc0527d0e 2026-01-07T18:38:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/d-wave-quantum-acquires-arch-backed-quantum-circuits-to-accelerate-the-developme-b89cc4ca8220769a 2026-01-07T18:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/chutes-ladders-ardent-health-appoints-new-ceo-kff-founding-president-ceo-to-reti-e138573847600506 2026-01-07T15:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-expands-reach-of-the-eco-synthesis-manufacturing-platform-through-a-sign-64e3e4769d76d4bf 2026-01-07T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-receives-18-million-payment-from-scilex-holdings-bringing-current-returns-fb0772bb2f77c6e8 2026-01-07T13:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-named-finalist-in-two-categories-for-the-2026-scope-awards-dddc037d88597de4 2026-01-07T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arkadiankadun-siltaremontti-aiheuttaa-muutoksia-liikennejarjestelyihin-luonnonti-9fae02a1909c9327 2026-01-07T06:13:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-testing-options-for-pathologists-3d24292c51cde877 2026-01-06T23:11:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/partners-in-cancer-care-324daf9ba63f3d93 2026-01-06T23:08:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-announces-first-patient-dosed-in-phase-ib-proof-of-concept-efe4f7e16b68ca61 2026-01-06T16:12:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/lem-surgical-showcased-in-nvidia-ces-2026-keynote-c4420ada544d4284 2026-01-06T15:28:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-announces-research-collaboration-and-license-agreement-with-4e055cbbd85e51b2 2026-01-06T13:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-data-review-efficiency-with-interactive-review-listings-9393fe3edf20dfcc 2026-01-06T12:37:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/pierre-fabre-un-modele-d-excellence-en-actionnariat-salarie-c77edac3c30de620 2026-01-06T08:31:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-to-attend-44th-annual-j-p-morgan-healthcare-conference-and-join-panel-d-882ba2fc52179c50 2026-01-06T06:38:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/numeros-de-contacto-de-consejo-superior-de-salud-publica-21354d1e046ee4f9 2026-01-05T21:31:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-to-report-fourth-quarter-and-fiscal-year-2025-financial-res-a91f598079267710 2026-01-05T21:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updating-of-summaries-of-product-characteristics-due-to-changed-atc-codes-for-20-2253bacd6a1ee501 2026-01-05T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-with-halozyme-enhanze-technology-for-higher-dosing-0faf930cc3be813c 2026-01-05T05:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-arecor-s-arestat-technology-to-increase-drug-dosing-f59a5c4eafde992a 2026-01-05T05:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-solutions-to-deliver-higher-doses-f381064851fe3ccd 2026-01-05T05:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-akiyuki-taruno-has-taken-up-his-post-in-the-cellular-and-molecular-physiolo-fc945e5af176864b 2026-01-05T04:22:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-to-present-at-j-p-morgan-healthcare-conference-b297148fefe6b36b 2026-01-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-announces-fda-lifts-clinical-hold-on-gh001-clearing-path-for-global-c5a7f68eceb62eed 2026-01-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference-858ca3525c7b31fb 2026-01-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-evolution-of-health-literacy-challenges-opportunities-for-trial-recruitment-7e31ce5fd3cb3dd8 2026-01-02T16:08:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/exercise-snacks-how-to-sneak-more-exercise-in-your-day-9467518d51ff754d 2026-01-02T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-to-announce-ind-status-for-gh001-0ddf44c05fa50496 2026-01-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/elevate-your-dining-experience-with-eco-friendly-plates-and-bowls-86311217839ad663 2026-01-01T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-2025-taught-us-about-making-clinical-research-work-better-33baa90ccaf81935 2025-12-31T19:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/summarizing-pharma-biotech-deals-2025-d8b136f6a1da3814 2025-12-31T12:12:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-reviewed-study-demonstrates-strong-agreement-between-techcyte-s-ai-assisted-b9cf6cb40c8961d3 2025-12-30T00:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-nailing-platform-femur-bdef212e362c36ad 2025-12-29T18:36:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-to-present-at-the-44th-annual-j-p-morgan-healthcare-confere-05d6a10df38d97a2 2025-12-29T14:41:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-therapies-in-transition-analytical-and-clinical-insights-2dd351416778c221 2025-12-29T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-un-ano-en-el-que-avanzamos-juntos-por-la-salud-en-america-latina-659ffa887e96b650 2025-12-26T14:09:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmic-holdings-announces-new-leadership-framework-ceo-coo-titles-discontinued-8569159caca85206 2025-12-25T08:52:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulvac-receives-the-2025-tsmc-excellent-performance-award-d44fc98ad0fdc05d 2025-12-25T01:44:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceo-2025-year-in-review-07fcc8b1e7c022ed 2025-12-23T21:56:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-s-2025-landmark-year-of-clinical-deployments-and-regulatory-approvals-498e1d027aef2c31 2025-12-23T07:33:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-scientist-honoured-for-advancing-equitable-cancer-research-707296041ae347b6 2025-12-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-final-results-and-expiration-of-exchange-offers-7e9d466182210e2b 2025-12-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/echonous-a-year-of-building-what-clinicians-need-7b6f9c51ada37030 2025-12-22T20:29:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthofix-academy-and-abs-websites-go-live-with-a-new-look-education-across-speci-d16a06358574fbec 2025-12-22T18:50:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-reflections-from-obio-ceo-6b2936e4987b9a43 2025-12-22T15:59:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-marketing-authorization-for-ravicti-oral-liquid-1-1-g-ml-for-urea-cycl-0cd8faad65444b3f 2025-12-22T15:58:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthex-large-bone-circular-fixator-4c096b0b9c138218 2025-12-22T14:38:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-announces-collaboration-with-tandem-diabetes-care-to-integrate-auto-7db3b0a81c189efa 2025-12-22T14:18:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/11-clips-that-defined-2025-dcfe4b8f73e0a3ae 2025-12-22T12:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-research-coordinator-onboarding-programme-october-2025-intake-fd7b9cf7bc79b962 2025-12-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-obtains-manufacturing-and-marketing-approval-in-japan-for-upneeq-mini-oph-087159e3a50117b6 2025-12-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-translation-top-of-mind-at-research-day-23b651561dbebe0f 2025-12-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-biosciences-announces-rescheduling-of-special-meeting-of-shareholders-to-67b1eb274e9fb62c 2025-12-19T22:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-revolutionizes-clinical-trials-from-design-certainty-to-peak-performance-9e7086a55ae2dc6b 2025-12-19T16:01:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-announces-completion-of-dose-escalation-in-phase-1-2-clinica-51bf966de2cc6d92 2025-12-19T13:00:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/tyrer-cuzick-and-the-myrisk-hereditary-cancer-test-with-riskscore-risk-assessmen-691e0925a2b1f1f6 2025-12-18T19:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthofix-orthopedics-is-now-orthofix-limb-reconstruction-6a90d1a3f3a141ac 2025-12-18T16:57:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/meilleurs-voeux-2026-641164eaaf739498 2025-12-18T15:16:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantum-physics-may-hold-the-key-to-detecting-cancer-early-c09131cc99c04bd1 2025-12-18T12:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-and-swisscat-showcase-the-future-of-materials-discovery-5888a9738d8287a9 2025-12-18T04:53:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bazelet-group-has-initiated-restructuring-proceedings-before-the-israeli-distric-92acb92ba7a83b58 2025-12-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matthew-singleton-viking-therapeutics-bd9b565d9e6c4c9d 2025-12-17T18:31:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-a-rowland-jr-viking-therapeutics-d912b3c50a566f66 2025-12-17T18:31:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/kathy-rouan-ph-d-viking-therapeutics-8ec3581a82edb78c 2025-12-17T18:31:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/matthew-w-foehr-viking-therapeutics-9e8ce68d92f1e8bd 2025-12-17T18:31:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-software-platforms-reverse-enshittification-62b7129b442e585c 2025-12-17T17:51:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/lawson-macartney-dvm-ph-d-viking-therapeutics-c542243bb9b44674 2025-12-17T17:35:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/brian-lian-ph-d-viking-therapeutics-02610775d9f72d59 2025-12-17T17:34:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/geoffrey-barker-ph-d-viking-therapeutics-8ae61aab408755de 2025-12-17T17:32:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/danish-led-space-mission-to-map-the-lunar-surface-8cf796c72de4c175 2025-12-17T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eu-raises-its-biotech-ambition-eucope-welcomes-the-act-s-strategic-direction-bf8ce5396e5dce8b 2025-12-17T11:53:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/observing-synapses-in-action-708a3b5914330581 2025-12-17T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newsletter-18-5aa59b759fcfd6bf 2025-12-17T09:25:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-launches-next-generation-ai-technology-platform-e8d7cc265d0cd7d3 2025-12-17T07:01:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-invested-in-nurturing-the-next-generation-of-researchers-57b82b77868f50ab 2025-12-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reflecting-on-research-milestones-at-the-annual-research-celebration-7b7abe2bd92c55e4 2025-12-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/echonous-com-reader-favorites-the-top-ten-news-blog-posts-of-2025-ea33fa31282fd5ac 2025-12-16T23:43:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-pooled-cell-painting-crispr-screening-platform-enables-de-novo-inference-of-ge-821d2a3dd7dde973 2025-12-16T22:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insitro-validates-ai-enabled-posh-platform-in-nature-communications-bridging-cri-92f90a93dd06036f 2025-12-16T21:09:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/inspire-ignite-innovate-shaping-clinical-trial-technology-together-da914770308b88a3 2025-12-16T19:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-economic-impact-of-payment-terms-on-clinical-research-sites-47e23afff2f8a147 2025-12-16T18:28:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-texas-at-arlington-s-imprint-ushers-in-a-new-era-with-beacon-disco-81f89b20303df794 2025-12-16T18:19:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-with-foresight-diagnostics-on-their-acquisition-by-natera-bafdfac0aab8d764 2025-12-16T17:41:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/efpia-and-vaccines-europe-see-biotech-act-and-revision-of-the-mdr-ivdr-as-a-posi-5918bc6dcd8480f7 2025-12-16T17:31:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/efpia-and-vaccines-europe-back-the-eu-safe-hearts-plan-to-improve-cardiovascular-b2cdaaa49cb7df77 2025-12-16T16:48:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/brenntag-and-seqens-partner-for-the-commercialization-of-non-gmp-pharmaceutical-f77b98007b9d341d 2025-12-16T15:55:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/jordan-ambassador-to-japan-visits-tokyo-campus-b374623b4ea103e6 2025-12-16T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/norstella-s-real-world-data-ai-executive-forum-highlights-ced43c2be7c0444b 2025-12-16T14:00:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ucph-spin-out-company-sonohaler-invents-a-new-inhaler-for-respiratory-patien-02483f86a31ac83b 2025-12-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-are-more-young-adults-getting-appendix-cancer-22a438e1f2223c8e 2025-12-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wartosc-i-znaczenie-ochrony-w-asnosci-intelektualnej-dla-rozwoju-innowacji-gospo-ffa91936ebd8a18b 2025-12-16T10:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eucope-response-to-the-sant-report-on-the-critical-medicines-act-d79346cb361fadeb 2025-12-16T09:20:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/investor-blog-obio-at-ici-2025-the-triangle-of-innovation-in-action-4cc28d55733f868e 2025-12-15T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/at-the-roussillon-site-the-development-of-the-future-paracetamol-production-unit-fb8aa744f87ed0bb 2025-12-15T15:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zimmer-biomet-launches-two-new-foot-and-ankle-solutions-for-complex-trauma-cases-133b9eed29198ff4 2025-12-15T15:07:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-employee-s-recovery-from-an-esophageal-disease-through-minimally-invasive-sur-951d02c07cfa010d 2025-12-15T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-additional-investment-in-corporate-venture-capital-fund-olympus-1d8715f84288cd1b 2025-12-14T23:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-triples-venture-capital-fund-investment-to-strengthen-medtech-leadership-db202f7b10d97dc7 2025-12-14T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mokgadi-fafudi-substandard-and-falsified-medical-products-4b8420e5518edb66 2025-12-13T05:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidson-holds-signing-ceremony-to-commence-rights-issue-for-n21billion-to-fortify-92580930fd8d406f 2025-12-12T17:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ash-2025-highlights-67ccf0f809eaaaa3 2025-12-12T14:39:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-multi-functional-single-cell-profiling-matters-in-immunotherapy-53a5401270cc6361 2025-12-12T10:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-i-do-this-ashish-sharma-ba9e750b4d03dc19 2025-12-12T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-evolving-role-of-medical-writers-in-epi-189ea70de139aced 2025-12-11T22:10:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/driving-innovation-together-helping-biopharmaceutical-partners-deliver-breakthro-fb9e3a34a43bbf2a 2025-12-11T21:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fast-exam-how-a-pocus-protocol-changed-trauma-care-194495c1dff7de9a 2025-12-11T17:49:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/odpowiedz-efpia-na-porozumienie-w-sprawie-pakietu-farmaceutycznego-trzeba-zrobic-24dfd22a38d64a35 2025-12-11T17:40:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-advanced-pulsed-field-ablation-technology-for-next-generation-cardia-abd3e7d8d01e3f50 2025-12-11T15:33:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/keep-your-pooch-safe-and-comfy-a-must-have-for-every-dog-parent-d63752cac07b02b5 2025-12-11T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/eucope-statement-on-the-political-agreement-on-the-eu-general-pharmaceutical-leg-5b4a6bf179a65f60 2025-12-11T09:41:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-rules-for-personal-import-of-medicines-to-denmark-as-of-1-january-2026-17f1aa0a2a75ad7b 2025-12-11T07:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-a-global-fih-adc-therapy-trial-for-lung-cancer-eb3b6b0156fd7801 2025-12-10T17:42:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-inside-story-of-the-billionaires-fighting-for-space-38a3468f1e43ce05 2025-12-10T11:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-announces-2026-officers-1e955f5a132a0bea 2025-12-10T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endocrine-disruptors-exposure-to-methylparaben-and-bisphenol-s-during-pregnancy-6900ba264928b2e8 2025-12-09T23:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-closed-system-performance-how-cpc-s-microcnx-connectors-enable-scalabl-7c7f5acd2b8ac3cf 2025-12-09T20:33:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-emavusertib-added-to-azacitidine-and-venetoclax-combination-e38c36d9d9087e8d 2025-12-09T17:47:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathai-s-aim-mash-ai-assist-becomes-first-ai-powered-tool-to-receive-fda-qualifi-7875ccaebc7ab0a2 2025-12-09T16:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/december-2025-newsletter-2c69d8999e2e631b 2025-12-09T16:01:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-the-passing-of-our-chairman-and-ceo-562d1aba97ffd181 2025-12-09T14:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/going-live-lessons-from-cyberknife-system-installation-in-melbourne-c724a65e961ffa4f 2025-12-09T11:04:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-one-third-of-dementia-cases-in-germany-could-be-prevented-285558648f6b807e 2025-12-09T09:39:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-san-diego-health-earns-highest-ranking-for-obstetric-infant-care-b0ffc71ad2d2101c 2025-12-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/csci-celebrates-fourth-annual-christmas-market-at-jcbc-c4c1562f2c523488 2025-12-08T17:19:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-atinary-s-new-biopole-office-and-team-culture-3871f061f04be1eb 2025-12-08T13:48:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/ash-2025-cellectis-presents-development-plan-to-further-enhance-high-response-ra-cba0905aba500857 2025-12-08T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulvac-honored-by-samsung-electronics-at-appreciation-day-2025-cbbe1bf01a1c4f68 2025-12-08T04:07:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/schedule-13d-73591710abd27367 2025-12-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esmo-asia-2025-oral-presentation-ficerafusp-alfa-750-mg-qw-and-pembrolizumab-in-866b8b1c26955c94 2025-12-06T13:12:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-s-tuspetinib-triple-drug-therapy-featured-at-the-2025-ash-annual-meeting-b8af4536d365eb3a 2025-12-06T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-biostar-a824643d0e35446a 2025-12-06T12:11:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-hospital-it-infrastructure-and-kosmos-ultrasound-device-integratio-5321974c17a7d32d 2025-12-05T23:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/genesis-molecular-ai-appoints-sergey-edunov-as-senior-vice-president-of-foundati-35abab1e6f303e7c 2025-12-05T21:39:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/disease-areas-beam-therapeutics-9987a22eb10a3464 2025-12-05T15:55:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/patients-beam-therapeutics-4b94f4ba9da4fcd3 2025-12-05T15:51:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/nordic-pilot-project-simplifies-language-requirements-e7ed12ff30576fe3 2025-12-05T14:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iqvia-s-tracy-mayer-on-building-truly-patient-centric-clinical-trials-b6fa3af7be5cd1ea 2025-12-05T14:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-05-2025-press-release-ir-news-aflibercept-intraocular-injection-kit-40-mg-ml-87b5314ed3461086 2025-12-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-e-0be76d3a176377e6 2025-12-04T22:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-first-in-class-opportunity-with-emi-le-a-novel-adc-077cd3e8f4879d2c 2025-12-04T18:03:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/element-biosciences-launches-certified-service-provider-program-for-tetontm-cyto-7f4c7e86147e1a5e 2025-12-04T15:13:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/juhana-rauramo-joins-blueprint-genetics-as-the-new-vice-president-and-general-ma-42cf231600fb016e 2025-12-04T14:18:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-beam-therapeutics-87de1ec98c99b109 2025-12-04T14:02:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-year-in-review-scientific-innovations-at-charite-226d1f768999ff74 2025-12-04T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blueprint-genetic-s-gene-list-for-diagnostic-panel-customization-has-been-expand-aaead007131f0ea8 2025-12-04T06:05:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ai-safety-is-like-a-bolt-in-a-croissant-3a0cb62a0f745f66 2025-12-03T12:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-a-correct-lymphoma-diagnosis-matters-d2d6610f0991917b 2025-12-03T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/funding-success-for-spin-out-company-gastrobody-therapeutics-399b22e0098248db 2025-12-03T10:34:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-03-2025-press-release-ir-news-santen-and-seri-collaborate-to-advance-disease-6985725bde0c6671 2025-12-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-data-reviews-diy-methods-vs-best-in-class-systems-4fa1cf58799a5976 2025-12-02T16:58:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/shareholder-call-series-part-3-key-themes-from-the-analyst-q-a-570ccdeda8707d85 2025-12-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-honored-for-site-innovation-in-the-2025-clinical-trials-arena-excelle-e9eca18893e13cfe 2025-12-02T15:32:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/eucope-council-position-on-the-critical-medicines-act-brings-improvement-but-fur-5786d4eb0c60b462 2025-12-02T15:00:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-partners-with-atum-to-accelerate-timelines-for-cell-line-developme-302d525e2acddfc1 2025-12-02T14:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-receives-2025-clinical-trials-arena-site-innovation-award-for-r-d-lea-0712beb95fb5304b 2025-12-02T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diet-and-cancer-cabbages-essential-allies-of-immunotherapy-f461244d992ddb1c 2025-12-02T10:00:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/greig-rooney-joins-cpi-as-managing-director-for-pharma-and-healthtech-bb19918a54a1d62d 2025-12-02T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-leads-africa-in-two-major-international-rankings-215a4cbe4c94b299 2025-12-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eucope-publishes-white-paper-on-strengthening-atmp-manufacturing-in-europe-3632851923c3a6ec 2025-12-01T13:39:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-medical-showcases-ct-innovation-at-rsna-2025-cbee355656d99c04 2025-12-01T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/infant-bacterial-therapeutics-ab-secures-partnership-with-recipharm-advanced-bio-a061b6bfebfc7454 2025-12-01T07:00:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/informationen-fur-patients-und-familien-d6d3f0e173bfe024 2025-12-01T03:50:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-0f9385fd1f713b01 2025-12-01T01:46:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-crc-profession-with-scri-academy-at-temasek-polytechnic-opportunit-44ff88efb698e2bb 2025-12-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-kigali-to-the-continent-uct-s-impact-at-africa-health-collaborative-conveni-b729cf0df07f597c 2025-12-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/america-latina-frente-a-la-competitividad-biofarmaceutica-una-oportunidad-para-i-a618f6f0f33a0e32 2025-11-28T14:21:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-announces-global-commercial-launch-of-alphenix-4d-ct-with-aquilion-one-ins-a0c86bf3cc8fecf5 2025-11-28T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/launch-of-mobirex-i9-smart-edition-a-high-end-mobile-x-ray-system-with-enhanced-2217512f23392712 2025-11-28T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/last-day-for-submission-of-applications-for-certificates-of-free-sale-to-export-95f726e9481f409b 2025-11-28T09:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-receives-the-jacques-cresson-award-671763ab85acd884 2025-11-28T08:05:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/invited-talk-at-the-27th-ieee-electronics-packaging-technology-conference-eptc-2-26b8afae0a03187d 2025-11-28T01:39:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/uct-helps-unveil-hidden-pre-colonial-cities-with-lidar-e17725927f630187 2025-11-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/researchers-warn-climate-change-could-expand-habitats-for-malaria-mosquitoes-45c3aad266b5e120 2025-11-27T10:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/company-statements-biocon-biologics-global-biopharmaceutical-company-b899d7cafc7c32e7 2025-11-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-state-agency-of-medicines-successfully-completed-the-european-commission-rev-46b55cdd7eb523a4 2025-11-26T13:00:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/enno-spillner-im-interview-auf-dem-eigenkapitalforum-in-frankfurt-0d38bafa889b8094 2025-11-26T11:37:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/telomir-and-mira-pharmaceuticals-advance-through-key-development-milestones-with-05400adf2d87fc0b 2025-11-26T08:00:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-doubles-growth-showcases-new-releases-and-strengthened-partnershi-490d286c97299210 2025-11-26T06:57:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-that-saves-sight-utah-clinic-uses-breakthrough-technology-to-bring-specialty-54c23acd3cb385e1 2025-11-25T18:30:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/important-information-regarding-medicine-price-and-product-range-changes-between-3552552c702a4897 2025-11-25T09:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-gut-brain-plays-a-central-role-for-allergies-13de80b999d5f990 2025-11-25T08:22:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunity-outbreaks-and-building-vaccine-sovereignty-247eb33464efe195 2025-11-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/form-6-annual-general-meeting-of-shareholders-to-beheld-on-december-30-2025-4fcf9191eda7ee32 2025-11-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secondary-cns-lymphoma-clinical-outcomes-sno-2025-poster-e4f8ae9cd733d0a9 2025-11-24T21:07:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeaim-lymphoma-molecular-profiling-and-cns-penetration-sno-2025-poster-f0f3f5d33b066c65 2025-11-24T21:06:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeaim-lymphoma-clinical-outcomes-sno-2025-poster-412595e87771e103 2025-11-24T21:06:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-to-host-5th-annual-ophthalmology-day-on-december-1-2025-7d9148fb94e03583 2025-11-24T18:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-non-negotiable-foundation-for-scaling-ai-in-clinical-trials-da98d1106631f431 2025-11-24T16:46:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/shareholder-call-series-part-2-advancing-pivotal-programs-toward-major-clinical-df41d48d42d70a83 2025-11-24T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/powerful-medical-wins-medtech-innovator-2025-bc0c6769cd940f4e 2025-11-24T12:56:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-reports-third-quarter-2025-financial-results-and-provides-corporate-up-604bc92944e3ef3f 2025-11-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-biostar-12aad09c55dc2d34 2025-11-24T11:16:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/voting-rights-registered-capital-2a0c70155bc0d453 2025-11-22T14:49:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-nouveau-magazine-visions-n-8-est-sorti-d20ba0cfd4f8696f 2025-11-21T17:10:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pro-pack-expo-2026-9e1f67f6bbaecf5c 2025-11-21T13:15:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaconex-2026-322c0c4bb5b81c06 2025-11-21T13:10:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidson-appoints-two-new-female-independent-non-executive-directors-7087a3998973d2cf 2025-11-21T11:40:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-to-manufacture-aavantgarde-s-dual-vector-gene-therapies-for-inheri-39e3a6ed53a3e7c0 2025-11-21T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulvac-receives-best-partner-award-from-sk-hynix-recognized-for-continuous-commit-8cd41ac3c71a42f7 2025-11-21T05:43:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/violence-is-a-normal-part-of-life-for-many-young-children-0728d31db47f8961 2025-11-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celerion-welcomes-dr-steven-evans-as-senior-cardiologist-to-enhance-cardiovascul-fe300bdad285dec0 2025-11-20T13:08:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-secret-to-gorgeous-hair-revealed-why-you-need-this-tool-in-your-routine-76955e443f7f8445 2025-11-20T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/award-for-lars-lannfelt-who-paved-the-way-for-the-alzheimer-s-drug-lecanemab-fa64b77d2145cd66 2025-11-20T12:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-open-water-swimming-helps-my-anxiety-69e6c8fc118b6d2d 2025-11-20T11:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulvac-to-exhibit-at-vacuum2025-e0689e2edb0b97df 2025-11-20T07:17:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/assaf-recognises-uct-leading-scholars-research-excellence-897f4597e032cac1 2025-11-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-two-track-mind-how-brainy-emory-student-nikki-boon-became-the-world-s-greatest-5e4590496131ae44 2025-11-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comunicado-novos-caminhos-novas-oportunidades-38f65f9af318fe50 2025-11-19T21:04:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cro-decoder-what-site-centric-really-means-and-what-it-doesn-t-9b3b6f1c4c6763e0 2025-11-19T16:49:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/wvu-health-system-independence-health-system-target-late-2026-for-merger-2cee2dcc64afcc4c 2025-11-19T14:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-publishes-nature-communications-article-on-a-non-viral-gene-editing-pr-2216c8493f89024d 2025-11-19T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-be-a-polymath-7806fd2883149ddc 2025-11-19T11:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/facing-cancer-during-the-holidays-2d76ccefe18cb7d3 2025-11-19T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agc-biologics-and-repair-biotechnologies-partner-on-novel-mrna-therapeutic-to-co-126095ce3a181525 2025-11-19T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptose-biosciences-announces-arrangement-agreement-for-acquisition-by-hanmi-phar-cb1e6c6b797b5ee1 2025-11-19T06:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultra-processed-foods-documented-negative-health-impacts-and-concrete-proposals-5053fdb19c5096d9 2025-11-18T23:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-to-host-digital-health-forum-on-november-24-2025-5a0763e3c0d652c5 2025-11-18T19:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-partners-in-44-9-million-r-d-projects-to-transform-sustainable-medicines-man-372842e1e7311503 2025-11-18T16:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-breast-cancer-clinical-trials-984e98d9f2ae5c61 2025-11-18T16:21:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-and-chemspeed-s-demo-lab-opening-0f4e14ed0d2db996 2025-11-18T15:07:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-to-report-third-quarter-2025-results-on-november-24-2025-9f06f911f48d9146 2025-11-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostikum-group-selects-oxipit-cxr-suite-after-rigorous-multi-vendor-evaluati-9dff4ee83c659f09 2025-11-18T06:51:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-researchers-take-centre-stage-at-soapbox-science-2025-4897b2d9efa73174 2025-11-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-estonian-medicinal-products-market-in-the-third-quarter-2025-eeb226f5a7fbd389 2025-11-17T15:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-core-principles-of-building-patient-centric-clinical-trials-45546713b29a3bba 2025-11-17T15:03:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-announces-completion-of-series-a-2-financing-to-accelerate-018531b5a3d2641e 2025-11-17T14:57:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-reports-fiscal-third-quarter-2025-financial-results-01a4ac5da2cc19ea 2025-11-17T13:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-pharmaceuticals-inc-declares-dividend-distribution-of-common-stock-purcha-35c3e2c1b4118113 2025-11-17T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-announces-changes-to-board-and-executive-leadership-team-6eb2ae7256e04d24 2025-11-17T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sounds-of-science-podcast-episode-23-impact-of-eu-legislations-on-the-competitiv-19f54218450d72a5 2025-11-17T09:52:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-world-s-oldest-rna-extracted-from-woolly-mammoth-af9fbd4f722463ec 2025-11-17T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-announces-chief-financial-officer-transition-ad7745599cdc56ef 2025-11-17T05:45:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/lanzamiento-de-la-app-doctorsv-para-atencion-medica-virtual-c77d294280a932a4 2025-11-15T16:10:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-releases-first-quarter-2026-financial-results-and-provides-ope-df6125b7b2f4bf6f 2025-11-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lanzamiento-de-la-app-doctorsv-para-atencion-medica-virtual-55a351cb726b7c26 2025-11-14T20:21:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/chembio-receives-a-grant-for-development-of-a-rapid-point-of-care-test-for-preec-802247264e2c9642 2025-11-14T20:07:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/salud-como-inversion-una-apuesta-por-el-desarrollo-y-la-equidad-en-america-latin-92a1f233569fa3c2 2025-11-14T17:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/base-editing-beam-therapeutics-b95046a43c837444 2025-11-13T19:34:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-just-risk-genetic-testing-is-shaping-breast-cancer-treatment-d382dd23c127dd7a 2025-11-13T19:17:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/metsera-acquired-by-pfizer-in-10-billion-deal-to-accelerate-obesity-drug-develop-df090a64808af8f1 2025-11-13T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seminario-de-medicina-china-tradicional-inteligente-f508be39889f2261 2025-11-13T16:04:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-northern-cluster-aiming-to-shape-uk-s-bio-industrial-future-8da50014c34cdd80 2025-11-13T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-hematologic-oncology-b899821fbf9d5b72 2025-11-13T14:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-study-of-a-novel-left-atrial-pressure-sensor-the-microtech-lvad-s-ac32eee9ebf95ce9 2025-11-13T13:40:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-provides-business-update-and-reports-third-quarter-2025-financial-b5a2482727d9b6df 2025-11-13T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-researchers-at-sund-are-ascending-investigators-b24691b1effc5cd8 2025-11-13T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/third-quarter-2025-financials-operational-update-209119dd9b5891e0 2025-11-12T23:09:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/numerion-labs-publishes-breakthrough-ai-research-on-ultra-fast-screening-of-hype-d80bad94d50dc69b 2025-11-12T21:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-third-quarter-2025-financial-results-and-provides-corporate-u-82eaff817d222a31 2025-11-12T21:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-does-dealmaking-tell-us-about-the-therapies-of-tomorrow-1c4616a650b8da29 2025-11-12T13:48:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/collaborating-with-the-entire-history-of-human-expression-ce1b93927dc742c4 2025-11-12T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-strengthens-management-team-with-key-appointments-2d43543efe3edead 2025-11-12T10:09:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-appoints-jose-pablo-morales-m-d-as-chief-medical-officer-fa1e56f2c44bf303 2025-11-11T20:57:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-plating-platformtm-hip-trauma-54da3d8f79cd1d06 2025-11-11T17:18:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/sophia-genetics-and-element-biosciences-unite-sequencing-power-and-ai-analytics-1c9fa1fa663da453 2025-11-11T12:59:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/danish-medicines-agency-strengthens-its-organisational-foundation-to-prepare-for-370c18bb88992553 2025-11-11T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lem-surgical-achieves-major-us-clinical-milestone-799733f40eae28cf 2025-11-10T15:28:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ophthalmic-innovation-by-the-decades-the-2010s-8d92ca0e916095e6 2025-11-10T14:37:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eye-exam-is-becoming-an-ai-exam-c0423098eecc5e64 2025-11-10T14:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/light-horse-therapeutics-selected-by-the-american-chemical-society-as-one-of-the-1d45c3767cf81d84 2025-11-10T13:58:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/it-s-time-to-act-why-trump-is-good-for-european-biopharma-27b44a9ec9dbfc70 2025-11-10T13:49:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/double-trouble-viral-co-infections-and-their-role-in-cancer-progression-3a5a3be0350922fa 2025-11-10T05:38:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/sitc-2025-poster-presentation-dual-targeting-of-tgf-b-and-egfr-with-ficerafusp-a-f4e7fae52d26b3c9 2025-11-08T15:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-reports-third-quarter-2025-financial-results-and-provides-business-upd-a4ef63770737f9c9 2025-11-07T21:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesityweek-presentation-additional-p2a-study-data-87c6441e553f531e 2025-11-07T21:23:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/adapting-to-change-the-real-fright-in-clinical-trials-e908e17ec6312122 2025-11-07T17:12:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacodynamic-and-pharmacokinetic-activity-of-cx-801-a-masked-ifn-2b-probody-c-5b03e5c6de78374f 2025-11-07T15:12:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cx-908-a-probody-t-cell-engager-targeting-cdh3-and-cd3-induces-tumor-regressions-efa651a3d62cfb54 2025-11-07T15:10:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-visit-lasting-impact-a-myrisk-provider-story-438350b5a9c0b1b0 2025-11-06T19:46:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-maison-du-don-ouvre-ses-portes-4f546136da5998b6 2025-11-06T10:42:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-inc-announces-pricing-of-100-million-common-stock-offering-2be1cd421f24c246 2025-11-06T05:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-reports-third-quarter-2025-financial-results-and-provides-business-u-8bb7b502dd66f8c1 2025-11-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-inc-announces-proposed-public-offering-a1c2c128c6afbe16 2025-11-05T21:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/upstream-bioprocessing-seven-hot-topics-for-the-next-24-months-1826c87c8f04e1e9 2025-11-05T20:09:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-abb-mettler-toledo-and-agilent-are-building-the-first-self-learning-and-44541124d11c562c 2025-11-05T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-china-and-the-future-of-open-borders-in-science-d803664c1ed3d8b8 2025-11-05T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-celebrates-10-years-of-biologics-innovation-in-darlington-b632e0a5d9fc0064 2025-11-05T11:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acute-leukemia-in-children-exposure-to-certain-air-pollutants-at-birth-could-be-148fa933b530607e 2025-11-05T08:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-beam-therapeutics-b5dba9b0b0513f75 2025-11-04T19:54:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/csafe-s-innovative-air-recirculation-system-designed-with-performance-in-mind-3d2908306488d5c4 2025-11-04T18:28:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-for-biostar-07c0bb454f67ca1a 2025-11-04T13:55:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/lung-cancer-in-young-adults-a-survivor-s-story-02d430c8d3125701 2025-11-04T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/christine-fox-corporate-officers-teva-ce1613d71d9a4224 2025-11-04T08:23:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-enters-uk-market-to-drive-faster-higher-quality-mri-with-subtlehd-7f932b3cd32ca9dc 2025-11-04T06:09:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-expands-housing-and-real-estate-coverage-with-appointment-of-ryan-gilbert-5ce791e732440073 2025-11-03T18:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/functional-fast-and-unbiased-tcr-discovery-with-bruker-s-optofluidic-platform-27177f75e8bf43e0 2025-11-03T18:03:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-to-present-a-development-update-for-eti-cel-at-ash-2025-7d45fc409915b522 2025-11-03T14:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-deadline-for-submitting-applications-concerning-marketing-authorisations-an-116d2abea9792c29 2025-11-03T08:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarker-driven-research-transforming-treatments-for-rare-cancers-4230d3cbe11a99e7 2025-11-03T01:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/form-6-k-financial-and-operating-results-for-the-first-half-of-2025-16591147ddf536fb 2025-11-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-basics-for-investigators-e3476f530cf49a3b 2025-11-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novembre-mois-de-depistage-des-cancers-masculins-0c56403d46abda99 2025-11-01T09:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-to-report-third-quarter-financial-results-on-november-7-2025-77c3c7cc729bf907 2025-10-31T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hinge-pediatric-plating-systemtm-ffe72eba4b9d2bb4 2025-10-31T20:12:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fassier-duval-telescopic-intra-medullary-system-2175aa94f8ac0b50 2025-10-31T20:02:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-practices-to-ensure-a-smooth-cro-handoff-and-data-continuity-0a4dab46715d7a06 2025-10-31T16:16:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-b6e0cde2b0ddecf7 2025-10-31T10:28:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/transactions-with-treasury-shares-ccffc3e36c92342a 2025-10-31T10:27:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/gm-proposals-ii-2e24362cdacf4c12 2025-10-31T10:27:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-fbd9bf2182cfbece 2025-10-31T10:27:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-fec1b499e15c1c7a 2025-10-31T10:26:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/transaction-with-treasury-shares-a413b0b3f92f0474 2025-10-31T10:26:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-34f123ecfc90a805 2025-10-31T10:25:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/modification-of-extraordinary-announcement-transaction-of-person-discharging-man-caa764340b9654e9 2025-10-31T10:25:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-1f3e675a9cfee50b 2025-10-31T10:25:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/voting-rights-registered-capital-03475bf30aa571c2 2025-10-31T10:25:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/transactions-with-treasury-shares-31847da93d2b7921 2025-10-31T10:25:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-978798132552816f 2025-10-31T10:25:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/transactions-with-treasury-shares-6d0fbff716279e88 2025-10-31T10:25:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-a448acd99248e9f7 2025-10-31T10:25:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-announcement-96b099b6f289af15 2025-10-31T10:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/amended-corporate-action-timetable-b4e58f30ee2e0543 2025-10-31T10:25:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/voting-rights-registered-capital-10852e6da8507376 2025-10-31T10:25:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/voting-rights-registered-capital-3a1aae51ddb00796 2025-10-31T10:25:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/transaction-with-treasury-shares-a7aadb6a4098a603 2025-10-31T10:25:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/anne-kathrin-stoller-to-become-new-ceo-at-bachem-772055b3bcd3fa05 2025-10-31T04:41:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-research-coordinator-level-3-programme-august-2025-intake-a0baaf757df0207f 2025-10-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-every-home-cook-needs-a-micro-pressure-cooker-in-their-kitchen-dba5a7720cfbe685 2025-10-30T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-appoints-john-harrison-as-clinical-vice-president-1dbfb65fe1db1338 2025-10-30T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/97-percent-of-women-in-denmark-experience-symptoms-during-menopause-e94f303a08ae39eb 2025-10-30T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/far-beyond-the-skin-psoriasis-und-begleiterkrankungen-a57cbd2dc5f4fbba 2025-10-30T10:59:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthy-future-highlights-infographic-0c407fdcdeaf4c58 2025-10-30T10:07:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-plating-platformtm-hip-deformity-d2072fbcd05380ed 2025-10-29T20:11:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-to-present-at-evercore-isi-s-8th-annual-healthcare-conference-fb6011fb19f94609 2025-10-29T18:26:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/genesis-says-its-new-ai-model-bests-alphafold-3-6073cdd7ea64cd00 2025-10-29T16:49:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/contextflow-collaborates-with-vuno-and-mesalvo-to-advance-cardiac-arrest-predict-176f8ad7eef0cf11 2025-10-29T16:46:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-s-2024-healthy-future-report-highlights-sustainability-32d3a347267086da 2025-10-29T15:35:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/interactive-map-of-clinical-trials-in-the-eu-now-available-in-all-eu-languages-2d1cf9115e1eeaf4 2025-10-29T12:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-the-frontiers-of-research-at-the-lux-ai-summit-c2d907cd03a93af0 2025-10-29T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-3-2-3b75c69cea893522 2025-10-29T10:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-introduces-a-nbi-txitm-observation-mode-to-the-evis-x1tm-endoscopy-syste-4f7b710c4545bc43 2025-10-29T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pmcardio-reports-positive-rct-results-and-late-breaking-clinical-science-for-ste-281ac6aaaaa3ec2c 2025-10-28T21:53:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-inc-announces-closing-of-common-stock-offering-1a2db60ef0a07cfe 2025-10-28T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genesis-molecular-ai-unveils-pearl-66bd2267a4656db7 2025-10-28T18:35:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-pearl-the-next-generation-foundation-model-for-drug-discovery-ac71b3d1fc290019 2025-10-28T18:30:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/moody-s-upgrades-teva-amid-growth-strategy-success-84f46b5242754e9f 2025-10-28T17:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-exemplary-ecovadis-scores-in-2025-8fccdb1751c09eba 2025-10-28T15:27:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-a-benchmark-in-csr-recognized-by-ecovadis-bc4ffad7ebe3e17b 2025-10-28T15:26:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/reflections-from-esmo-2025-8476d3f5abbe9b44 2025-10-28T13:27:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/researchers-develop-an-ultrasound-probe-capable-of-imaging-an-entire-organ-in-4d-e91eceaf8e21c43f 2025-10-28T10:00:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-is-now-listed-on-aws-marketplace-1160fe5cefb00c59 2025-10-28T09:47:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/recipharm-secures-major-additional-grant-to-develop-ai-enabled-manufacturing-tec-3ad3457345dbfb8c 2025-10-28T08:00:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/dementia-new-model-of-home-care-proves-effective-in-practice-55baf7d1fac7ef47 2025-10-27T12:58:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-selected-by-institut-curie-for-ai-assisted-cancer-diagnostics-1d8b7d54bb0a3c60 2025-10-27T08:30:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-inc-announces-pricing-of-common-stock-offering-7f9731c5a47539a2 2025-10-26T23:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-s-sdlabs-platform-is-soc-2-compliant-8a2dd10272e950fc 2025-10-24T09:44:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/air-pollution-in-europe-a-groundbreaking-assessment-of-a-new-measure-of-particul-a258fde5f464ef39 2025-10-24T07:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-eat-like-it-s-summer-all-year-it-could-confuse-your-internal-clock-d845a8e1a79e70c9 2025-10-24T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-prostate-cancer-genomics-with-ai-powered-morphometric-analysis-89aeb5670de76bd3 2025-10-23T15:36:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-influence-inserm-highlights-its-scientific-collaborations-with-the-a196a8c06e7c5307 2025-10-23T15:33:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-releases-letter-to-shareholders-highlighting-developments-in-its-oral-ins-fb1b823c773748a2 2025-10-23T12:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/independent-research-fund-denmark-funds-27-research-projects-at-sund-b5bc7e9f62683461 2025-10-23T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-secures-financing-of-strategic-growth-initiatives-81347c97c929daf0 2025-10-23T04:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-announces-progress-in-building-k-start-up-and-expansion-of-its-site-in-vi-7373d3b823825069 2025-10-23T04:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-launches-setaneo-ophthalmic-solution-0-002-in-japan-for-the-treatment-of-6a0c685b787dfa1f 2025-10-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-reports-third-quarter-2025-results-0330586f6c46f2ec 2025-10-22T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-present-and-future-of-wargaming-0d2b6f4189b34c36 2025-10-22T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-use-virus-filtration-controllers-and-systems-for-modern-bioprocessing-c226d2351619da17 2025-10-22T05:29:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/triangle-multiplication-is-all-you-need-for-biomolecular-structure-representatio-b46e7682bc9912a5 2025-10-21T23:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-calls-for-urgent-collaboration-to-close-uk-medtech-innovation-gaps-and-deliv-16ceaaa21c6dc49b 2025-10-21T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/csci-s-professor-sarah-teichmann-elected-to-the-us-national-academy-of-medicine-be6d1a34863e6363 2025-10-21T15:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-launches-new-surgical-energy-device-for-hemostatic-cutting-and-vessel-se-7562a19ffb2cfd98 2025-10-21T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ms-research-updates-october-2025-09933e2246277649 2025-10-21T13:55:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-the-appointment-of-joe-todisco-to-board-of-directors-54fcad0918cbacf3 2025-10-21T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astraveus-further-strengthens-world-class-leadership-team-to-advance-development-cbffe414d4cc0b22 2025-10-21T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-announces-positive-findings-from-proof-of-concept-study-with-baye-0dd924172ba9a3fe 2025-10-21T06:03:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-assessors-trained-in-sterile-products-assessment-93e1b87651fbcba9 2025-10-21T04:38:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-engages-stakeholders-on-the-review-of-the-masa-c72a88c3d6a9db70 2025-10-21T04:37:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-feasibility-study-on-endoscopy-infection-control-systems-in-india-select-e30c190d7a50cdb9 2025-10-21T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrate-the-2025-president-s-award-for-outstanding-service-to-socra-winner-abb-bfaa90e24c939307 2025-10-20T18:01:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/perfusion-the-beating-heart-of-single-cell-biology-and-cancer-immunotherapy-0a2921d6fd24b582 2025-10-20T14:58:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/esmo-2025-poster-presentation-ficerafusp-alfa-driven-tumor-penetration-via-emt-a-758c5f25617ad10a 2025-10-20T14:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subretinal-implant-partially-restores-vision-in-amd-patients-9c8917b289f4520c 2025-10-20T12:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-announces-delisting-from-nasdaq-46b748e4b5763c2c 2025-10-20T11:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-announces-late-breaking-poster-presentation-at-acr-convergence-2025-of-9aff061b0c4637c0 2025-10-20T11:37:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-korea-signs-an-exclusive-promotion-and-distribution-agreement-for-vegf-in-42d5d42414a84654 2025-10-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-yearbook-2025-of-the-state-agency-of-medicines-7e4a6d93337f3441 2025-10-17T10:41:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanded-access-beam-therapeutics-96f1d9767c39b49f 2025-10-16T19:30:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-r-amp-d-day-highlights-lasme-cel-s-potential-to-address-significant-un-6a02e10048639ec9 2025-10-16T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-hosts-r-amp-d-day-today-showcasing-pipeline-progress-and-long-term-val-294ddb0d4d85cf9f 2025-10-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meridian-bioscience-appoints-new-ceo-and-executive-team-to-accelerate-global-gro-7060a36db3706f2e 2025-10-16T06:56:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/c2-cryoballoon-technology-asset-purchase-agreement-with-merit-medical-systems-9c316ea867de6888 2025-10-15T23:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-expands-tmt-research-team-with-nick-altmann-and-allan-verkhovski-511cb090a12b403e 2025-10-15T17:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rms-requests-and-national-applications-3a8821672ebf4599 2025-10-15T15:48:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-appoints-mark-pruzanski-as-ceo-f4a48fd9a02148c2 2025-10-15T11:01:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-selected-for-2025-cdmo-leadership-awards-europe-5c25a2ae6ce02a3c 2025-10-14T14:32:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-new-with-kidney-cancer-and-renal-cell-carcinoma-treatment-c4ca2a8d7916e9fa 2025-10-14T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/baroness-evans-joins-cpi-board-as-non-executive-director-0123924799807747 2025-10-14T09:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-true-to-life-story-featuring-the-fight-with-cancer-of-former-wba-champion-9e42cb81e181fdb7 2025-10-14T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-san-diego-health-and-palomar-health-receive-approval-to-form-joint-powers-aut-6708caacc60b98c4 2025-10-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/smarter-library-prep-for-whole-genome-sequencing-53c9689d26b9b0e9 2025-10-11T19:26:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-years-later-psomagen-s-participation-in-the-topmed-2-0-program-ff8fefc6d01621e8 2025-10-10T15:22:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-acquires-orbital-therapeutics-and-its-in-vivo-rna-platform-7443f5a4e1f2281f 2025-10-10T13:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-the-impact-of-mutations-57767fcd06e950ed 2025-10-10T06:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/responsetm-5-5-6-0-1d25663106181fe1 2025-10-09T15:56:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/discover-the-game-changer-elevate-your-play-with-the-best-wireless-gaming-headse-ab9695a32b7c9d4f 2025-10-09T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/celerion-earns-aahrpp-full-reaccreditation-for-five-years-strengthening-commitme-fe14b49726f4ef37 2025-10-09T12:27:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/sehkraft-erhalten-anti-vegf-therapien-gegen-schwere-retinopathien-891afbcd69650a48 2025-10-09T06:45:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-announces-novel-therapies-symposium-presentation-and-posters-at-the-875d3735bc963727 2025-10-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-completes-third-fda-inspection-validating-quality-of-its-direct-to-pa-abdedc16510d92ab 2025-10-08T13:29:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-initiates-global-investments-exceeding-100m-in-2025-6fafbcb1189003b5 2025-10-08T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/csafe-strengthens-temperature-controlled-portfolio-with-the-launch-of-a-reusable-517921ff48234f67 2025-10-07T21:52:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/myriad-genetics-continued-investment-in-molecular-residual-disease-mrd-testing-d-0b7f2204f4ee5fd0 2025-10-07T18:01:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-strengthens-capacity-in-the-regulation-of-biosimilars-37bf1ea1bcb070fa 2025-10-07T13:23:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/level-of-processing-of-plant-products-impact-on-cardiovascular-health-710a5ebf0568bdc5 2025-10-07T13:09:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-impact-of-advanced-radiosurgery-on-trigeminal-neuralgia-f699c3815c5cf59a 2025-10-07T10:43:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-to-present-data-on-non-viral-gene-therapy-and-tale-base-editors-at-the-fbac36c3e5d0c610 2025-10-07T06:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-the-optotm-cld-with-population-dynamics-kit-for-improved-stability-p-a440892f2fbb47db 2025-10-06T21:02:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/emavusertib-in-combination-with-gemcitabine-and-nab-paclitaxel-in-metastatic-or-7cb681d78b3a4fc3 2025-10-06T20:01:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/cbeyond-p2a-data-nimacimab-as-mono-and-combination-therapy-0e6ca4a9aa44e30b 2025-10-06T17:50:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-strengthens-consumer-research-coverage-with-the-addition-of-rob-dickerson-a-3b0798567c62514b 2025-10-06T17:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/62-consejo-directivo-de-la-ops-tres-declaraciones-para-avanzar-hacia-una-salud-m-c244b554abd1384d 2025-10-06T16:28:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-announces-selection-as-finalist-for-2025-prix-galien-usa-best-digit-210347946afbee66 2025-10-06T14:44:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/independent-rct-and-late-breaking-science-pmcardio-to-take-center-stage-at-tct-2-5f9e8a9474c0e333 2025-10-06T14:19:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-paper-comparison-of-illumina-and-ultima-sequencing-platforms-for-10x-genom-2e39ecf641255b0f 2025-10-06T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mise-a-disposition-du-nemluvio-nemolizumab-uniquement-dans-les-pharmacies-de-vil-8f06602dcf8bb54a 2025-10-06T08:15:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/twist-bioscience-and-element-biosciences-advance-collaboration-with-launch-of-ne-f79e527f00f3f887 2025-10-06T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-launches-secureflex-a-single-use-fine-needle-biopsy-device-c4ee207ed9452326 2025-10-06T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-difference-between-pharmacokinetics-and-pharmacodynamics-9b6180159e0dcbfe 2025-10-05T23:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/afn-resolution-on-genomic-data-sovereignty-920e003e9a162ccf 2025-10-03T17:42:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/bertie-gottgens-joins-stem-cell-reports-as-a-new-editorial-board-member-73e7fe1424bc9023 2025-10-03T16:23:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/published-integrated-report-2025-650b9fda92b356a0 2025-10-03T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-centre-for-core-facilities-strengthens-research-infrastructures-c5fab05b048b9f5b 2025-10-02T18:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-prostate-cancer-gene-testing-to-guide-treatment-decisions-insights-as-we-h-d7b2b09c9987a632 2025-10-01T16:33:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-announces-strong-2025-growth-expands-market-leadership-in-ai-imag-39751704ec7e06b8 2025-10-01T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/riskgaming-state-of-the-union-04ab8a112c770243 2025-10-01T11:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/program-specific-assistant-professor-program-specific-researcher-postdoctoral-sc-1cd3d121698b594b 2025-10-01T09:10:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-want-to-provide-optimal-treatment-without-delay-after-a-cancer-diagnosis-dc7b1817c60bf31b 2025-10-01T06:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-provider-misconceptions-in-ovarian-cancer-genetic-testing-cb0e2fb77a0cdb3b 2025-09-30T22:15:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-doctors-won-t-work-for-free-2dcfe65b3bb86a0c 2025-09-30T22:12:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/autonomous-ai-helps-ssm-health-improve-eye-screening-boost-equity-5c36e49af8acd392 2025-09-30T22:11:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/bambusa-therapeutics-announces-highly-positive-healthy-volunteer-results-and-fir-8e486bc5e80e3f3b 2025-09-30T14:56:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-launches-olysense-cad-ai-in-the-us-and-europe-e4879104e900fded 2025-09-30T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jurgen-schlebrowski-ubernimmt-geschaftsfuhrung-der-ruhrlandklinik-55c406e60040882b 2025-09-30T12:40:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/body-image-after-breast-cancer-surgery-0bdcb10e3b445e84 2025-09-30T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovative-uk-brazil-nigeria-partnership-to-revolutionise-cassava-farming-in-nig-e8a9ed0c3bab2d5b 2025-09-30T09:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-campylobacter-fast-accurate-diagnostics-for-better-gi-outcomes-ee7fd49cdf2b35fb 2025-09-30T08:23:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-commits-to-advancing-sustainable-packaging-enabled-by-duponttm-tyvek-wit-0524d49400617913 2025-09-30T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/breaking-new-ground-in-functional-single-cell-analysis-meet-the-2025-beacon-disc-a5d983b891503010 2025-09-29T22:37:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-level-peer-analysis-solving-a-gap-in-competitive-intelligence-06b7294927fc93a3 2025-09-29T17:16:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-h-pylori-why-timely-testing-and-retesting-matters-ef40573475c04d08 2025-09-29T13:42:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/konferencja-nie-rownosc-w-dostepie-do-zdrowia-jak-stawic-czo-a-barierom-i-wykluc-ccfd99d2d0127497 2025-09-29T13:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shiga-toxin-producing-e-coli-the-urgent-need-for-accurate-antibiotic-free-manage-74c1d24022b29a44 2025-09-29T10:53:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/joint-professorship-for-susanne-wegmann-at-dzne-and-charite-9fe2e4474b9b7c9b 2025-09-29T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/783761a61ca15440 2025-09-26T08:59:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/coo-4ca0a5c9c2f6cd9e 2025-09-26T08:58:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceo-92ff546203b87fe7 2025-09-26T08:57:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-5e1f849f7342e4cd 2025-09-26T08:51:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/mas-de-200-plazas-vacantes-para-profesionales-de-la-carrera-de-medicina-que-sean-f975c612ab2326d2 2025-09-25T20:34:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/universitatsklinikum-essen-erhalt-dge-zertifikate-fur-vollkost-und-pflanzenbasie-fef9586c872f4a43 2025-09-25T10:54:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/08589bbf815e2a36 2025-09-25T09:58:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrocytes-the-unexpected-conductors-of-brain-networks-ecb33fd452b34577 2025-09-24T15:00:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-global-future-of-wargaming-in-lithuania-5d2a943eb94558a8 2025-09-24T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-named-to-time-s-inaugural-list-of-the-world-s-top-healthtech-comp-426440b7aa198b35 2025-09-24T03:37:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/demonstrating-the-clinical-utility-of-foundation-medicine-s-high-quality-tests-a-a89b20b302eb8ede 2025-09-23T20:15:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-to-report-third-quarter-2025-financial-results-on-october-2-4fd6c6ed7a3119ca 2025-09-23T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/changing-the-course-of-npc-long-term-evidence-for-disease-modification-in-a-hete-37a5fe2994e59080 2025-09-23T13:19:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/kids-with-brain-tumors-deserve-better-542ab6d2573aa70f 2025-09-22T18:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/arch-s-seaport-therapeutics-included-on-fierce-biotech-s-2025-fierce-15-list-of-4c15d7d290edd3d1 2025-09-22T14:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-ab9035fa2b606ad6 2025-09-22T12:26:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/healx-strengthens-focus-on-preventing-cancer-recurrence-by-leveraging-its-ai-pow-229981dd4c3f9029 2025-09-22T11:59:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/natus-medical-incorporated-75b4c769bf97fad4 2025-09-22T09:04:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/element-biosciences-files-competition-and-patent-infringement-countersuits-again-f7165cac1323d770 2025-09-22T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-wait-indicator-2025-como-estan-los-tiempos-de-espera-en-los-sistemas-de-caeb1538938be6ab 2025-09-19T16:19:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/arch-backed-dispatch-bio-and-sironax-named-to-endpoints-11-list-of-most-exciting-03be6b753aaac559 2025-09-19T16:00:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-launches-the-single-point-of-contact-spoc-network-against-substandard-fals-6b755d0dffe88a8a 2025-09-19T15:12:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuproba-sustituto-de-queso-0fbbd64785ec2e72 2025-09-19T13:37:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuproba-sustituto-de-harina-c3881680076e73fa 2025-09-19T13:37:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-latest-issue-of-technical-journal-no-86e-has-been-published-d0feb8eb7de6bff7 2025-09-19T00:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/discover-how-the-dog-walking-bag-can-transform-your-dog-walks-711b8d790a2eb314 2025-09-18T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-can-analogs-help-pharma-companies-forecast-effectively-c7e48de198c9545a 2025-09-18T09:11:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtech-industry-innovators-and-investors-call-for-urgent-action-to-unblock-uk-m-dd51767372399f38 2025-09-18T08:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/driving-efficiency-in-lentivirus-manufacturing-with-fixed-bed-bioreactors-156e5f81345d9ef6 2025-09-17T18:01:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/behind-the-scenes-of-our-new-scenario-southwest-silicon-77279704329abf6f 2025-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emory-will-be-tuition-free-for-students-whose-families-earn-200-000-or-less-110572551bce1a80 2025-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-san-diego-health-honored-as-top-performer-in-quality-care-29cef02e431fd00b 2025-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nutricion-6dd6d1401f46e538 2025-09-16T13:49:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/catcher-300-54f9999e6154274a 2025-09-16T13:25:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/catcher-300-d49ca99f40d872f2 2025-09-16T13:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-just-a-groundbreaking-ceremony-construction-begins-for-the-berlin-cent-b86fbe5ca6919997 2025-09-16T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-i-do-this-gerard-brown-8c8a06fc41ecab03 2025-09-15T16:19:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-completes-acquisition-of-select-assets-of-bioreference-health-s-innovati-a6e42c6129b2f69e 2025-09-15T14:44:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/worldwide-clinical-trials-appoints-alistair-macdonald-as-chief-executive-officer-4245cd0e14983acb 2025-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genomics-the-digitization-of-biology-and-canada-s-ai-opportunity-ff8c7ede299b2c3c 2025-09-15T13:50:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/dzne-launches-podcast-90-milliarden-with-host-marco-schreyl-6743e2df9754f593 2025-09-15T05:37:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/orange-county-bio-astraveus-bringing-cell-therapies-closer-to-patients-8bf555df622854b6 2025-09-13T07:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-and-strengthening-national-medicines-regulatory-authorities-global-best-178e8418f2088d21 2025-09-12T07:07:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-executive-officer-junya-kiyota-of-ulvac-inc-receives-special-award-at-n-58beb41a7cc72525 2025-09-12T04:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-power-of-px-why-patient-experience-is-the-most-overlooked-driver-of-growth-i-4aeb179fe187bd95 2025-09-11T20:44:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/changes-to-the-cannabis-flower-monograph-now-open-for-public-consultation-9567e3e851381b79 2025-09-11T13:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-letter-to-the-stxbp1-community-92e591bc293a8efb 2025-09-10T20:29:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-joins-the-aws-partner-network-7409ec98a2577fb1 2025-09-10T11:17:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-compute-and-ai-will-create-next-gen-superapps-4ddd85833bebbfc6 2025-09-10T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-drugs-and-cancer-treatment-research-and-risks-bc74147917d45475 2025-09-10T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-power-of-ai-in-advanced-therapy-medicinal-products-atmps-a8761922e48db4b1 2025-09-09T16:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-arimoclomol-in-a-pediatric-substudy-of-niemann-pick-disea-b87c5cadce64465d 2025-09-09T14:50:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/arimoclomol-upregulates-expression-of-genes-belonging-to-the-coordinated-lysosom-959a14e592f86dc9 2025-09-09T14:37:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/arimoclomol-for-the-treatment-of-niemann-pick-disease-type-c-in-a-real-world-set-c2d93446495f5878 2025-09-09T14:36:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-results-across-a-12-month-double-blind-randomized-trial-and-an-open-lab-c7f971ab91e1bb7d 2025-09-09T14:35:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/consulta-publica-requerimientos-tecnicos-administrativos-808e7ac3055356dd 2025-09-08T17:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/komentarz-dot-nowelizacji-kodeksu-postepowania-cywilnego-3be0822b316f779d 2025-09-08T14:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/talphera-announces-private-placement-financing-of-up-to-29-million-priced-at-the-0ecf8459600c3b7b 2025-09-08T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-inc-announces-collaboration-with-infinimmune-inc-to-support-antibo-9fda741d9383686e 2025-09-08T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/banner-health-testing-for-vision-loss-using-new-artificial-intelligence-system-82352f6737f9920e 2025-09-05T21:19:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-genomic-testing-is-transforming-treatment-decisions-in-intermediate-risk-pro-7709d7af0bbad703 2025-09-04T17:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/50-years-after-the-monoclonal-antibody-breakthrough-why-precision-medicine-still-859d7d772e930a8c 2025-09-04T15:30:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/facing-fear-finding-strength-jodi-s-story-of-genetic-testing-and-prevention-5d52aa4d0955fbb4 2025-09-04T15:22:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-announces-distribution-partnership-with-macrolux-medical-for-single-use-53673529fea9182e 2025-09-04T14:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-and-catalent-announce-partnership-enabling-universal-access-to-clinic-3cf3ea7e9de837a5 2025-09-04T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electronic-leaflets-for-veterinary-medicinal-products-have-too-small-font-size-8a44c34cb832912e 2025-09-04T11:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-radiotherapy-awareness-day-a-call-to-action-to-make-radiotherapy-understoo-5314f1f61a79d850 2025-09-04T10:27:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/enno-spillner-im-interview-mit-borsen-radio-network-ag-bei-den-hamburger-investo-a1242ab731e40dc3 2025-09-04T09:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-uk-innovators-selected-to-transform-patient-flow-through-5g-enabled-healthc-e576f585777191b1 2025-09-04T09:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erc-starting-grants-for-up-and-coming-talents-at-charite-and-bih-a9758f480bf3226e 2025-09-04T09:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-ways-a-women-s-genetic-testing-provider-should-align-with-your-value-based-car-392108782417dd64 2025-09-04T07:13:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/genetic-testing-in-the-c-suite-five-things-health-system-leaders-need-to-know-no-a5c3a181a927ac56 2025-09-04T07:09:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-impact-of-myriad-women-s-health-on-hereditary-cancer-risk-assessmen-5cf81586ec9c8f1a 2025-09-04T07:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modernizing-genetic-counseling-in-women-s-health-programs-enhancing-clinical-wor-6edf8b406811548c 2025-09-04T07:07:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-ways-a-genetic-testing-provider-should-help-streamline-women-s-health-medica-2bfc90335fd2714f 2025-09-04T07:04:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/misdirected-increased-dementia-risk-associated-with-errors-of-the-brain-s-compas-c470983cd3781427 2025-09-04T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidson-signs-mou-with-japanese-firm-at-ticad9-bed18f9fbffcc4f1 2025-09-03T13:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/america-s-degrowth-lawyers-need-to-learn-from-china-0693493672e1bf69 2025-09-03T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-kristen-krysko-wins-2025-rachel-horne-prize-for-women-s-research-in-ms-14ec64d88ecc1c1b 2025-09-03T09:24:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-human-potential-to-power-vaccine-innovation-a3153f0f1ffad4aa 2025-09-03T08:47:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/five-arch-backed-companies-and-executives-named-to-fierce-50-list-of-those-makin-59c5681657578d31 2025-09-02T20:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpi-and-quotient-sciences-to-accelerate-rna-drug-development-with-joint-venture-fccd528a51a54501 2025-09-02T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-at-esc-2025-83526b9fa7ae9bba 2025-09-01T09:52:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-launches-latest-ebus-bronchoscope-bf-ucp190f-in-emea-and-apac-992a5dca2009f372 2025-09-01T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/auda-nepad-strengthening-africa-s-vigilance-systems-for-medical-products-7983249d876b91db 2025-08-28T18:36:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbmcs-or-whole-blood-strategic-applications-in-phase-i-studies-ad87526b4bf72d07 2025-08-28T16:55:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/elevate-your-style-find-the-perfect-cute-makeup-bag-for-every-occasion-1a754d28b5defc37 2025-08-28T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-support-97d1d2a83ce100f9 2025-08-27T18:13:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cia-in-the-21st-century-07c269a7e24d6d2f 2025-08-27T14:07:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-talk-to-your-children-about-vaping-2c50fafa03da56b7 2025-08-27T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wysoka-pozycja-polskiego-rynku-komercyjnych-badan-klinicznych-szansa-dla-polskic-a63177cee5fdb3de 2025-08-26T09:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-the-power-of-aws-a-smarter-cloud-journey-with-corbus-83fe2c5f762a583b 2025-08-25T13:37:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/najlepsze-praktyki-wybierania-przeciwcia-do-immunohistochemii-monoklonalne-vs-po-1e580a826b27e64b 2025-08-25T07:45:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoya-sbt-fadb1961b80560a8 2025-08-22T03:05:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoya-group-commits-to-science-based-targets-to-accelerate-climate-action-c56d9a70883d24c7 2025-08-22T03:05:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-gains-twist-biosciences-prolab-status-for-ngs-applications-3676e20cf8b0ff5f 2025-08-21T20:11:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-lean-team-playbook-how-small-biotechs-can-nail-ich-e6-r3-without-a-large-qa-84b0fe3edcdaed0a 2025-08-21T14:31:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/ectrims-endorses-the-radiologically-isolated-syndrome-consortium-risc-bb5d8887278aee1a 2025-08-21T13:33:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/pmcardio-expands-heart-attack-detection-to-patient-bedside-through-roche-cobas-p-deb21a25c86dede2 2025-08-21T07:59:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-estonian-medicinal-products-market-in-the-second-quarter-of-2025-9c31d8d5b7032b2c 2025-08-21T07:33:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-atlas-transforming-surfactant-monitoring-in-bioprocessing-0c243ac919665ac4 2025-08-20T17:26:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-expands-corporate-executive-committee-to-include-chief-operations-officer-ef88a93c748dc9cb 2025-08-20T13:58:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/agentic-ai-in-drug-discovery-why-we-must-start-from-scratch-2701a7087cce558a 2025-08-20T11:46:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/test-8c698efa237b4f1c 2025-08-20T11:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/time-and-statista-name-arch-a-top-venture-firm-in-the-u-s-27e7361235d2a337 2025-08-19T15:00:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxipit-welcomes-new-strategic-advisor-7a7089b36aacb105 2025-08-19T07:44:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-medicine-shipping-precision-shipping-for-specialty-rx-0feaa078bd79c7ab 2025-08-18T16:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ngs-meets-antibodies-a-new-era-in-precision-medicine-and-therapy-optimization-f3868934af50ef77 2025-08-15T09:36:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/insights-into-smelling-problems-associated-with-alzheimer-s-077cda584b8f89a7 2025-08-15T08:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/revenue-at-september-30-2020-a0f7bf6d04f50193 2025-08-14T12:33:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/chiffre-d-affaires-au-30-septembre-2020-50ac6463f5df2dfc 2025-08-14T12:33:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-reports-q2-financial-results-and-provides-business-update-c93348b2605348df 2025-08-13T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taking-vitamins-or-dietary-supplements-during-cancer-treatment-71882132fcfa6f14 2025-08-13T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-continues-expansion-in-latin-america-subtlehd-mr-tm-now-commercia-914b4db0b325a2db 2025-08-13T04:37:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/lab-services-c75beb66ec190509 2025-08-12T21:46:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-d387123f310827bb 2025-08-12T20:10:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-potential-the-role-of-dna-encoded-antibodies-in-modern-bioengineering-f3b6b894e51d9941 2025-08-12T12:29:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-every-decision-counts-equipping-pharma-sales-teams-for-market-success-2340b92a85c57656 2025-08-11T18:02:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cerebral-cortex-ages-less-than-thought-aa8c622ee868a4d5 2025-08-11T09:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/web-eaf4dc7270202d3c 2025-08-08T02:08:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-website-maintenance-48cc9ae7c6df0bb0 2025-08-08T02:08:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-the-role-of-excel-in-a-forecaster-s-software-toolkit-ee332bb59a822400 2025-08-07T15:17:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/say-goodbye-to-pet-hair-mess-the-grooming-pet-brush-you-didn-t-know-you-needed-5e91c4dec9d78085 2025-08-07T12:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-r3-timewarp-redemption-preventable-risks-and-how-to-avoid-them-in-a-trial-bf06cd1b46cafcd6 2025-08-06T21:14:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-gen-peptides-for-smarter-mab-production-6cc6889603741a3c 2025-08-06T20:45:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/procc-amplia-numero-de-bolsistas-de-produtividade-do-cnpq-0032428bf3599548 2025-08-06T14:05:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-mythbusters-revelations-debunking-compliance-myths-to-keep-your-trial-on-tra-71721560c9ba3cab 2025-08-05T19:20:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-announces-6-5-million-investment-at-vizag-site-and-fda-inspection-succes-1118f015929a71bd 2025-08-05T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-reports-second-quarter-2025-financial-results-amp-business-updates-3eb26aed87973c59 2025-08-04T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/smarter-cell-culture-strategies-for-vaccine-manufacturing-three-essential-resour-4de6d8bc7bd7491b 2025-08-04T17:03:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/join-icecure-at-the-2025-cirse-annual-meeting-in-barcelona-2fc6c30bbfab09c1 2025-08-04T12:16:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/experience-the-freedom-of-choice-breast-cryoablation-with-icecure-at-eusobi-2025-af69952deb8f31a1 2025-08-03T13:32:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidson-founder-dr-ayebae-retires-appoints-biola-adebayo-as-new-md-ceo-3ee08c40dfc3571d 2025-08-02T04:47:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-3-1-3d11896d2b3b8fab 2025-07-31T23:59:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/meeting-the-moment-transforming-oncology-care-through-innovation-urgency-and-emp-ab2ff314a28d0fdb 2025-07-31T15:19:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/genome-canada-2024-25-annual-report-3ae9883b602bc4f7 2025-07-31T00:25:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-awards-breakthrough-device-status-to-the-dpp-syphilis-tnt-assay-369882f72dfaf1da 2025-07-29T16:00:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-support-someone-facing-cancer-bc31b939858067a0 2025-07-29T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-medical-announces-the-release-of-radrex-i5-flex-edition-a-general-radiogra-3f42c98348ed7894 2025-07-29T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/english-edition-of-the-state-agency-of-medicines-2024-annual-report-now-publishe-3c80ee62baaf1344 2025-07-29T08:42:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/element-biosciences-surpasses-50-aviti24tm-5d-multiomic-system-installations-in-8cef4a239a74ccff 2025-07-29T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellectis-to-report-second-quarter-2025-financial-results-on-august-4-2025-113c43496c59d2a6 2025-07-28T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/powerful-medical-receives-40-million-non-dilutive-grant-to-accelerate-early-diag-950619cf2b0ced62 2025-07-28T13:29:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-announces-entry-into-definitive-agreement-for-sale-of-tecelra-lete-c-b340e3ccc56afc7a 2025-07-28T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mcgrath-outpatient-pavilion-opens-at-uc-san-diego-health-91226bcf8b67bb2a 2025-07-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jeremy-bender-on-biotech2050-7b7bcf87ce42ca31 2025-07-25T14:21:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-shows-strong-growth-in-the-first-half-of-2025-81807b27e3997482 2025-07-24T11:20:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/request-for-proposals-economic-study-on-genomics-biotechnology-and-the-biorevolu-452911ae1c824a60 2025-07-23T19:06:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/lem-surgical-strengthens-leadership-with-two-medtech-veteran-executives-7d99e0ec9cc2b093 2025-07-23T15:36:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-stephen-buchwald-joins-atinary-s-advisory-board-a7a299e1271faab4 2025-07-22T09:12:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-reports-second-quarter-2025-results-420174518a407b93 2025-07-21T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bucaner-25ew-a95da7131d740131 2025-07-21T03:02:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/bucaner-25ew-7fbfa4cf6256bdfb 2025-07-21T03:02:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina-3d2555fa245a39e7 2025-07-17T14:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-shares-positive-data-on-schizophrenia-drug-902db0279f2ed828 2025-07-17T11:45:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-publishes-q1-2025-aide-memoire-for-investors-a69811bfbf92174f 2025-07-17T11:43:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-efpia-disclosure-transparency-in-pharma-funding-30c52719228a895b 2025-07-17T09:17:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/corporate-officers-teva-pharmaceuticals-50e85cc2499ec47b 2025-07-17T09:09:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-eric-a-hughes-corporate-officers-teva-bda14efb6a8917be 2025-07-17T09:08:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/kathleen-veit-corporate-officers-teva-pharmaceuticals-3a24bbfe671ce362 2025-07-17T09:08:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/mark-sabag-corporate-officers-teva-pharmaceuticals-9222866e1f3d985f 2025-07-17T09:08:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/matthew-shields-corporate-officers-teva-pharmaceuticals-93b031c2f56b82f8 2025-07-17T09:07:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/nir-baron-corporate-officers-teva-pharmaceuticals-e02185053a0e136c 2025-07-17T09:07:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/placid-jover-corporate-officers-teva-3655744949ae5f72 2025-07-17T09:06:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/richard-daniell-corporate-officers-teva-pharmaceuticals-90576ca011dd493b 2025-07-17T09:06:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/richard-francis-82278b0dc32e5c93 2025-07-17T09:06:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-retinal-camera-helps-detect-eye-issues-earlier-02999bf95022f69c 2025-07-16T20:38:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-i-learned-at-scrs-west-a-glimpse-into-the-future-of-site-operations-481b29bff76272cf 2025-07-16T14:19:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-unveils-medtech-s-first-innovation-cro-icro-redefining-r-d-in-a-capital-913a4c8bc4339032 2025-07-15T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-cpvt-community-3b452461749271b4 2025-07-08T15:01:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-security-of-onshore-manufacturing-b976341b22c624ba 2025-07-03T19:02:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/rep-miller-meeks-hosts-capitol-hill-briefing-showcasing-breakthroughs-in-healthc-07e2e3d2a8ba50aa 2025-07-01T15:12:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/healx-and-sci-ventures-join-forces-to-uncover-cures-for-paralysis-with-ai-driven-7b539c408f974473 2025-07-01T11:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-possibilities-for-advanced-therapy-medicinal-products-in-estonia-5a3558ee66ee7238 2025-07-01T10:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/aece4cf11bcc21df 2025-07-01T06:37:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-37-completes-second-fda-inspection-as-enrollment-leader-in-phase-3-asthm-bfe13999e069d897 2025-06-30T22:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-presents-at-1st-annual-european-biopharma-obesity-innovation-forum-5c888826040c4dc1 2025-06-30T15:26:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-flamma-group-receives-funding-from-regione-lombardia-657c5aa239ae42ff 2025-06-30T15:13:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-announces-further-35m-expansion-at-farmabios-to-double-footprint-and-fue-7b6b3a8611f92719 2025-06-30T11:05:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/850dc2d8d3083e78 2025-06-30T05:05:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-flamma-group-expands-globally-reinforcing-its-commitment-to-growth-ac01d9b03751acba 2025-06-27T17:38:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinopharmtech-at-cphi-pmec-china-2025-exhibition-544ef8871c88b5c5 2025-06-26T15:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/alphaiota-expands-strategic-partnership-with-pmcardio-to-launch-first-ai-powered-7a08b89973e0bca2 2025-06-26T14:28:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/powerful-medical-awarded-1m-eu-funded-grant-by-slovak-ministry-of-economy-to-adv-2f9bdf0ebb7ad642 2025-06-26T14:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/hematology-solutions-9bb6dcc75cb5ee19 2025-06-26T12:23:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/award-for-lars-lannfelt-who-paved-the-way-for-the-alzheimer-s-drug-lecanemab-b235856f44104d14 2025-06-26T07:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-deep-tms-targets-brain-networks-for-mood-regulation-9b65c313a5b3a2b9 2025-06-25T19:53:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-chu-de-toulouse-cherche-une-derniere-ou-un-dernier-volontaire-pour-l-etude-cl-04a44196e919b2e4 2025-06-25T14:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-science-kluczem-do-rozwoju-gospodarczego-polski-21cc5234444b0afd 2025-06-25T12:47:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/refugiados-e-politicas-de-exclusao-historias-do-nazismo-holocausto-e-exilio-no-b-2c235241ef642914 2025-06-25T12:31:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-study-embracing-ai-for-efficient-chest-x-ray-reporting-and-quality-assuranc-b39dedf77364d891 2025-06-25T07:23:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-preparedness-against-the-threat-of-mosquito-borne-diseases-in-the-e8204632f65df358 2025-06-25T07:07:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/yale-school-of-medicine-8436f7fc9033c60b 2025-06-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biosimilar-markt-wachst-mit-beeindruckender-dynamik-e7098d58adc84315 2025-06-24T07:38:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/let-the-science-lead-why-inclusion-in-clinical-trials-matters-this-pride-month-8b7b34840af855e8 2025-06-24T07:33:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-to-report-second-quarter-2025-financial-results-on-july-21-107d59e7a3f66ac4 2025-06-23T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atinary-and-chemspeed-teaming-up-for-self-driving-labs-3014fadf69d698cd 2025-06-23T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/minimum-service-from-21-july-till-4-august-c51a4d779c11e5e1 2025-06-23T09:51:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-pmec-china-2025-exhibition-invitation-56cc1a0f1e2abeb0 2025-06-23T08:51:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mithilfe-der-anleihe-mehr-okonomisches-potential-ausschopfen-5a085dc80a0279ae 2025-06-23T08:29:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/invention-of-an-mri-system-enabling-multiplanar-real-time-cardiac-scanning-witho-3cd7ebeb9184f4cb 2025-06-20T09:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glycan-based-therapeutics-examining-the-potential-of-glycan-research-in-advanced-45b5ec88ee723dc5 2025-06-18T15:59:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploiting-the-efficiency-of-glycan-protein-associations-a-cutting-edge-techniqu-c343679e877ef87d 2025-06-18T15:55:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovations-in-glycosylation-pathways-defining-the-progress-of-biotechnological-2ee8ce0bd9449c26 2025-06-18T15:53:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/breakthroughs-in-glycan-biosynthesis-shaping-the-advancement-of-biomanufacturing-ce78642e13ae50e4 2025-06-18T15:23:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-appoints-jim-alecxih-as-chief-executive-officer-59e6eaa20211c69d 2025-06-18T12:02:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-awards-breakthrough-device-status-to-the-sure-check-hiv-self-test-c81b4002ccb1d628 2025-06-17T15:54:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/justica-reprodutiva-desafios-interseccionais-na-saude-coletiva-4ce3b915b1ee173b 2025-06-17T14:34:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-at-eshre-2025-8cd9d789d42d5afe 2025-06-17T11:02:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/enabling-a-breakthrough-in-gene-therapy-a-case-study-in-analytical-support-for-c-28404625baeac48a 2025-06-16T14:25:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-announces-promising-long-term-outcomes-for-c-car039-a-novel-cd19-cd20-b-fbe56bacea140ae2 2025-06-16T11:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-to-host-q1-2025-earnings-call-on-may-7-at-8-am-et-fd566ddc03260aff 2025-06-16T09:17:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/highlights-from-the-isrs-cns-summit-2025-the-cyberknife-system-s-impact-in-radio-84312e59bd752483 2025-06-13T16:06:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/formycon-beim-mwb-research-roundtable-8902d5f147124bda 2025-06-13T12:00:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-choose-the-right-quality-management-system-for-highly-regulated-industrie-03b6268d54a64f3c 2025-06-13T09:25:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/wiktor-janicki-zosta-wybrany-na-stanowisko-prezesa-zarzadu-zwiazku-pracodawcow-i-f9c5d598c29a0e19 2025-06-12T16:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/26-years-of-democracy-renewing-our-commitment-to-national-development-545ca82f26cbffa8 2025-06-12T09:16:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/microtech-announces-the-first-u-s-atrial-microsensor-implantations-as-part-of-it-7d980ed8b0708b83 2025-06-12T05:59:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-receives-fda-ind-clearance-for-its-iv-administered-gene-therapy-for-park-f14b6e6282238c71 2025-06-11T11:45:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/womens-month-siphiwe-ledingwane-director-of-pr-comms-projects-at-ipasa-on-resili-da96f14dd35c1486 2025-06-11T11:11:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-potential-668db477f20402d2 2025-06-11T11:04:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sorbonne-university-takes-part-in-vivatech-with-a-program-centred-on-its-innovat-4631e2d63e201656 2025-06-11T08:41:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-aurelien-breton-a-champion-of-patient-access-to-innovation-in-south-61e250589eb08623 2025-06-10T20:43:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-the-future-of-therapeutic-delivery-a-new-look-at-lonza-s-extracellul-298577673c7569dc 2025-06-10T20:29:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/etude-coper-une-etude-nationale-explore-les-causes-physiopathologiques-du-covid-08716bacd73bb4b3 2025-06-10T15:20:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/et-si-moliere-n-etait-pas-mort-en-1673-obvious-et-sorbonne-universite-imaginent-f2fb35a75e88a24e 2025-06-10T12:50:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/minimizing-direct-packaging-costs-versus-freight-costs-486bf8013d95053e 2025-06-10T09:00:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryopak-cube10-a-flexible-high-performance-universal-shipper-8fc944ff350377ee 2025-06-10T06:10:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/maravai-lifesciences-appoints-bernd-brust-as-chief-executive-officer-and-member-8cf531d9ac9e2cd5 2025-06-09T12:35:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukio-2025-reflections-autonomous-ai-is-ready-the-question-is-are-we-ready-to-use-10eedb8f937f78ce 2025-06-09T09:02:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovations-fr-on-astraveus-revolutionizing-cell-therapy-a4d5f32d483fb8ac 2025-06-08T07:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/may-highlights-from-powerful-medical-pmcardio-3-0-launch-stemi-research-and-clin-f20797fe2c78c170 2025-06-07T08:55:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-white-paper-compares-olink-explore-ht-performance-on-illumina-and-ultima-gen-1ebe03388a0b4cd4 2025-06-06T18:04:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/estro-2025-research-highlights-7a7ac460c25432a7 2025-06-06T15:40:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-cios-chose-exeevo-built-on-microsoft-s-1-low-code-platform-e50fe5ab1446540c 2025-06-06T13:10:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/informations-sur-la-cyberattaque-dont-sorbonne-universite-a-fait-l-objet-886fc5e8edb5f1e2 2025-06-06T07:37:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/euv-a4b696ba903cc103 2025-06-06T00:42:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-video-of-hoya-s-euv-photomask-blanks-is-released-23aac6ce412eaa38 2025-06-06T00:42:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/enabling-antigen-agnostic-antibody-discovery-to-identify-novel-vaccine-epitopes-b9af44346b00a783 2025-06-05T16:50:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxipit-partners-with-vestre-viken-to-pilot-ai-in-chest-x-ray-diagnostics-b1b0cdff4ecc72f1 2025-06-05T11:37:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-environment-day-2025-a-call-to-action-for-a-greener-future-7af966fadaa27fef 2025-06-05T09:29:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/element-biosciences-to-present-at-the-2025-human-cell-atlas-general-meeting-b577a42ce04db634 2025-06-05T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-swarm-intelligence-to-improve-treatment-of-acute-stroke-74a5949be68384b2 2025-06-05T06:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-for-medicine-selected-to-support-regulatory-submissions-for-the-nation-dcad6ce096ddef27 2025-06-05T06:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-deep-tms-for-adolescent-depression-based-on-large-real-wo-56c7f9dd50f8d766 2025-06-04T17:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-s-chasse-sur-rhone-site-successfully-passes-its-ninth-consecutive-regula-aff9cfffc33eee52 2025-06-04T09:47:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-15-years-of-innovation-at-foundation-medicine-d24a44260df5103a 2025-06-03T15:18:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/bachem-mourns-the-loss-of-company-founder-dr-h-c-peter-grogg-b018167ef88bfac1 2025-06-03T13:25:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/usine-nouvelle-on-astraveus-mini-factory-industrialization-7f1207541ce2801c 2025-06-02T19:06:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-diagnostics-what-physicians-need-to-know-about-artificial-intelligenc-7cd6139e3f06cbee 2025-06-02T14:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/wvu-medicine-uniontown-hospital-introduces-ai-powered-retinal-camera-for-early-d-3d353fa442442e72 2025-06-02T14:06:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-launches-global-patient-advisory-board-to-ensure-engagement-in-clin-dda17c2f8f054e99 2025-06-02T12:44:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2025-poster-presentation-a-multicenter-randomized-double-blind-phase-2-3-st-d5c4ed2c0642a4c7 2025-06-02T12:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-2025-oral-presentation-ficerafusp-alfa-with-pembrolizumab-in-patients-with-0a658d5ad8c5d6dc 2025-06-01T19:43:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/a8c8d8f1be423272 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/verkazia-iii-0b534a24322c2c43 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-1-b25b953163ef898b 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/40-mg-ml-67f33da1addb1d1f 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-seri-64b045b09c102925 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/11-21-0999589c4005de10 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/s-web-1-s-2e7093c9e5282436 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-002-3d79944fb460d5db 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-vegf-40d9f311ccd95c13 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lx-3-4608b2897ee5fa3b 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-world-sight-day-be-my-eyes-167-26-8b80b0a181a8e58b 2025-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeaim-lymphoma-molecular-profiling-and-cns-penetration-asco-2025-poster-4e0d47acfe086774 2025-05-31T16:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-nicholas-alp-speaks-with-clinical-trials-arena-about-progress-of-patient-cent-053da8ba95eb5aad 2025-05-30T13:59:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/contextflow-curagita-partner-to-improve-lung-cancer-and-lung-disease-diagnostics-6a5840bf0e1c7df2 2025-05-30T06:35:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/uz-leuven-and-contextflow-collaborate-on-a-pilot-to-advance-chest-imaging-analys-03b458cd67b13e03 2025-05-30T06:33:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-receives-fda-fast-track-designation-for-its-potential-first-in-class-iv-1b1e426dd60f51e4 2025-05-29T11:45:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-and-eda-formalises-the-operationalisation-framework-under-the-memorandum-o-3756cd5319c17aa8 2025-05-29T04:36:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/como-la-inversion-en-la-salud-impulsa-el-bienestar-y-la-innovacion-en-latam-270895da28932a08 2025-05-28T17:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-rising-tide-of-weight-reduction-therapies-f53e17bd9a2b5b44 2025-05-28T13:00:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ciencia-e-saude-pela-vida-125-anos-de-historia-da-fiocruz-d75bd91b7bc4cf76 2025-05-27T16:48:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-on-the-trail-to-the-backlands-photographs-of-the-scientific-expeditions-61aac207f5683111 2025-05-27T16:28:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-appoints-morwan-choli-phd-as-senior-vice-president-of-global-regulatory-e863c579aa928836 2025-05-27T14:56:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-receives-rmat-designation-for-c-car168-for-the-treatment-of-refractory-1b7b4f73e02c43ed 2025-05-27T14:28:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategic-partnership-in-italy-between-centogene-and-bianalisi-b716ea255d449ee1 2025-05-27T12:43:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/breakthroughs-in-glycan-biosynthesis-transforming-the-future-of-biotechnological-41bc39c19a8887fa 2025-05-27T12:31:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/biosimilarpreise-in-den-usa-sind-bereits-auf-europaischem-niveau-b8c35d961b353e95 2025-05-27T11:36:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmetcdx-ae801165baffa6b9 2025-05-23T18:55:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-presents-new-data-on-c-car168-for-the-treatment-of-autoimmune-diseases-145a2882d142d86d 2025-05-23T03:48:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/die-starke-strategischer-partnerschaften-in-der-biotechnologie-motor-fur-innovat-97d89a922a4dbdac 2025-05-21T08:26:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cso-and-r-d-insights-and-successes-perspective-group-b2aae874c50204c1 2025-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cmo-insights-and-successes-perspective-group-93323357dda9850a 2025-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cfo-and-board-director-insights-and-successes-perspective-gro-3e56663fa7c120dc 2025-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cbo-cb8j4-53d38c5b1ac33579 2025-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blog-3-perspective-group-f97641681fce3bc2 2025-05-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-cappin-d3f97a46cabe03df 2025-05-20T23:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-announces-promotion-of-sofia-baig-to-president-precision-for-medicine-1ec40f9bf90e275e 2025-05-20T04:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-at-eshg-2025-030a43fd9ab4e5a5 2025-05-19T14:02:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/sitemap-beam-therapeutics-1babced292a06aec 2025-05-19T14:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/base-editing-applications-beam-therapeutics-249fec9a5cdbb071 2025-05-19T13:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-pmcardio-for-individuals-3-0-a-new-era-in-ai-powered-second-opinions-85a72c94f6182097 2025-05-19T13:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-announces-upcoming-oral-presentations-at-lupus-2025-4cfd8d920b83d843 2025-05-17T06:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/zambia-hosts-auda-nepad-technical-working-team-6b266f221acdaea2 2025-05-16T08:50:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/download-poster-small-is-powerful-demonstrating-the-potential-of-a-novel-microfl-78b4627cc259d143 2025-05-16T07:44:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/profound-medical-annual-general-and-special-meeting-of-shareholders-voting-resul-12be91f6f9d2a5fb 2025-05-14T20:54:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/profound-medical-annual-general-and-special-meeting-of-shareholders-voting-resul-03a447648c0c8279 2025-05-14T20:54:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-presents-new-glp-toxicology-data-supporting-recent-fda-ind-clearance-of-d992b1507cf90361 2025-05-14T11:45:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-commits-to-the-implementation-of-the-african-union-smart-safety-surveillan-3184bac47bdc0451 2025-05-14T10:42:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidson-leads-the-future-of-sustained-growth-in-healthcare-52461893d401b558 2025-05-14T08:24:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/rms-requests-and-national-applications-cf8fa46954cb9c9d 2025-05-13T11:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-reports-q1-financial-results-and-provides-business-update-6c96ce0b1335eafb 2025-05-13T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemspec-2025-5db5a26ab1dc8c8f 2025-05-13T10:06:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-confidence-at-speed-how-fidi-uses-oxipit-ai-through-carpl-in-emergenc-1054eee247a1e6e6 2025-05-13T07:41:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-foundation-medicine-s-flexomx-labtm-a-flexible-research-lab-to-support-the-9deba01f2a0259aa 2025-05-12T16:24:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-receives-fda-ind-clearance-for-its-first-in-class-iv-administered-gene-t-5d112ee6f67f9c96 2025-05-12T11:45:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/presentations-and-publications-beam-therapeutics-f8e72616edb47ba1 2025-05-09T17:31:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/rna-editing-with-crispr-cas13-beam-therapeutics-e09520a135410272 2025-05-09T16:22:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmable-base-editing-of-a-t-to-g-c-in-genomic-dna-without-dna-cleavage-beam-8bd26e7226f05b8c 2025-05-09T16:22:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/improved-base-excision-repair-inhibition-and-bacteriophage-beam-therapeutics-5d1cc0704ba9a9eb 2025-05-09T16:21:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-the-dna-specificity-and-applicability-of-base-editing-through-protein-f992dfafd262b125 2025-05-09T16:21:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/increasing-the-genome-targeting-scope-and-precision-of-base-editing-with-enginee-bd0344aa17ddf4ce 2025-05-09T16:20:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmable-editing-of-a-target-base-in-genomic-dna-without-double-stranded-dna-18bcab425e3b6f99 2025-05-09T16:20:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/re-usable-versus-disposable-packaging-3563c212165538c8 2025-05-09T14:20:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/2024-pharmacy-statistics-key-figures-and-trends-161ae077306602b3 2025-05-09T10:15:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/profound-medical-announces-first-quarter-2025-financial-results-01213c11fb387b51 2025-05-08T20:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/profound-medical-announces-first-quarter-2025-financial-results-7945823029800a8b 2025-05-08T20:34:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioprocess-insider-on-astraveus-necstgen-cgt-bottlenecks-78ed3b5ee94e3d91 2025-05-08T19:07:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-landscape-single-arm-robots-in-hard-tissue-surgical-robotics-b17006508ebdc79a 2025-05-08T16:06:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-tariffs-and-sanctions-in-your-supply-chain-0946ab9df904587e 2025-05-08T09:05:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-amet-lorem-dolor-glavrida-agestas-042206005dbbad6b 2025-05-08T06:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cfo-and-board-director-insights-and-successes-perspective-gro-3cacc37bed34e407 2025-05-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cbo-and-coo-insights-and-successes-perspective-group-f6510321052e8c71 2025-05-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dolor-sit-amet-consectetur-adipiscing-d696acad32207f6d 2025-05-07T18:33:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-one-health-system-is-embedding-diabetic-retinopathy-screening-into-primary-c-eeff5a4b06d8a971 2025-05-07T16:38:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/15-real-world-examples-of-ai-solving-complex-problems-across-industries-today-38823426820308b7 2025-05-07T16:38:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-to-report-q1-2025-financial-and-business-updates-on-tuesday-may-13-2-0d890aa3fd7433a8 2025-05-07T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-healthcare-advanced-synthesis-completes-the-acquisition-of-cerbios-4202ef1bd8ac2708 2025-05-07T07:31:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/gen-news-astraveus-necstgen-car-t-partnership-ffdc6d9937419a2e 2025-05-06T19:09:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-gene-therapy-review-astraveus-necstgen-car-t-collaboration-498d2bf52a9c0fdf 2025-05-06T19:08:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/giro-saude-destaca-aumento-de-diagnosticos-de-autismo-e-aprovacao-de-novo-medica-5d06e8f9f17ce40d 2025-05-06T13:37:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/celerion-launches-enhanced-version-of-labnotes-bioanalytical-data-management-sof-df9c228ff890e9b4 2025-05-06T12:04:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-is-now-officially-in-brazil-1679ab6e1c317123 2025-05-06T11:31:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/healx-appoints-christopher-moertel-as-global-head-of-clinical-development-5fe48524cde61806 2025-05-06T08:16:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceo-yossi-bar-presents-lem-surgical-at-lsi-usa-25-ff70ee22ee807d42 2025-05-06T01:46:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-selected-as-key-service-provider-will-utilize-ultima-genomics-ug-100tm-336bf638609faa5e 2025-05-05T15:55:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/reproductive-genetics-portfolio-launch-pgt-a-and-carrier-services-8cc956cbd26c46bf 2025-05-03T09:00:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/brainsway-to-showcase-deep-tms-at-the-2025-american-psychiatric-association-annu-92a763c02fb7bbe9 2025-05-02T18:41:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/brainsway-to-showcase-deep-tms-at-the-2025-american-psychiatric-association-annu-b04d12aa97206302 2025-05-02T17:06:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-drug-development-the-role-of-model-informed-approaches-in-advancing-c-6ce71940afa2b44e 2025-05-01T15:38:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/hasta-temsilciligi-4f3a08ad524bbb04 2025-05-01T05:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/form-6-k-intercure-announces-fy2024-results-and-provides-q1-2025-update-revenue-7b453c846456523d 2025-05-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/profound-medical-to-participate-in-the-2025-bloom-burton-co-healthcare-investor-a9caba59ebe3bb38 2025-04-30T20:54:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/smarter-faster-safer-celerion-unveils-major-upgrade-to-labnotes-bioanalytical-so-91cf86b48ad2f3ed 2025-04-30T15:26:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/form-20-f-869c0f768e6936a3 2025-04-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/initial-perioperative-data-from-captain-randomized-trial-demonstrate-mri-guided-290b8c57748426f8 2025-04-29T11:46:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/initial-perioperative-data-from-captain-randomized-trial-demonstrate-mri-guided-0871659b58e2281c 2025-04-29T11:46:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/yale-school-of-medicine-52a0ef08ffc19fb8 2025-04-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-for-medicine-welcomes-matt-grow-as-new-cco-32ebf7d77fa18127 2025-04-28T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-to-present-progress-updates-at-the-asgct-annual-meeting-including-nhp-gl-a816e45b4955b552 2025-04-28T20:35:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-pharmaceuticals-announces-36-9-million-investment-and-strategic-collabora-e52e4becc89cb7ff 2025-04-28T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kasr-al-aini-lance-le-programme-de-medecinefrancaise-kaf-en-2025-2026-une-etapes-42a11ec8690aa571 2025-04-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saved-jobs-2b205a3d14c02f6a 2025-04-25T22:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-announces-initiation-of-first-in-human-clinical-trial-with-n-709f2c6007223edf 2025-04-25T17:00:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-for-medicine-and-pathai-announce-strategic-collaboration-to-advance-ai-44bcc24df188cff8 2025-04-25T15:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-launches-triallenstm-an-ai-powered-operations-dashboard-for-ecoa-an-d72a18d238905db2 2025-04-24T12:54:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/giving-new-life-to-medicines-and-new-options-to-patients-fighting-cancer-bccc06d3ab68cb70 2025-04-23T22:04:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-mrna-encoded-masked-il-12-improves-systemic-tolerability-while-maintaining-an-42cfb3fbb5351642 2025-04-22T22:00:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/comunicado-gardenal-frisium-e-urbanil-3f06d535e8ad0f1d 2025-04-22T17:45:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-reports-first-quarter-2025-results-dbe8ed5a3ecd7b41 2025-04-21T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zimmer-biomet-completes-acquisition-of-paragon-28-a5889770641844fa 2025-04-21T15:27:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/good-clinical-podcast-season-3-21cf432fa374e04c 2025-04-18T15:55:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/job-32cbd4d825215ed9 2025-04-17T20:33:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-us-at-asembia-s-axs25-summit-d86b7e86c6be98a9 2025-04-17T14:27:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-endorses-human-relevant-nonclinical-models-a-welcome-shift-for-monoclonal-an-b3a0f3c785c8e762 2025-04-17T14:08:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/current-openings-beam-therapeutics-a0245c91917bf32c 2025-04-16T17:06:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooperacao-social-e-mnu-promovem-curso-de-formacao-em-saude-antirracista-nas-fav-c5dd86d046925bfb 2025-04-16T16:30:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/hereditary-alzheimer-s-blood-marker-for-defective-neuronal-connections-rises-ear-2158496c6e0429af 2025-04-16T08:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-milestone-in-advancing-cancer-care-1-000-peer-reviewed-publications-and-counti-5583e1ec3375382f 2025-04-15T17:58:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-authorizes-alzheimer-s-drug-lecanemab-73d405d61d6bf1ca 2025-04-15T16:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-published-in-organic-process-research-development-oprd-a-new-method-for-a-940e623bc81b3dde 2025-04-15T14:49:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/profound-medical-aua-2025-investor-event-agenda-a7535da22af608b3 2025-04-15T11:54:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-overview-of-human-and-veterinary-medicines-for-2024-e8e7253fba077497 2025-04-14T09:45:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/1ec7811829812d15 2025-04-14T01:01:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-deep-learning-to-discover-functional-antibodies-for-sars-cov-2-with-picomo-281ffebd612137e5 2025-04-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deep-learning-based-protein-therapeutics-design-to-treat-her2-cancers-c85a321b349aaa63 2025-04-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recherche-et-patrimoine-culturel-signature-d-une-convention-partenariale-entre-s-ba68e7c1347951e8 2025-04-11T09:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-momentous-occasion-unfolded-at-cairo-university-grand-celebration-hall-where-t-42212f71a70683ab 2025-04-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-agency-of-medicines-successfully-passes-international-audit-ranking-among-838952ade76fb449 2025-04-08T08:31:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-awarded-as-global-leader-in-biologics-manufacturing-87e6077292106b0d 2025-04-03T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glycan-based-treatments-exploring-the-capabilities-of-glycan-biology-in-modern-m-6f639eee0ecb4634 2025-04-03T11:56:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovations-in-glycosylation-pathways-shaping-the-advancement-of-biotechnologica-6cfdfb10b23acf2b 2025-04-03T11:51:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-presents-new-data-from-glp-toxicology-study-in-nhps-demonstrating-potent-345a9a1700b643a9 2025-04-03T11:45:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/ema-skizziert-ma-geschneiderten-klinischen-ansatz-fur-die-entwicklung-von-biosim-ae7317a2b189fcc7 2025-04-03T10:31:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/genial-s-step-by-step-guide-for-preparing-for-laboratory-inspections-to-achieve-4026942e88764f99 2025-04-03T10:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scrip-asks-what-does-2023-hold-for-biopharma-part-6-artificial-intelligence-1d8008fb562ac55f 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-opens-lab-space-in-jlabs-nyc-89df1cbd402622d0 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-looks-to-unlock-the-therapeutic-promise-of-mini-proteins-2c713c84ff7c85e0 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chatgpt-is-just-the-tip-of-the-iceberg-in-content-creating-artificial-intelligen-142d2938e84ebbfa 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-uses-ai-to-generate-therapeutic-mini-proteins-daed5d61d3b5f361 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-has-secured-a-footing-in-drug-discovery-where-does-it-go-from-here-393c0eb27ec27d78 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-selected-to-participate-in-the-aws-generative-ai-accelerator-3ef0c1e2bc8bee74 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-drug-design-replace-drug-discovery-current-jlabs-resident-ordaos-thinks-so-a-7a51b9cb6431d3d7 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-and-fatiabgen-partner-to-optimize-therapeutics-for-challenging-oncology-c-cb28d18b67e2118a 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-generative-ai-revolution-is-creating-the-next-phase-of-autonomous-enterprise-d7b29f55cc572ac2 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-announces-a-joint-development-agreement-to-create-novel-therapeutics-for-216ab1967c1df866 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-announces-appointment-of-ziwei-liang-phd-to-role-of-chief-science-officer-ed2f20ceed57900d 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-nonexomics-deal-shines-light-on-novel-mini-proteins-9e20868e8636e45b 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-and-nonexomics-announce-research-collaboration-947b5c1a39ced1c4 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mini-proteins-combine-best-of-monoclonals-and-small-molecule-drugs-f764db4ab0ea8ef1 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordaos-raises-5-million-in-seed-to-accelerate-drug-design-and-discovery-96e42bbd4ffc2386 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vyant-bio-inc-ordaos-bio-and-cellaria-inc-announce-collaboration-to-design-and-q-504a9cf75d13aec5 2025-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sollis-health-redefining-urgent-and-emergency-care-5b4c8544ddd887ae 2025-04-01T22:46:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/evan-lippman-corporate-officers-teva-pharmaceuticals-96d8a11cd6987449 2025-04-01T06:17:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-acquires-cerbios-pharma-sa-da16b3281c2cf1b5 2025-03-31T15:01:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-awarded-best-on-time-delivery-at-2025-cdmo-leadership-awards-0b7116b098430f87 2025-03-31T13:07:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/pipeline-sellas-life-sciences-7cad498ad18220fc 2025-03-31T05:34:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/adare-honored-with-2025-outsourced-pharma-cdmo-leadership-award-ba986433f7f0f5d1 2025-03-28T14:22:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermittent-fasting-increases-sex-drive-in-male-mice-an-approach-for-low-libido-9d73a9cf2242651d 2025-03-28T08:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/adamas-consulting-strengthens-resources-in-apac-d33d31cba61d9206 2025-03-28T01:34:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/ergomed-ssu-team-named-finalists-in-the-pharmatimes-international-clinical-resea-41a32195411503ea 2025-03-28T01:32:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-adds-bioinformatic-capabilities-for-its-spatial-biology-customers-partn-3f9ccb5d2ea26da4 2025-03-27T20:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/14-hidden-it-costs-of-veeva-and-salesforce-b9346209958acff5 2025-03-26T18:45:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/paige-launches-new-system-wide-ai-application-for-the-gastrointestinal-tract-3b408e2edd668762 2025-03-25T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rein-therapeutics-8d7c210e9ae7760e 2025-03-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-case-for-strong-governance-in-supply-chains-6e6351505bf40dcb 2025-03-21T13:40:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-cancer-centre-and-5d-clinics-a-joint-venture-to-expand-access-to-advanced-r-7d126ba5dfd278e2 2025-03-21T10:59:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/mastering-life-sciences-events-3166709fe7b9338a 2025-03-20T19:04:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-advancing-cancer-diagnosis-80a40bd5e25cce0f 2025-03-20T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-provides-q4-and-full-year-2024-business-update-181389fad4ccab10 2025-03-20T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yale-school-of-medicine-90d7d28cb3c68fda 2025-03-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/noramco-ceo-lee-karras-discusses-25-million-halo-investment-with-pharmtech-14ef73e759b467c8 2025-03-19T20:20:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/nvidia-spotlights-digital-diagnostics-as-ai-healthcare-pioneer-at-gtc-2025-566e027d7f74f143 2025-03-19T13:11:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpace-holdings-inc-to-report-first-quarter-2025-financial-results-on-april-21-9add52b303c6242d 2025-03-18T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-explores-nvidia-isaac-for-healthcare-in-surgical-robotics-5b2567bf476c1b14 2025-03-18T20:02:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-kalif-corporate-officers-teva-pharmaceuticals-ef3f7ace83337c66 2025-03-17T13:49:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-688ffbfd1436d983 2025-03-17T02:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/thank-you-1e0e9a31195bec68 2025-03-14T17:37:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-to-exhibit-at-2025-american-society-of-breast-surgeons-asbrs-annual-meet-3340880ff90b23ce 2025-03-13T14:57:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-recognized-with-internationally-renowned-if-design-award-for-31st-consecut-fe35f53565bebc8a 2025-03-13T12:55:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/increased-risk-of-dementia-study-evaluates-digital-memory-tests-for-home-use-c7ef30777f53d0fc 2025-03-13T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-to-report-full-year-and-q4-2024-financial-and-business-updates-on-th-1200a3efa8cb4739 2025-03-12T20:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-announces-acquisition-of-select-assets-of-bioreference-health-s-innovati-e15cd0891ba9f5e2 2025-03-11T12:42:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/solve-field-teams-biggest-time-killers-73b04ee4c2009d85 2025-03-11T11:48:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-appoints-seasoned-biotech-leaders-to-board-of-directors-ad7908bfe259ade2 2025-03-11T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-selected-for-2025-cdmo-leadership-awards-79e75629e265f02b 2025-03-10T20:10:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-to-exhibit-at-the-2025-society-of-breast-imaging-sbi-symposium-d44c47f7a785f949 2025-03-10T12:53:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-women-in-the-workplace-progress-challenges-and-advice-to-future-fema-33810762962cf797 2025-03-08T08:00:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/unleash-the-power-of-rwe-in-ltfu-studies-with-dcts-b8e250f260c77768 2025-03-07T14:35:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-appoints-abbas-kazimi-as-chief-executive-officer-45dd90bebe1c0a11 2025-03-07T13:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/achieving-personalization-at-scale-in-life-sciences-2223f5ae4c6d742c 2025-03-06T16:33:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-pharmaceuticals-issues-letter-to-shareholders-9d61e258d0708553 2025-03-04T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-expands-commercial-payload-production-capabilities-at-le-mans-to-strengt-dc6d9fd80f2bb6d6 2025-03-04T08:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-to-exhibit-and-join-the-hands-on-cryoablation-sessions-at-the-european-c-deb5b55004444cd6 2025-03-01T08:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/cerbios-pharma-s-a-boosts-production-capabilities-for-hpapis-and-adcs-91fe165801afa1a9 2025-02-28T14:01:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/sbrt-for-prostate-cancer-understanding-the-evidence-of-the-pace-b-trial-8d1c93124f28a861 2025-02-27T11:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-general-meeting-of-shareholders-of-intercure-ltd-53298fe02579cce8 2025-02-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/annual-general-meeting-of-shareholders-of-intercure-ltd-b6f680bb0566afd2 2025-02-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-introduces-aplio-beyond-a-premium-ultrasound-solution-aimed-at-expert-user-0df74a7e5c5a0e3c 2025-02-26T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comunicado-transferencia-de-titularidade-dos-registros-dos-medicamentos-gardenal-b676dbf2e0984008 2025-02-25T17:19:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-expands-production-scale-multiomic-services-with-ultima-genomics-ug-100-047812b65d28c4e2 2025-02-25T14:23:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/explanation-of-language-requirements-for-medical-devices-for-manufacturers-d2c03a955dbe3180 2025-02-25T14:10:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-achieves-research-milestone-in-collaboration-with-lilly-decb8fd21dd3ecdb 2025-02-25T13:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-instructions-for-safety-advice-tools-ed54a4bc7384c1a9 2025-02-25T08:37:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-might-ai-be-heading-bf9c330f3a127a78 2025-02-24T18:20:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/shape-the-future-of-cancer-care-attend-the-2025-oncology-clinical-trials-confere-3865b477d63495a4 2025-02-24T15:54:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/maravai-lifesciences-completes-acquisition-of-the-dna-and-rna-business-of-offici-c0d9c249077e4246 2025-02-24T15:16:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/healx-announces-first-patient-dosed-in-phase-2-trial-evaluating-hlx-1502-for-the-15c02be8de5c3e74 2025-02-24T11:56:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-practice-aifi-pilot-started-in-five-dutch-hospitals-0a462a89e0cf1fab 2025-02-22T18:39:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/faster-more-accurate-diagnoses-at-lilleb-lt-hospital-9cc96b90770e6d17 2025-02-22T16:03:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-game-changing-features-you-may-have-missed-in-florence-ebinders-2edab148062abe45 2025-02-21T20:43:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-clinical-trials-conference-march-27-28-2025-nashville-tn-9e909bca82f4be29 2025-02-20T15:53:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/malignancy-scoring-in-limburg-weilburg-a-decisive-step-into-the-future-fbeeac261a6243a4 2025-02-20T15:47:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/incyte-and-genesis-therapeutics-announce-strategic-ai-focused-research-collabora-08d827c529ad09df 2025-02-20T15:24:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ai-revolution-in-pharma-will-2025-be-the-breakthrough-year-99ed5d9d87e485da 2025-02-20T12:45:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-announces-exclusive-clinical-trial-license-for-the-spurtm-ai-enable-3c266c61c2d338db 2025-02-18T12:55:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/nura-bio-expands-leadership-team-with-c-suite-appointments-f5d912f828f30cba 2025-02-18T12:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-inspire-duchenne-positive-initial-clinical-tria-794e6950da7eec67 2025-02-18T11:55:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cinq-premieres-entreprises-rejoignent-la-cite-de-l-innovation-sorbonne-universit-bbd56b07af096e9b 2025-02-18T10:07:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/supply-of-equipment-and-transfer-of-production-technologies-to-a-biotechnologica-ed8b16c2bc78b13c 2025-02-17T14:59:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-aids-relief-efforts-for-california-wildfires-2eb1c6f6dad13ff8 2025-02-15T08:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-announces-agreement-for-the-acquisition-of-preferred-stock-and-6e87bafad43219c4 2025-02-13T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-nouveau-programme-d-ia-en-humanites-numeriques-offre-une-comprehension-approf-58ef67f886ef72de 2025-02-13T13:08:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/guerre-en-ukraine-les-avions-obliges-d-emprunter-des-itineraires-plus-longs-augm-ffc8fb5cb88c40a0 2025-02-13T09:22:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/312552-2-a3125712eefd36d3 2025-02-12T23:31:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/zimmer-biomet-announces-definitive-agreement-to-acquire-paragon-28-fe0547c4daa7430c 2025-02-12T18:57:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/acceptance-of-lepure-equipment-and-consumables-5572394e1580d5c0 2025-02-12T14:10:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/axplora-announces-50-million-investment-in-glp-1-manufacturing-at-mourenx-france-cc0a6c97473cd3fa 2025-02-12T07:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intercure-names-alexander-rabinovich-as-chairman-replacing-ehud-barak-8627791e64a0d126 2025-02-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-announces-transformative-joint-venture-to-accelerate-development-and-comm-d0c8bb5541a775b2 2025-02-11T14:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-to-exhibit-at-the-st-gallen-breast-cancer-conference-2025-0daae8a9d48fdf12 2025-02-10T09:15:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-road-ahead-for-small-molecule-apis-in-2025-1537507bee7234f9 2025-02-09T13:41:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-appoints-evelyn-d-an-to-board-of-directors-as-audit-committee-0de3b89bdd8884e9 2025-02-07T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pi-industries-wins-the-prestigious-golden-peacock-national-quality-award-for-yea-66cc699cd785d6ac 2025-02-07T07:25:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemspec-europe-2024-7580a66105af482f 2025-02-07T07:23:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-milan-2024-5a74544b388bb1ec 2025-02-07T07:21:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanding-access-to-radiotherapy-in-ghana-a-conversation-with-rev-dr-kofi-adesi-5ea352e12683101e 2025-02-05T13:02:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/lab-findings-support-the-concept-that-reducing-neuroinflammation-could-help-figh-e36db3e91529770b 2025-02-04T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidson-healthcare-plc-appoints-three-new-directors-4301b68597916866 2025-02-03T17:42:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-era-of-precision-medicine-for-childhood-cancer-394e0016e33d8632 2025-02-03T15:41:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-cancer-day-united-by-unique-inspiring-stories-from-people-affected-by-canc-a22f71e71cb072ff 2025-02-03T14:50:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/psomagen-adds-olink-reveal-for-affordable-discovery-level-proteomics-4682825aa87ba330 2025-02-03T14:48:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-esg-risks-and-opportunities-in-the-manufacturing-supply-chain-715807d5ce9f1a0f 2025-02-03T09:20:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-product-launch-centogenome-ultra-fast-abd61ec259d81685 2025-02-01T08:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-meeting-to-be-held-on-february-3-2025-amendment-regarding-the-private-placemen-e63587b27d6631bb 2025-02-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-to-participate-in-the-guggenheim-securities-smid-cap-biotech-confere-f3a9956145d8a26c 2025-01-30T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivering-a-complete-gastric-cancer-solution-for-you-and-your-patients-2c6aae21ea7a4eb8 2025-01-29T17:05:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/maravai-lifesciences-acquires-assets-and-intellectual-property-from-molecular-as-a8402b661588c756 2025-01-28T21:36:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/day-one-s-next-chapter-in-oncology-innovation-54a4611bd3296b48 2025-01-27T21:05:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-health-challenges-prioritizing-equitable-and-affordable-access-in-lmics-2fcc7ef268f8feb3 2025-01-27T09:41:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-extraordinary-general-meeting-was-adjourned-to-february-3-2025-due-to-lack-o-7865d52ba7cdde82 2025-01-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplier-code-of-conduct-36c7147ca180f0cd 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-sustainability-of-social-accountability-standards-0539ba09858ed5ff 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-assessment-reports-csr-projects-c58ba3c48475725a 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-mission-objectives-6b4c452772484518 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/access-to-healthcare-0362c153bb7e0f6e 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/eugia-sterile-injectables-oncology-solutions-64782d2c99405576 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/curateq-pharmaceutical-contract-development-manufacturing-c86ab07916e5ae87 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-facts-about-hiv-aids-e15707c6080132c8 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/apitoria-specialty-pharmaceuticals-biologics-8235420fe8a3e079 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurobindo-pharma-usa-inc-apusa-3f5c33b14af68d64 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/unpaid-and-unclaimed-dividend-as-on-294d3de7db7f5434 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/scheme-of-arrangements-e2fe538f19c78901 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/registrar-share-transfer-agent-96696df36a2a38a6 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/financial-highlights-consolidated-cc962de343078212 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/buyback-of-shares-d1ac64ec5910b08b 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/annual-reports-42244a6ba397e260 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/code-of-conduct-024466e32f8f0f9b 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/code-of-practices-and-procedures-for-fair-disclosure-40cb640ccf0bb120 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/investor-relations-aurobindo-pharma-financial-reports-ea48c02b6b0c07fd 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/committed-to-healthier-life-3cfbc8c291b22420 2025-01-24T12:14:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryopak-s-future-centered-upon-sustainable-cold-chain-packaging-solutions-2e36c415058e6d49 2025-01-23T14:05:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/yale-school-of-medicine-e90fbaee21e21662 2025-01-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/controler-un-bras-robot-pour-le-handicap-le-projet-extender-laureat-du-concours-935e4c3a3a604313 2025-01-21T09:51:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/over-two-decades-of-ai-powered-precision-how-synchrony-has-revolutionized-real-t-1667622c2d77e949 2025-01-17T10:50:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/polyps-and-ulcer-detection-b7cf589e82368829 2025-01-16T14:42:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivering-a-complete-lung-cancer-solution-for-you-and-your-patients-8e8559ff10fcb6a6 2025-01-15T17:10:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivering-a-complete-colorectal-cancer-solution-for-you-and-your-patients-a78b7995f97cd297 2025-01-15T16:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivering-a-complete-breast-cancer-solution-for-you-and-your-patients-38cec6e138af00b7 2025-01-15T16:33:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptimmune-announces-u-s-fda-breakthrough-therapy-designation-granted-to-letetr-af350ff575249b4c 2025-01-13T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-receives-nyse-noncompliance-notice-5b611ed90715162c 2025-01-10T22:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rms-requests-and-national-applications-ef51b1763e84c4ee 2025-01-10T16:02:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/light-horse-therapeutics-debuts-with-62-million-series-a-financing-316a9b4241b7df4d 2025-01-10T00:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-endodino-a-breakthrough-in-endoscopic-ai-62797576a50848fd 2025-01-09T17:06:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/light-horse-therapeutics-enters-into-strategic-collaboration-with-novartis-d22bac9ce03943e5 2025-01-09T15:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-announces-clinical-progress-in-oncology-therapeutic-pipeline-925572289183db6b 2025-01-09T13:08:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-announces-positive-topline-results-from-two-studies-of-lixudebart-ale-f0-643a104db389125a 2025-01-09T08:50:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/dinov2-and-the-ai-revolution-in-healthcare-f619155ac7826ecd 2025-01-08T17:00:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-fa-community-d2d9b5dd24c04ed6 2025-01-07T21:21:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-untapped-potential-of-endoscopy-videos-in-precision-medicine-8a42fb69e2a2aba8 2025-01-07T15:20:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-announces-abbvie-opt-in-for-first-genetic-medicine-program-from-neurodeg-4c8e10f825ed11f9 2025-01-07T12:45:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-transforming-gi-research-ff66bc2f504913ed 2025-01-06T22:19:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/microtech-announces-first-human-case-of-implantable-microsensor-for-heart-failur-3a52aeeb6d839a86 2025-01-05T10:28:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/overcoming-barriers-to-supply-chain-integration-15de062f2a3117f2 2025-01-03T07:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/15-effective-ways-to-cope-with-seasonal-depression-and-brighten-your-winter-days-e874c29361047b48 2025-01-02T16:42:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/2023-year-in-review-perspective-group-aeb0baf1fe15ece0 2025-01-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2022-year-in-review-perspective-group-6ed3c22b1389b6d5 2025-01-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/socra-2024-year-in-review-what-to-expect-in-2025-d12acb99f32783fa 2024-12-26T20:01:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/forging-forward-our-progress-in-biopharmaceutical-partnerships-and-outlook-for-s-913d7133e273582f 2024-12-24T21:19:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-endotone-a-natural-solution-for-endometriosis-relief-e3879ba2c20db13d 2024-12-24T12:37:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-use-cross-selling-to-drive-hcp-engagement-dc09236a6fef9731 2024-12-23T14:47:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-royal-marsden-nhs-foundation-trust-embracing-technological-advancements-in-r-89d54c172b9673d1 2024-12-23T14:33:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-to-attend-43rd-annual-j-p-morgan-healthcare-conference-and-join-panel-a-fdd3244c5d97928f 2024-12-23T07:18:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/krishna-maridi-joins-signant-health-as-chief-financial-officer-bbb84c18266afe3e 2024-12-20T13:35:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/estonia-s-drug-utilization-research-practices-receive-international-recognition-e51507a7bb6e2090 2024-12-20T11:54:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/record-breaking-attendance-at-accuray-french-speaking-users-meeting-d51ba80fb4f827f0 2024-12-19T16:45:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-announces-2025-officers-and-new-members-84f127b694d3547b 2024-12-19T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-biotherapeutics-to-present-at-43rd-annual-j-p-morgan-healthcare-conferen-54d0c6696ecae874 2024-12-19T12:45:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/extraordinary-general-meeting-of-shareholders-to-be-held-on-october-28-2024-d14ac69529efc874 2024-12-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-service-hours-during-the-holidays-2024-2025-357dbc8b41d66f96 2024-12-17T10:35:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-agents-enhancing-life-sciences-productivity-7a6df31fddc53660 2024-12-12T19:10:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/keep-an-eye-on-diabetic-retinopathy-39fe32eeb91e64fe 2024-12-12T18:25:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-releases-publication-showcasing-benefits-of-centralized-monitoring-implemen-223c78577da5504e 2024-12-12T17:00:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-announces-publication-of-a-review-paper-on-tight-junction-proteins-and-k-ec9f60bc4af4d07b 2024-12-12T11:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/genesis-therapeutics-expands-leadership-team-with-appointments-of-chief-scientif-5f992d78c6d93164 2024-12-11T16:56:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-critical-role-of-quality-assurance-in-clinical-trials-best-practi-17b2033734ad9a23 2024-12-11T15:54:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/september-through-december-at-owlstone-medical-f1818c9460f44460 2024-12-11T15:51:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/highlights-from-a-busy-summer-5e38c8f02114372f 2024-12-11T15:51:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-54bdcbee47325604 2024-12-10T16:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-year-outcomes-from-the-bionics-and-nireus-trials-9283659ff14bbe14 2024-12-10T09:53:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/intercure-announces-first-half-of-2024-results-revenue-of-nis-126-million-and-ad-744f9c183e5cba61 2024-12-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoya-corporation-acquired-the-remaining-shares-of-plasmabiotics-sas-a0dd6f3d6dd046d8 2024-12-09T08:13:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-mouldable-mind-eu-funds-bonn-neuroscientist-with-around-two-million-euros-496f7bf5920de1b1 2024-12-09T07:57:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-preclinical-data-demonstrate-potential-of-capsida-s-iv-gene-therapy-for-stxb-9b3f66c42c6635b4 2024-12-06T17:00:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-insights-into-npc-a-form-of-childhood-dementia-c2b511f51f683112 2024-12-06T07:39:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/unraveling-the-biosimilar-paradox-38988271d6840736 2024-12-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cairo-university-achieves-significant-leaps-in-the-times-arab-rankings-for-2024-cc4bc284f8d45785 2024-12-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anna-s-story-navigating-life-with-her-son-s-brain-tumor-diagnosis-609520029ec4c26c 2024-12-03T17:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-depression-in-older-adults-challenges-stigma-and-treatment-with-br-adda984f77b38ab8 2024-12-03T16:32:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/jonathan-milner-ph-d-appointed-as-non-executive-chairman-of-healx-b4e24db8e422b5de 2024-12-03T13:50:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-to-lead-development-and-manufacturing-of-alanis-therapeutics-antag-1d01870ba79f2c60 2024-12-03T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nora-s-journey-with-pediatric-low-grade-glioma-plgg-test-post-197d8cb377d4cf36 2024-12-02T17:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/common-nordic-packages-for-better-availability-511ce9ecdc2e8960 2024-12-02T15:13:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-yearbook-of-2024-3fe0360a5804df17 2024-12-02T13:13:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-estonian-state-agency-of-medicines-takes-over-responsibility-for-medical-dev-f8ba86e3f7691bfd 2024-12-02T12:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/canon-medical-systems-expands-the-boundaries-of-ct-imaging-a875431073838b24 2024-12-02T08:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-looks-at-benefits-of-amyloid-pet-in-unclear-dementia-aab8bb0b91bbb4e7 2024-11-29T07:03:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-art-of-radiotherapy-what-unusual-patients-have-taught-me-f6e2c40314f406cf 2024-11-28T16:27:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/contextflow-set-to-secure-europe-s-first-radiology-ai-reimbursement-contract-3059565047e8c592 2024-11-27T12:51:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-diagnostics-and-google-cloud-collaborate-to-combat-diabetic-retinopathy-a0d8d8144e431450 2024-11-26T18:55:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/success-at-prostate-sbrt-course-in-miami-7ae3e2212abbe42f 2024-11-26T15:47:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinopharmtech-eda-group-took-part-in-the-international-exhibition-pharmtech-ingr-dbbee795d17d5c57 2024-11-25T14:23:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-based-remote-robotic-assisted-surgery-demonstration-successfully-completed-t-90e78587ab46a137 2024-11-25T13:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-biotherapeutics-to-present-at-7th-annual-evercore-healthconx-conference-7927a611079be5f1 2024-11-25T12:45:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanding-radiotherapy-access-in-pakistan-an-interview-with-dr-tariq-mahmood-0ba3ce761d331791 2024-11-22T13:27:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/boltz-1-democratizing-biomolecular-interaction-modeling-e879d909f8d1a64d 2024-11-20T23:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opening-hours-during-holidays-2024-7790b10d38dd19b5 2024-11-20T13:11:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/rms-requests-ce7a8832e952673b 2024-11-20T12:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/bradon-s-story-be56a8977e971132 2024-11-18T15:09:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-receives-fda-fast-track-designation-for-ale-p02-for-the-treatment-of-cld-242f0c8b6c575879 2024-11-18T11:35:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-presents-preclinical-data-from-study-of-c-car168-for-the-treatment-of-a-a23103164bbb3ead 2024-11-16T21:01:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/curiosity-ignited-showcasing-how-ai-is-accelerating-discoveries-3fea98616a7f7d45 2024-11-14T17:26:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/genesis-therapeutics-announces-new-equity-investment-and-collaboration-with-nvid-60d5ea786c00695f 2024-11-13T16:29:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/healx-announces-agreement-with-sanofi-to-seek-new-rare-disease-indications-for-c-beadaaf5b59387fe 2024-11-13T10:59:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-signs-strategic-transaction-with-private-equity-group-charme-capital-p-97e36f2e5af7f259 2024-11-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/socra-s-2024-annual-conference-connection-inspiration-and-innovation-in-clinical-fbc281e959448ae7 2024-11-12T20:03:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-are-we-in-the-treatment-of-advanced-breast-cancer-today-7302d997e1e238d5 2024-11-12T15:28:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-biotherapeutics-to-present-new-preclinical-data-for-potential-best-in-cl-530c4b569c5c3fdd 2024-11-12T12:45:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-therapeutics-raises-181-4-million-in-an-oversubscribed-series-d-financin-334c376f22b33271 2024-11-12T12:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/maravai-lifesciences-plans-to-acquire-dna-and-rna-business-of-officinae-bio-adva-e74c1c281f70aca9 2024-11-07T23:12:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-presents-positive-updated-data-from-phase-1-2-clinical-trial-c2a788b659fff4d7 2024-11-07T15:06:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-reports-third-quarter-2024-results-and-provides-business-update-6c3b50b5505591dd 2024-11-07T12:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radspeak-by-contextflow-can-ai-help-reduce-the-satisfaction-of-search-bias-18c157e35636535e 2024-11-07T10:31:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-inspire-duchenne-update-expansion-41d6a043739b0671 2024-11-06T21:44:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/speaker-ai-can-help-optometrists-practice-to-the-top-of-their-license-1d99d653b3dacd10 2024-11-06T19:51:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-10-digital-diagnostics-platforms-e4b5737c0be68b1d 2024-11-06T19:49:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-to-present-at-the-stifel-2024-healthcare-conference-2c2ce5be3261ff8a 2024-11-05T15:00:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-to-present-clinical-and-preclinical-data-for-oki-219-at-the-2024-san-anto-394bd7c32922228f 2024-11-01T14:00:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/nine-ways-an-ai-medical-crm-empowers-msls-a9466a518910d3bb 2024-10-31T19:01:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/microsoft-unveils-new-ai-innovations-for-healthcare-a896ba6493e4fef3 2024-10-31T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-announces-the-termination-of-mat2203-partnership-negotiations-a53ae413bb87ba8d 2024-10-31T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-a-meeting-of-cairo-university-s-council-prof-mohamed-sami-abdel-sadek-has-ann-ba18c2b644fdd503 2024-10-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/welcoming-seaport-therapeutics-to-our-portfolio-e3269f0c3b32e4c1 2024-10-30T21:53:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-and-sprim-pro-align-to-advance-eclinical-solutions-bb7afb545ff22f23 2024-10-30T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-orphan-drug-designation-to-capsida-biotherapeutics-for-potential-trea-d6b50648157069c9 2024-10-30T11:45:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/sgrt-on-the-radixact-system-ways-of-enhancing-radiotherapy-delivery-with-vitalho-d4554e01d25a9bbf 2024-10-30T08:16:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/for-the-third-consecutive-time-the-international-accreditation-of-the-architectu-0f9fe3bc2ebfb363 2024-10-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/9a093705a0d9ae57 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/8d34403710a67cfc 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/r-d-b910aeb9a956a1db 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-macrogen-b6fb6082eb58d835 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/701847f5b7e748d1 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/7bc90b928ca2cd9c 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/a7e57d36d65fe1b0 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/8faa727cc07eb601 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/996ddb54c3365622 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ad7037124190d01d 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/0da5601c2cd13360 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-ngs-225e3e627238b86f 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/9640f4c3783878f0 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/36af62b9141e2c24 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-a437bad3fe258d6d 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/4f5af6aedbd6f826 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/c8fb3316a04dc544 2024-10-29T02:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-grants-fast-track-designation-for-hlx-1502-in-neurofibromatosis-type-1-n-3da3d19ac397b7c3 2024-10-28T14:24:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-tests-with-fmr1-repeat-expansion-added-to-blueprint-genetics-offering-ce10b9209e1b7469 2024-10-28T11:08:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-mosquitoes-and-mosquito-borne-diseases-are-the-new-normal-12f8a588311d7501 2024-10-24T07:10:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/chembio-diagnostics-inc-receives-a-grant-for-development-of-a-dpp-congenital-syp-b151ad2ac4ffeb6e 2024-10-23T20:33:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-ink-announces-the-promotion-of-john-pappadakis-to-chief-commercial-offi-4e0180ff0fbc8ce5 2024-10-23T11:59:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimbus-therapeutics-presents-first-preclinical-data-on-novel-wrn-inhibitor-ntx-4-95d3143f1de42434 2024-10-23T11:27:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/hepatitis-the-silent-epidemic-destroying-lives-728a90a1a3758261 2024-10-22T09:42:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-ssu-team-awarded-bronze-in-the-pharmatimes-clinical-researcher-of-the-year-th-f0c4cdf936dd90d3 2024-10-21T22:21:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/2024-fda-dct-guidance-be6f56412673632f 2024-10-21T13:37:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/redcap-project-building-a-tool-for-the-distribution-and-management-of-research-s-5887867468fb9dc8 2024-10-21T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cairo-university-has-achieved-a-remarkable-global-milestone-ranking-first-in-egy-96497e03671b389d 2024-10-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paragon-28-launches-the-phantom-fibula-nail-system-for-less-invasive-fracture-re-fad5db05632174c4 2024-10-17T15:38:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/solving-the-top-five-life-sciences-event-risks-c7792a7ba5e9ac9d 2024-10-17T12:35:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-will-shape-the-future-of-new-york-f308042aefcba748 2024-10-16T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/franchise-petro-s-chili-chipstm-89557be541a6b4b3 2024-10-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-depression-awareness-month-2024-a-spotlight-on-treatments-80a9b65c26818add 2024-10-15T13:39:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-mohamed-sami-abdel-sadek-announced-that-the-faculty-of-arts-at-cairo-univer-b0c2d10d75e858f4 2024-10-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-deep-transcranial-magnetic-stimulation-versus-high-freque-9a0f9cdc48938488 2024-10-11T17:27:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/microsoft-expands-ai-capabilities-to-shape-a-healthier-future-40e4781298bd982e 2024-10-10T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adare-pharma-solutions-wins-cphi-award-for-drug-delivery-device-innovation-2e8162f0722cb90b 2024-10-09T13:09:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-2024-advancements-acquisitions-and-collaborations-are-shaping-the-future-7855c2d02d04da08 2024-10-09T11:45:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/blueprint-genetics-introduces-6-new-reproductive-carrier-screening-tests-with-fm-550f2ec021deee23 2024-10-08T09:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-pharmaceuticals-announces-restructuring-of-scilex-holding-company-debt-1d53ef99ae91b421 2024-10-07T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-data-demonstrate-substantial-therapeutic-potential-of-capsida-s-iv-gene-ther-325ef051f265f0b4 2024-10-07T11:45:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-implantation-of-the-championir-drug-eluting-peripheral-stent-88c480ad19f90303 2024-10-07T11:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-announces-new-general-manager-in-italy-68fa89297683f6a1 2024-10-07T09:31:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-president-of-cairo-university-welcomes-a-delegation-from-the-chinese-people-fa6fc21861304db0 2024-10-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-announces-closing-of-merger-with-reneo-pharmaceuticals-and-concurrent-pri-b3b2c21b739b529d 2024-10-04T23:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-announces-receipt-of-nasdaq-delisting-notification-2fe3a9c3ca94d3bb 2024-10-04T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paragon-28-introduces-a-novel-right-angle-drill-for-the-apex-3dtm-total-ankle-re-97f44b5d78537c47 2024-10-04T14:24:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/valneva-canada-wins-international-rx-award-1bec464edddccc12 2024-10-02T11:51:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-therapeutics-receives-fda-ind-clearance-for-ale-p02-a-novel-cldn1-adc-fo-d41865675f7391b6 2024-10-02T11:01:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/scaling-data-toward-pan-cancer-foundation-models-7e9088bf48fca4f6 2024-10-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cel-sci-selects-ergomed-as-cro-as-it-gears-up-for-confirmatory-fda-registration-4f675adb9711455a 2024-09-30T22:27:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-biotech-update-a-strong-start-to-the-year-holds-promise-through-2024-and-f7c459bcefca80c8 2024-09-29T11:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ushering-in-a-new-era-of-personalized-treatment-for-advanced-prostate-cancer-abb1a04fcc6d5b8e 2024-09-27T19:11:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/gps-proposed-mechanism-of-action-animation-sellas-life-sciences-0ccb343b0be868cc 2024-09-26T14:26:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/trilink-biotechnologies-alphazyme-collaborate-to-launch-new-cleanscribetm-rna-po-91d3bb29d50acdee 2024-09-23T17:53:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-sustainability-challenges-in-companies-with-corbus-fa452493f9a92f26 2024-09-19T12:33:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/adare-pharma-solutions-and-laxxon-medical-3d-printing-collaboration-ea16be0d715fd85f 2024-09-18T18:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/nura-bio-closes-series-a-financing-with-68-million-in-new-funds-bringing-total-r-1e52de09a379d23d 2024-09-17T10:28:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/valneva-scotland-wins-rospa-silver-award-4dc7607a0ce9965c 2024-09-16T12:24:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-oral-glp-1-analogs-for-obesity-market-insights-challenges-and-delive-879cbe810e748138 2024-09-12T18:02:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-transcranial-magnetic-stimulation-therapy-in-managing-anxiety-disord-0b6d420476aa8ddf 2024-09-11T19:00:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/exeevo-crm-versus-veeva-vault-34c91a30b8c7320e 2024-09-11T16:39:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/issued-hoya-integrated-report-2024-343f29aea0487ab8 2024-09-10T01:38:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/transform-your-organization-s-strategic-sourcing-practices-07b9739d019b57e5 2024-09-09T09:16:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/0c6c12efc1d7e175 2024-09-09T05:25:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/fa12fc467b95857e 2024-09-09T05:21:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/8c965b8a35de9a3d 2024-09-09T05:17:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ace14d720884b1b5 2024-09-09T05:13:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/paragon-28-launches-the-r3flextm-stabilization-system-to-anatomically-repair-ank-03302f56951f8b5c 2024-09-04T17:22:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-expands-eclinical-solutions-with-iqvia-partnership-f5f90b2813ef50e6 2024-09-04T13:08:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-biotherapeutics-to-participate-in-upcoming-investor-and-industry-confere-f9ad72c54b711a7a 2024-09-04T11:45:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-appoints-jonathan-freve-cfo-f8d0dc72fdebb205 2024-09-03T11:12:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/424967c3a8dc7233 2024-09-02T12:06:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-power-of-ai-to-enable-precision-medicine-fe47d04621a6c894 2024-09-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/944d14290720eae2 2024-08-28T18:48:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/fourth-pop-up-care-village-shifts-focus-to-meet-needs-of-calgary-s-unhoused-3a5bdea438fa307d 2024-08-23T16:17:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/paige-launches-ai-tool-that-screens-505-genes-for-improved-cancer-diagnosis-4624a5e3b6d20569 2024-08-23T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-history-of-the-petro-petro-s-chili-chipstm-792d944691c9c6cd 2024-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cairo-university-scores-silver-in-the-stars-sustainability-tracking-assessment-r-dccd088e3350a049 2024-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cairo-university-maintains-its-leadership-in-international-rankings-and-its-posi-acc632a1ef28df1f 2024-08-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-enters-cooperative-agreement-with-seven-star-pharmaceutical-services-to-e-9f0b9eee4733d663 2024-08-15T15:44:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-receives-delisting-notice-from-nasdaq-e41f6ecc7c148396 2024-08-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-publication-in-brain-journal-reveals-15-of-parkinson-s-disease-cases-a-4c685b0d1069e497 2024-08-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-reports-second-quarter-2024-financial-results-and-provides-a-b-0241b330cb6ae42a 2024-08-14T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paragon-28-announces-the-launch-of-smart-28sm-portal-and-first-case-using-smart-a6e448f08f012854 2024-08-14T17:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-inspire-duchenne-update-936360d0697a0d94 2024-08-13T23:42:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/paragon-28-appoints-chadi-chahine-as-chief-financial-officer-and-executive-vice-d1231585f22f2649 2024-08-12T16:03:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-red-sea-crisis-is-impacting-global-logistics-6de4a0d5f82b0d59 2024-08-12T09:28:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-announces-reverse-stock-split-cd8ffcefa0312167 2024-08-08T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-reports-second-quarter-2024-results-and-provides-business-update-474a7f26b0181e76 2024-08-08T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/facultad-de-medicina-convoco-a-mas-de-2-100-personas-durante-el-dia-del-patrimon-21021187e4ec0d24 2024-08-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adare-pharma-solutions-relocates-headquarters-to-philadelphia-boosting-local-eco-c918e95d92d0d7cc 2024-08-01T18:14:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/paige-publishes-open-source-ai-pathology-models-for-cancer-r-d-8f821fcfe760d562 2024-08-01T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healx-announces-47-million-series-c-financing-and-fda-clearance-of-phase-2-ind-f-97c71ca244966594 2024-08-01T10:59:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/yearbook-of-the-state-agency-of-medicines-2023-f56bd0b0595fe530 2024-07-31T10:08:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-announces-successful-completion-of-the-first-hysterectomy-perfo-e85f32a7031adc08 2024-07-30T12:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-motion-matters-the-advantage-of-real-time-tracking-b441247c415e8e54 2024-07-30T11:13:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/educacion-medica-hacia-2050-facultad-de-medicina-universidad-de-chile-1d7cc6cda61ff89f 2024-07-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-essentials-for-building-a-customer-focused-consulting-team-c4771f08c2646a58 2024-07-26T14:02:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-announces-the-appointment-of-dylan-hartley-ph-d-as-chief-scientific-offic-20692609b39bd0ea 2024-07-25T22:07:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-5-current-project-management-trends-for-2024-59fa1d6406aacdcc 2024-07-25T17:56:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-puts-a-focus-on-andy-lamb-senior-director-global-strategic-partnerships-4ed536892bb312fc 2024-07-23T22:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/following-a-successful-fda-inspection-kbi-biopharma-extends-and-expands-commerci-8231da4c1e5f8d72 2024-07-23T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-nov-2018-c-maxcyte-e322dbb886444286 2024-07-17T10:43:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-q4-2018-maxcyte-7f38c0cc11fe4cde 2024-07-17T10:43:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-newsletter-q2-2022-maxcyte-d073e2bf2e88bd64 2024-07-17T10:43:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-newsletter-q4-2022-maxcyte-05017c12ac99a9b3 2024-07-17T10:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-newsletter-april-2023-this-quarter-s-edition-includes-our-new-pa-2373768b372bccd5 2024-07-17T10:39:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-newsletter-q2-2023-this-quarter-s-edition-includes-our-new-partn-0ce7071632835177 2024-07-17T10:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-newsletter-q3-2023-this-quarter-s-edition-includes-our-new-partn-bf6de545e9bf69c5 2024-07-17T10:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-minutes-newsletter-q4-2023-this-quarter-s-edition-includes-our-new-partn-2ffc2353762b1413 2024-07-17T10:37:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-puts-a-focus-on-yuqi-zhu-senior-scientist-cell-therapy-process-developme-d91aded3fc1aace3 2024-07-17T10:11:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-panacea-pharma-projects-limited-rebrands-to-primevigilance-ee45ad003ca14cec 2024-07-15T22:56:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-appoints-paul-richmond-as-chief-commercial-officer-f68785ae8fa3c0ca 2024-07-15T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2024-key-drug-delivery-insights-straight-from-your-partner-s-c-suite-b311d7b3be1689aa 2024-07-15T12:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-elkhosht-cairo-university-s-egyptian-informatics-journal-eij-has-risen-global-9ca2758ed20133ad 2024-07-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-elkhosht-announces-an-increase-in-the-impact-factor-of-the-journal-of-the-egy-6e4b9c49f94d5173 2024-07-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cu-journal-review-of-economics-and-political-science-makes-it-into-the-q2-level-8085dd69b28f403e 2024-07-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paige-cofounder-thomas-fuchs-diagnosis-on-improving-cancer-patient-outcomes-with-20d0dded087e6667 2024-07-10T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intercure-ltd-announces-proposed-voluntarydelisting-from-the-toronto-stock-excha-8530dfd05acc7a09 2024-07-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-elkhosht-the-cairo-university-journal-of-veterinary-sciences-and-medicine-mak-dffdc3bb35d0d5af 2024-07-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/which-drug-delivery-technologies-should-you-know-about-in-2024-09b4aa3c390b46b6 2024-07-08T20:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-announces-2m-non-dilutive-financing-tranche-and-reduction-in-outstanding-ca6bd1389e29b97f 2024-07-08T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-ergomed-appoints-dr-sy-pretorius-as-chief-executive-officer-5fc36da3c0e6831f 2024-07-08T07:00:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-dia-con-google-gemini-en-la-facultad-de-medicina-facultad-de-medicina-univers-26a68ed40fdcc1ed 2024-07-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cairo-university-continues-its-global-progress-and-ranks-260th-globally-in-the-l-2756a8989a994a42 2024-07-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/customized-release-through-dispersed-dosage-formats-driving-patient-acceptance-a-b375ba1979e16613 2024-07-01T13:00:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/oramed-pharmaceuticals-inc-announces-the-buy-back-of-its-common-stock-aa44395c42dc01e3 2024-06-26T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remembering-dr-neil-t-thompson-00c1be87d43f151a 2024-06-25T15:23:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/watch-now-the-importance-of-an-end-to-end-cdmo-73830f015385ca1f 2024-06-24T19:58:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-reports-successful-treatment-of-patient-with-limb-threatening-8afe582fc309dea0 2024-06-24T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/following-in-the-footsteps-of-the-leaders-of-arab-thought-an-algerian-thesis-loo-a66478537c3f122f 2024-06-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-elkhosht-receives-a-visit-from-the-head-of-the-african-scholars-forum-and-the-ead3259221630473 2024-06-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cso-placement-successes-perspective-group-a240a446a9da5174 2024-06-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/applied-dna-and-alphazyme-conclude-linea-tm-rnap-manufacturing-scale-up-project-50bd25ae6e7264cc 2024-06-20T21:53:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/california-transparency-in-supply-chains-act-69aa64dbd3744444 2024-06-20T18:14:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-announces-preclinical-trv045-data-providing-insight-into-novel-mechanism-d02c25aefcd3574c 2024-06-20T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/c-path-and-centogene-mou-to-enhance-collaboration-in-lysosomal-disease-research-76e4c9ee9ba219a6 2024-06-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-announces-the-appointment-of-rogan-nunn-j-d-as-general-counsel-and-secret-58d460f59af3ab5c 2024-06-19T21:47:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-elkhosht-welcomes-a-high-level-delegation-from-fudan-university-of-china-to-c-e3b62716b46c4928 2024-06-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-risk-to-resolution-a-breakthrough-in-nitrosamine-analysis-mitigation-5d96cf204b338895 2024-06-14T19:50:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-s-oral-mat2203-to-be-featured-in-fireside-chat-hosted-by-a-g-p-94a0c34db04a85e3 2024-06-13T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-elkhosht-et-l-ambassadeur-de-france-inaugurent-le-bureau-national-de-l-agence-28b08158750548e2 2024-06-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cairo-university-continues-its-development-journey-with-the-release-of-the-third-0adf631ca17cf582 2024-06-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diversifying-the-supply-of-raw-materials-53529b0c6385bb51 2024-06-12T20:30:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/zamra-signs-a-memorundum-of-understanding-with-the-egyptian-drug-authority-eda-439f03a06a39154e 2024-06-07T11:46:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-good-pharmacovigilance-practice-with-adamas-consulting-d279d09d498e4b81 2024-06-05T22:58:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/abelzeta-announces-clinical-data-showing-preliminary-anti-tumor-activity-for-c-c-e1f57cddda3fb1eb 2024-06-05T03:12:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-humble-beginnings-to-a-list-cancer-fighter-paige-s-remarkable-journey-5ee10b7685a75dc7 2024-06-04T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-announces-adoption-of-all-resolutions-tabled-at-2024-annual-general-me-135bcabda9dcc9fc 2024-05-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ce-approval-for-medinol-s-elunir-perltm-drug-eluting-stent-system-8f7c8f5d7e5a780a 2024-05-30T08:19:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-receives-fda-orphan-drug-designation-for-lixudebart-to-treat-idiopathic-a9997c7ecad773ba 2024-05-29T11:00:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/tcfd-disclosure-updated-in-2024-4acb975fbd01b721 2024-05-27T08:00:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-raj-dave-of-cardiovascular-experts-of-pa-implanted-the-elunir-perl-des-b310d6e83b9b6166 2024-05-23T09:02:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-early-feasibility-study-for-our-groundbreaking-championirtm-drug-el-ed8654a816b71107 2024-05-23T07:52:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-considerations-during-spontaneous-coronary-artery-dissection-in-the-pos-82e6264040fa4808 2024-05-23T06:46:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/unveiling-the-impact-of-cytosorb-therapy-on-fluid-balance-in-septic-shock-patien-1a32da5f40e85f36 2024-05-21T08:51:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/centogene-reports-full-year-2023-financial-results-and-recent-business-highlight-6254dda7592507b1 2024-05-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-reports-first-quarter-2024-results-and-provides-business-update-8a5182858e3db1d0 2024-05-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trilink-biotechnologies-collaborates-with-johns-hopkins-university-to-establish-ce5804c4b945e646 2024-05-14T17:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/alentis-announces-presentations-on-claudin-1-in-fibrosis-at-the-era-and-ats-conf-013e2a354f1c4ab1 2024-05-14T11:01:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/reneo-pharmaceuticals-and-onkure-announce-proposed-merger-058d197e307eadff 2024-05-13T11:36:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-biotherapeutics-to-present-preclinical-data-for-parkinson-s-disease-asso-ecbfa7584a9d0ee2 2024-05-10T10:00:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-innovative-research-projects-earn-latest-funding-from-vcu-s-arts-humanities-a-316b86d9d2db513e 2024-05-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sequencing-services-for-whole-genome-and-whole-exome-research-use-53e0c7756686cf89 2024-05-09T11:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-boosts-ecoa-leadership-with-operational-innovations-a2f959533f7e3df3 2024-05-08T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/capsida-biotherapeutics-presents-new-preclinical-evidence-indicating-novel-first-0b4960b4488a4432 2024-05-07T10:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/video-working-together-to-end-neurofibromatosis-speech-at-the-ctf-patient-summit-ffc8f214b9b298d0 2024-05-03T09:02:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/worldwide-clinical-trials-recognized-with-coveted-2024-cro-leadership-awards-bas-7081303524145546 2024-05-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-acquires-leading-pathology-and-histology-provider-horus-scientific-ab0404d952afa780 2024-05-01T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trilink-biotechnologies-and-lonza-enter-into-non-exclusive-license-and-supply-ag-0ef2f3c1cc68a11f 2024-04-30T14:32:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-announces-publication-of-data-from-its-u-s-investigational-devi-b6a8ca78d22b5174 2024-04-30T13:57:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotient-sciences-wins-2024-cro-leadership-awards-77e5fc9488a48cda 2024-04-23T19:54:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/trilink-biotechnologies-announces-new-san-diego-facility-for-late-phase-mrna-dru-10dbf7aa6d44d581 2024-04-18T16:40:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovative-strides-in-ai-for-cancer-diagnosis-bb571fc5f36eaa28 2024-04-16T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-announces-diversity-and-inclusion-site-resource-grants-program-c34eaa934ac401f3 2024-04-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oleds-innovations-manufacturing-markets-schrodinger-7887185ac0e7bbea 2024-04-11T19:49:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/water-binding-and-hygroscopicity-in-conjugated-polyelectrolytes-nature-communica-098bbe6777e3354a 2024-04-11T17:52:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-polar-ether-based-electrolyte-solutions-for-stable-high-voltage-non-aqueous-646b190e30c32a9d 2024-04-11T17:48:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/utech-europe-2024-schrodinger-351bf59195d1c338 2024-04-11T17:32:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/hop-bitterness-in-beer-evaluated-by-computational-analysis-79045acb52d36cf3 2024-04-11T16:45:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-synthesis-and-molecular-modeling-of-new-and-safe-azole-oxime-esters-with-f3e40cc1f52605a3 2024-04-11T16:33:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/polymorphic-amyloid-nanostructures-of-hormone-peptides-involved-in-glucose-homeo-66e2537407a79d6b 2024-04-11T16:19:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-future-is-lab-celebrating-the-49th-annual-lab-week-dec892d7e8daf680 2024-04-11T16:13:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/structural-basis-of-odorant-recognition-by-a-human-odorant-receptor-nature-ee914523ea4da689 2024-04-11T16:01:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-heart-transplant-outcomes-the-role-of-cytosorb-f1ab5e38e8b33fb7 2024-04-11T10:20:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-to-showcase-miniaturized-robotic-assisted-surgery-at-sages-2024-67e3b0bb3b8b353c 2024-04-10T12:08:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/automated-digital-prediction-of-chemical-degradation-products-schrodinger-cce5980d560b25ac 2024-04-10T01:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cerbios-pharma-commits-to-sustainability-with-new-solar-panel-installation-in-lu-963fa5447bb03545 2024-04-08T11:54:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-precision-medicine-has-power-to-transform-pregnancy-health-a-conversation-wi-d05a31025e21854e 2024-04-03T02:29:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-r-d-placement-successes-perspective-group-4295a9f3e2bc9ab2 2024-04-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointm-4213f97be5e1a9be 2024-04-01T11:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-reports-fourth-quarter-2023-results-and-provides-corporate-update-ba72a2b7b4e2ebbd 2024-04-01T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/it-system-incident-at-our-group-982e5a0ba1ae09be 2024-04-01T01:13:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/intercure-announces-preliminary-estimated-2023-revenue-of-nis-351-million-and-eb-2f0a30138972a763 2024-04-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-announces-acquisition-of-select-assets-of-bioreference-health-s-diagnost-8173954152f5e15a 2024-03-28T13:37:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/interphex-2024-schrodinger-31779b6087f84c2c 2024-03-27T14:02:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/epitope-mapping-cryo-em-in-silico-schrodinger-4673ac9dd87396d6 2024-03-27T13:58:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/peyton-howell-speaks-to-acro-s-2024-outlook-ed3437e413eb29c8 2024-03-27T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-cmo-placement-successes-perspective-group-31a235aad5acc26d 2024-03-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-recognized-as-a-leader-in-all-six-categories-of-the-2024-cdmo-lead-2185a897695e78d4 2024-03-21T15:19:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/schrodinger-free-energy-calculations-beyond-small-molecule-binding-predicting-an-c128b1341dedc6d4 2024-03-20T13:37:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/biologics-2024-schrodinger-e47833d5e365be0b 2024-03-20T13:37:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-drug-discovery-schrodinger-71f10f2dabe932b0 2024-03-20T13:37:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/lab-of-the-future-congress-2024-schrodinger-822c2a9501dceec0 2024-03-20T13:36:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/9th-fragment-based-drug-discovery-meeting-schrodinger-dcb646871c26cf9b 2024-03-20T13:36:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioit-world-schrodinger-e01e416e436e1d7e 2024-03-19T18:07:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-s-mira-surgical-system-to-be-featured-among-elite-ai-enabled-in-8122c483ea819066 2024-03-18T08:33:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/noramco-announces-strategic-alignment-with-purisys-and-halo-pharma-launching-the-35d79baa6b4abb1a 2024-03-14T18:15:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/terms-sellas-life-sciences-26720c9e5b81d978 2024-03-14T03:22:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/sitemap-sellas-life-sciences-74061236a2d03064 2024-03-14T03:22:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-board-of-director-placement-successes-perspective-group-d9a06a7b7a73067d 2024-03-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contextflow-winner-of-the-healthy-hub-competition-from-four-health-insurance-com-942a63f1dbd350d3 2024-03-13T17:18:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-signs-strategic-platform-license-with-walking-fish-therapeutics-to-suppo-0eea594cf3fda9ec 2024-03-13T06:09:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-signs-strategic-platform-license-with-prime-medicine-to-advance-next-gen-b9e58d00e054f418 2024-03-13T06:07:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-amm-founding-member-pr-60ee74c1c7d19452 2024-03-13T06:07:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-and-lion-tcr-form-partnership-to-support-global-expansion-of-lion-tcrs-t-da7b00edea232878 2024-03-13T05:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-secures-strategic-platform-license-with-imugene-limited-for-advancement-4dfa4958208672fa 2024-03-13T05:53:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-and-wugen-sign-strategic-platform-license-expedite-scale-04c5f0e0691756af 2024-03-13T05:52:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/parkinson-s-vaccine-seen-to-target-toxic-alpha-synuclein-in-phase-1-trial-parkin-6c0da0699c309a9e 2024-03-11T13:22:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-changes-transitioning-to-the-new-iso-15189-standard-genial-f14dd42fbaee0393 2024-03-07T16:02:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/join-bioreference-in-raising-awareness-for-national-colorectal-cancer-awareness-01cfe577729d12da 2024-03-07T15:57:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/acro-releases-key-highlights-from-survey-on-americans-views-on-clinical-trials-a-e0785c4604496453 2024-03-01T12:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accurate-modeling-of-receptor-functional-response-gpcrs-and-beyond-schrodinger-83459bb2b39090c4 2024-02-29T15:54:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-47th-annual-composites-materials-structures-conference-schrodinger-7d08ba794ec80f11 2024-02-28T15:25:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-receives-fda-authorization-for-the-mira-surgical-system-as-the-1372114f3a6de9ed 2024-02-24T21:59:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmc-analytical-control-strategies-for-drug-development-69a9fcdd0368b547 2024-02-22T16:33:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/cutting-edge-solutions-empowering-clinical-trials-with-specialized-genomic-testi-cd9f5ed6d76309ed 2024-02-21T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-announces-publication-of-preclinical-data-in-molecular-therapy-demonstra-4f03fc4fe6ea46b3 2024-02-21T12:05:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-announces-the-appointment-of-samuel-agresta-m-d-as-chief-medical-officer-a7ca8bdc917eef00 2024-02-15T14:37:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/surgery-in-space-tiny-remotely-operated-robot-completes-first-simulated-procedur-490f61910978d9b3 2024-02-13T15:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/intercure-provides-an-update-regarding-nir-oz-facility-b196998e1cedf651 2024-02-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taking-heart-health-to-heart-bioreference-health-commitment-to-american-heart-mo-fa7aac6d92226aef 2024-02-12T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-cancer-care-a-look-at-bioreference-healthtm-impact-8f18075224a65851 2024-02-06T18:24:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-ceo-insights-and-successes-perspective-group-871ccf700a6b92d4 2024-02-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-recent-board-placements-perspective-group-50b56df332870926 2024-02-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaxxinity-and-university-of-florida-collaborate-on-research-supporting-neurodege-688913e85c837bec 2024-01-31T11:09:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-s-miniaturized-surgical-robot-en-route-to-the-international-spa-4b2e7bff284bbe20 2024-01-30T09:38:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-biotech-ai-and-ml-triumphs-in-2023-cc095a3fe9e99732 2024-01-29T12:18:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/reflecting-on-scientific-achievements-in-2023-b50bf08b7ab39ac7 2024-01-24T22:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-vaccine-to-live-in-space-what-s-happening-in-a-florida-lab-may-help-earthlings-80994ebfe7fa9e9f 2024-01-19T03:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/florida-company-developing-space-vaccines-that-can-make-aging-humans-stronger-wf-610b1af1db70ee9b 2024-01-18T15:52:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-space-travel-research-deliver-a-frailty-vaccine-longevity-technology-7be225da2403c4fc 2024-01-18T15:48:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaxxinity-university-of-central-florida-launch-collaboration-to-advance-medicine-bd6d4fe736882988 2024-01-18T03:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-inc-and-argonaut-manufacturing-services-inc-forge-strategic-allian-1f5907d14be33097 2024-01-16T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/florence-scope-2024-e6e03c2096299087 2024-01-08T21:27:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/custom-mobile-petro-s-chili-chipstm-04b9fb2a0a78a247 2024-01-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-announces-ind-clearance-by-u-s-fda-enabling-phase-1-initiation-for-its-mu-11f32ae8d799a337 2024-01-04T13:50:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/reflections-on-ai-and-pharmaceutical-innovation-in-2023-4c2b4ffc733d05bb 2023-12-29T12:22:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-announces-the-closing-of-4-million-concurrent-private-placement-and-warr-b72d2865c866d8ae 2023-12-28T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevena-inc-announces-4-million-concurrent-private-placement-and-warrant-exercis-953df1ff2cb41a8d 2023-12-27T14:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-service-hours-during-the-holiday-season-33d87c44865b3aa1 2023-12-22T17:08:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/large-molecule-bioanalysis-using-lc-ms-2c50c92d678d4e71 2023-12-21T13:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/festival-of-biologics-us-2024-schrodinger-8d88752619f34eea 2023-12-19T01:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-veranex-acquires-leading-preclinical-services-provider-t3-labs-4dc7a8abe3b0df36 2023-12-14T05:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-a-quality-culture-to-improve-healthcare-manufacturing-55f4ee64d77c5028 2023-12-12T18:46:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/hats-shop-petro-s-chili-chipstm-9083f326a210a584 2023-12-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gifts-shop-petro-s-chili-chipstm-238b78a908c9a757 2023-12-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apparel-shop-petro-s-chili-chipstm-1dd6ea9f6b652bf9 2023-12-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-gallery-petro-s-chili-chipstm-3ca084b006efa643 2023-12-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jobs-petro-s-chili-chipstm-fbcfa1027daab69a 2023-12-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-ceo-transition-revenue-guidance-2023-a575fd17b8b003f5 2023-12-11T21:35:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/lc-ms-applications-in-drug-development-1678c61b8cf979d0 2023-12-08T17:14:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-inc-appoints-maggie-chen-as-site-head-of-patriot-park-mammalian-cg-a4cc864dab782123 2023-12-05T14:45:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/por-que-a-producao-de-um-medicamento-demora-tantos-anos-355eb8b3823fd6de 2023-12-04T13:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/o-que-e-classe-terapeutica-de-um-medicamento-6ac94b45db540c50 2023-11-30T17:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/qual-a-diferenca-de-dose-x-dosagem-nas-praticas-farmaceuticas-df50121de0b0e7ae 2023-11-25T13:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-quality-reproductive-screening-duo-tests-added-to-blueprint-genetics-produc-1883e40b67123469 2023-11-16T12:23:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-and-homology-medicines-announce-merger-agreement-d1ac2b07e281f448 2023-11-16T12:11:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-regains-worldwide-rights-to-bempikibart-adx-914-from-amgen-7e82bc81dde97f77 2023-11-16T12:10:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-duchenne-community-f427893b2d753ceb 2023-11-14T03:05:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/conditionally-activated-ifna-induces-an-inflammatory-tumor-microenvironment-in-p-9c365f84f50bb2e4 2023-11-07T18:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/noramco-announces-the-acquisition-of-the-cambrex-drug-product-business-unit-6f3f448aa44616e7 2023-11-02T17:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-ways-site-enablement-platforms-support-the-white-house-s-call-for-a-stronger-c-359f0644cc36443e 2023-10-30T15:51:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/medinol-receives-fda-approval-for-next-generation-elunir-perltm-drug-eluting-cor-b7f54672ed940383 2023-10-25T11:47:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-appoints-saul-fink-ph-d-as-chief-technology-officer-adec37edd170cd26 2023-10-24T20:05:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/o-que-e-dose-terapeutica-e-qual-sua-importancia-fc120656ef282400 2023-10-20T13:00:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotient-sciences-appoints-thierry-van-nieuwenhove-as-ceo-88f09316d72915c8 2023-10-19T13:31:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/leveraging-conditional-activation-to-localize-antibody-drug-conjugates-to-the-tu-67384c8d2897f98c 2023-10-18T16:06:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/virgotrials-accelerating-patient-recruitment-for-clinical-trial-research-5898feddd02e32c0 2023-10-17T22:15:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/micromed-s-associe-a-natus-7701f7684dfb9d7f 2023-10-16T21:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/o-que-sao-medicamentos-genericos-eles-possuem-a-mesma-eficacia-dos-marca-01a68efa7ec0cd69 2023-10-13T13:00:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/sistemas-combinados-emg-iom-501c76ef1d72baf9 2023-10-12T01:32:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cartografia-cerebral-26554675fea2975d 2023-10-12T01:26:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/mappatura-del-cervello-dcb77422f6d100c5 2023-10-12T00:52:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/sistemi-combinati-emg-iom-b991e51c544f9896 2023-10-12T00:49:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/gehirn-mapping-b916b161f24bdea3 2023-10-11T23:25:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/cartographie-du-cerveau-4620e627053a481c 2023-10-11T23:25:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/emg-iom-kombi-systeme-e2d3ac27ce9dfb6c 2023-10-11T21:10:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/emg-iom-combo-systems-28c1cf5545aac872 2023-10-11T21:04:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/systemes-mixtes-emg-iom-5acf9bd95eda85bd 2023-10-11T02:59:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurocirugia-9ee22a0b808b44ce 2023-10-10T21:18:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/cateteres-serie-camino-1104hm-para-el-camino-icp-monitor-14f8f652b2914726 2023-10-10T20:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/cateteres-serie-camino-1104b-para-el-camino-icp-monitor-e31146e9606bfc55 2023-10-10T20:28:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/cateter-camino-1104l-para-el-camino-icp-monitor-610de26f192d2684 2023-10-10T20:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cateter-camino-1104g-para-el-camino-icp-monitor-c370e2f29a4bf3bd 2023-10-10T20:25:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pcr-as-a-bioanalytical-tool-for-gene-and-cell-therapy-b8a9e73a6ce236db 2023-10-10T20:17:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmi-di-assistenza-f9a460fd4b33708e 2023-10-05T23:49:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/programmes-de-services-b90533ed2589a917 2023-10-05T22:54:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/programas-de-servicios-4879a0464876742f 2023-10-05T22:42:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/bo-ject-dhn-disposable-hypodermic-injectable-needle-electrodes-test-6aae2ad3ca19bdc3 2023-09-28T18:27:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-2nd-china-russia-forum-on-biopharmaceutical-technologies-and-business-cooper-1b5fd4a3106504f9 2023-09-25T13:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-appoints-ann-howell-pharm-d-as-vice-president-of-regulatory-af58f1be3d411e46 2023-09-20T12:41:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/trust-the-key-to-operational-success-in-post-covid-19-oncology-trials-882e6f2cbf276515 2023-09-19T13:16:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/publications-sellas-life-sciences-71a5f3fb4a1dd016 2023-09-19T12:57:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cdk9-sellas-life-sciences-abc6fcf26faae6ca 2023-09-19T12:53:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/wt1-antigen-sellas-life-sciences-3ae3d7becba58763 2023-09-19T12:47:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-appoints-ryan-roberts-as-chief-commercial-officer-2c1815bb32f87f5c 2023-09-18T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/o-que-e-farmacovigilancia-8fface9a5f406c1c 2023-09-14T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-and-horizon-therapeutics-plc-announce-dosing-of-first-patient-in-phase-2-2458eefcb4481d0e 2023-09-13T12:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pop-one-618b8a6388b063f5 2023-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kbi-biopharma-inc-expands-global-portfolio-with-launch-of-suremabtm-for-faster-m-32451451a7debf12 2023-09-12T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plus-qu-une-simple-detection-de-nodules-76cb0b2b27f570cd 2023-08-31T13:53:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/nura-bio-initiates-phase-i-clinical-trial-for-its-oral-brain-penetrant-sarm1-inh-e1324ab6af31fe24 2023-08-25T12:53:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/thyme-care-transforming-the-oncology-patient-experience-head-on-46f90f2e050d0da5 2023-08-23T17:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicamentos-podem-ser-guardados-fora-da-sua-embalagem-original-9629e65cba231b6a 2023-08-21T12:00:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-document-distribution-with-ipassport-document-download-links-genial-8d89946acb6e22fc 2023-08-11T07:57:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-testing-of-cell-therapies-46eefe9cdd29df0c 2023-08-09T13:18:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/kohlberg-signs-a-definitive-agreement-to-acquire-majority-stake-in-worldwide-cli-876dc3b3025774b5 2023-08-07T13:36:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/business-of-biotech-biotech-cash-management-with-allan-shaw-74c6802b8f3d4f76 2023-08-06T13:29:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-benefits-of-adopting-a-quality-management-system-qms-in-a-laboratory-setting-e0511fd47b22a386 2023-08-04T06:34:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-importance-of-document-control-for-passing-inspections-genial-05fb34321a84660b 2023-08-01T11:51:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-group-shares-first-half-2023-placements-perspective-group-a400b8ce58ea1f34 2023-07-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioanalytical-support-for-gene-therapy-programs-2992dafd2a332823 2023-07-24T12:57:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-s-almanac-how-is-an-increased-focus-on-patient-centric-concerns-influenci-4fc88f732553c0ff 2023-07-21T13:27:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinopharmtech-working-meetings-in-china-and-factory-acceptance-of-the-technologi-ee0fdba2d3fdddaf 2023-07-17T14:20:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/pm360-the-state-of-the-union-in-cancer-innovation-ca522c251d3f3a5e 2023-07-13T13:26:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/business-meetings-at-cphi-pmec-china-4c160bf8ef06959e 2023-07-13T04:07:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/construction-in-the-belgorod-region-340388dfed52ded8 2023-07-13T04:04:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-a-petro-petro-s-chili-chipstm-b8de1fea81de21df 2023-07-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-signs-strategic-platform-license-with-lyell-immunopharma-48e1cb138096794d 2023-07-10T13:07:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/learning-about-darkness-veranahealth-com-1775d7d53bb8f21e 2023-07-07T21:38:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/inaugural-verana-hackathon-veranahealth-com-fefc81da14e7fb0d 2023-07-07T21:19:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/happy-holidays-from-verana-health-veranahealth-com-2fc4b7999089bdd5 2023-07-07T20:48:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-what-are-practices-seeing-veranahealth-com-ef27fcae9a176998 2023-07-07T20:45:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-update-from-verana-health-veranahealth-com-531c8f46e473b2fd 2023-07-07T20:42:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/generating-regulatory-grade-real-world-evidence-beyond-oncology-veranahealth-com-83b604b4e0781826 2023-07-07T20:33:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/janssen-verana-health-moving-real-world-data-science-forward-to-advance-clinical-515909ba8d64d32f 2023-07-07T20:30:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-round-up-real-world-data-insights-from-aao-iris-registry-analyses-veran-fd7613b0e996040d 2023-07-07T19:53:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-bright-future-for-data-insights-in-ophthalmology-veranahealth-com-43fee52676b2cdef 2023-07-07T19:39:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantitative-sciences-making-a-real-world-impact-with-real-world-data-veranaheal-b695ebdee95e9cb5 2023-07-07T19:29:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/simultaneous-multi-bias-analysis-allows-for-more-credible-causal-effect-estimati-1b4b79de9229d15a 2023-07-07T19:26:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-prompt-data-curation-elucidates-the-effects-of-covid-19-on-real-world-practi-6740b61fb0e78198 2023-07-07T19:22:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-curation-in-the-modern-medical-era-veranahealth-com-5f9e0e9210f9e1c8 2023-07-07T19:19:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-real-world-studies-by-curating-datasets-and-tokenizing-de-identified-p-ac64f25a7b17a8a3 2023-07-07T19:17:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/embracing-progress-in-health-care-delivery-and-clinical-research-veranahealth-co-590260b62de19d9c 2023-07-07T19:14:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/genentech-and-verana-health-track-long-term-treatment-of-namd-veranahealth-com-c0a067fcdb7ac2a1 2023-07-07T19:12:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-the-use-of-real-world-data-for-regulatory-decision-making-veranahealth-d2434db30b45932f 2023-07-07T19:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-practices-for-transforming-real-world-data-into-a-quality-asset-for-healthc-175fec78467d9245 2023-07-07T18:38:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/ehr-data-vs-claims-data-and-the-power-of-combining-the-two-real-world-data-sourc-afc3690c59228943 2023-07-07T18:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-at-work-verana-health-s-new-self-service-platform-for-data-labeling-430f0e5e1c8b9e1e 2023-07-07T16:52:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/ipassport-customer-testimonial-labskin-genial-7cf2f7db052631be 2023-07-07T12:59:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-science-leader-ways-to-face-new-bio-funding-banking-risks-644dc2c89583a6c8 2023-07-03T13:23:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/blueprint-genetics-introduces-the-new-screening-tests-family-giving-actionable-i-168909596ff16ca6 2023-06-29T10:19:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/onclive-dr-coupe-on-the-investigation-of-imm60-plus-pembrolizumab-in-advanced-me-433fe7571d024fd8 2023-06-26T13:25:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncologytube-imm60-and-pembrolizumab-study-for-advanced-melanoma-nsclc-793e73b6f50c1ae4 2023-06-21T13:21:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/canberra-clinical-genomics-ipassport-genial-87fd9cb457f45b6e 2023-06-15T08:09:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/surmodics-receives-fda-510-k-clearance-for-pouncetm-lp-thrombectomy-system-76f059d1083168f1 2023-06-14T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cookie-declaration-dyne-therapeutics-53d0c6a1c68f6a57 2023-06-13T21:44:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/business-of-biotech-the-innovation-reduction-act-with-allan-shaw-5928aebe11210064 2023-06-06T13:18:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-announces-54-million-series-c-financing-60020f70f6e6c109 2023-05-23T09:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/designing-conditionally-activated-probody-cytokines-to-localize-antitumor-activi-fc8c3bfaa3591c18 2023-05-17T23:08:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/worldwide-clinical-trials-partners-with-every-cure-to-accelerate-discovery-of-tr-d90638feab22c76d 2023-05-11T11:30:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/hpapi-and-adc-payload-manufacturing-capacity-expansion-e022c0d8f63e6f14 2023-05-10T06:00:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcing-xinthera-s-acquisition-by-gilead-sciences-21c54528ccbee4e3 2023-05-09T23:17:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-establishes-new-scientific-advisory-board-comprised-of-globally-recogniz-00e86dcdf9fcc3b2 2023-05-08T16:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maxcyte-appoints-douglas-swirsky-as-chief-financial-officer-86ff92ace4bfa7a4 2023-05-08T15:59:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecule-to-market-meet-the-lean-keen-biotech-ac3bbb0b92bc23e5 2023-05-01T13:17:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecule-to-market-why-biotechs-are-feeling-the-bite-fea65757d70158f5 2023-04-28T13:14:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/biosynex-completes-acquisition-of-chembio-diagnostics-inc-27c33852e882c296 2023-04-27T14:33:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-commitment-video-dyne-therapeutics-3d57b3d9aad9dc98 2023-04-26T20:12:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/board-testimonials-perspective-group-49ede94dc22910b7 2023-04-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-5-considerations-for-medical-wearables-389b0b9492f8c769 2023-04-25T14:16:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/mastering-the-challenges-of-continuous-glucose-monitor-design-95cd2f3babe7c4c7 2023-04-20T19:45:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/receptor-occupancy-flow-cytometry-assays-f41f873bc1591103 2023-04-14T14:07:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/pierre-fabre-annonce-l-acquisition-de-la-marque-meme-43cd60f4efa4aed6 2023-04-12T07:34:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/gen-making-the-transition-from-academia-to-ceo-bc49559781efcd11 2023-04-05T13:12:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/dyne-culture-video-dyne-therapeutics-9c2b293ab064a42f 2023-03-28T15:12:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/genial-at-ichg-2023-genial-62a540e30fac94a2 2023-03-20T08:53:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-bi-457225fc9c492838 2023-03-20T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-iso-15189-standard-is-changing-and-what-that-means-for-you-genial-103039a0e8ddcb75 2023-03-09T15:27:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-group-2h22-highlights-perspective-group-117c3ff31f256b25 2023-03-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimize-medical-device-design-with-magnesium-thixomolding-0430d6da5cc05ebe 2023-02-24T22:32:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/chembio-announces-the-receipt-of-clia-waiver-for-its-dpp-hiv-syphilis-system-062e34b98cb99f9c 2023-02-24T15:34:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-disease-day-2023-dyne-therapeutics-35ab44813a281b54 2023-02-23T23:49:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-site-with-foresite-meet-michael-rome-bb1c4a1c0d44b0ad 2023-02-14T05:02:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/metal-injection-molding-makes-a-big-impact-on-small-parts-742d0411795dbb60 2023-02-08T22:07:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/student-group-champions-accessibility-pilot-project-in-lecture-halls-a2ed1d439ecfd22e 2023-01-23T16:40:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-online-ipassport-user-group-a-great-success-genial-b342b35df67cf6b2 2023-01-04T14:58:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-bod-insights-and-successes-perspective-group-b33774967bbd1a3c 2022-12-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/famhp-reminds-of-need-for-customer-declaration-for-buyers-of-category-1-or-2-che-2a61114878240163 2022-12-22T13:44:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-service-hours-during-the-holiday-season-3db0d60095771230 2022-12-15T15:47:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/results-of-a-phase-2-study-of-praluzatamab-ravtansine-cx-2009-in-patients-with-a-1d42e3dfbdeb17c9 2022-12-14T17:13:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/force-for-good-service-day-2022-dyne-therapeutics-06f04359d2774392 2022-12-13T11:54:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-acquires-fusion-biotec-to-continue-accelerating-medtech-diagnostic-solut-cb6ef59a19c80ad2 2022-12-13T05:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-shares-ceo-insights-and-successes-perspective-group-2078637d2a489f09 2022-12-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-appoints-robbie-alton-pharm-as-vice-president-of-clinical-op-9522a4f287aba3e8 2022-12-06T12:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/dm1-story-billydean-dyne-therapeutics-9f9eebc2275b0628 2022-11-28T17:45:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/creation-of-the-green-impact-index-consortium-0aff166fc9e0acd2 2022-11-23T13:58:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/remdesivir-steroids-tied-to-better-covid-hospital-outcomes-ff68ffc222fb6876 2022-11-22T22:31:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/dm1-story-joachim-dyne-therapeutics-2f6500b734cfe911 2022-11-22T20:10:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/dm1-story-loraine-dyne-therapeutics-68cb348c25e19f72 2022-11-22T20:08:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/dmd-story-ravi-dyne-therapeutics-bbd5d6a1a535aaba 2022-11-22T20:06:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/cx-801-conditionally-activatable-interferon-alpha-2b-improves-tolerability-and-e-ce9a7be56ab700e2 2022-11-15T14:22:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/noramco-announces-submission-and-reactivation-of-the-drug-master-file-for-active-8c7724d49d89bad4 2022-11-01T20:25:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-and-horizon-therapeutics-plc-announce-dosing-of-first-patient-in-phase-2-d552c88ac9a35864 2022-10-27T12:30:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/tim-ferris-jenny-harries-and-mauricio-barreto-confirmed-to-join-hdr-uk-s-annual-e3fe3450c72d14e7 2022-10-27T10:50:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-a-clinical-stage-biotechnology-company-focused-on-therapeutics-that-rest-50cf1178046054f7 2022-09-20T12:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-memoriam-stephen-kaldor-5d2aba43ce108fd1 2022-09-16T23:24:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/joachim-and-tim-c48e1fdd89ab3276 2022-09-14T20:01:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/nura-bio-reports-preclinical-data-validating-a-conserved-mechanism-of-inhibition-8e351388ee4cc2d0 2022-09-14T01:26:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/marc-freeman-wins-first-annual-drs-ayeez-and-shelena-lalji-family-als-endowed-aw-625ad7a8e8f9f3cd 2022-09-14T01:11:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/tailoring-the-selection-of-target-payload-and-tumor-type-to-maximize-the-therape-f6d11a59eb0d3a8a 2022-09-07T15:57:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/diana-and-jordan-2022-dc30fb85c9986213 2022-09-07T10:50:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/chembio-diagnostics-awarded-3-2-million-contract-from-the-cdc-for-development-an-c6043ab99c542e7d 2022-09-06T18:03:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-to-present-at-3rd-annual-jefferies-asia-forum-sirnaomics-b18b7a7d05f84048 2022-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rdd2022-65a28d2af63cb85a 2022-08-31T14:09:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-advances-galaheadtm-based-rnai-therapeutics-for-treatment-of-compleme-a05d4da297bc3fc7 2022-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-announces-that-janssen-has-received-approval-from-european-commission-for-9fb12bd315582d2a 2022-08-24T22:18:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/most-common-risks-to-accreditation-during-inspection-genial-524b17d1c061fb8f 2022-08-24T20:26:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-2022-interim-results-presentation-will-be-held-on-31-august-2022-sirn-990a3adaea73112e 2022-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-becoming-a-constituent-of-hang-seng-family-of-indexes-sirnaomics-6933c075006fbfeb 2022-08-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-and-horizon-therapeutics-announce-collaboration-in-autoimmune-diseases-9a51f58e969d3e34 2022-08-15T12:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-develops-peptide-docking-vehicle-pdovtm-designed-for-an-enhanced-galn-9ac699319a041008 2022-08-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alzheimer-s-disease-navigating-the-challenging-journey-to-a-cure-95e1be650058e827 2022-08-03T14:33:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-fshd-day-2022-27d67f56ac52ddfc 2022-07-22T14:44:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/which-medicines-and-foods-should-a-heart-patient-avoid-16c9b7702311f2d0 2022-07-20T21:04:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/genial-s-white-paper-on-risk-genial-988e66403dfa39c0 2022-07-19T07:15:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/q32-bio-presents-new-preclinical-data-at-the-international-society-of-nephrology-1cfa8f3efc335543 2022-06-23T11:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-appoints-kevin-s-litwiler-ph-d-as-senior-vice-president-of-d-4a9bdfb2c030f14d 2022-06-21T15:07:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/shelia-violette-founder-and-chief-scientific-officer-of-q32-bio-to-present-at-th-5323717c5f4e7a96 2022-06-08T13:39:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-research-collaboration-helps-shorten-the-path-to-diagnosis-for-rare-disease-a65be634c7f25cd3 2022-06-07T07:51:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-announces-first-patient-dosed-in-the-phase-1b-2-nautilus-tri-e2ab8da81ab32c70 2022-06-02T11:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/thoughts-on-the-affinivax-acquisition-8930b3361b1f660d 2022-05-31T21:31:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-additional-r-d-laboratory-unit-17f7bc411cf48397 2022-05-31T13:25:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/comentario-em-formacao-e-educacao-por-apifarma-contactos-e-localizacao-apifarma-189b67793c97f250 2022-05-26T03:26:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/blueprint-genetics-a-quality-leader-in-genetic-testing-embraces-new-eu-regulatio-d9948986b9059c85 2022-05-25T07:19:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/comentario-em-areas-de-intervencao-por-novo-membro-apifarma-informar-portal-de-c-4d73178c0a2ffe46 2022-05-23T12:00:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-will-present-clinical-study-results-and-development-strategy-for-canc-c534f82bb56cfd65 2022-05-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-tech-outlook-top-10-eu-cmo-s-2022-cerbios-cover-story-april-2022-c49e7a85f4e36fee 2022-04-29T06:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/actions-terrain-aupres-des-pharmaciens-et-des-medecins-d35b9e838e878d57 2022-04-25T14:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/produits-soutenus-par-des-unites-operationnelles-et-des-reseaux-de-medecins-spec-75131070eb3fe743 2022-04-25T12:08:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-expands-boulder-footprint-with-the-opening-of-a-new-research-8d5374e3974b6d08 2022-04-25T11:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-10-most-common-risks-of-homegrown-document-control-compliance-solutions-geni-a4e2b85638012e62 2022-04-21T13:46:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/cerbios-announces-the-near-finalization-of-a-new-cgmp-unit-for-cytotoxic-a-furth-3b572972061d9d46 2022-04-13T07:00:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-announces-promising-preclinical-data-on-oki-179-in-ras-mutat-167573f36fc0dd18 2022-04-08T17:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmf-filmmaker-in-residence-2022-058d5518bd52432f 2022-04-05T22:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rnaimmune-secures-27-million-series-a-round-of-financing-for-development-of-mrna-f7ef5d6c2216c299 2022-03-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-to-spin-off-its-omniab-business-through-merger-with-avista-public-acquisi-73b3830e8aab8cc5 2022-03-23T01:56:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientist-for-in-vivo-pharmacology-e4d1b6fa343634ad 2022-03-18T13:24:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/creating-the-perfect-birth-playlist-video-481b0417c3f82baa 2022-03-17T23:05:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-delivery-evolution-drives-complexity-in-quality-control-0fd977bbf4f8564c 2022-03-17T19:20:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/an2-therapeutics-appoints-dr-mel-spigelman-m-d-to-its-board-of-directors-106d3b2b1cf51b4f 2022-03-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-to-present-latest-developments-on-its-galnac-based-liver-targeting-pl-299cbafa11bc867d 2022-03-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-disease-day-video-presentation-29815595a3223d38 2022-03-11T16:12:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-to-present-late-breaking-preclinical-data-on-oki-179-at-the-ac02884ed0398a7c 2022-03-08T21:30:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/noramco-celebrates-diversity-and-international-women-s-day-9372f414aae9942d 2022-03-07T17:05:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukrainan-sota-yliopiston-suositukset-bc22074d536e24f6 2022-03-04T10:06:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/genial-and-cirdan-to-offer-a-genomics-enabled-lis-solution-to-healthcare-custome-dda5db3468d2e91b 2022-03-03T09:01:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/an2-therapeutics-announces-epetraborole-granted-orphan-drug-designation-in-the-u-33017b307b42d639 2022-02-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an2-therapeutics-reports-phase-1b-data-for-oral-epetraborole-5b6ab8f90be67ed8 2022-02-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-appoints-jason-leverone-cpa-as-chief-financial-officer-b09f6047fd6b725c 2022-02-08T12:01:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/disposals-of-own-shares-51b9e5c6ddcf66ff 2022-02-04T19:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ucb-announces-positive-data-in-myasthenia-gravis-with-zilucoplan-phase-3-study-r-eaa4eab3a7ed175d 2022-02-04T06:00:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/transparency-notification-fmr-llc-1505c3048aeaabf4 2022-02-02T19:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/welcoming-the-foresite-fellows-333699c1dc2f5b9d 2022-02-02T17:20:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ucb-receives-positive-chmp-opinion-recommending-approval-of-briviact-brivaraceta-c7aea2d3b3b36e31 2022-02-02T06:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/ucb-commences-tender-offer-to-acquire-zogenix-inc-fc8dbf4433c66450 2022-02-01T17:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/disposals-of-own-shares-7667f42ac9a0333a 2022-01-28T19:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/bimzelx-bimekizumab-approved-in-japan-for-the-treatment-of-plaque-psoriasis-gene-6d8c7375ceb871b1 2022-01-24T06:00:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/disposals-of-own-shares-63b26ace5603549b 2022-01-21T19:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-top-line-results-for-bimzelx-bimekizumab-in-second-phase-3-psoriatic-ar-9e14d5f46b58ad15 2022-01-21T06:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/an2-therapeutics-provides-regulatory-update-6f8c46052087b319 2022-01-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ucb-to-acquire-zogenix-c9108461b729adca 2022-01-19T06:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-appoints-nicholas-a-saccomano-ph-d-to-its-board-of-directors-871f2ca72c468427 2022-01-18T12:03:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/an2-therapeutics-closed-80-million-series-b-financing-c04fef7e6c00b9c5 2022-01-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sirnaomics-ltd-listed-on-main-board-of-hkex-sirnaomics-0e298ffc7d50c9c5 2021-12-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fall-eye-on-the-future-forum-eff-summit-2020-61c888b56f8c07ed 2021-12-28T11:59:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-academy-of-optometry-aaopt-annual-meeting-2020-2ea41bdbbf9b343c 2021-12-28T11:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-perspectives-series-usher-syndrome-and-retinitis-pigmentosa-91de0b73f1512f1a 2021-12-28T11:57:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/proqr-top-line-results-phase-1-2-trial-of-sepofarsen-in-lca10-patients-679b815bf39f5701 2021-12-28T11:57:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-perspectives-series-lca10-and-sepofarsen-0f60f423fbdb1830 2021-12-28T11:56:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-academy-of-ophthalmology-aao-annual-meeting-2020-8ab075e51cc8088f 2021-12-28T11:55:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-academy-of-ophthalmology-aao-annual-meeting-2021-cd07731d16011434 2021-12-28T11:55:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-association-for-research-in-vision-and-ophthalmology-arvo-annual-meeting-202-f2c08f058cb411dd 2021-12-28T11:54:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-s-partner-cstone-pharmaceuticals-receives-approval-in-china-for-sugemalim-982eac427fad6a11 2021-12-22T04:00:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-announces-positive-topline-first-in-human-phase-1-results-fo-815732fd9deea7bd 2021-12-14T12:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/noramco-announces-submission-of-drug-master-file-for-lisdexamfetamine-dimesylate-1a09f14764f574df 2021-12-03T12:30:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/give-back-spreadlove-petro-s-chili-chipstm-2e8c32c90ac523b2 2021-11-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/customer-renewal-nonacus-ltd-genial-1237fdb9852c471a 2021-11-12T15:12:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/onkure-therapeutics-appoints-mark-l-boys-ph-d-as-vice-president-of-discovery-che-39348825474ad2c0 2021-11-09T11:01:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-pursuing-plans-for-omniab-to-become-a-standalone-public-company-fc31fd0f9211ad2d 2021-11-09T05:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/genial-appoints-simon-peck-as-new-managing-director-genial-c665e2003c3a664c 2021-11-08T12:58:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/blueprint-genetics-further-enhances-the-clinical-utility-of-its-testing-offering-b2cfb2ec91ec259c 2021-10-30T11:20:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/mark-hawtin-managing-director-genial-99db819692d4742c 2021-10-29T10:14:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-joiners-genial-4bfb7d9231ef3a54 2021-10-29T09:42:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/blueprint-genetics-and-biomarin-collaborate-to-launch-a-sponsored-testing-progra-5cfd9951da99b778 2021-10-26T11:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/inspirational-speakers-and-marshmallow-challenge-0bc3891b159dedc9 2021-10-20T09:40:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-scan-for-oct-12-2021-460903e855a969b4 2021-10-12T18:37:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/ipassport-v3-6-0-coming-soon-genial-652482954c235f74 2021-10-12T09:33:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhanced-access-to-genetic-testing-for-individuals-with-auditory-neuropathy-the-05a2a2b22821ff2a 2021-09-22T14:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/loraine-s-story-dyne-therapeutics-5300580b20dc85c1 2021-09-13T13:41:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-in-pediatric-epilepsy-supports-the-value-of-early-genetic-testing-as-a-2b7dcb39d3b40a22 2021-09-13T10:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-collaboration-aims-to-accelerate-rare-disease-diagnostics-by-combining-f76b6362ab9e833d 2021-09-09T10:01:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-s-partner-gloria-biosciences-receives-approval-in-china-for-zimberelimab-403cbc59740048e6 2021-08-30T05:00:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-health-information-technology-in-the-optimization-of-patient-outcome-cfd55a5b1c9606b3 2021-07-29T09:09:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/reducing-everyday-challenge-non-target-embolization-26c4216d0228eeea 2021-07-29T09:09:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/reduire-le-risque-quotidien-de-l-embolisation-non-ciblee-0c3fbd8236b62886 2021-07-29T09:09:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-life-sciences-seeing-past-the-hype-c7887fafd3c6a05d 2021-07-29T09:09:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/l-ia-appliquee-aux-sciences-de-la-vie-au-dela-du-phenomene-de-mode-ad963636c0026621 2021-07-29T09:09:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-you-join-guerbet-you-ve-chosen-a-human-scale-worldwide-leader-f8c472d2cf3b801f 2021-07-29T09:09:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/en-rejoignant-guerbet-vous-choisissez-un-leader-mondial-a-taille-humaine-1b1b47e3eb90c122 2021-07-29T09:09:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/guerbet-signe-un-accord-avec-icometrix-pour-la-commercialisation-exclusive-d-ico-ee7b9e445197d75a 2021-07-29T05:52:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/guerbet-and-ibm-watson-health-announce-a-second-co-development-project-as-part-o-bc847a91adf2e2ac 2021-07-29T05:52:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/guerbet-et-ibm-watson-health-annoncent-un-deuxieme-projet-de-codeveloppement-dan-914d33983408d912 2021-07-29T05:52:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/2018-revenue-9f25539fcb034813 2021-07-29T05:52:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/chiffre-d-affaires-2018-36074e8084121054 2021-07-29T05:52:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/2019-half-year-results-9c7890f61b389ae1 2021-07-29T05:52:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/resultats-semestriels-2019-97b8651eed859e14 2021-07-29T05:52:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/revenue-at-30-june-2019-7868bed685541a06 2021-07-29T05:52:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/chiffre-d-affaires-au-30-juin-2019-ce264ac305c4b70a 2021-07-29T05:52:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/genscript-biotech-and-ligand-pharmaceuticals-enter-into-global-omniab-licensing-ab64318686fe7bf4 2021-06-02T18:12:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-my-retina-tracker-genetic-testing-program-continues-to-expand-with-spark-the-18a1fb0ec2efa312 2021-05-25T14:03:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/force-video-dyne-therapeutics-c46a0fd032fd8641 2021-05-13T21:07:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/finding-strength-beyond-muscle-dyne-therapeutics-3026a50d35bb4f29 2021-05-07T17:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspectives-article-dyne-therapeutics-ff9f9356ef69b5b2 2021-04-25T16:20:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/quest-diagnostics-and-blueprint-genetics-to-present-new-insights-from-genetic-te-2cc04ac64d7d21d4 2021-04-13T12:03:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-scan-for-apr-06-2021-aa309335c2872203 2021-04-06T19:50:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/parlez-vous-francais-c6027cbc3fa12de6 2021-03-23T17:03:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/knee-injection-vs-knee-replacement-which-is-best-for-chronic-knee-pain-a382a015a5e02bf6 2021-03-18T21:48:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ucalgary-political-science-interviews-our-colleague-and-associate-dean-internati-1892c98010b521a6 2021-03-17T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pop-two-petro-s-chili-chipstm-255c49faad08b340 2021-03-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-association-for-pediatric-ophthalmology-aapos-virtual-meeting-c59a464e815837a3 2021-03-01T16:29:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/hint-of-orange-iced-tea-petro-s-chili-chipstm-7361e2a3defb1fde 2021-03-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-engagement-in-the-era-of-gene-therapy-19ae172983d6eede 2021-02-24T06:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/soumettre-une-demande-d-autorisation-generale-d-activite-9f3a90af7b8d064b 2021-02-18T20:01:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-perspectives-series-disease-education-and-endpoints-in-usher-syndrome-6b14efb2440da5ee 2021-02-16T20:05:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-study-finds-evidence-indicating-the-nrap-gene-to-be-a-significant-cause-of-r-4055a27420b509e6 2021-02-03T19:02:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-positive-phase-2-results-for-neflamapimod-in-mild-to-modera-7dab2ed8d5f5afd7 2021-01-14T21:01:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-presentation-of-positive-clinical-trial-results-with-neflam-c59d3664a3fdac3f 2021-01-14T21:01:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-publication-of-preclinical-results-demonstrating-potential-9a94575e5c58e905 2021-01-14T21:00:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/reflecting-on-the-past-year-looking-toward-new-horizons-59ecd3d1e895a3c6 2020-12-24T17:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/centres-de-vaccination-contre-la-covid-19-bc1926095021b4a5 2020-12-24T15:33:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-letter-of-gratitude-3cbc72c1d404a7fe 2020-12-21T17:15:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/hc-wainwright-virtual-bioconnect-2021-conference-964d4e37ba37a2f0 2020-12-17T16:52:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-gap-between-veterinary-and-human-musculoskeletal-health-8e49741bb366bce7 2020-12-09T18:23:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/my-engagement-and-leadership-at-orchard-and-why-it-s-important-43c27dd1995f32b3 2020-12-07T08:45:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/social-work-researcher-to-help-create-national-plan-to-stop-violence-against-wom-fdb6252ca0064c01 2020-11-23T23:01:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-announces-clinical-and-regulatory-progress-by-multiple-partners-with-omni-588d89e8640ea2d6 2020-11-23T15:06:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/3rd-annual-evercore-isi-virtual-healthconx-conference-c85e8de4ed5345c6 2020-11-13T16:57:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-focus-dyne-therapeutics-08f1f93f65e8f31a 2020-10-01T13:42:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/hsc-gene-therapy-for-neurological-conditions-fd7b9151b817013a 2020-09-28T19:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-expands-omniab-antibody-discovery-platform-through-the-acquisitions-of-xc-7ec6b621051ccdcd 2020-09-10T15:10:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/h-c-wainwright-22nd-annual-global-investment-conference-b370f2a4e618418f 2020-09-03T18:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/citi-s-15th-annual-biopharma-virtual-conference-d4105c066aeade86 2020-09-03T18:52:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/chardan-virtual-4th-annual-genetic-medicines-conference-2b7320523b7fdd3f 2020-09-03T18:50:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/gene-therapy-comes-in-many-forms-b2a4491d78486ed8 2020-09-03T03:00:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-scan-for-sep-02-2020-2cee1a60645407e8 2020-09-02T19:50:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-orchard-s-5-year-anniversary-59154dfb3bdeabb5 2020-09-01T14:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-2020-cy-frank-legacy-lecture-6e7a54376f4d6681 2020-09-01T13:33:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-omniab-partner-immunovant-announced-positive-topline-results-from-multice-3fb9c8012a6663a2 2020-08-25T15:20:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/nura-bio-announces-publication-of-structural-and-mechanistic-regulation-of-the-p-d29f749c6d272574 2020-08-08T01:27:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/cstone-announces-that-omniab-derived-cs1001-anti-pd-l1-phase-3-trial-met-the-pri-1c5b979a1b9a35a2 2020-08-07T15:25:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-gene-therapy-manufacturing-a-key-to-long-term-growth-and-sustain-fee3b626856a8ccf 2020-07-23T19:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/coronavirus-and-the-fight-led-by-the-famhp-the-famhp-carries-out-hundreds-of-con-4f99be18f22caddb 2020-07-10T07:37:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/resultat-du-vote-par-resolution-assemblee-generale-ordinaire-du-29-juin-2020-6f71374b758773d8 2020-07-08T09:03:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/assemblee-generale-ordinaire-des-actionnaires-tenue-le-29-juin-2020-17dfe39f87e92e72 2020-07-03T10:53:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/coronavirus-and-the-fight-led-by-the-famhp-solutions-implemented-by-the-famhp-in-3db4afb307f99a1b 2020-07-01T13:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulaire-de-vote-par-correspondance-a-l-assemblee-generale-8953b65e905f1ef6 2020-06-08T09:59:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/conseil-d-administration-tenu-le-26-05-2020-5d786780beb4defc 2020-06-08T09:47:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/avis-de-convoncation-de-actionnaires-588d450afa2e1922 2020-06-08T09:46:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/servier-completes-the-acquisition-of-symphogen-085eebfdc33b0de5 2020-06-04T13:32:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/129096-2-f8ce67a3fe58b38a 2020-05-22T08:18:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/129094-2-76e10abbbe60d0e6 2020-05-22T08:14:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-to-pursue-covid-19-antibody-therapy-in-a-collaboration-with-aarhus-uni-ba32ec62fad9865e 2020-05-12T11:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/coronavirus-new-version-of-belgian-directive-for-management-of-clinical-trials-d-89911367df9dacf1 2020-05-07T12:35:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/guerbet-high-in-the-gaia-index-for-the-2nd-year-running-1de653fbc66b7b34 2020-05-07T05:25:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/guerbet-en-bonne-position-dans-le-gaia-index-2019-pour-la-2eme-annee-consecutive-26c6454ae386f00a 2020-05-07T05:25:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/myeyesite-creating-a-patient-owned-repository-of-inherited-retinal-disease-data-01203bcea1336ba9 2020-04-24T15:32:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/servier-underskriver-endelig-aftale-om-at-erhverve-symphogen-en-f-rende-antistof-f0804f74f63d6172 2020-04-03T14:01:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/servier-signed-a-definitive-agreement-to-acquire-symphogen-a-leading-antibody-di-644302a799f8211f 2020-04-03T14:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-scan-for-apr-02-2020-894e63e727060943 2020-04-02T20:17:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/stewardship-resistance-scan-for-apr-02-2020-966ff2c185cde65a 2020-04-02T20:15:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/pilot-project-on-simultaneous-national-scientific-advice-starts-1-february-2020-cd263520f87a3e0b 2020-01-15T14:56:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-us-at-dcat-week-54cb29df465b475d 2020-01-08T20:50:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/an2-therapeutics-launches-with-12-million-in-series-a-faf44fc4d89aa59d 2019-11-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-wellocracy-radio-show-with-pharm-tosin-oguntoye-157debe7e8b49617 2019-10-08T15:36:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-wellocracy-radio-show-with-pharm-funmbi-okoya-88f81da4d3d7bbb3 2019-10-08T15:34:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-wellocracy-radio-show-with-pharm-kehinde-adepoju-7fd62ee03d9e592a 2019-10-08T15:33:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-wellocracy-radio-show-with-pharm-muyiwa-olagunju-c519b76054d2777b 2019-10-08T15:31:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/stewardship-resistance-scan-for-aug-30-2019-fe40c1c359a10a09 2019-08-30T20:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-remote-clinical-trial-monitoring-is-the-new-standard-af96534a76ce7ba0 2019-08-22T18:49:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-therapeutics-reports-second-quarter-2019-financial-results-and-progres-df69668e88784edb 2019-08-12T19:19:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/overcoming-four-common-challenges-in-multicenter-research-032b9df0c97b4183 2019-07-29T14:00:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-initiates-new-study-with-neflamapimod-for-the-treatment-of-cognitive-1b035be5d76dc352 2019-07-15T15:11:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-appoints-noel-donnelly-as-cfo-cervomed-9020e02879cbd45d 2019-07-09T20:17:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-initiates-new-study-with-neflamapimod-for-the-treatment-of-cognitive-4d4b1bf0211945d8 2019-07-09T20:16:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-the-etmf-and-eisf-why-and-why-now-dc09e17c0086f73c 2019-07-09T19:49:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-to-host-kol-breakfast-briefing-on-potential-of-neflamapimod-in-alzhei-d6736cb850a151be 2019-06-27T13:56:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-to-present-at-upcoming-investor-conferences-in-june-cervomed-10d33c99d08c7305 2019-06-27T13:56:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-closes-11-2-million-financing-round-to-advance-development-of-neflama-eddc3cbe14961863 2019-06-27T13:55:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-to-present-at-bio-ceo-investor-conference-cervomed-05d408af80dd1f3a 2019-06-27T13:55:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-phase-2b-reverse-sd-study-of-neflamapimod-fully-enrolled-ce-d90fd03540a05405 2019-06-27T13:49:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-clinical-study-presentations-at-the-11th-clinical-trials-on-548fc983a61b19cc 2019-06-27T13:47:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-secures-20-5-million-in-series-b-financing-cervomed-7a7c13c6c72af84a 2019-06-27T13:47:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-publication-of-positive-alzheimer-s-disease-clinical-study-47b6c29b9acc3933 2019-06-27T13:47:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-presentation-of-new-mechanism-of-action-data-regarding-nefl-281b93a755dc0714 2019-06-27T13:47:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-presentation-of-new-positive-clinical-data-with-neflamapimo-8247bda68fb3931a 2019-06-27T13:47:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-positive-results-with-neflamapimod-vx-745-in-two-phase-2a-c-d6d76443596e49d0 2019-06-27T13:43:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-issuance-of-multiple-new-patents-covering-vx-745-a-selectiv-07ea1d6f7bb1ef38 2019-06-27T13:37:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-scientific-publication-of-results-demonstrating-pro-cogniti-f7af07e8e97bc730 2019-06-27T13:35:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/eip-pharma-announces-first-patient-dosing-in-phase-2-clinical-studies-of-a-novel-6e84ada2257b25d4 2019-06-27T13:34:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/technology-in-multicenter-clinical-trials-48129494b309c35f 2019-06-26T15:15:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/afcon-2019-kicks-off-today-4c1e2acee845b3f3 2019-06-21T10:54:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-therapeutics-to-present-preclinical-data-on-its-clinical-stage-sgc-sti-7c4d1674bb6e9fdf 2019-06-11T16:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-stella-okoli-ceo-emzor-pharmaceutical-to-be-inducted-into-nigerian-women-hall-e38c43f026130852 2019-06-06T10:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-therapeutics-to-present-data-on-its-sickle-cell-disease-program-at-upc-49a7000df4252d7b 2019-06-04T18:43:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-para-1000-features-in-music-video-ringi-ringi-by-akuchi-ft-olamide-4cf1ebe0393087df 2019-05-22T12:35:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-publishes-discovery-and-pre-clinical-data-on-first-chicken-derived-ant-a27c6452a9c956b1 2019-05-16T05:01:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-announces-new-capital-raise-and-explores-strategic-options-4f892e91d824db14 2019-05-15T06:06:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-therapeutics-provides-a-corporate-and-pipeline-overview-as-a-newly-lau-d694520d4024aba0 2019-05-13T13:26:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-to-host-corporate-overview-call-on-may-13-2019-854fd6a37930da55 2019-04-25T15:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-technology-s-value-in-a-world-of-precision-medicine-and-research-0bb99037ac1de6bf 2019-04-23T01:50:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-announces-the-appointment-of-andreas-busch-ph-d-as-chief-innovation-of-1c85b073b4ac595f 2019-04-09T14:04:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-launches-as-clinical-stage-biopharmaceutical-company-harnessing-the-po-2c855a20ce5307fa 2019-04-02T12:14:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/alcoa-c-in-clinical-trial-electronic-document-management-2a2d8ed87d31f3ab 2019-03-27T19:59:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/stewardship-resistance-scan-for-mar-18-2019-113a7ecbb67ca456 2019-03-18T21:19:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-s-position-on-the-bbc-documentary-on-codeine-4c4b6fea0ab814b8 2019-03-14T06:57:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotics-before-miscarriage-surgery-not-tied-to-fewer-infections-aad9068f0cc8537b 2019-03-13T21:03:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclerion-the-planned-r-d-spin-off-of-ironwood-pharmaceuticals-secures-commitmen-8c167fbec319984f 2019-02-26T16:11:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-key-advantages-of-eregulatory-e60b64ac09b7a4be 2019-02-12T19:21:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/observations-from-tmf-summit-2019-the-post-etmf-world-ec17f8fb42e3744e 2019-01-30T15:42:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/ironwood-announces-filing-of-form-10-registration-statement-in-connection-with-p-2c71c8cea7b5c039 2019-01-28T18:17:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-lauren-begnaud-transitioned-65-sites-to-eregulatory-at-us-oncology-68f78c4cf1be5b97 2019-01-18T21:27:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/thank-you-for-a-great-2018-4be5433d6f3fff9e 2018-12-28T17:15:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-expectations-of-clinical-trial-operations-leaders-in-2019-b915fcbab1565b66 2018-12-19T20:33:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-observations-from-site-solutions-summit-80e14c8203e06909 2018-10-24T18:23:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-ways-florence-ebinderstm-accelerates-study-startup-67c7d629c3d5b8fe 2018-09-12T19:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/florence-named-to-top-100-places-to-work-in-atlanta-1c3324b832fe33ad 2018-09-10T16:30:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-elects-new-board-members-to-support-the-company-s-long-term-developmen-1718f03f7afff91f 2018-09-03T06:49:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-strategies-for-ich-gcp-e6-r2-compliance-35bc55667144afba 2018-08-17T18:50:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/guide-fda-inspections-of-trial-sites-with-electronic-systems-730190f2aa9ee911 2018-08-13T14:32:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-must-have-capabilities-when-evaluating-eregulatory-platforms-f4023151d49ec8ba 2018-08-07T15:39:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/rhos-walker-becomes-chief-strategy-officer-at-hdr-uk-e2920c985a83804d 2018-06-26T15:03:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-further-strengthens-its-immuno-oncology-pipeline-by-advancing-into-two-0b9d66742071f84d 2018-05-30T13:39:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-non-antibiotic-drugs-affect-gut-bacteria-could-promote-resistance-9697faec8b2db8a6 2018-03-19T22:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ferias-internacionales-2025-5369ef95ba963bb2 2018-01-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-receives-milestone-payment-for-initiation-of-phase-1b-trial-in-infecti-7435995af5be3218 2017-11-30T11:00:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-presents-detailed-results-for-randomized-phase-2-study-with-sym004-in-6f8d14d116672d29 2017-09-11T10:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-presents-sym004-phase-2-data-at-esmo-2017-congress-e5f7f67779635f11 2017-08-31T10:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/una-nueva-ubicacion-360cec66a05fe141 2017-07-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-announces-second-milestone-payment-for-imp701-program-immutep-lag-3-0cc9f02686a3e495 2017-07-15T21:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-announces-approval-for-the-initiation-of-the-insight-clinical-trial-79d5b0c12f56bc19 2017-07-08T21:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-announces-pricing-of-us-5-0-million-registered-direct-offering-of-i-313209f4e951d088 2017-06-28T21:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/operational-update-immutep-lag-3-immunotherapy-for-cancer-autoimmune-disease-cc9e0d02a859a9df 2017-06-25T21:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asco-poster-2017-immutep-lag-3-immunotherapy-for-cancer-autoimmune-disease-ec5ed4b8f64963fc 2017-06-05T21:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lag-3ig-imp321-demonstrates-positive-safety-and-efficacy-qualities-in-breast-can-cf1336f89e2e3190 2017-06-03T21:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-announces-formation-of-clinical-advisory-board-immutep-lag-3-immuno-1564e8eb89283363 2017-05-30T21:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-prima-biomed-aipac-clinical-trial-to-be-presented-at-2017-asco-confere-14b168803738dac6 2017-05-16T21:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-receives-approval-for-third-cohort-of-phase-i-melanoma-trial-immute-f9c4de77732e8704 2017-04-17T21:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-receives-a-492-144-tax-refund-from-australian-government-immutep-la-e04eaa6395c28e04 2017-04-11T21:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yenilikci-ilaclar-145b0a22a60a421e 2017-04-04T07:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/doktorunuzla-gorusme-oncesi-ve-sonras-haz-rl-klar-n-z-yapmay-unutmay-n-b571879473460367 2017-04-04T07:29:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/ak-lc-ilac-kullan-m-c26a6fac2e16deff 2017-04-04T07:18:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-completes-recruitment-for-second-patient-cohort-in-melanoma-trial-a-b7cf663aed9a9d45 2017-03-15T22:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kullan-m-talimat-n-tan-yal-m-f85dd897034af359 2017-03-02T15:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/usa-patent-grants-for-imp321-in-cancer-immutep-lag-3-immunotherapy-for-cancer-au-b01c54e146f9318a 2017-03-01T22:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hasta-haklar-ve-sorumluluklar-bb2b7d641bd612c2 2017-03-01T14:14:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-things-to-know-about-colorectal-cancer-screenings-48dccb4a27998a33 2017-02-27T18:28:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-half-2017-operational-update-immutep-lag-3-immunotherapy-for-cancer-autoim-e6d7e42a642de5aa 2017-02-24T22:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-receives-a-860-000-tax-credit-payment-from-french-government-immute-b1e55bf028621cc1 2017-02-13T22:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-to-present-at-2nd-annual-cancer-immunotherapy-conference-immutep-la-650d6d85e77e7a3b 2017-01-23T22:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-commences-randomised-phase-iib-clinical-trial-for-imp321-in-breast-7cc3ac201c45d835 2017-01-20T22:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-to-maintain-nasdaq-listing-immutep-lag-3-immunotherapy-for-cancer-a-26084c2d69ae5535 2017-01-18T22:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-commences-recruitment-for-second-cohort-of-melanoma-trial-immutep-l-fdcaacbbd90853e7 2017-01-12T22:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-biomed-enters-new-material-transfer-agreement-with-cytlimic-immutep-lag-3-f2045de6100a04d2 2017-01-05T22:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prima-announces-new-product-candidate-imp761-a-lag-3-agonist-antibody-immutep-la-20d0cb50a8f4034a 2017-01-02T22:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-names-new-chief-financial-officer-bf7e8ae16e1c69c8 2016-09-15T07:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/symphogen-s-founding-ceo-kirsten-drejer-steps-down-and-becomes-executive-directo-5557264535723c98 2016-08-18T07:08:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-tips-to-help-men-prioritize-preventive-care-and-regular-checkups-c2a2ae8685dd2cd1 2014-08-29T22:45:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-medicament-n-est-pas-un-bonbon-682762f336ab8f02 2011-09-12T13:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/miracle-mineral-solution-or-mms-warning-e82775677b4cea91 2010-10-11T22:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctua-1-4-2009-6108a031f3330974 2009-01-01T15:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctua-1-4-2008-8e74d176b2d1f6a6 2008-01-01T14:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nimesulida-asegura-tu-suministro-b4ae5b67b0a2f412 1778-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xilitol-optimiza-tu-sourcing-3497cf2653fa01a1 1777-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitafoods-europe-2026-d07679373c5bd970 1771-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proximas-ferias-2025-9979ee31d5908091 1756-07-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/encuentranos-en-cphi-worldwide-58f8d6a89e0b0106 1756-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/better-stands-bronce-conseguido-9fec4c9c212740f9 1751-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eggshell-power-alivio-articular-5b8f9292aba45769 1750-04-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kalita-bienestar-cardiometabolico-24445aa94ee1df3c 1750-01-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/salud-de-las-piernas-cc8d5ddc928ef493 1748-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dos-aliados-naturales-para-el-bienestar-digestivo-e5c6a1a1b87829f3 1747-01-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bromeyal-enzimas-proteoliticas-302417b3714d4356 1744-07-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nos-vemos-en-vitafoods-48c0440f3f149d03 1744-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mejora-la-movilidad-con-axtragyl-4a8803e6f0877df9 1743-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/okara-el-ingrediente-del-futuro-dce1cfe4ce8b4eda 1742-06-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-2024-en-milano-e3479e9b0699084c 1721-12-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingredientes-para-piensos-aff2692f44264300 1717-01-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nutraceuticals-europe-2024-de353354245c0b9f 1706-08-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/los-esperamos-en-la-cphi-f904cffcabc6c3bf 1697-06-01T00:00:00.000Z weekly 0.7